NZ733157B2 - Agonistic tnf receptor binding agents - Google Patents
Agonistic tnf receptor binding agents Download PDFInfo
- Publication number
- NZ733157B2 NZ733157B2 NZ733157A NZ73315716A NZ733157B2 NZ 733157 B2 NZ733157 B2 NZ 733157B2 NZ 733157 A NZ733157 A NZ 733157A NZ 73315716 A NZ73315716 A NZ 73315716A NZ 733157 B2 NZ733157 B2 NZ 733157B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- xis
- anins
- antibody
- cdrs
- amino acid
- Prior art date
Links
- 239000011230 binding agent Substances 0.000 title claims abstract description 346
- 230000001270 agonistic Effects 0.000 title claims description 32
- 102000003298 Tumor Necrosis Factor Receptors Human genes 0.000 title description 12
- 108060008683 Tumor Necrosis Factor Receptors Proteins 0.000 title description 12
- 230000027455 binding Effects 0.000 claims abstract description 147
- 238000009739 binding Methods 0.000 claims abstract description 139
- 101710040446 CD40 Proteins 0.000 claims abstract description 56
- 102100013137 CD40 Human genes 0.000 claims abstract description 56
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 26
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 26
- 101710040535 TNFRSF9 Proteins 0.000 claims abstract description 18
- 102100009537 TNFRSF9 Human genes 0.000 claims abstract description 18
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 14
- 102000004965 antibodies Human genes 0.000 claims description 554
- 108090001123 antibodies Proteins 0.000 claims description 554
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 330
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 70
- 239000003795 chemical substances by application Substances 0.000 claims description 54
- 150000001413 amino acids Chemical class 0.000 claims description 45
- 241000282414 Homo sapiens Species 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 20
- 229940035295 Ting Drugs 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 6
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000000546 pharmaceutic aid Substances 0.000 claims description 2
- 108020003175 receptors Proteins 0.000 abstract description 70
- 210000004027 cells Anatomy 0.000 description 140
- 101700056583 CD27 Proteins 0.000 description 70
- 102100019459 CD27 Human genes 0.000 description 70
- 102000005962 receptors Human genes 0.000 description 68
- 235000001014 amino acid Nutrition 0.000 description 49
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 42
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 description 42
- 230000004913 activation Effects 0.000 description 34
- 201000010099 disease Diseases 0.000 description 33
- KISFEBPWFCGRGN-UHFFFAOYSA-M sodium;2-(2,4-dichlorophenoxy)ethyl sulfate Chemical compound [Na+].[O-]S(=O)(=O)OCCOC1=CC=C(Cl)C=C1Cl KISFEBPWFCGRGN-UHFFFAOYSA-M 0.000 description 33
- 239000000427 antigen Substances 0.000 description 28
- 102000038129 antigens Human genes 0.000 description 26
- 108091007172 antigens Proteins 0.000 description 26
- 238000004166 bioassay Methods 0.000 description 26
- 230000000694 effects Effects 0.000 description 26
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 24
- 108010071919 Bispecific Antibodies Proteins 0.000 description 22
- 201000011510 cancer Diseases 0.000 description 22
- 125000005647 linker group Chemical group 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 21
- 239000005089 Luciferase Substances 0.000 description 20
- 108060001084 Luciferase family Proteins 0.000 description 20
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 20
- 102000018358 Immunoglobulins Human genes 0.000 description 19
- 108060003951 Immunoglobulins Proteins 0.000 description 19
- 102100012634 RAD51B Human genes 0.000 description 18
- 101710002981 RAD51B Proteins 0.000 description 18
- 230000000875 corresponding Effects 0.000 description 18
- 101700026010 AB27 Proteins 0.000 description 16
- 230000014509 gene expression Effects 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 15
- 239000002773 nucleotide Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 13
- 230000001413 cellular Effects 0.000 description 12
- 102100001188 RAD1 Human genes 0.000 description 11
- 108060006872 RAD1 Proteins 0.000 description 11
- 210000001744 T-Lymphocytes Anatomy 0.000 description 11
- 210000003719 B-Lymphocytes Anatomy 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 10
- 239000000969 carrier Substances 0.000 description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 210000000612 Antigen-Presenting Cells Anatomy 0.000 description 9
- 108090001007 Interleukin-8 Proteins 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- 210000001519 tissues Anatomy 0.000 description 9
- 206010003816 Autoimmune disease Diseases 0.000 description 8
- 206010027476 Metastasis Diseases 0.000 description 8
- -1 TNFRI Proteins 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 201000009910 diseases by infectious agent Diseases 0.000 description 8
- 239000003446 ligand Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000035693 Fab Effects 0.000 description 7
- 210000000987 Immune System Anatomy 0.000 description 7
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 6
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 6
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 230000004075 alteration Effects 0.000 description 6
- 108010045030 monoclonal antibodies Proteins 0.000 description 6
- 102000005614 monoclonal antibodies Human genes 0.000 description 6
- 238000000159 protein binding assay Methods 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 235000004400 serine Nutrition 0.000 description 6
- 206010059512 Apoptosis Diseases 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- 108020004999 Messenger RNA Proteins 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 231100000599 cytotoxic agent Toxicity 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000002825 functional assay Methods 0.000 description 5
- 200000000018 inflammatory disease Diseases 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 229920002106 messenger RNA Polymers 0.000 description 5
- 229960000060 monoclonal antibodies Drugs 0.000 description 5
- 210000000056 organs Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000001225 therapeutic Effects 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 210000004369 Blood Anatomy 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 102100008795 NGFR Human genes 0.000 description 4
- 102100003107 TNFRSF25 Human genes 0.000 description 4
- 101710038569 TNFRSF25 Proteins 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- 241000209149 Zea Species 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000001580 bacterial Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 235000005824 corn Nutrition 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N ADRIAMYCIN Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 3
- 241000283725 Bos Species 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 210000004443 Dendritic Cells Anatomy 0.000 description 3
- 206010012601 Diabetes mellitus Diseases 0.000 description 3
- 229960004679 Doxorubicin Drugs 0.000 description 3
- 101700079540 FAS Proteins 0.000 description 3
- 230000036499 Half live Effects 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 206010025135 Lupus erythematosus Diseases 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 102000007312 Recombinant Proteins Human genes 0.000 description 3
- 108010033725 Recombinant Proteins Proteins 0.000 description 3
- 108010070144 Single-Chain Antibodies Proteins 0.000 description 3
- 102000005632 Single-Chain Antibodies Human genes 0.000 description 3
- 101710040448 TNFRSF4 Proteins 0.000 description 3
- 102100013135 TNFRSF4 Human genes 0.000 description 3
- 206010052779 Transplant rejections Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000003213 activating Effects 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 230000020411 cell activation Effects 0.000 description 3
- 108091006028 chimera Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000139 costimulatory Effects 0.000 description 3
- 239000002254 cytotoxic agent Substances 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037240 fusion proteins Human genes 0.000 description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000004068 intracellular signaling Effects 0.000 description 3
- 210000004962 mammalian cells Anatomy 0.000 description 3
- 239000002609 media Substances 0.000 description 3
- 201000006417 multiple sclerosis Diseases 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 125000002652 ribonucleotide group Chemical group 0.000 description 3
- 125000003616 serine group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 3
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-N-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-N,1-N-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 2
- 101700027111 3SA0 Proteins 0.000 description 2
- 101710027066 ALB Proteins 0.000 description 2
- 108009000433 Amyotrophic lateral sclerosis (ALS) Proteins 0.000 description 2
- 241000083586 Aylostera eos Species 0.000 description 2
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 description 2
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 description 2
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Belustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 2
- 210000004556 Brain Anatomy 0.000 description 2
- 102100005830 CD70 Human genes 0.000 description 2
- JCKYGMPEJWAADB-UHFFFAOYSA-N Chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 2
- 229960004630 Chlorambucil Drugs 0.000 description 2
- 229920001405 Coding region Polymers 0.000 description 2
- 206010009839 Coeliac disease Diseases 0.000 description 2
- 206010009887 Colitis Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 206010011401 Crohn's disease Diseases 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 229960004397 Cyclophosphamide Drugs 0.000 description 2
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 2
- STQGQHZAVUOBTE-VGBVRHCVSA-N DAUNOMYCIN Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 2
- 101710008039 DR3R Proteins 0.000 description 2
- 229960000975 Daunorubicin Drugs 0.000 description 2
- 102000010170 Death domain Human genes 0.000 description 2
- 108050001718 Death domain Proteins 0.000 description 2
- 101710038596 EDA2R Proteins 0.000 description 2
- 102100013113 EDA2R Human genes 0.000 description 2
- 101700058454 EDAR Proteins 0.000 description 2
- 102100011199 EDAR Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102100016439 FAS Human genes 0.000 description 2
- 208000007475 Hemolytic Anemia Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 102000015434 Humanized Monoclonal Antibodies Human genes 0.000 description 2
- 108010064750 Humanized Monoclonal Antibodies Proteins 0.000 description 2
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 101710040442 LTBR Proteins 0.000 description 2
- 102100013136 LTBR Human genes 0.000 description 2
- 208000007764 Legionnaires' Disease Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 2
- 206010061289 Metastatic neoplasm Diseases 0.000 description 2
- CFCUWKMKBJTWLW-BKHRDMLASA-N Mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 2
- 229960004857 Mitomycin Drugs 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 101710038602 NGFR Proteins 0.000 description 2
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 2
- 206010053643 Neurodegenerative disease Diseases 0.000 description 2
- 229920001850 Nucleic acid sequence Polymers 0.000 description 2
- 206010061536 Parkinson's disease Diseases 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 229960003171 Plicamycin Drugs 0.000 description 2
- 102000018795 RELT Human genes 0.000 description 2
- 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 2
- 102000010498 Receptor Activator of Nuclear Factor-kappa B Human genes 0.000 description 2
- 229920001914 Ribonucleotide Polymers 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 108091008153 T cell receptors Proteins 0.000 description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
- 101710030970 TNFRSF10B Proteins 0.000 description 2
- 102100012980 TNFRSF10B Human genes 0.000 description 2
- 101710030969 TNFRSF10C Proteins 0.000 description 2
- 102100012977 TNFRSF10C Human genes 0.000 description 2
- 101710030968 TNFRSF10D Proteins 0.000 description 2
- 102100011904 TNFRSF10D Human genes 0.000 description 2
- 101710030909 TNFRSF13B Proteins 0.000 description 2
- 102100009744 TNFRSF13B Human genes 0.000 description 2
- 101710030862 TNFRSF13C Proteins 0.000 description 2
- 102100009743 TNFRSF13C Human genes 0.000 description 2
- 102100008790 TNFRSF14 Human genes 0.000 description 2
- 101710038603 TNFRSF18 Proteins 0.000 description 2
- 102100003096 TNFRSF18 Human genes 0.000 description 2
- 101710038571 TNFRSF19 Proteins 0.000 description 2
- 102100003097 TNFRSF19 Human genes 0.000 description 2
- 101710008042 TNFRSF21 Proteins 0.000 description 2
- 101710022317 TNFRSF6B Proteins 0.000 description 2
- 102100009560 TNFRSF6B Human genes 0.000 description 2
- 101710040533 TNFRSF8 Proteins 0.000 description 2
- 102100009538 TNFRSF8 Human genes 0.000 description 2
- 102100011846 TNFSF4 Human genes 0.000 description 2
- 229940094937 Thioredoxin Drugs 0.000 description 2
- 206010043778 Thyroiditis Diseases 0.000 description 2
- 229960003048 Vinblastine Drugs 0.000 description 2
- HOFQVRTUGATRFI-XQKSVPLYSA-N Vinblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 HOFQVRTUGATRFI-XQKSVPLYSA-N 0.000 description 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 2
- 229960004528 Vincristine Drugs 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 2
- 230000007961 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Effects 0.000 description 2
- 230000005164 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Effects 0.000 description 2
- 230000000890 antigenic Effects 0.000 description 2
- 201000009030 carcinoma Diseases 0.000 description 2
- 102000021408 chitin binding proteins Human genes 0.000 description 2
- 108091010307 chitin binding proteins Proteins 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 229960004316 cisplatin Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 101700067609 ctx Proteins 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 230000001472 cytotoxic Effects 0.000 description 2
- 239000002619 cytotoxin Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N dilactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000002068 genetic Effects 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229940050526 hydroxyethylstarch Drugs 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000001861 immunosuppresant Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002503 metabolic Effects 0.000 description 2
- 230000001394 metastastic Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 description 2
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 201000003176 severe acute respiratory syndrome Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 102000002933 thioredoxin family Human genes 0.000 description 2
- 108060008226 thioredoxin family Proteins 0.000 description 2
- 230000035916 transactivation Effects 0.000 description 2
- LXZZYRPGZAFOLE-UHFFFAOYSA-L transplatin Chemical compound [H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H] LXZZYRPGZAFOLE-UHFFFAOYSA-L 0.000 description 2
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 2
- 230000003612 virological Effects 0.000 description 2
- OMJKFYKNWZZKTK-UXBLZVDNSA-N (5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide Chemical compound CN(C)N\N=C1\N=CN=C1C(N)=O OMJKFYKNWZZKTK-UXBLZVDNSA-N 0.000 description 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N 1,4-Butanediol, dimethanesulfonate Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 102100001249 ALB Human genes 0.000 description 1
- 229940100198 ALKYLATING AGENTS Drugs 0.000 description 1
- 229940100197 ANTIMETABOLITES Drugs 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 description 1
- 208000000230 African Trypanosomiasis Diseases 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 206010001897 Alzheimer's disease Diseases 0.000 description 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N Amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 206010002556 Ankylosing spondylitis Diseases 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003246 Arthritis Diseases 0.000 description 1
- 229960001230 Asparagine Drugs 0.000 description 1
- 229940009098 Aspartate Drugs 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 208000005783 Autoimmune Thyroiditis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 210000002469 Basement Membrane Anatomy 0.000 description 1
- 229960000686 Benzalkonium Chloride Drugs 0.000 description 1
- 241000335423 Blastomyces Species 0.000 description 1
- 229960001561 Bleomycin Drugs 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 102100003755 CCNO Human genes 0.000 description 1
- 101700047412 CCNO Proteins 0.000 description 1
- 108010046080 CD27 Ligand Proteins 0.000 description 1
- 108010029697 CD40 Ligand Proteins 0.000 description 1
- 102100003729 CD40LG Human genes 0.000 description 1
- 101700017377 CD70 Proteins 0.000 description 1
- 102100006400 CSF2 Human genes 0.000 description 1
- 229940095731 Candida albicans Drugs 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007554 Cardiac failure Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N Chlormethine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- OSASVXMJTNOKOY-UHFFFAOYSA-N Chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 1
- 229960004926 Chlorobutanol Drugs 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 210000004507 Chromosomes, Artificial Anatomy 0.000 description 1
- 210000004436 Chromosomes, Artificial, Bacterial Anatomy 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 241000223205 Coccidioides immitis Species 0.000 description 1
- IAKHMKGGTNLKSZ-INIZCTEOSA-N Colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- 229920002676 Complementary DNA Polymers 0.000 description 1
- 210000002808 Connective Tissue Anatomy 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 241000699679 Cricetulus migratorius Species 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 206010011777 Cystinosis Diseases 0.000 description 1
- 210000000172 Cytosol Anatomy 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N DL-aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 229960000640 Dactinomycin Drugs 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 206010013023 Diphtheria Diseases 0.000 description 1
- 230000036947 Dissociation constant Effects 0.000 description 1
- 101700057458 Drice Proteins 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000033147 ERVK-25 Human genes 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N Emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 229940088598 Enzyme Drugs 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N Ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005420 Etoposide Drugs 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N Etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 210000002744 Extracellular Matrix Anatomy 0.000 description 1
- 230000036809 Fabs Effects 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 206010017604 Galactosaemia Diseases 0.000 description 1
- 206010017758 Gastric cancer Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 229940065521 Glucocorticoid inhalants for obstructive airway disease Drugs 0.000 description 1
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000001786 Gonorrhea Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- IUAYMJGZBVDSGL-UHFFFAOYSA-N Gramicidin Chemical compound N1C(=O)C(CC(C)C)NC(=O)C(CCCN)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(CC=2C=CC=CC=2)NC(=O)C(CC(C)C)NC(=O)C(CCCN)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C1CC1=CC=CC=C1 IUAYMJGZBVDSGL-UHFFFAOYSA-N 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 201000004779 Graves' disease Diseases 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 206010019280 Heart failure Diseases 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 210000003958 Hematopoietic Stem Cells Anatomy 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 208000007514 Herpes Zoster Diseases 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 240000006600 Humulus lupulus Species 0.000 description 1
- 201000001971 Huntington's disease Diseases 0.000 description 1
- 210000004408 Hybridomas Anatomy 0.000 description 1
- 241000282619 Hylobates lar Species 0.000 description 1
- 206010062060 Hyperlipidaemia Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010021024 Hypolipidaemia Diseases 0.000 description 1
- 208000003532 Hypothyroidism Diseases 0.000 description 1
- ZCYVEMRRCGMTRW-RNFDNDRNSA-N I-131 Chemical compound [131I] ZCYVEMRRCGMTRW-RNFDNDRNSA-N 0.000 description 1
- 229940072221 IMMUNOGLOBULINS Drugs 0.000 description 1
- 229960000310 ISOLEUCINE Drugs 0.000 description 1
- 108010004484 Immunotoxins Proteins 0.000 description 1
- 229940055742 Indium-111 Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 206010061255 Ischaemia Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 229920001320 Leader sequence (mRNA) Polymers 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 241000222722 Leishmania <genus> Species 0.000 description 1
- 208000004554 Leishmaniasis Diseases 0.000 description 1
- 206010024324 Leukaemias Diseases 0.000 description 1
- 210000001165 Lymph Nodes Anatomy 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102100002306 MAP3K8 Human genes 0.000 description 1
- 101710039067 MAP3K8 Proteins 0.000 description 1
- 210000002540 Macrophages Anatomy 0.000 description 1
- 208000002780 Macular Degeneration Diseases 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 229960004961 Mechlorethamine Drugs 0.000 description 1
- 210000004379 Membranes Anatomy 0.000 description 1
- 210000002901 Mesenchymal Stem Cells Anatomy 0.000 description 1
- 208000008466 Metabolic Disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- VFKZTMPDYBFSTM-KVTDHHQDSA-N Mitobronitol Chemical compound BrC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CBr VFKZTMPDYBFSTM-KVTDHHQDSA-N 0.000 description 1
- 229960001156 Mitoxantrone Drugs 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N Mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000003627 Muscular Dystrophy Diseases 0.000 description 1
- 210000004126 Nerve Fibers Anatomy 0.000 description 1
- 208000009025 Nervous System Disease Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 206010029305 Neurological disorder Diseases 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 208000006660 Niemann-Pick Disease Diseases 0.000 description 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Nitrumon Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
- 210000001331 Nose Anatomy 0.000 description 1
- 108010042215 OX40 Ligand Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001452677 Ogataea methanolica Species 0.000 description 1
- 210000003463 Organelles Anatomy 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N PUROMYCIN Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 1
- 229950010131 PUROMYCIN Drugs 0.000 description 1
- 229960001592 Paclitaxel Drugs 0.000 description 1
- 208000008443 Pancreatic Carcinoma Diseases 0.000 description 1
- 229940049954 Penicillin Drugs 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 229940072417 Peroxidase Drugs 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108090000437 Peroxidases Proteins 0.000 description 1
- 210000003800 Pharynx Anatomy 0.000 description 1
- 229960005190 Phenylalanine Drugs 0.000 description 1
- 206010035718 Pneumonia legionella Diseases 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N Procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N Proprasylyt Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 239000007759 RPMI Media 1640 Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 229940081969 Saccharomyces cerevisiae Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010039447 Salmonellosis Diseases 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 1
- 210000000278 Spinal Cord Anatomy 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 229960005322 Streptomycin Drugs 0.000 description 1
- 229960001052 Streptozocin Drugs 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N Streptozotocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010042602 Supraventricular extrasystoles Diseases 0.000 description 1
- 229940037128 Systemic Glucocorticoids Drugs 0.000 description 1
- 101710038600 TNFRSF12A Proteins 0.000 description 1
- 102100008791 TNFRSF12A Human genes 0.000 description 1
- 101710038524 TNFRSF1B Proteins 0.000 description 1
- 102100003105 TNFRSF1B Human genes 0.000 description 1
- 101710038599 TNFRSF21 Proteins 0.000 description 1
- 101710025695 TNFSF4 Proteins 0.000 description 1
- 108060008443 TPPP Proteins 0.000 description 1
- 229960001278 Teniposide Drugs 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 229940033663 Thimerosal Drugs 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L Thiomersal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229920000401 Three prime untranslated region Polymers 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 208000001756 Virus Disease Diseases 0.000 description 1
- 101710019504 XAB2 Proteins 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Xylocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002730 additional Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 201000005188 adrenal gland cancer Diseases 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 201000001320 atherosclerosis Diseases 0.000 description 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 description 1
- 229960000626 benzylpenicillin Drugs 0.000 description 1
- 102000024070 binding proteins Human genes 0.000 description 1
- 108091007650 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229960005243 carmustine Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000006082 chickenpox Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 201000003963 colon carcinoma Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 201000011231 colorectal cancer Diseases 0.000 description 1
- 201000009230 common cold Diseases 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001268 conjugating Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 201000007336 cryptococcosis Diseases 0.000 description 1
- GBOGMAARMMDZGR-TYHYBEHESA-N cytochalasin B Chemical compound C([C@H]1[C@@H]2[C@@H](C([C@@H](O)[C@@H]3/C=C/C[C@H](C)CCC[C@@H](O)/C=C/C(=O)O[C@@]23C(=O)N1)=C)C)C1=CC=CC=C1 GBOGMAARMMDZGR-TYHYBEHESA-N 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 201000004624 dermatitis Diseases 0.000 description 1
- 231100000406 dermatitis Toxicity 0.000 description 1
- 230000001627 detrimental Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960002694 emetine Drugs 0.000 description 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000003511 endothelial Effects 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000003260 fluorescence intensity Methods 0.000 description 1
- 108091006031 fluorescent proteins Proteins 0.000 description 1
- 102000034387 fluorescent proteins Human genes 0.000 description 1
- 101700068417 fol1 Proteins 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 230000002538 fungal Effects 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 150000002337 glycosamines Chemical group 0.000 description 1
- 239000001963 growth media Substances 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 201000010238 heart disease Diseases 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002008 hemorrhagic Effects 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 239000002596 immunotoxin Substances 0.000 description 1
- APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 1
- 230000002458 infectious Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 230000003834 intracellular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 229960002247 lomustine Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 201000010453 lymph node cancer Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000003278 mimic Effects 0.000 description 1
- 229960005485 mitobronitol Drugs 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent Effects 0.000 description 1
- 201000011252 phenylketonuria Diseases 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920003258 poly(methylsilmethylene) Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000023 polynucleotide Polymers 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 201000004681 psoriasis Diseases 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 230000002799 radiopharmaceutical Effects 0.000 description 1
- 230000001690 radiotoxic Effects 0.000 description 1
- 231100000336 radiotoxic Toxicity 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 230000000268 renotropic Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000003248 secreting Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000002612 sleeping sickness Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000003444 succinic acids Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 229930003347 taxol Natural products 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 230000002103 transcriptional Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 230000001052 transient Effects 0.000 description 1
- 102000035402 transmembrane proteins Human genes 0.000 description 1
- 108091005683 transmembrane proteins Proteins 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cells Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- VWQVUPCCIRVNHF-OUBTZVSYSA-N yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Abstract
The present invention relates to binding agents capable of binding to receptors of the TNF superfamily. In particular, binding agents capable of binding to CD40 and 4-1BB (CD137)receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits. id molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
Description
Agonistic TNF receptor binding agents
cal Field of the Invention
The present invention relates to binding agents g to receptors of the TNF superfamily, in '
particular binding agents binding to at least two different ors of the TNF superfamily, as
well as to their use in medicine. The present invention further relates to nucleic acid molecules
encoding such binding agents, to cells comprising such nucleic acid molecules and to
pharmaceutical compositions and kits.
Background of the ion
Receptors for tumor necrosis factor (TNF) superfamily ligands are oligomeric, mostly ic,
type I or type ill transmembrane proteins and contain one to six cysteine-rich domains (CRDs) in
their extracellular domain (Naismith J.H. and Sprang SR. (1998), TRENDS in Biochemical
Sciences 23(2):74—79). Moreover, several receptors for TNF superfamily ligands contain death
domains (DDs) that recruit caspase-interacting proteins following ligand binding to initiate the
extrinsic pathway of caspase activation.
us receptors of the TNF superfamily have been identified so far, including 4—1BB
(CD137), BAFFR, BCMA, CD27, CD30, CD40, DCR3, DR3 (TRAMP), DR6, EDAR, Fas
(CD95), FN14 (TWEAK-R), GITR, HVEM, LTBR, NGFR (CD271), OPG, 0X40 (CD134),
RANK (TRANCE-R), RELT, TACI, TNFR], TNFRZ, R1, TRAIL-R2, TRAIL-R3,
TRAIL-R4, TROY and XEDAR (Bodmer, J.L. et a1. (2002), TRENDS in Biochemical Sciences,
27(1):19-26).
h timely sion and intricate signaling, receptors of the TNF superfamily and their
corresponding ligands act to regulate cell responses, including activation, proliferation,
differentiation, and apoptosis. While critical to the regulation of beneficial processes, such as
immune defense and hematopoiesis, TNF signaling is also implicated in genesis,
transplant ion, virus replication, bone resorption, diabetes and autoimmune diseases.
W0 2016/110584
tic agents specifically binding to one or more receptors of the TNF amily are,
therefore, considered as potential therapeutics in the prevention and/or ent of s
diseases and disorders.
Accordingly, it was an object of the present invention to provide novel agonistic binding agents
targeting ors of the TNF superfarnily, in particular agonistic binding agents targeting at
least two different receptors of the TNF superfarnily.
Summary of the Invention
In one aspect, the present invention relates to a binding agent comprising at least two binding
s, wherein a first binding domain binds to a first or of the tumor necrosis factor
(TNF) amily and a second binding domain binds to a second or of the TNF
superfamily, wherein the first receptor and the second receptor are different.
In one embodiment, the binding agent is an agonistic binding agent.
In one embodiment, the binding agent is a bispecific molecule, preferably a bispecific antibody.
In one ment, the binding agent is in the format of a full-length antibody or an antibody
fragment.
In one embodiment, the first receptor and the second receptor are selected from the group
consisting of CD40, CD27, 0X40 (CD134) and 4-1BB (CD137).
In one embodiment, the first binding domain or the second binding domain binds to CD27,
wherein the binding agent comprises
(a) the heavy chain complementarity determining region(s) HCDRl, HCDRZ and/or
HCDR3, and/or
the light chain complementarity determining region(s) LCDRI, LCDRZ and/or LCDR3
of an antibody selected from the group consisting of ABZ7_1 to AB27_186 as shown in
Table 7; and/or
(b) the heavy chain variable domain (VH) or a variant or fragment thereof and/or the light
chain variable domain (VL) or a variant or fragment thereof
W0 20161110584
of an antibody selected from the group consisting of AB27_1 to AB27_186
as shown in
Table 7.
In one embodiment, the first binding domain or the second binding domain binds to 0X40
(CD134), wherein the binding agent comprises
(a) the heavy chain complementarity determining region(s) HCDRI, HCDR2 and/0r
HCDR3, and/or
the light chain complementarity determining region(s) LCDRl, LCDR2 and/or LCDR3
of an antibody selected from the group ting of AB134_1 to AB134_92 as shown in
Table 8; and/or
(b) the heavy chain variable domain (VH) or a variant or fragment thereof and/or the light
chain variable domain (VL) or a variant or fragment thereof
of an antibody selected from the group consisting of AB134__1 to AB} 34_92 as shown in
Table 8.
In one embodiment, the first binding domain or the second binding domain binds to 4-1BB
(CD137), n the binding agent comprises
(a) the heavy chain complementarity determining region(s) HCDRl, HCDR2 and/or
HCDR3, and/or
the light chain complementarity determining region(s) LCDRl
, LCDR2 and/or LCDR3
of an antibody selected from the group ting of AB137_1 to AB137_12 as shown in
Table 9; and/or
(b) the heavy chain le domain (VH) or a variant or fragment thereof and/or the light
chain variable domain (VL) or a t or fragment thereof
of an antibody selected from the group consisting of AB137_1 to ABl37_12 as showu in
Table 9.
In one embodiment, the first g domain or the second binding domain binds to CD40,
wherein the binding agent comprises
(a) heavy chain complementarity determining region(s) HCDRI having the amino acid
sequence of SEQ ID NO: 2323, HCDRZ having the amino acid sequence of SEQ ID NO:
2324 and/or HCDR3 having the amino acid sequence of SEQ ID NO: 2325, and/or
light chain mentarity determining region(s) LCDRl having the amino acid “
sequence of SEQ ID NO: 2326, LCDR2 having the amino acid ce of SEQ ID NO:
2327 and/or LCDR3 having the amino acid sequence of SEQ ID NO: 2328; and/or
W0 2016/110584
(b) heavy chain variable domain (VH) having the amino acid sequence of SEQ ID NO: 2321
or a variant or fragment thereof and/or light chain variable domain (VL) having the
amino acid sequence of SEQ ID NO: 2322 or a variant or fragment f.
In one embodiment,
(a) the first binding domain binds to CD40 and the second binding domain binds to CD27;
(b) the first binding domain binds to CD40 and the second binding domain binds to 0X40
(CD134);
(c) the first binding domain binds to CD40 and the second binding domain binds to 4-lBB
(CD137);
(d) the first binding dcrnm'n binds to 4-1 BB (C0137) and the second binding domain binds to
CD27;
(e) the first binding domain binds to 4-1BB (CD137) and the second binding domain binds to
0X40 ); or
(t) the first binding domain binds to 0X40 (CD134) and the second binding domain binds to
CD27.
In one ment, the binding agent comprises one or more heavy chain constant domains of
an immunoglobulin and/or light chain constant domains ofan immunoglobulin.
In another , the present invention relates to a binding agent that binds to CD27, sing
(a) the heavy chain complementarity determining (s) HCDRl, HCDR2 and/0r
HCDR3, and/or
the light chain mentarity determining region(s) LCDRI , LCDR2 and/or LCDR3
of an antibody selected from the group consisting of AB27_1 to AB27m186-as shown in
Table 7; and/or
(b) the heavy chain variable domain (VH) or a variant or fragment thereof and/or the light
chain variable domain (VL) or a variant or fragment thereof
of an antibody ed from the group consisting of AB27_1 to ABZ7_186 as shown in
Table 7.
In another aspect, the present invention relates to a binding agent that binds to 0X40 (CD134),
comprising
(a) the heavy chain complementarity determining region(s) HCDRl, HCDR2 and/or
HCDR3, and/or
W0 20161110584
the light chain complementarity determining region(s) LCDRI, LCDRZ and/or LCDR3
of an antibody selected from the group consisting of AB134_1 to ABI34_92
as shown in
Table 8; and/or
(13) the heavy chain le domain (VH) or a variant or fragment thereof and/or the light
chain variable domain (VL) or a variant or fragment thereof
of an antibody selected from the group consisting of ABI34_1 to ABI34_92
as shown in
Table 8.
In another aspect, the present invention relates to a binding agent that binds to 4-1BB ),
comprising
(a) the heavy chain complementarity ining region(s) HCDRI, HCDR2 and/0r
HCDR3, and/or
the light chain complementarity determining region(s) LCDRl, LCDR2 and/
or LCDR3
of an antibody selected from the group consisting of ABl37gl to AB137_l2
as shown in
Table 9; and/or
(b) the heavy chain variable domain (VH) or a t or fragment thereof and/or the light
chain variable domain (VL) or a variant or fragment thereof
of an antibody selected from the group consisting of ABI37_1 to AB137_12
as shown in
Table 9.
In one embodiment, the binding agent is an agonistic binding agent.
In one embodiment, the binding agent is in the format of a flail-length antibody
or an antibody
fragment.
In one embodiment, the binding agent comprises one or more heavy chain
constant s of
an immunoglobulin and/or light chain nt domains of an immunoglobulin.
In another , the present invention relates to a binding agent g to the
same epitope(s)
as a binding agent as defined above.
In another aspect, the present invention relates to a c acid molecule encoding
a binding
agent as defined above, wherein, preferably, the nucleic acid molecule is contained in a vector.
W0 2016/110584
In another aspect, the t invention relates to a cell comprising a nucleic acid molecule as
defined above.
Ln another , the present invention relates to a ceutical composition comprising, as
an active agent, a binding agent as defined above, a nucleic acid le as defined above, or a
cell as defined above.
In one ment, the pharmaceutical composition further comprises a pharmaceutically
acceptable carrier and/or excipient.
In another aspect, the present invention relates to a kit comprising a binding agent as defined
above, a nucleic acid molecule as defined above, a cell as defined above, or a pharmaceutical
composition as defined above.
In another aspect, the present invention relates to a binding agent as defined above, a nucleic
acid molecule as defined above, a cell as defined above, or a pharmaceutical composition as
defined above for use as a medicament.
In r aspect, the present invention relates to a binding agent as defined above, a nucleic
acid molecule as defined above, a cell as defined above, or a pharmaceutical composition as
defined above for use in the treatment of a disease selected from the group consisting of ,
infectious diseases, inflammatory diseases, metabolic diseases, autoimmune disorders,
degenerative diseases, apoptosis—associated diseases and transplant rejections.
Brief Description of the Figures
Figure 1 shows g curves of reference antibodies against CD27, CD134 and CD137 to the
respective recombinant protein, as determined by enzyme-linked irnmunosorbent assay (ELISA).
Figure 2 shows the expression of CD27, CD134 and CD137 on the cell surface of HT1080 cell
lines overexpressing CD27, CD134 and CD137, respectively, as determined by fluorescence-
activated cell sorting (FACS).
W0 2016/110584
Figure 3 shows binding curves of reference antibodies against CD27, CD134 and CD137 to
CD27, CD134 and CD137 expressed on the cell surface of corresponding HT1080 cell lines, as
determined by a cellular binding assay.
Figure 4 shows the activation curve of an tic anti-CD27 nce antibody with or
without cross-linking, as determined by ELISA measuring the IL-8 concentration in the
supernatants of CD27-overexpressing HT1080 cells.
Figure 5 shows exemplary activation curves of agonistic anti-CD27, anti-CD134 and anti-
CD137 dies under cross-linking conditions, as determined by ELISA measuring the IL-8
concentration in the supernatants of target-overexpressing HT1080 cells.
Figure 6 shows the expression of CD27, CD40, CD134 and CD137 on the cell surface of stable
transfectants of HEK293_NFngfp_luc cells (A) and of stable transfectants of K562 cells (B)
overexpressing CD 7, CD40, CD134 and CD137, respectively, as determined by FACS (white
curves: control without antibody; grey curves: antibody ng).
Figure 7 shows the is of two examples (A and B) of a bispecific dy simultaneously
targeting CD40 and CD137 (CD137xCD40). Activation of CD137 was measured by luciferase
activity (relative light units, RLU) of HEK293mNFK_CD137_ _luc upon incubation with
ted bispecific antibodies and D40 for trans-presentation or K562_wt for control.
Activation of CD40 was measured by luciferase activity (RLU) of
HEK293_NFK_CD40_ fp_luc upon incubation with indicated bispecific antibodies and
K562_CD137 for trans-presentation or t for control. The two parental monospecific,
bivalent antibodies (CD137 IgGl or CD40 IgG1) and (ii) the two monovalent antibodies with
one irrelevant arm (CD137 x control, CD40 x control) served as controls for the bispecific
CD137xCD40 antibodies. Only bispecific CD137xCD4O antibodies resulted in activation of
CD137 and CD40 upon trans-presentation by CD40 and CD137, respectively. Used
sequences of
variable domains of anti-CD137 and anti-CD40 antibodies are fied by the abbreviation
AB137 and AB40, respectively.
Figure 8 shows the analysis of a bispecific antibody aneously targeting CD40 and CD27
(CD27xCD40). Activation of CD27 was measured by luciferase activity (RLU) of
HEK293_NFK_CD27Mgfp_1uc upon incubation with the indicated bispecific antibody and
K562_CD40 for presentation or K562_wt for control. Activation of CD40 was measured
W0 10584
by rase activity (RLU) of HEK293_NFK_CD40_gfp_luc upon incubation with the
indicated bispecific antibody and K562_CD27 for trans-presentation or t for control.
The two parental monospecific, bivalent antibodies (CD27 lgGl or CD40 IgG1) and (ii) the two
monovalent dies with one irrelevant arrn (C027 x control, CD40 x control) served as
controls for the bispecific CD27xCD4O antibody. The bispecific CD27xCD40 antibody resulted
in superior activation of CD27 and CD40 upon trans-presentation by CD40 and CD27,
respectively. Used sequences of variable domains of anti-CD27 and anti-CD40 antibodies are
identified by the abbreviation AB27 and AB40, respectively.
Figure 9 shows the analysis of two examples (A and B) of a bispecific antibody aneously
targeting CD40 and CD134 (CD134xCD40). Activation of CD134 was measured by luciferase
activity (RLU) of _NFK_CD134_gfp_luc upon incubation with the indicated bispecific
antibodies and D40 for trans-presentation or K562_wt for l. Activation of CD40
was measured by luciferase activity (RLU) of HEK293_NFK_CD40_gfp_luc upon incubation
with antibodies and K562_CD134 for trans-presentation or K562_wt for control. The two
parental monospecific, bivalent antibodies (CD134 IgGl or CD40 IgG1) and (ii) the two
monovalent antibodies with one irrelevant arm (CD134 x control, CD40 x l) served as
controls for the bispecific CD134xCD40 antibodies. Bispecific CD134xCD40 antibodies
resulted in superior activation of CD134 and CD40 upon trans-presentation by CD40 and
CD134, respectively. Used sequences of variable domains of anti-CD134 and anti-CD40
antibodies are identified by the abbreviation AB134 and A840, respectively.
Figure 10 shows the expression of CD27, CD134 and CD137 on the cell surface of double
ectants of HEK293fiNFK_gfp_luc cells overexpressing CD27 + CD134
(HEK293wNFK_CD27_CD134_gfp__luc), CD134 + CD137
(HEK293_NFK_CD1 34_CD1 37_gfp_luc) and CD27 + CD137
(HEK293_NFK_CD27_CD137_gfp_luc), respectively, as determined by FACS (white curves:
control without antibody; grey curves: antibody staining).
Figure 11 shows the analysis of a bispecific antibody simultaneously targeting CD27 and
CD134 (CD134xCD27). Activation of CD27 and CD134 was ed by rase ty of
HEK293*NFK_CD27_CD134_gfp_1uc upon incubation with the indicated bispecific antibody;
maximum RLUs are shown. The two al monospecific, bivalent antibodies (CD134 IgGl or
CD27 IgG1) and (ii) the two monovalent antibodies with one irrelevant arm (CD134 x control,
CD27 x control) served as controls for the bispecific CD134XCD27 antibody. The bispecific
W0 10584
CD134xCD27 antibody resulted in superior activation of HEK293_NFK_CD27_CD134_gfp_luc
as compared to the four corresponding controls. Used sequences of variable domains of anti-
CD134 and anti-CD27 antibodies are identified by the abbreviation AB134 and AB27,
respectively.
Figure 12 shows the analysis of two es (A and B) of a ifie dy simultaneously
targeting CD134 and CD137 xCDl37). Activation of CD134 and CD137 was measured
by luciferase activity of HEK293_NFK__CD134_CD137_gfp_luc upon incubation with the
indicated bispecific antibodies; maximum RLUs are shown. The two parental ecific,
bivalent dies (CD134 IgGl or CD137 lgGl) and (ii) the two monovalent antibodies with
one irrelevant arm (CD134 x control, CD137 x control) served as controls for the bispecific
CD134xCDl37 antibodies. Bispecific CD134xCDl37 antibodies resulted in activation of
HEK293_NFK_CD134‘CD137wgfp_luc, whereas the four corresponding controls did not result
in measurable activation of the double transfectant. Used sequences of variable s of anti-
CD134 and anti-CD137 antibodies are identified by the abbreviation A8134 and A3137,
respectively.
Figure 13 shows the analysis oftwo examples (A and B) of a bispecific dy simultaneously
targeting CD27 and CD137 (CD137xCD27). Activation of CD27 and CD137 was measured by
luciferase activity of HEK293_NFK_CD27MCD137_gfp_luc
upon incubation with the indicated
ific antibodies; maximum RLUs are shown. The two parental ecific, bivalent
antibodies (CD137 IgGl or CD27 IgG1) and (ii) the two monovalent antibodies with one
irrelevant arm (CD137 x control, CD27 x control) served as controls for the bispecific
CD137xCD27 antibodies. Bispecific CD134xCD27 antibodies ed in superior activation of
HEK293_NFK_CD27_CD137_gfpflluc as compared to the two control antibodies with one
irrelevant arm. Used sequences of variable domains of anti-CD137 and anti-CD27 antibodies
identified by the abbreviation AB137 and AB27, respectively.
Detailed ntion of the Invention
Although the t invention is described in detail below, it is to be understood that this
invention is not limited to the particular methodologies, protocols and reagents described herein
as these may vary. It is also to be understood that the terminology used herein is for the
purpose
of describing particular embodiments only, and is not intended to limit the
scope of the present
invention which will be limited only by the appended claims. Unless defined otherwise, all
technical and scientific terms used herein have the same meanings as commonly understood by
one of ordinary skill in the art.
In the following, the ts of the present invention will be described. These elements are
listed with specific embodiments, however, it should be tood that they may be combined
in any manner and in any number to create additional embodiments. The variously described
es and preferred embodiments should not be construed to limit the present invention to
only the explicitly described embodiments. This ption should be understood to support and
encompass embodiments which combine the explicitly described embodiments with any number
of the disclosed and/or preferred elements. Furthermore, any permutations and combinations of
all described elements in this application should be considered sed by the description of the
present application unless the context indicates otherwise.
Preferably, the terms used herein are defined as described in “A multilingual ry of
biotechnological terms: (IUPAC Recommendations)”, H.G.W. erger, B. Nagel, and H.
Kblbl, Eds., Helvetica Chimica Acta, 0 Basel, Switzerland, (1995).
The practice of the present invention will employ, unless otherwise indicated, conventional
methods of try, biochemistry, cell biology, immunology, and recombinant DNA
techniques which are explained in the literature in the field (cf., e.g., lar Cloning: A
Laboratory Manual, 2nd Edition, J. Sambrook et al. eds, Cold Spring Harbor Laboratory Press,
Cold Spring Harbor 1989).
Throughout this specification and the claims which follow, unless the context requires otherwise,
the word “comprise”, and variations such as “comprises” and ”comprising”, will be understood
to imply the inclusion of a stated member, integer or step or group of members, integers or steps
but not the exclusion of any other member, integer or step or group ofmembers, integers or steps
although in some embodiments such other member, integer or step or group ofmembers, integers
or steps may be ed, i.e. the subject—matter consists in the inclusion of a stated member,
3O r or step or group of members, integers or steps. The tenns “a” and “an” and “the” and
similar reference used in the context of describing the invention (especially in the context of the
claims) are to be ued to cover both the singular and the plural, unless otherwise indicated
herein or clearly dicted by context. Recitation of ranges of values herein is merely
intended to serve as a shorthand method of referring individually to each separate value falling
within the range. Unless otherwise indicated herein, each dual value is incorporated into
the specification as if it were individually recited herein. All methods described herein can be
med in any suitable order unless otherwise indicated herein or otherwise clearly
contradicted by context. The use of any and all examples, or exemplary language (e.g., “such
as”), provided herein is intended merely to better illustrate the invention and does not pose a
tion on the scope of the invention otherwise d. No language in the specification
should be construed as indicating any non-claimed element ial to the practice of the
invention.
Several documents are cited throughout the text of this specification. Each of the nts
cited herein (including all patents, patent applications, scientific publications, manufacturer's
specifications, instructions, etc), whether supra or infra, are hereby incorporated by reference in
their entirety. Nothing herein is to be construed as an admission that the invention is not entitled
to antedate such sure by virtue ofprior invention.
The term tor of the TNF amily” preferably refers to a receptor selected from the
group consisting of 4-1BB (CD137), BAFFR, BCMA, CD27, CD30, CD40, DCR3, DR3
(TRAMP), DR6, EDAR, Pas (CD95), FNl4 (TWEAK-R), GITR, HVEM, LTBR, NGFR
(CD271), OPG, 0X40 (CD134), RANK (TRANCE-R), RELT, TACI, TNFRI, TNFR2, TRAIL-
R1, TRAIL-R2, TRAIL-R3, TRAIL—R4, TROY and XEDAR.
The term “receptor of the TNF superfamily”, as used herein, also includes variants of a given
or of the TNF superfamily.
The term “variant” according to the invention refers, in patticular, to mutants, splice variants,
conformation variants, ms, allelic variants, species variants and species gs, in
particular those which are naturally present. An allelic variant relates to an alteration in the
normal sequence of a gene, the significance of which is often unclear. Complete
gene sequencing
ofien identifies numerous allelic ts for a given gene. A species homolog is a nucleic acid or
amino acid sequence with a different species of origin from that of a given nucleic acid or amino
acid sequence. The term “variant” shall encompass any posttranslationally modified variants and
conformation variants.
According to the present invention, the first or and the second receptor of the TNF
superfamily are preferably selected from the group consisting of CD40, CD27, 0X40 (CD134)
and 4—1BB (CD137).
CD40, also referred to as tumor necrosis factor or superfamily member 5 FS), is
the receptor for the ligand TNFSFS/CD40L. CD40 is known to transduce TRAF6- and
MAP3K8-mediated signals that te ERK in macrophages and B-cells, leading to induction
of immunoglobulin secretion. In one embodiment, CD40 is human CD40, having UniProt
accession number P25942.
CD27, also referred to as TNFRSF7, is the receptor for the ligand CD70/CD27L. CD27 is
believed to play a role in survival of activated T cells and a role in sis through association
with SIVAl. In one embodiment, CD27 is human CD27, having UniProt accession number
P26842.
0X40 ), also referred to as TNFRSF4, is the receptor for the ligand
TNFSF4/OX40L/GP34. 0X40 (CD134) is a costimulatory molecule implicated in long-term T
cell immunity. In one embodiment, 0X40 (CD134) is human 0X40 (CD134), having UniProt
accession number P43489.
4-1BB (CD137), also referred to as TNFRSF9, is the receptor for the ligand /4-IBBL. 4-
lBB (CD137) is believed to be involved in T cell activation. In one embodiment, 4-lBB
(CD137) is human 4-lBB (CD137), having t accession number Q07011.
The term “binding domain” characterizes in connection with the present invention a structure,
e. g., of an antibody, which binds to/interacts with a given target structure/antigen/epitope. Thus,
the binding domain ing to the invention ates an “antigen-interaction site” or
“antigen-binding site”.
The term “antigen” relates to an agent such as a protein or peptide comprising an epitope against
which an immune response is directed and/or is to be directed.
The term “peptide” according to the invention comprises oligo- and polypeptides and refers to
substances sing two or more, preferably 3 or more, preferably 4 or more, preferably 6 or
more, preferably 8 or more, preferably 9 or more, preferably 10 or more, preferably 13 or more,
preferably 16 more, ably 21 or more and up to preferably 8, 10, 20, 30, 40 or 50, in
particular 100 amino acids joined covalently by peptide bonds. The term “protein” refers to large
peptides, preferably to peptides with more than 100 amino acid residues, but in l the terms
“peptides” and “proteins” are synonyms and are used interchangeably herein.
The term “epitope” refers to an antigenic determinant in a molecule, i.e., to the
part in a molecule
that is recognized by the immune system, for example, that is recognized by
an antibody. For
example, epitopes are the discrete, three-dimensional sites on an antigen, which are recognized
by the immune system. Epitopes usually consist of chemically active surface groupings of
molecules such as amino acids or sugar side chains and usually have specific three dimensional
structural teristics, as well as specific charge characteristics. Conformational and non-
Conformational epitopes are distinguished in that the binding to the former but not the latter is
lost in the ce of denaturing solvents. An epitope of a protein preferably comprises a
continuous or discontinuous portion of said protein and is preferably n 5 and 100,
preferably between 5 and 50, more ably between 8 and 30, most preferably between 10 and
amino acids in , for example, the epitope may be preferably 8, 9, 10, 11, 12, 13, 14, 15,
16, 17, 18, 19, 20, 21, 22, 23, 24, or 25 amino acids in length.
Mapping of epitopes recognized by binding agents can be med as described in detail in
"Epitope Mapping Protocols” (Methods in Molecular Biology) by Glenn E. Morris ISBN-
0896039 and in "Epitope Mapping: A Practical Approach" Practical Approach Series, 248
by Olwyn M. R. Westwood, Frank C. Hay.
The term “agonistic binding agen ”, as used herein, refers to a binding
agent, which activates the
receptor(s) of the TNF superfarnily it is binding to. In one embodiment, the binding agent
induces IL-8 release from and/or activates the NF-KB pathway in the ce11(s) expressing the
receptor(s) of the TNF superfamily it is g to. In one embodiment, the binding agent is a
activating binding agent, simultaneously activating receptors of the TNF amily, e.g.,
said first and second receptor, located on different cells, In another embodiment, the binding
agent is a cis-activating binding agent, simultaneously activating receptors of the TNF
superfamily, e.g., said first and second receptor, located on the same cell.
The term “binding” ing to the invention preferably relates to a c binding. A binding
agent, such as an antibody or fragment thereof, is specific for a predetermined target if it is
capable of binding to said predetermined target while it is not (substantially) capable of binding
to other targets.
According to the present invention, a binding agent, such as an antibody or fragment thereof, is
capable of binding to a predetermined target if it has a significant y for said predetermined
target and binds to said predetermined target in rd assays. “Affinity” or ng affinity”
W0 20161110584
is ofien measured by equilibrium dissociation constant (Kn). Preferably, the term “significant
affinity” refers to the binding to a predetermined target with a iation constant (Kn) of 10'5
M or lower, 106 M or lower, 10'7 M or lower, 10'3 M or lower, 10‘9M or lower, 10'10M or lower,
'll M or lower, or 10le or lower.
An agent is not (substantially) capable of binding to a target if it has no significant affinity for
said target and does not bind significantly, in particular does not bind detectably, to said target in
standard assays. Preferably, the agent does not detectably bind to said target if present in a
concentration of up to 2, preferably 10, more preferably 20, in particular 50 or 100 1.1ng or
higher. ably, an agent has no significant affinity for a target if it binds to said target with a
Kn that is at least 10-fold, loo-fold, 103-fold, 104-fold, lOS-fold, or lOG-fold higher than the K0
for binding to the predetermined target to which the agent is capable of binding. For example, if
the Kn for binding of an agent to the target to which the agent is capable of binding is 10'7 M, the
Kn for binding to a target for which the agent has no significant affinity would be at least 1045 M,
10-5 M, 104 M, 10-3 M, 10-2 M, or 10-1 M.
Binding of an agent to a target can be determined experimentally using any suitable method; see,
for example, Berzofsky et a1., "Antibody-Antigen Interactions" In Fundamental Immunology,
Paul, W. 13., Ed., Raven Press New York, N Y (1984), Kuby, Janis Immunology, W. H. Freeman
and Company New York, N Y (1992), and s described herein. ies may be readily
determined using conventional techniques, such as by equilibrium dialysis; by using the e
2000 instrument, using general procedures outlined by the manufacturer; by radioimmunoassay
using radiolabeled target antigen; or by another method known to the skilled artisan. The affinity
data may be analyzed, for example, by the method of Scatchard et al., Ann NY. Acad. ScL,
511660 (1949). The measured affinity of a particular antibody-antigen interaction can vary if
measured under different conditions, e.g., salt tration, pH. Thus, measurements of affinity
and other antigen-binding ters, e.g., K13, 1050, are preferably made with rdized
solutions of antibody and antigen, and a rdized buffer.
3O The term “antibody” refers to a glycoprotein comprising at least two heavy (H) chains and two
light (L) chains inter-connected by disulfide bonds. The term “antibody” includes monoclonal
antibodies, inant antibodies, human dies, humanized antibodies, chimeric
dies and combinations of any of the foregoing. Each heavy chain is sed of a heavy
chain variable region (VH) and a heavy chain constant region (CH). Each light chain is
comprised of a light chain variable region (VL) and a light chain constant region (CL). The
variable regions and constant regions are also referred to herein as variable domains and constant
domains, respectively. The VH and VL regions can be turther subdivided into regions of
ariability, termed complementarity determining regions (CDRs), interspersed with regions
that are more conserved, termed framework regions (FRs). Each VH and VL is composed of
three CDRs and four FRs, arranged from amino-terminus to carboxy—terminus in the following
order: FRl, CDRl, FR2, CDR2, FR3, CDR3, FR4. The CDRs of a VB are termed HCDRl,
HCDR2 and HCDR3, the CDRs of a VL are termed LCDRl, LCDRZ and LCDR3. The variable
regions of the heavy and light chains contain a binding domain that interacts with an antigen.
The nt regions of an antibody comprise the heavy chain constant region (CH) and the light
chain constant region (CL), wherein CH can be further ided into constant domain CH1, a
hinge region, and constant domains CH2 and CH3 (arranged from amino-terminus to carboxy-
terminus in the ing order: CH1, CH2, CH3). The constant regions of the antibodies
mediate the g of the immunoglObulin to host tissues or factors, including various cells of
the immune system (e.g., effector cells) and the first component (Clq) of the classical
complement system.
Antibodies may be derived from different species, including but not limited to
mouse, rat, ,
guinea pig and human.
Antibodies described herein include IgA such as IgAl or IgAZ, lgGl, IgGZ, IgG3, IgG4, IgE,
IgM, and IgD antibodies. In various embodiments, the dy is an IgGl antibody, more
ularly an IgGl, kappa or IgGl, lambda isotype (i.e. IgGl, K, 1.), an IgG2a antibody (e.g.
IgGZa, K, it), an IgGZb antibody (e.g. IgGZb, K, 7t), an IgG3 antibody (e.g. IgG3, K, it) or an IgG4
antibody (e.g. lgG4, K, it).
As used herein, “isotype” refers to the antibody class (e.g., IgM or IgGl) that is encoded by
heavy chain constant region genes. “Isotype ing” refers to the phenomenon by which the
class, or isotype, of an antibody changes from one 1g class to one of the other lg classes.
The term “monoclonal antibody”, as used herein, refers to a preparation of antibody molecules of
single molecular composition. A monoclonal dy displays a single binding specificity and
affinity. In one embodiment, the monoclonal antibodies are produced by a oma which
includes a B-cell obtained from a non-human animal, e.g., a mouse, fused to an immortalized
cell.
The term “recombinant antibody”, as used , includes all antibodies that are prepared,
expressed, created or isolated by recombinant means, such as (a) antibodies isolated from an
animal (e.g., a mouse) that is transgenic or transchromosomal with respect to the
immunoglobulin genes or a oma ed rom, (b) antibodies isolated from a host
cell transformed to express the antibody, e.g., from a transfectoma, (0) antibodies isolated from a
recombinant, combinatorial antibody library, and (d) antibodies prepared, expressed, created or
isolated by any other means that involve splicing of immunoglobulin gene sequences to other
DNA sequences.
The term “recombinant” in the context of the t invention means “made through genetic
engineering”. Preferably, a binant object”, such as a inant antibody or nucleic
acid“ is not lly occurring.
The term “naturally occurring”, as used herein, as d to an object refers to the fact that an
object can be found in nature. For example, a polypeptide or polynucleotide sequence that is
present in an organism (including viruses) that can be isolated from a source in nature and which
has not been intentionally modified by man in the laboratory is naturally occurring.
The term “human antibody”, as used herein, is intended to include antibodies having variable
and constant regions derived from human germline immunoglobulin sequences. Human
antibodies may include amino acid residues not encoded by human germline immunoglobulin
sequences (cg, mutations introduced by random or site'specific mutagenesis in vitre or by
somatic mutation in vivo).
The term “humanized antibody” refers to a molecule having an antigen binding site that is
substantially d from an immunoglobulin from a non-human species, wherein the remaining
immunoglobulin structure of the molecule is based upon the structure and/or sequence of a
human immunoglobulin. The antigen binding site may either comprise complete variable regions
(VH and VL) fused onto constant domains (e.g., the constant domains of IgGl/K), or only the
mentarity determining regions (CDRs) grafted onto appropriate framework regions in the
variable regions. n binding sites may be wild-type or modified by one or more amino acid
substitutions, e.g. modified to resemble human globulins more y. Some forms of
humanized antibodies preserve all CDR sequences (for example a humanized mouse antibody
which contains all six CDRs from the mouse antibody). Other forms have one or more CDRs
which are altered with respect to the original antibody.
The term “chimeric antibody” refers to those antibodies wherein
one portion of each of the
amino acid sequences of heavy and light chains is homologous to corresponding
sequences in
antibodies d from a particular species or belonging to a particular class, while the
remaining segment of the chain is gous to corresponding ces in another. Typically,
the variable region of both light and heavy chains mimics the variable regions of antibodies
derived from one species of mammals, while the constant portions
are homologous to sequences
of antibodies derived from another. One clear advantage to such chimeric forms is that the
variable region can conveniently be derived from tly known sources using readily
available B-cells or hybridomas from non-human host organisms in combination with
constant
s derived from, for example, human cell preparations. While the variable region has the
advantage of ease of preparation and the specificity is not affected by the source, the constant
region being human, is less likely to elicit an immune response from a human subject when the
antibodies are injected than would the constant region from a non human
source. However, the
definition is not limited to this particular example.
The antibodies described herein are preferably isolated. The term “isolated antibody”,
as used
herein, is intended to refer to an antibody which is substantially free of other antibodies having
different antigenic specificities. An isolated antibody that specifically binds to an epitope,
isoform or variant of a given receptor of the TNF superfamily
may, r, have cross-
reactivity to other related antigens, e.g., from other species (e.g., Species homologs of said
receptor). er, an isolated dy may be substantially free of other cellular al
andfor chemicals.
The term “antibody fragment” refers to one or more fragments of
an antibody that retain the
ability to specifically bind to an n and may also be referred to as “antigen-binding
fragmen ” of an antibody. It has been shown that the antigen-binding function of an dy can
be perforated by fragments of a full-length antibody. Examples of binding fragments
encompassed within the term “antibody fragment” include (i) Fab fragments, monovalent
fragments consisting of the VL, VH, CL and CH regions; (ii) F(ab')2 fragments, bivalent
fragments comprising two Fab fragments linked by a disulfide bridge at the hinge ; (iii) Fd '
nts consisting of the VH and CH regions; (iv) Fv nts consisting of the VL and VH
regions of a single arm of an dy, (v) dAb fragments (Ward et al., (1989) Nature 341: 544-
546), which consist of a VH region; (vi) isolated complementarity determining regions (CDR),
and (vii) ations of two or more ed CDRs which may Optionally be joined by a
synthetic linker. Furthermore, although the two regions/domains of the Fv fragment, VL and VH,
are coded for by separate genes, they can be joined, using recombinant methods, by a synthetic
linker that enables them to be made as a single n chain in which the VL and VH regions
pair to form monovalent molecules (known as single chain Fv (scFv); see e. g., Bird et a1. (1988)
Science 242: 423-426; and Huston et a1. (1988) Proc. Natl. Acad. Sci. USA 85: 5879-5883).
Such single chain dies are also intended to be encompassed within the term “antibody
fragment”. A further example is a binding-domain immunoglobulin fusion protein comprising (i)
a g domain polypeptide that is fused to an immunoglobulin hinge region polypeptide, (ii)
an immunoglobulin heavy chain CH2 constant region fused to the hinge region, and (iii) an
immunoglobulin heavy chain CH3 constant region fused to the CH2 constant region. The
binding domain polypeptide can be a heavy chain variable region or a light chain variable region.
The g-domain immunoglobulin fusion proteins are further disclosed in US 2003/0118592
and US 2003/0133939. These antibody fragments are obtained using conventional ques
known to those with skill in the art, and the fragments are screened for utility in the same manner
as are intact antibodies.
The terms “pa ”
or “fragment” are used interchangeably herein and refer to a continuous
element. For example, a part of a ure such as an amino acid sequence or protein refers to a
continuous element of said structure. A portion, a part or a fragment of a structure preferably
comprises one or more functional properties of said ure. For e, a portion, a part or a
fragment of an epitope or peptide is preferably immunologically equivalent to the epitope or
e it is derived fiom. A part or fragment of a n sequence preferably comprises a
sequence of at least 6, in particular at least 8, at least 12, at least 15, at least 20, at least 30, at
least 50, or at least 100 utive amino acids of the protein sequence.
When used in connection with VH and VL domains, the term “fragment” preferably refers to one
or more of the complementarity-determining regions (CDR3), preferably at least the CDR3
variable region, of the heavy chain variable region (VH) and/or of the light chain le region
(VL). In one embodiment, said one or more of the complementarity-detennining regions (CDRs)
are selected from a set of complementarity-determining regions CDRl, CDR2 and CDR3. In a
particularly preferred embodiment, the term “fragment” refers to the complementarity-
determining regions CDRl, CDR2 and CDR3 of the heavy chain variable region (VH), i.e.
HCDRI, HCDR2 and HCDR3, and/or of the light chain variable region (VL), i.e. LCDRl,
LCDR2 and LCDR3.
WO 10584
The teaching given herein with respect to specific amino acid
sequences, e.g., those shown in the
sequence listing, is to be ued so as to also relate to variants of said specific sequences
resulting in sequences which are functionally equivalent to said specific sequences, e.g., amino
acid sequences exhibiting properties identical or similar to those of the specific amino acid
sequences. One important preperty is to retain binding to a target.
For example, the sequences shown in the sequence listing can be modified
so as to remove one
or more, preferably all free cysteine residues, in particular by ing the cysteine residues by
amino acids other than ne, preferably serine, alanine, threonine, glycine, tyrosine, leucine
or methionine, most preferably e or serine.
It will be appreciated by those skilled in the art that, in particular, the
ces of the CDRs and
variable regions can be modified Without losing the ability to bind the first and/or the second
receptor of the TNF amily. For example, CDR regions will be either identical or highly
homologous to the regions of antibodies specified . By “highly homologous” it is
plated that from 1 to 5, preferably from 1 to 4, such as 1 to 3 or 1 or 2 substitutions may
be made in the CDRs. In addition, the hypervariable and variable s
may be modified so
that they show substantial homology with the regions of antibodies Specifically disclosed herein.
2O For the es of the present invention, “variants” of an amino acid
sequence, in particular
variants of a heavy chain variable domain (VH) or of a light chain variable domain (VL),
comprise amino acid insertion ts, amino acid addition variants, amino acid deletion
variants and/or amino acid substitution variants. Amino acid deletion variants that comprise the
deletion at the N—tenninal and/or C-terminal end of the protein are also called inal and/or
C-terminal truncation variants.
particular amino acid sequence. In the case of amino acid sequence variants having an insertion,
one or more amino acid residues are inserted into a particular site in
an amino acid sequence,
although random insertion with appropriate screening of the resulting product is also possible.
Amino acid addition variants comprise amino- and/or y—terminal fiJSiOIlS of
one or more
amino acids, such as l, 2, 3, 5, 10, 20, 30, 50, or more amino acids.
Amino acid deletion variants are characterized by the removal of one or
more amino acids from
the sequence, such as by l of l, 2, 3, 5, 10, 20, 30, 50, or more amino acids. The deletions
may be in any position of the protein.
Amino acid tution variants are characterized by at least one residue in the sequence being
removed and another e being inserted in its place. ence is given to modifications
being in positions in the amino acid sequence which are not conserved between homologous
proteins or peptides and/or to ing amino acids with other ones having similar properties.
Preferably, amino acid substitutions in protein variants are conservative amino acid substitutions.
A conservative amino acid substitution involves substitution of an amino acid with another one
ofthe same family of amino acids, i.e., amino acids which are related in their side chains (e.g., in
terms of the electrical charge and/or size). Naturally occurring amino acids are lly divided
into four families: acidic (aspartate, glutamate), basic (lysine, arginine, histidine), non-polar
(alanine, , leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), and
uncharged polar (glycine, asparagine, glutamine, cysteine, serine, ine, tyrosine) amino
acids. alanine, tryptophan, and tyrosine are sometimes classified jointly as aromatic amino
acids.
Preferably the degree of similarity, preferably identity between a given amino acid sequence and
an amino acid sequence which is a variant of said given amino acid sequence will be at least
about 60%, 65%, 70%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%,
92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%. The degree of similarity or identity is given
preferably for an amino acid region which is at least about 10%, at least about 20%, at least
about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at
least about 80%, at least about 90% or about 100% of the entire length of the reference amino
acid sequence. For example, if the nce amino acid sequence consists of 200 amino acids,
the degree of similarity or identity is given preferably for at least about 20, at least about 40, at
least about 60, at least about 80, at least about 100, at least about 120, at least about 140, at least
about 160, at least about 180, or about 200 amino acids, preferably continuous amino acids. In
preferred embodiments, the degree of rity or identity is given for the entire length of the
reference amino acid sequence. The alignment for determining sequence similarity, preferably
sequence identity can be done with art known tools, preferably using the best sequence
alignment, for example, using Align, using standard settings, preferably EMBOSS::needle,
Matrix: Blosum62, Gap Open 100, Gap Extend 0.5.
“Sequence similarity” indicates the percentage of amino acids that either are identical or that
represent conservative amino acid tutions. “Sequence identity” n two amino acid
sequences indicates the percentage of amino acids that are identical n the sequences.
The term “percentage identity” is intended to denote a percentage of amino acid residues which
are identical between the two sequences to be compared, obtained after the best alignment, this
percentage being purely statistical and the differences between the two sequences being
distributed randomly and over their entire length. Sequence comparisons between two amino
acid sequences are conventionally carried out by comparing these
sequences after having aligned
them optimally, said comparison being carried out by segment or by "Window of comparison" in
order to identify and compare local s of sequence similarity. The optimal alignment of the
sequences for comparison may be produced, besides manually, by means of the local homology
algorithm of Smith and Waterman, 1981, Ads App. Math. 2, 482, by means of the local
homology algorithm of Neddleman and Wunsch, 1970, J. Mol. Biol. 48, 443, by means of the
rity search method of n and Lipman, 1988, Proc. Natl Acad. Sci. USA 85, 2444, or
by means of computer programs which use these algorithms (GAP, BESTFIT, FASTA, BLAST
P, BLAST N and TFASTA in Wisconsin cs Software Package, Genetics Computer Group,
575 Science Drive, Madison, Wis).
The percentage identity is calculated by determining the number of identical positions between
the two ces being compared, dividing this number by the number of positioris compared
and multiplying the result obtained by 100 so as to obtain the percentage identity n these
two sequences.
Binding agents in accordance with the present invention may be at least bispecific or
multispecific, such as trispecific, tetraspecific and so on.
The term “bispecific molecule” refers to a le that has two different binding specificities
and thus may bind to two ent types of antigen, such as a first and a second receptor of the
TNF superfamily. Such bispecific molecule may be in the format of an antibody le or of
an antibody-like le or of a protein scaffold with antibody-like properties or of a cyclic
peptide with at least two binding specificities.
The term “bispecific antibody”, as used herein, refers to an antibody comprising two antigen-
binding sites, a first binding site having affinity for a first antigen or epitope and a second
2016/050308
binding site having binding affinity for a second antigen or epitope distinct from the first. In
particular, a bispecific antibody is an artificial protein that is composed of fragments of two
different antibodies (said fi'agments of two different dies forming two binding domains)
and consequently binds to two ent types of antigen.
A bispecific molecule/antibody according to the invention is engineered to simultaneously bind
to a first receptor of the TNF superfamily and to a second receptor of the TNF superfamily,
wherein the first receptor and the second receptor are different and may be located on the same
cell (“cis”) or different cells (“trans”).
In one embodiment, the first or and the second receptor are located on the same cell and
are selected from the group consisting of CD27, 0X40 (CD134) and 4-1BB (CD137). In one
ment, said cell is a T cell.
In another embodiment, the first receptor and the second receptor are located on different cells,
wherein the first or is CD40 and the second receptor is selected from the group consisting
of CD27, 0X40 (CD134) and 4-1BB (CD137). In. one embodiment, said different cells are an
antigen-presenting cell (APC), such as a dendritic cell, expressing CD40 and a T cell expressing
the second receptor selected from the group consisting of CD27, 0X40 (CD134) and 4-1BB
(CD137).
Bispecific (full-length) antibodies may be obtained by covalently/chemically linking two
(monoclonal) antibodies or by conventional -hybridoma techniques. Covalent g of
two monoclonal antibodies is described, for e, in Anderson (1992), Blood 80:2826-34. In
the t of this invention, one of the antibodies is c for the first ” of the TNFlUVU}!IUI
superfamily and the other one for the second receptor of the TNF superfamily.
Alternatively, bispecific (full-length) antibodies may be obtained by using the knobs-into-holes
technology, which allows the hetero-dimen'zation of antibody heavy chains by introducing
specific ons in the CH3 dimer interface, e.g., in the CH3 dimer interface of IgG1 or lgG4.
This technology is described, for example, in Spiess C. et a1. (2013), Journal of Biological
Chemistry 288(37):26583-93; Labrijn A.F. et al. (2013), PNAS 110(13):5145—50; and WO
2008/119353 A1.
In one embodiment, the bispecific antibody is a bispecific single-chain antibody.
As used herein, a “bispecific single—chain antibody” denotes a single polypeptide chain
comprising two binding domains. Each binding domain ses one VH region, wherein the
VH region of the first binding domain specifically binds to the first receptor of the TNF
superfamily (RECl), and the VH region of the second binding domain cally binds to the
second receptor of the TNF superfamily (RECZ). The two binding domains
are optionally linked
to one another by a short peptide linker. Each binding domain may additionally comprise
variable region from an antibody light chain (VL), the VH region and VL region within each of
the first and second binding domains being linked to one another via along peptide linker, which
is long enough to allow the VH region and VL region of the first g domain and the VH
region and VL region of the second binding domain to pair with one another.
In one embodiment, the ponding variable heavy chain regions (VH) and the ponding
variable light chain regions (VL) are ed, from N—terminus to C-terminus, in the order
VH(REC1)—VL(REC1)-VH(REC2)-VL(REC2), VH(REC2)-VL(REC2)-V.H(REC l)-VL(REC1)
or VH(REC2)—VL(REC2)-VL(REC1)—VH(REC1). It is, however, also envisaged that the
ific single chain antibodies of the invention comprise other domain arrangements, such as
1)-VH(RECl)—VH(RECZ)-VL(REC2), VL(RECl)-VH(RECl)-VL(REC2)—VH(REC2),
l)-VL(REC1)—VL(RECZ)-VH(REC2), VL(REC2)-VH(REC2)—VH(REC1)-VL(REC1),
VL(REC2)-VH(REC2)—VL(RECl)—VH(REC1).
Peptide linkers are generally designed to provide flexibility and protease resistance. In one
embodiment, the peptide linker is a e-serine-threonine-rich linker or glycine-serine-rich
linker, wherein at least 50%, preferably at least 60%, more preferably at least 70%, more
preferably at least 80%, even more preferably at least 90% of the amino acids are a glycine or
serine or threonine residue or a glycine or serine residue, respectively. In another embodiment,
the amino acids are selected from e, serine and threonine, i.e., the peptide linker is
exclusively composed of glycine, serine and ine residues (referred to as a glycine-serine-
threonine linker). In yet another embodiment, the peptide linker is exclusively composed of
glycine and serine residues (referred to as a glycine-serine linker). Short peptide linkers may
3O consist of 12 or less such as 11, 10, 9, 8, 7, 6, 5, 4, 3 or 2 amino acids, and preferably, 5 or 6
amino acids. Short peptide linkers preferably comprise the amino acid
sequences SGGGGS or
GGGGS. Long peptide linkers may consist of 12 or more, such as 15 to 25
or 15 to 20 or 15 to
18 amino acids, and may, for example, be ed from (GGGGS)3 ,(GGGGS)4 and (GGGGS)5.
In one embodiment, the binding agent of the invention is in the format of
a bispecific antibody
fragment.
2016/050308
The binding agent according to the invention may be one of various types of bivalent and
trivalent single-chain variable nts (scFvs), filSlOtl proteins mimicking the le
domains of two antibodies. A single~chain variable fragment (scFv) is a fusiOn protein of the
variable regions of the heavy (VH) and light chains (VL) of immunoglobulins, connected with a
peptide linker of ten to about 25 amino acids. The peptide linker is usually rich in glycine for
flexibility, as well as serine or threonine for solubility, and can either connect the N-terminus of
the VH with the C-terminus of the VL, or vice versa. Divalent (or nt) -chain variable
fragments (di-scFvs, bi-scFvs) can be engineered by linking two scFvs. This can be done by
producing a single peptide chain with two VH and two VL regions, yielding tandem scFvs. The
invention also includes multispecific molecules comprising more than two scFvs binding
domains. This makes it possible that the molecule comprises either multiple antigen specificities
and is a trispecific, pecific, or multispecific molecule, or the molecule is a bispecific
molecule comprising more than one scFv binding domain with specificity for the same antigen.
In ular, the molecule of the invention may be a pecific single chain Fv.
In one embodiment, the binding agent comprises two Fab regions, one being directed against the
first receptor of the TNF amily and the other being directed against the second receptor of
the TNF superfamily. In one embodiment, the binding agent is an antigen-binding fragment
(Fab)2 complex. The (Fab)2 complex is composed of two Fab fragments, one Fab fragment
comprising a Fv domain, i.e. VH and VL domains, binding to the first receptor of the TNF
superfamily, and the other Fab fragment comprising a Fv domain binding to the second or
of the TNF superfamily. Each of the Fab nts may be composed of two single chains, 3.
VL-CL module and a VH-CH module. Alternatively, each of the individual Fab fragments may
be ed in a single chain, preferably, VL—CL—CH-VH, and the individual variable and
constant domains may be connected with a e linker. In general, the individual single chains
and Fab fragments may be connected via disulfide bonds, adhesive s, chemical linkage
and/or peptide 1inker(s). The g agent may also se more than two Fab fragments, in
particular, the molecule may be a Fab3, Fab4, or a multimeric Fab complex with specificity for
2, 3, 4, or more different antigens. The invention also includes ally linked Fabs.
Another possibility is the creation of scFvs with peptide linkers that are too short for the two
variable regions to fold together (about five amino acids), forcing scFvs to dimerize. This type is
known as diabodies. Still shorter peptide linkers (one or two amino acids) lead to the formation
of trimers, so-called triabodies or tribodies. Tetrabodies have also been produced. They exhibit
an even higher affinity to their targets than diabodies.
A diabody (Kipriyanov, Int. J. Cancer 77 (1998), 763-772) is a small bivalent and bispecific
antibody fragment. Diabodies comprise a heavy chain variable domain (VH) connected to a light
chain variable domain (VL) on the same polypeptide chain (VH-VL) connected by a peptide
linker that is too short to allow pairing between the two domains on the
same chain. This forces
pairing with the complementary s of r chain and promotes the assembly of a
dimeric molecule with two functional antigen-binding sites. To construct bispecific diabodies of
the invention, the V-domains of an antibody binding to the first receptor of the TNF superfamily
(RECl) and an antibody binding to the second receptor of the TNF superfami1y(RECZ) may be
fused to create the two chains 1)—VL(REC2) and VH(REC2)-VL(REC1). Each chain by
itself is not able to bind to the respective antigen, but recreates the functional antigen binding
sites of an anti-RECI antibody and an anti-REC2 antibody on pairing with the other chain. To
this end, a e linker that is too short to allow g between the two domains
on the same
chain is used. The two scFv molecules, with a linker between heavy chain variable domain and
light chain variable domain that is too short for intramolecular dimerization, are co-expressed
and self assemble to form bi-specific molecules with the two g sites at opposite ends.
In one embodiment, the bispecific antibody nt binding to the first receptor of the TNF
superfamily (RECl) and the second receptor of the TNF superfamily (RECZ) is a minibody,
preferably, a minibody sing two single VH-VL—C chains that are connected with each
other via the constant domain (C) of each chain. According to this aspect, the corresponding
variable heavy chain regions (VH), corresponding variable light chain regions (VL) and constant
domains (C) are arranged, from N-terminus to C-terminus, in the order VH(REC1)-VL(RECI)-
(C) and VH(REC2)-VL(REC2)—C, wherein C is preferably a CH3 . Pairing of the
constant domains results in formation of the minibody.
in one embodiment, the bispecific binding agent is in the format of an antibody—like molecule
with a heavy chain containing two consecutive N-tenninal le domains with different
specificities and a light chain with two consecutive variable domains with different specificities
resulting in four binding s with two ent specificities (Wu et a1. , Nat.
Biotechnology 25(1 1))
g agents according to the invention may also comprises an amino acid sequence for
tating secretion of the molecule, such as a N-terminal secretion signal, and/or one or more
labels or tags facilitating binding, purification or detection of the molecule.
Preferably, the secretion signal is a signal sequence that allows a sufficient passage through the
secretory pathway and/or secretion of the binding agent into the extracellular environment.
Preferably, the ion signal sequence is cleavable and is removed from the mature binding
agent. The secretion sigial sequence preferably is chosen with respect to the cell or organism
wherein the binding agent is produced in.
A “label or tag facilitating binding, purification or detection of the melee e” is meant to e
any labels/tags known in the art for these purposes. Particularly preferred are affinity tags, such
as chitin binding protein (CBP), e binding protein (MBP), glutatluone-S-transferase (GST)
and poly(His) (e. g., Hiss); solubilization tags, such as thioredoxin (TRX) and polymANP);
cinematography tags, such as a FLAG-tag; epitope tags, such as VS-tag, g and ;
and fluorescent or luminescent labels or tags, such as fluorescent proteins (e.g., GFP, YFP, RFP
etc), fluorescent dyes and luciferase.
The amino acid sequence of a peptide label or tag may be introduced at any position within
the amino acid ce of the binding agent, and may, for example, take the shape of a loop
within the encoded protein structure or it may be N-terminally or inally fused. The label
or tag may further contain a cleavage site that allows a removal of the label or tag from the
g agent. Similarly, non-peptidic labels or tags, e.g, fluorescent dyes, may be conjugated to
the binding agent at any suitable site.
g agents of the invention may contain, e.g., in addition to said first and second binding
domain, a further binding domain which serves egg. to enhance selectivity for a specific cell type.
This can be achieved, e.g., by providing a binding domain that binds to another antigen
sed on said specific cell type.
Binding agents of the invention may r comprise one or more modifications increasing the
stability of the binding agent. The term “stability” of the binding agent relates to the “half-life”
of the binding agent, e.g., in viva. “Half-life” relates to the period of time which is needed to
eliminate half of the activity, amount, or number of molecules.
The binding agent may, for example, be conjugated to a half-life extension module. Such
modules are known to a person skilled in the art and include, for example, albumin, an albumin-
binding domain, an immunoglobulin-binding domain, an FeRn—binding motif, and, in particular,
a polymer. Particularly preferred polymers include hylene glycol (PEG), hydroxyethyl
starch (HES), polysialic acid and metic e
sequences.
The binding agents described herein may be conjugated to a therapeutic moiety
or agent, such as
a cytotoxin, a drug (e.g., an immunosuppressant) or a radioisotope. A cytotoxin or cytotoxic
agent includes any agent that is detrimental to and, in particular, kills cells. Examples include
taxol, cytochalasin B, gramicidin D, ethidium bromide, emetine, mitomycin, etoposide,
tenoposide, Vincristine, vinblastine, colchicin, doxorubicin, daunorubicin, oxy anthracin
dione, mitoxantrone, mithramycin, mycin D, l-dehydrotestosterone, glucocorticoids,
procaine, aine, lidocaine, propranolol, and puromycin and analogs or gs thereof.
Suitable therapeutic agents for forming conjugates include, but are not limited
to, antimetabolites
(e.g., methotrexate, 6-mercaptopurine, 6-thi0guanine, bine, fludarabin, S-fluorouracil
decarbazine), alkylating agents (e.g., mechlorethamine, thioepa chlorambucil, lan,
carrnustine (BSNU) and lomustine (CCNU), cyclophosphamide, busulfan, dibromomannitol,
,..,. (A streptozotocin, mitomycin C, and cis-dichlorodiarnine platinum (II) (DDP) cisplatin),
anthracyclines (e.g., daunorubicin (formerly ycin) and doxorubicin), antibiotics (e.g.,
dactinomycin (formerly actinomycin), bleomycin, mithramycin, and mycin (AMC), and
anti-mitotic agents (e.g., vincristine and vinblastine). In a red embodiment, the therapeutic
agent is a cytotoxic agent or a radiotoxic agent. In another embodiment, the therapeutic agent is
an immunosuppressant. In yet another ment, the therapeutic agent is GM-CSF. In a
preferred embodiment, the therapeutic agent is doxorubicin, cisplatin, cin, sulfate,
carmustine, chlorambucil, cyclophosphamide or ricin A.
Binding agents also can be conjugated to a radioisotope, e.g., iodine-131, yttrium-90 or indium-
111, to generate cytotoxic radiopharmaceuticals.
Techniques for conjugating such therapeutic moiety to binding agents, such as antibodies or
fragments thereof, are well known, see, e.g., Amon et al., "Monoclonal dies For
targeting Of Drugs In Cancer Therapy", in Monoclonal Antibodies And Cancer
Therapy, Reisfeld et al. (eds. ), pp. 243-56 (Alan R. Liss, Inc. 1985); Hellstrom et 31.,
"Antibodies For Drug Delivery", in Controlled Drug Delivery (2nd Ed.), Robinson et al. (eds),
pp. 623-53 (Marcel Dekker, Inc. 1987); Thorpe, "Antibody Carriers Of Cytotoxic Agents In
Cancer Therapy: A Review", in Monoclonal dies '84: Biological And Clinical
Applications, Pineheraet al. (eds. ), pp. 475-506 (1985); "Analysis, Results, And Future
Prospective Of The Therapeutic Use Of Radiolabeled Antibody In Cancer Therapy", in
Monoclonal Antibodies For Cancer Detection And Therapy, Baldwin et al. (eds), pp. 303-16
(Academic Press 1985), and Thorpe et al., "The Preparation And Cytotoxic Properties Of
Antibody—Toxin Conjugates", Immunol. Rev., 62: 119=58 (1982).
The present invention provides a binding agent comprising at least two binding domains,
wherein a first binding domain binds to a first receptor of the tumor necrosis factor (TNF)
superfamily and a second binding domain binds to a second receptor of the TNF superfarnily,
wherein the first receptor and the second receptor are ent.
In one ment, the first binding domain binds to CD40 and the second g domain
binds to CD27, wherein, preferably, the binding agent ses
one or more CDRs or one or more variable domains of antibody AB40_1, and
one or more CDRs or one or more le domains of an antibody AB27_X, wherein X is
selected from the group consisting of 1 to 186, as shown in Table 7.
“AB40_1” refers to an antibody binding to CD40, which comprises
(a) heavy chain complementarity determining regions HCDRl having the amino acid
sequence of SEQ ID NO: 2323, HCDR2 having the amino acid sequence of SEQ ID NO:
2324 and HCDR3 having the amino acid ce of SEQ ID NO: 2325, and
light chain complementarity determining s LCDRI having the amino acid sequence
of SEQ ID NO: 2326, LCDR2 having the amino acid sequence of SEQ ID NO: 2327 and
LCDR3 having the amino acid ce of SEQ ID NO: 2328; and
(b) heavy chain variable domain (VH) having the amino acid sequence of SEQ ID NO: 2321
and light chain variable domain (VL) having the amino acid sequence of SEQ ID NO:
2322.
In various embodiments, the binding agent comprises one or more CDRs or one or more le
domains of antibody AB40_1 and X is l; the binding agent comprises one or more CDRs or one
or more variable domains of antibody AB40_1 and X is 2; the binding agent ses one or
more CDRs or one or more variable domains of antibody AB40_1 and X is 3; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 4;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 5; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 6; the binding agent comprises one or more CDRs or one
or more variable domains of antibody AB40_1 and X is 7; the binding agent comprises one or
more CDRs or one or more variable domains of antibody AB40_1 and X is 8; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 9;
the g agent comprises one or more CDRs or one or more variable s of antibody
AB40_1 and X is 10; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40*1 and X is 11; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 12; the binding agent comprises
or more CDRs or one or more variable domains of antibody AB40__I and X is 13; the binding
agent ses one or more CDRs or one or more variable domains of antibody AB40_1 and X
is 14; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 15; the binding agent comprises one or more CDRs or one or more
variable s of antibody AB40_1 and X is 16; the binding agent ses one or more
CDRs or one or more le domains of antibody AB40_1 and X is 17; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 18;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 19; the binding agent ses one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 20; the binding agent comprises one or more CDRs
one or more variable domains of antibody AB40_1 and X is 21; the binding agent comprises
or more CDRs or one or more variable domains of antibody AB40__1 and X is 22; the binding
agent comprises one or more CDRs or one or more le domains of antibody AB40_1 and X
is 23; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 24; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 25; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 26; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 27;
the binding agent comprises one or more CDRs or one or more le domains of antibody
AB40_1 and X is 28; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 29; the g agent comprises one
or more CDRs or
one or more variable domains of antibody AB40_1 and X is 30; the binding agent ses
or more CDRs or one or more variable domains of antibody AB40_1 and X is 31; the binding
agent comprises one or more CDRs or one or more le domains of antibody AB40g1 and X
is 32; the binding agent comprises one or more CDRs or one or more le domains of
antibody AB40_1 and X is 33; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 34; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 35; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 36;
W0 20161110584
the binding agent comprises one or more CDRs or one or more variable domains of dy
AB40_1 and X is 37; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40'_1 and X is 38; the binding agent comprises one or more CDRs or
one or more le domains of antibody AB40_1 and X is 39; the binding agent comprises one
or more CDRs or one or more variable domains of antibody AB40_1 and X is 40; the binding
agent comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X
is 41; the binding agent ses one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 42; the g agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 43; the binding agent comprises one or more
CDRs or one or more variable s of antibody AB40_1 and X is 44; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 45;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 46; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 47; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 48; the binding agent comprises one
or more CDRs or one or more variable domains of antibody AB40_1 and X is 49; the binding
agent comprises one or more CDRs or one or more le domains of antibody AB40_1 and X
is 50; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 51; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 52; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 53; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 54;
the binding agent ses one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 55; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 56; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 57; the g agent comprises one
or more CDRs or one or more le domains of antibody AB40fil and X is 58; the binding
agent comprises one or more CDRs or one or more variable s of antibody AB40_1 and X
is 59; the binding agent comprises one or more CDRs or one or more variable s of
antibody AB40_1 and X is 60; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 61; the binding agent comprises one or more
CDRs or one or more le domains of antibody AB40_1 and X is 62; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 63;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 64; the binding agent comprises one or more CDRs or one or more variable
2016/050308
domains of antibody AB40_1 and X is 65; the binding agent comprises one or more CDRs or
one or more variable s of antibody AB40_1 and X is 66; the binding agent comprises
or more CDRs or one or more variable domains of antibody AB4OAI and X is 67; the binding
agent comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X
is 68; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 69; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40”1 and X is ‘70-; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 71; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 72;
the binding agent ses one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 73; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 74; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 75; the binding agent ses
or more CDRs or one or more variable domains of antibody AB40_1 and X is 76; the binding
agent comprises one or more CDRs or one or more le s of antibody AB40_,1 and X
is 77; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_I and X is 78; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 79; the binding agent comprises
one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 80; the g agent
comprises one or more CDRs or one or more variable domains of antibody AB40_l and X is 81;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 82; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 83; the binding agent comprises one
or more CDRs or
one or more variable domains of antibody AB40_1 and X is 84; the binding agent comprises one
or more CDRS or one or more variable domains of antibody AB40_1 and X is 85; the g
agent ses one or more CDRs or one or more variable domains of dy AB40_1 and X
is 86; the binding agent ses one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 87; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 88; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 89; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 90;
the binding agent ses one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 91; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 92; the binding agent ses one
or more CDRs or
one or more variable domains of antibody AB40WI and X is 93; the binding agent comprises
WO 10584
or more CDRs or one or more variable domains of antibody AB40_1 and X is 94; the binding
agent comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X
is 95; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 96; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 97; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 98; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 99;
the binding agent comprises one or more CDRs or one or more le domains of antibody
AB40_1 and X is 100; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 101; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40__1 and X is 102; the binding agent comprises
o..e or more CDRs or one or more variable domains of antibody AB40_1 and X is 103; the
binding agent comprises one or more CDRs or one or more le domains of dy
AB40_1 and X is 104; the binding agent comprises one or more CDRS or one or more variable
domains of antibody AB40_1 and X is 105; the binding agent comprises one or more CDRs or
one or more le domains of antibody AB40m1 and X is 106; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 107; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 108; the binding agent comprises one or more CDRs or one or more variable
s of antibody AB40_1 and X is 109; the binding agent ses one or more CDRs or
one or more variable domains of antibody AB40M1 and X is 110; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40~1 and X is 111; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 112; the binding agent comprises one or more CDRs or one or more le
domains of antibody AB40wl and X is 113; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 114; the binding agent comprises
one or more CDRs or one or more le domains of antibody AB40_1 and X is 115; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40w1 and X is 116; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40m1 and X is 117; the binding agent comprises one or more CDRs or
one or more le domains of antibody AB40_1 and X is 118; the binding agent comprises
one or more CDRs or one or more le domains of antibody AB40_1 and X is 119; the
binding agent ses one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 120; the g agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 121; the binding agent comprises one or more CDRs or
2016/050308
one or more variable domains of dy AB40_1 and X is 122; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 123; the
binding agent comprises one or more CDRs or one or more variable s of antibody
AB40_1 and X is 124; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 125; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 126; the binding agent ses
one or more CDRs or one or more variable s of antibody AB40_1 and X is 127; the
binding agent comprises one or more CDRs or one or more variable s of antibody
AB40__1 and X is 128; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 129; the binding agent comprises one or
more CDRs or
one or more variable domains of antibody AB40_1 and X is 130; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 131; the
binding agent comprises one or more CDRs or one or more le s of antibody
AB40_1 and X is 132; the binding agent comprises one or more CDRs or one or more le
domains of antibody AB40_1 and X is 133; the binding agent comprises one
or more CDRs or
one or more variable domains of antibody AB40_1 and X is 134; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 135; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40g1 and X is 136; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 137; the binding agent comprises one or
more CDRs or
one or more variable domains of antibody AB40_1 and X is 138; the binding agent comprises
one or more CDRs or one or more variable domains of dy AB40_1 and X is 139; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 140; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 141; the binding agent comprises one or more CDRs or
one or more le domains of antibody AB40WI and X is 142; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 143; the
binding agent comprises one or more CDRs or one or more le domains of antibody
AB40_1 and X is 144; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 145; the binding agent comprises one or more CDRs
one or more variable domains of antibody AB40*1 and X is 146; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 147; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 148; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 149; the g agent comprises one
or more CDRS or
one or more variable domains of antibody AB40_1 and X is 150; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 151; the
binding agent comprises one or more CDRs or one or more variable s of antibody
AB40_1 and X is 152; the binding agent comprises one or more CDRs or one or more variable
domains of dy AB40ml and X is 153; the binding agent comprises one or more CDRs or
one or more le domains of antibody AB40_1 and X is 154; the binding agent comprises
one or more CDRS or one or more variable domains of antibody AB40_1 and X is 155; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40ml and X is 156; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 157; the binding agent comprises one or more CDRs Or
one or more variable domains of antibody AB40_1 and X is 158; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 159; the
binding agent comprises one or more CDRs or one or more le domains of antibody
AB40_1 and X is 160; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 161; the g agent comprises one or more CDRs or
one or more le domains of antibody AB40_1 and X is 162; the binding agent comprises
one or more CDRs or one or more variable s of antibody AB40_1 and X is 163; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40__1 and X is 164; the g agent ses one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 165; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 166; the binding agent campuses
one or more CDRs or one or more variable domains of antibody AB40_”1 and X is 167; the
binding agent ses one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 168; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 169; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 170; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 171; the
binding agent ses one or more CDRs or one or more le domains of antibody
AB40_1 and X is 172; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 173; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40__1 and X is 174; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 175; the
g agent comprises one or more CDRs or one or more variable domains of dy
AB40_1 and X is 176; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 177; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 178; the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40__1 and X is 179; the
binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 180; the binding agent comprises one or more CDRs or one or more variable
domains of dy AB40_1 and X is 181; the binding agent comprises
one or more CDRs or
one or more variable domains of antibody AB40_‘1 and X is 182; the binding agent comprises
one or more CDRs or one or more le domains of antibody AB4G_1 and X is 183; the
binding agent ses one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 184; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 185; or the binding agent comprises
one or more CDRs or
one or more variable domains of antibody AB40__1 and X is 186.
In one embodiment, the binding agent comprises one or more CDRs or
one or more variable
domains of antibody AB40_1 and X is 5.
In one ment, the first binding domain binds to CD40 and the second binding domain
binds to 0X40 ), wherein, preferably, the binding agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1, as defined above, and
one or more CDRs or one or more variable domains of an dy AB134_X, wherein X is
selected from the group consisting of l to 92, as shown in Table 8.
In various embodiments, the binding agent comprises one or more CDRs or
one or more variable
domains of antibody AB40_I and X is 1; the binding agent comprises one or more CDRs or one
or more variable domains of antibody AB40_1 and X is 2; the binding agent comprises
one or
more CDRs or one or more variable domains of antibody AB40_1 and X is 3; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 4;
the g agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 5; the g agent ses one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 6; the binding agent comprises
one or more CDRs or one
or more variable s of antibody AB40_1 and X is 7; the g agent comprises
one or
more CDRs or one or more variable domains of antibody AB40_1 and X is 8; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 9;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 10; the binding agent ses one or more CDRs or one or more variable
s of antibody AB40_1 and X is 11; the binding agent comprises one or more CDRs or
W0 20161110584
one or more variable domains of antibody AB40_1 and X is 12; the binding agent comprises one
or more CDRs or one or more variable domains of antibody AB40_1 and X is 13; the binding
agent comprises one or more CDRs or one or more variable s of antibody AB40_1 and X
is 14; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40#1 and X is 15; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40wl and X is 16; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40w1 and X is 17; the binding agent
comprises one or more CDRs or one or more variable domains of dy AB40_1 and X is 18;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 19; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 20; the binding agent comprises one or more CDRs or
one or more le domains of antibody AB40_1 and X is 21', the binding agent comprises one
or more CDRs or one or more variable s of antibody AB40_1 and X is 22; the binding
agent ses one or more CDRs or one or more variable domains of antibody AB40_1 and X
is 23; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 24; the binding agent ses one or more CDRs or one or more
le domains of antibody AB40_1 and X is 25; the binding agent comprises one or more
CDRs or one or more le domains of antibody AB40_1 and X is 26; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 27;
the g agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 28; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 29; the binding agent ses one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 30; the binding agent comprises one
or more CDRs or one or more variable domains of antibody AB40_1 and X is 31; the binding
agent ses one or more CDRS or one or more variable domains of antibody AB40_1 and X
is 32; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 33; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 34; the binding agent comprises one or more
CDRS or one or more variable domains of antibody AB40_1 and X is 35; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 36;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 37; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40fll and X is 38; the binding agent comprises one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 39; the binding agent ses one
or more CDRs or one or more variable domains of antibody AB40_1 and X is 40; the binding
agent comprises one or more CDRs or one or more variable domains of antibody AB40_I and X
is 41; the binding agent comprises one or more CDRs or one or
more variable domains of
antibody AB40_1 and X is 42; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 43; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 44; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 45;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_'1 and X is 46; the binding agent comprises one or more CDRs or one or more variable
s of antibody AB40_1 and X is 47; the binding agent comprises
one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 48; the binding agent comprises
or more CDRs or one or more variable domains of antibody AB40_1 and X is 49; the g
agent comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X
is 50; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 51; the binding agent comprises one or more CDRs or one or more
le domains of antibody AB40_1 and X is 52; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 53; the g agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 54;
the binding agent comprises one or more CDRs or one or more variable s of antibody
AB40_1 and X is 55; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 56; the binding agent comprises
one or more CDRs or
one or more variable domains of antibody AB40_1 and X is 57; the binding agent comprises
or more CDRs or one or more le domains of antibody AB40_1 and X is 58; the g
agent comprises one or more CDRs or one or more variable s of antibody 1 and X
is 59; the binding agent ses one or more CDRs or one
or more le domains of
antibody AB40~1 and X is 60; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40_1 and X is 61; the binding agent comprises one or more
CDRs or one or more variable domains of antibody AB40_1 and X is 62; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 63;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 64; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 65; the binding agent comprises
one or more CDRs or
one or more variable domains of dy AB40_1 and X is 66; the binding agent comprises
or more CDRs or one or more le domains of antibody AB40_1 and X is 67; the binding
agent ses one or more CDRs or one or more variable domains of antibody AB40_1 and X
is 68; the binding agent comprises one or more CDRs or one or more variable domains of
antibody AB40_1 and X is 69; the binding agent comprises one or more CDRS or one or more
variable domains of dy AB40_1 and X is 70; the binding agent comprises one or more
CDRS or one or more variable domains of antibody AB40‘1 and X is 71; the binding agent
comprises one or more CDRS or one or more variable domains of antibody AB40__] and X is 72;
the binding agent comprises one or more CDRS or one or more variable domains of antibody
AB40_1 and X is 73; the g agent comprises one or more CDRS or one or more variable
domains of antibody AB40A1 and X is 74; the binding agent ses one or more CDRS or
one or more variable domains of dy AB40_1 and X is 75; the binding agent comprises one
or more CDRS or one or more variable domains of antibody AB40_1 and X is 76; the binding
agent comprises one or more CDRS or one or more variable domains of antibody AB40_1 and X
is 77; the g agent comprises one or more CDRS or one or more variable domains of
antibody AB40_1 and X is 78; the binding agent comprises one or more CDRS or one or more
variable domains of antibody AB40_1 and X is 79; the binding agent comprises one or more
CDRS or one or more variable domains of antibody AB40_1 and X is 80; the binding agent
comprises one or more CDRS or one or more variable domains of antibody AB40_1 and X is 81;
the binding agent comprises one or more CDRS or one or more variable domains of dy
AB40_1 and X is 82; the binding agent comprises one or more CDRS or one or more variable
s of antibody AB40_1 and X is 83; the binding agent comprises one or more CDRS or
one or more variable domains of antibody AB40_1 and X is 84; the binding agent comprises one
2O or more CDRS or one or more variable domains of antibody AB40_1 and X is 85; the binding
agent comprises one or more CDRS or one or more variable domains of antibody AB40_1 and X
is 86; the g agent comprises one or more CDRS or one or more variable domains of
antibody AB40_1 and X is 87; the binding agent comprises one or more CDRs or one or more
variable domains of antibody AB40gl and X is 88; the binding agent comprises one or more
CDRS or one or more variable domains of dy AB40_1 and X is 89; the binding agent
ses one or more CDRS or one or more variable domains of antibody AB40_1 and X is 90;
the g agent comprises one or more CDRs or one or more variable domains of dy
AB40_1 and X is 91; or the binding agent ses one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 92.
In one embodiment, the binding agent comprises one or more CDRS or one or more variable
domains of antibody AB40_1 and X is 3. In another embodiment, the binding agent comprises
one or more CDRS or one or more variable domains of antibody AB40_1 and X is 81.
WO 10584
In one embodiment, the first binding domain binds to CD40 and the second binding domain
binds to 4-1BB (CD137), wherein, preferably, the binding agent comprises
one or more CDRs or one or more variable s of dy AB40~_1
, as defined above, and
one or more CDRs or one or more variable domains of an antibody AB137_X, wherein X is
selected from the group consisting of 1 to 12, as shown in Table 9.
In various embodiments, the binding agent comprises one or more CDRs
or one or more variable
domains of antibody AB40_1 and X is 1; the g agent comprises one or
more CDRs or one
or more variable domains of antibody AB40_1 and X is 2; the g agent comprises
one or
more CDRs or one or more variable domains of antibody AB40_1 and X is 3; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 4;
the binding agent comprises one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 5; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40__1 and X is 6; the binding agent comprises one
or more CDRs or one
or more variable s of dy AB40_1 and X is 7; the binding agent comprises
one or
more CDRs or one or more variable domains of antibody AB40_1 and X is 8; the binding agent
comprises one or more CDRs or one or more variable domains of antibody AB40_1 and X is 9;
the binding agent ses one or more CDRs or one or more variable domains of antibody
AB40_1 and X is 10; the binding agent comprises one or more CDRs or one or more variable
domains of antibody AB40_1 and X is 11; or the binding agent comprises one
or more CDRs or
one or more variable domains of dy AB40_1 and X is 12.
In one embodiment, the g agent comprises one or more CDRs or
one or more variable
domains of antibody AB40_1 and X is 2. In another embodiment, the g
agent comprises
one or more CDRs or one or more variable domains of antibody AB40_1 and X is 12.
In one embodiment, the first binding domain binds to 4-lBB (CD137) and the second binding
domain binds to CD27, wherein, preferably, the binding agent comprises
one or more CDRs or one or more variable domains of an antibody X, wherein X is
seiected from the group consisting of 1 to 12, as shown in Table 9, and
one or more CDRs or one or more variable domains of an antibody AB27_Y, wherein Y is
selected from the group consisting of 1 to 186, as shown in Table 7.
In various embodiments, X is 1 and Y is selected from the
group consisting of 1 to 186; X is 2
and Y is selected from the group consisting of 1 to 186; X is 3 and Y is selected from the
group
W0 10584 2016/050308
consisting of 1 to 186; X is 4 and Y is selected from the group consisting of 1 to 186; X is 5 and
Y is selected from the group consisting of 1 to 186; X is 6 and Y is selected from the group
consisting of 1 to 186; X is 7 and Y is selected from the group consisting of 1 to 186; X is 8 and
Y is selected from the group consisting of 1 to 186; X is 9 and Y is selected from the group
consisting of 1 to 186; X is 10 and Y is selected from the group consisting of 1 to 186; X is 11
and Y is selected from the group consisting of 1 to 186; or X is 12 and Y is selected from the
group consisting of ‘1 to 186.
In various embodiments,
insl;Xis1aninsZ;Xislanins 3;Xislanins4;Xislanins S;Xisl
anins6;Xislanins7;Xislanins8;Xis1anins9;Xislaninle;Xisland
Yis 11;Xis 1 anins 12;Xislanins 13;Xislanins 14; Xislanins 15;Xisland
Yis16;Xislanins 17;Xis1 aninsl8;Xis1anin319;Xis1anins20;Xis1 and
Yile;Xis1anin822;Xislanin323;Xislanin524;XislaninsZS;Xisland
Yi526;XislaninsZ7;Xislanins28;Xislanins29; in330;Xis1and
Yis31;Xis1anins32;Xislanins33;Xis1anins34; Xislanins35;Xisland
Yi336;Xislanins37;Xis1anins38;Xis1anins39; Xisl anins40;Xisland
Yis41;Xis1anins42;Xisianins43;Xislanins44;Xis1anins45;Xisland
Yis46;Xislanins47;Xislanins48;Xis1anins49; XislaninsSO;Xisland
Yis51;Xis1anins 52;Xisl aninsS3;Xis1aninsS4;Xis1 anins55;Xisland
Yis56;Xislanins 57;Xislanin358;Xislanins 59;Xislanins60;Xisl and
Yi361;Xislanins62;Xislanins63;Xislanins64;Xisl anins65;Xisland
Xis1anins67;Xis1anins68;Xislanins69;Xislanins70;Xisland
Yis71;Xis 1anins72;XisI anins73;Xis1anins74;Xis1anins7S;Xisland
Yis76;Xis1anins77;Xislanins78;Xislanins79;Xislanins80;Xisland
Yis81;Xislanins 82;Xislanins 83;Xislanins84;Xislanins 85;Xis 1 and
Yi586;Xislanin387;Xis1anin588;Xislanins89;Xis1anins9O;Xisland
Yis91;Xis1anins92;Xislanins93;Xislanins94;Xisl anins95;Xis1and
Yis96;Xis1anins97;Xislanin398;Xis 1anins99;Xisl anins100;Xisl
anins 101;Xis 1 anin3102;Xislanins103;Xislanins104;Xis 1 anins 105;
Xislanins 106;Xislanins 107;Xislanins 108;Xislanins slanins
110;Xislanins111;Xis1anins112;Xislanins113;Xisl anins 114;Xis1
anins 115;Xislanins slanins 117;Xis 1 aninsll8;Xislanins 119;
Xislanins120;Xislanin3121;Xisl 22;Xislanin5123;Xislanins
124;Xislanin5125;Xislanins126;Xislanin8127;Xislanins128;Xisl
2016/050308
anins129;Xislanins 130;Xis 1 anins 131;Xis 1 anins 132;Xislanins 133;
Xislanins 134;Xislanins 135;Xis1anins 136;Xisl anins 137;Xisl anins
138;Xis1anins139;Xislanins140;Xis1aninsl41;Xis1anins142;Xisl
anins 143;Xislanins 144;Xislanins 145;Xis 1 anins 146;Xislanins 147;
Xislanins 148;Xis 1 anins s 1 anins 150;Xisl anins 151;Xisl anins
152;Xis1anins153;Xislanins154;Xislanins155;Xislanin3156;Xisl
anins157;Xis1anins 158;Xis 1 anins 159;Xisland‘z’is 160;Xis1anins 161;
XislandY15162;Xis1anins 163;Xis1anins 164;Xisl 65;Xis1anins
166;Xis 1 anins 167;Xislaninsl68;Xis 1 deis 169; Xislanins 170;Xisl
anins 171;Xis 1 anins 172;Xislanins 173;Xis 1 anins 174;Xis 1 anins 175;
Xislaninsl76;Xislanins 177;Xislanins sl aninsl79;Xislanins
180;Xislanins 181;Xi31anins182;Xis 1 aninslS3gXis 1 anins 184;Xisl
anin3185;Xis 1 anins 186;
insl;XisZaninsZ;Xis2aninsS;XisZandYis4;Xis2and. - isS;XisZ
aninsG;XisZanins7;XisZanin58;Xis2anin39;Xi52aninle;XisZand
YisI];XisZanins12;Xis2anins13;Xis2a.nins14;Xis2anins15;XisZand
Yisl6;Xis2anins17;XisZanins18;Xis2aninsl9;Xis2aninsZO;Xi52and
Yis21;XisZanin322gXi32aninsZ3;XisZaninsZ4;Xi52anin325;Xi52 and
Yi526;Xi52aninsZ7;XisZanins28;XisZaninsZ9;XisZanins30;XisZand
Yis31;XisZanins32;Xi32aninsSS;Xis23nins34;XisZanins35;XisZ and
XisZanins37;Xi32anins38;XisZanins39;Xi52anins40;Xis2and
Yis41;Xis2anins42;Xi32anins43;XisZanins44;Xi52anins45;Xi52and
Yis46;Xis2anins47;Xi32anins48;XisZanins49;Xis2anins 50;Xi52and
YisSl;Xis2aninsSZ;XisZaninsS3;Xis2anins 54;XisZaninsSS;XisZand
Yis56;X132aninsS7;XisZanin358;Xis2anins59;XisZanins60;XisZand
Yis61;Xis2anins62;XisZanins63;XisZanins64;Xis2anins65;Xis2and
Yis66;Xis2anins67;XisZanins68;XisZanin569;Xi52anins7O;Xi52and
Yis71;Xi52anins72;XisZanins73;Xis2anins 74;Xis2anins75;Xi32and
Yis76;XisZanins77;XisZanins78;Xi32anins79;Xi52anin580;Xis2 and
Yis 2anins 82;Xi32anins 83;XisZanin384;Xi52anins85;Xis2and
Yis 86;Xi32anins 87;XisZanins 88;XisZanins89;XisZanin590;Xi52and
Yis9l;XisZanins92;XisZanins93;Xi52anins94;Xis2anins95;Xis2and
Yis96;Xis2anins97;XisZandYis98;Xis2anins99;Xi52anins100;Xis2
anins 101;Xi32 anins 102;XisZanins 103;Xis221nins lO4;XisZanins 105;
XisZanins106;Xi32anins107;Xi52anins108;XisZa.nins109;Xi32anins
110;XisZanins111;Xis2anins112;Xis2aninsll3;Xis2aninsll4;Xis2
anins115;Xis2anins116;XisZaninsll7;Xis2anins 118;Xi32anins119;
Xis2anins120;Xi32anins121;Xi32anin5122;Xi52 anins 123;XisZanins
124;XisZanins125;XiSZanins126;XisZanin5127;Xis2 anins128;Xi32
anins129;Xis2anins130;Xi52anins131;Xi32anins132;Xi32aninsl33;
XisZanins134;Xis2anins135;XisZaninsl36;Xi52 aninsl37;Xi32anins
138;Xi52anins 139;Xis23nins140;Xi32anins 141;XisZanins142;Xi52
anins143;XisZanins144;Xis2andYisl45;XisZanins 146;Xis2aninsI47;
XiSZanins 148;Xi52anins149;Xis2anins 150;XisZa.ndYis151;Xis2anins
152;XisZanins153;XisZanins154;Xis2anins155;Xi32 anins 156;Xi52
anins 157;Xis2anins 158;XiSZanins 159;Xis2anins 160;XisZanins 161;
XisZanins162;Xi82anin3163;XiSZanins l64;XisZanins165;XisZanins
166;Xi32anins167;XisZanins168;Xi32anins169;Xi32aninsl7O;Xis2
anins171;XisZanins172;XisZanins173;Xi52anins 174;Xi52aninsl75;
XisZanins 176;XisZanins177;Xi82anins17S;XisZanins179;XisZanins
180;Xis2anins181;XisZanins182;Xi32anins183;XisZanin5184;Xis2
anin3185;Xi52anin3186;
XisSanins1;Xis3aninsZ;Xis3anins3;Xis3anins4;Xis3anins5;Xis3
anins6;Xis3anins7;Xis3anin38;Xis3anins9;Xis3anins10;Xis3and
Yis11;Xis3anins12;Xis3anins13;Xis3aninsl4;Xis3aninslS;XisSand
Yis16;Xis3anins l7;XisBaninslS;Xis3anins l9;XisSa.ninsZO;Xis3and
Yi321;Xis3anins22;Xis3anin323;Xis3aninsZ4;Xis3 anin325;Xi53and
Yi526;Xi53anins27;Xis3anin328;Xis3anins29;Xis3anins 3and
Xis3anins 32;Xis3anins33;Xis3anins34;Xis3 anins35;Xis3 and
Yis36;Xis3anins37;Xi33anins38;Xis3anin339;Xis3anins40;Xis3&nd
Yis41;Xis3anins42;Xi53anins43;Xis3anins44;Xis3anins45;Xis3and
Yis46;Xis3anins47;XisSanins48;Xis3anins49;Xis3anins 50;Xis3and
YisSl;Xis3anin352;Xis3anins53;Xis3aninsS4;Xis3aninsSS;Xis3and
Xis3anins 57;Xis3anins 58;Xis3anins59;Xis3anins60;Xis3 and
Yis61;Xis3anins 62;Xis3anins63;Xis3anins64;Xis3anins65;Xis3and
Yis66;Xis3anins67;Xis3anins68;Xis3anins69;Xi53anins 70;Xis3 and
Yis71;Xis3anins72;Xis3anins73;Xis3anins74;Xis3anins 75;Xis3and
XisSanins 3anins78;Xis3anins79;Xis3anins 80;Xis3and
Yis81;Xis3anin882;Xis3andY1883;Xis3anins84;Xis3anins85;Xis3and
Yis 86;Xi53anins 87;XisSanins88;Xis3anins 89;Xis3anins 90;Xis3and
Yis91;Xis3anins92;Xis3anin393;Xis3anins94;Xis3anins95;Xis3and
Yis96;Xis3anin597;Xis3anins98;Xis3anins99;Xis3anin5100;Xi33
anins 101;Xis3anins 102.;Xis3anins 103;Xis3anins s3anins 105;
Xis3anins106;Xis3aninle7;Xis3anins108;Xis3 anin5109;Xis3anins
s3aninslll;Xis3anins112;Xis3aninsll3;Xis3 anins 114;Xi53
anins115;Xis3aninsll6;Xis3anins117;Xis3anins118;Xis3aninsll9;
Xis3anins120;Xis3anins121;Xis3anins122;Xis3 aninle3;Xis3anins
124;Xis3anin8125;Xi53aninle6;Xis3anins127;Xis3anins128;Xis3
anins129;Xis3anin5130;Xis3anins131;Xis3anins132;Xi33aninsl33;
Xis3anins134;Xis3anins135;Xis3anins136;Xis3 anins s3anins
138;Xi53aninsl39;Xis3anins l40;Xis3anins141;Xis3anins142;XisS
anins 143;Xis3anins 144;Xi33anins 145;Xis3anins 146;Xis3anins 147;
Xis3 aninsl48;Xis3 aninsl49;Xis3 anins 150;Xis3 anins 151;Xis3andY is
152;Xis3aninsIS3;Xis3anins154;Xis3aninS155;Xi53anins156;Xis3
aninslS7;Xis3anins 158;Xi53anins159;Xis3anins 160;Xis3anins 161;
XisB anins162;Xis3anins163;Xis3anins164;Xis3 anins165;Xi53anins
166;Xi53anins167;Xi53anins168;Xis3anins169;Xis3aninsl70;Xis3
anins 171;Xis3 anins l72;Xis3anins 173;Xis3 anins 174;Xis3 anins 175;
Xis3anins s3anins 177;Xis3anins 178;Xis3 anins l79;Xis3anins
180;Xis3anins181;Xis3anin5182;Xis3anins183;Xis3aninslS4;Xis3
anins s3anins 186;
Xis4anins1;Xis4aninsZ;Xis4aninsS;Xis4andYis4;Xis4anins5;Xis4
anins6;Xis4anins7;Xis4anins8;Xis4anins9;Xis4anins10;Xis4and
Yis11;Xis4anins12;Xis4anins l3;Xis4anins14;Xis4aninslS;Xis4and
Yis16;Xis4anins17;Xis4anins18;Xis4anins19;Xis4aninsZO;Xis4and
Yis21;Xis4aninsZZ;Xis4anins23;Xis4anins24;Xis4anin325;Xis4and
Yis26;Xis4anins27;Xis4aninsZ8;Xis4anins29;Xis4anins30;Xis4and
Yis31;Xis4anins 4anins33;Xis4anins34;Xis4anins35;Xis4and
Yis36;Xis4anins37;Xis4anins38;Xis4anins39;Xis4anins40;Xis4and
Yis41;Xis4anins42;Xis4anins43;Xis4anins44;Xis4anins45;Xis4and
Yis46;Xis4anins47;Xis4anins48;Xis4anins49;Xis4aninsSO;Xis4and
Yis51;Xis4anins 52;Xis4aninsS3;Xis4aninsS4;Xis4anins 55;Xis4and
YisS6;Xis4anins57;Xis4anin558;Xis4aninsS9;Xis4anins60;Xis4and
Yi361;Xis4anins 62;Xis4anin363;Xis4anins64;Xis4anins65;Xis4and
Yis66;Xis4anins67;Xis4anins68;Xis4anins69;Xis4anins 70;Xis4and
W0 2016/110584
Yis71;Xis4anins 72;Xis4anins73;Xis4anins74;Xis4anins75;Xis4and
Xis4anins 77;Xis4andYis78;Xis4anins79;Xis4anins80;Xis4and
Xis4anins 82;Xis4anins83;Xis4anin584;Xis4anins 85;Xis4and
Yis86;Xis4anins87;Xis4andYis88;Xis4anin389;Xis4anins90;Xis4and
Xis4andYis92;Xis4anins93;Xis4anins94;Xis4anins 95;Xis4and
Yis96;Xis4anins 97;Xis4anins98;Xis4anins99;Xis4aninleO;Xis4
anins 101;Xis4anins 102;Xis4anins 1102%;Xis4a1r1ins 104;Xis4anins 105;
Xis4anins106;Xis4anins107;Xis4anins108;Xis4anins109;Xis4anins
110;Xis4anins111;Xis4anins112;Xis4anins113;Xis4aninsll4;Xis4
15;Xis4anins116;Xis4anins 117;Xis4anins118;Xis4anins119;
Xis4anins120;Xis4anins121;Xis4anins122;Xis4anins123;Xis4anins
124;Xis4anins 125;Xis4anins 126;Xis4anins 127;Xis4anins 128;Xis4
anins s4anins 130;Xis4anins 131;Xis4anins 132;Xis4anins 133;
Xis4aninsl34;Xis4anins135;Xis4anins136;Xis4anin5137;Xis4anins
138;Xis4anins139;Xis4aninsl40;Xis4anins141;Xis4aninsl42;Xis4
anins 143;Xis4anins l44;Xis4anins 145;Xis4anins146;Xis4anins 147;
Xis4anins148;Xis4anins149;Xis4anins150;Xis4anins151;Xis4anins
152;Xis4anins153;Xis4anins154;Xis4anins155;Xis4anins156;Xis4
anins 157;Xis4anins 158;Xis4anins 159;Xis4anins l60;Xis4anins 161;
Xis4anins162;Xis4anins163;Xis4anins164;Xis4anins165;Xis4anins
166;Xis4anins 167;Xis4anins 168;Xis4anins 1693Xis4anins 170;Xis4
aninsl7l;Xis4anins172;Xis4anins173;Xis4anins174;Xis4anins 175;
Xis4anins 176;Xis4anins177;Xis4anins178;Xis4anins179;Xis4anins
180;Xis4anins181;Xis4anins182;Xis4anins183;Xis4anin5184;Xis4
anins 185;Xis4andY is 186;
XisSanins1;XisSaninsZ;XisSaninsS;XisSanins4;XisSaninsS;XisS
aninsé;XisSanins7;Xis5anins8;Xis§aninsQ;XisSanins lO;XisSand
Yisll;XisSanins12;XisSanins13;XisSanins14;XisSaninslS;XisSand
Xis5anins17;XisSaninsl8;XisSanins19;XisSaninsZO;XisSand
3O Yile;XisSanin322;Xis5anins23;XiSSanin524;XisSaninsZS;XisSand
Yi526;Xis5aninsZ7;XisSaninsZS;XisSanin329;XisSanins30;XisSand
Yi331;XiSSanins32;XisSanins33;XisSanins34;XisSanins 35;XisSand
Yis36;XisSanins37;XisSanins38;XisSanins39;XisSanins40;XisSand
Yis41;Xis5anins42;XisSanins43;XisSanins44;XisSanins45;XiSSand
Yis46;XisSanins47;XisSanins48;Xis5anins49;XisSanins 50;XisSand
Yis51;XiSSanins 52;XisSaninsS3;XisSanins 54;Xis5 S;Xis5and
YisS6;Xis5anins 57;XisSaninsSS;Xis5anins 59;Xi35 anins60;XisSand
Yis6l;XisSanin362;Xi35anins63;XisSanins64;XisSanins65;XisSand
Yis66;XisSanins67;XisSanins68;Xis5anins69;Xis5anins70;XisSand
Yis7l;XisSanins72;XisSanins73;Xis5anins74;XisSanins75;XisSand
Yis76;Xis5anins77;XisSanins78;Xis5anins79;XisS anins80;XisSand
Yis81;XisSanins 82;XisSanins 83;Xis$anins84;XisSaninsSS;XisSand
Yis86;Xis5anins 87;Xis$anins88;XisSaninsS9;XisSanins90;XisSand
Yi391;Xis5anins92;Xi35anins93;XisSanins94;XisS anins95;XiSSand
Yis96;Xis5anins97;Xis5anins98;XisSanins99;XisSanins100;Xi35
anins 101;Xis5anins102;XisSanins 103;XisSanins 104;XisSanins 105;
Xis5anins106;Xis5aninslO7;XisSaninleS;XisSanins109;Xis5anins
110;Xis5anins111;XisSanins112;Xi35anin8113;Xi35anins114;Xis5
aninsllS;XisSanins lI6;Xis5aninsll7;Xis5anins118;Xis5aninsll9;
XisSanins120;Xis$anins121;XiSSanin5122;Xi55anins123;XisSanins
124;Xis5anins125;XisSanins126;Xis5anins127;XisSanins128;Xi55
anins 129;Xi85anins 130;XisSanins l3l;XisSanins 132;Xi55anins 133;
Xis5anins134;XisSanins13S;XisSanins136;XisSaninsl37;XisSanins
138;Xis5anins139;XisSanins140;Xis5anins141;XisSanins142;Xis5
anins s5anins l44;Xis5anins 145;Xi35aninsl46;XisSanins 147;
XisSanins148;Xis5anins149;Xis5anins150;XiSSanins151;XisSanins
35anins153;XisSanins154;XisSanins155;XisSaninslS6;XisS
anins 157;Xi55aninslS8;XisSanins 159;Xis5anins 160;XisSanins 161;
XisSaninsl62;Xis5anins163;Xis53nins164;XisSanins165;XisSanins
166;XisSaninsl67;XisSanins168;Xi35aninsl69;XisSanins170;Xis5
anins 171;XisSanins172;Xis5anins l73;XisSanins l74;XisSanins 175;
insl76;XisSanins177;XisSanins178;Xis$anins179;XisSanins
s5anins181;XisSanins182;XisSanins183;XisSanins184;XisS
anins185;Xi35anins 186;
Xis6anins1;Xis6aninsZ;Xis6anins3;Xis6anins4;Xis6anins5;Xis6
anins6;Xis6anins7;Xis6aninsS;Xis6anins9;Xis6anins10;Xis6and
Yisll;XisGanins12;Xis6aninsl3;Xis6aninsl4;Xi36anins15;Xi56and
Yi516;Xi56anins17;Xis6anins18;Xis6aninsl9;Xis6anins20;Xi36and
Yis21;Xis6anin522;Xis6anins23;Xis6anin824;Xis6anins25;Xis6and
Xis6anin327;Xis6anins28;Xis6anin829;Xi36anins 30;Xis6and
Yis31;Xis6anins32;Xi36anins33;Xis6anin534;Xiséanins35;Xi86and
Yis36;Xis6anins37;Xis6anins38;Xiséanins39;Xis6anins40;Xis6and
Yis41;Xi56anins42;Xi36anins43;Xis6anins44;Xis6anins45;Xis6and
Yis46;Xis6anins47;Xi56anins48;Xis6anins49;Xis6anins 50;Xiséand
Xis6anins 52;Xis6anins53;Xis6anins54;Xis6anins55;Xis6and
YisS6;Xis6anins 57;Xis6aninsSS;XisGaninsS9;Xis6anins60;Xi56and
Yis61;Xi36anins62;Xiséanin563;Xiséanins64;Xi36an Yi565;Xiséand
Yis66;Xis6andYis67;Xis6andYis68;Xis6aninsfi9;Xis6anins70;Xis6and
Yis71;Xis6anins 72;Xi56anins73;Xis6anins74;Xis6anins75;Xis6and
Yis76;Xis6anins77;Xis6andYis78;Xis6anins'79;Xis6anins 80;Xis6and
Yis81;Xis6anins82;Xis6aninsS3;Xis6anins84;Xis6anins85;Xis6and
YisS6;Xis6anins 87;Xi56anins88;Xis6anins89;XisGanins90;Xis6and
Yis91;Xis6anins92;Xis6anins93;Xis6anins94;Xis6anins95;Xis6and
Yis96;Xis6andYis97;Xis6anins98;Xis6anins99;Xis6anins100;Xis6
anins 101;Xis6anins 102;Xis6anins s6anins 104;Xis6anins 105;
Xis6anins106;Xi56anins107;Xis6anins108;Xis6anins109;Xi56anins
110;Xiséanins111;Xi36anins112;Xis6anins113;Xis6aninsll4;Xis6
anins115;Xi56 anins 116;Xiséanins 117;Xi56anin5118;Xis6 aninsll9;
Xis6anins120;Xis6anins121;Xis6anins122;Xis6anins123;Xi56anins
124;Xis6anins125;Xis6anins126;Xis6anins127;Xi56anin8128;Xi36
anins 129;Xiséaninsl30;Xis6anins 131;Xis6anins 36anins 133;
XisSanins134;Xis6anins135;Xis6anins136;Xis6anins137;Xis6anins
138;Xis63nins139;Xis6anins140;Xis6anins141;Xis6anins142;Xis6
anins143;Xis6anins144;Xis6anins145;Xi36anins146;Xis6aninsl47;
ins i48;Xisfianins149;Xis6anins150;Xis6anins151;Xis6anins
s6anins153;Xis6anins154;Xis6anins155;Xis6anins156;Xis6
anins157;Xis6anins158;Xis6anins 159;Xis6anins 160;Xis6anins 161;
Xis6anins162;Xis6anins163;Xis6aninsl64;Xis6anins165;Xis6anins
166;Xis6anins167;Xis6aninsl68;Xis6anins169;Xi36anins170;Xis6
anins171;Xis6anins172;Xis6anins173;Xis6anins174;Xis6anins175;
XisGanins176;Xis6adeis177;Xis6anins178;Xis6anins179;Xis6anins
180;Xis6anins181;Xis6anins182;Xis6anins183;Xis6anins184;Xis6
anin5185;Xi36aninsl86;
Xis7aninS1;Xis7anin52;Xis7anins3;Xis7anins4;Xis7anins5;Xis7
anins6;Xis7anins7;Xis7aninsS;Xis7anins9;Xis7anins10;Xis7and
Yisll;Xis7anins12;Xis7aninsl3;Xis7anins14;Xis7aninslS;Xis7and
Yisl6;Xis7anins17;Xis7anins18;Xis7anins19;Xis7anin520;Xis7and
Yis21;Xis7andYis22;Xis7aninsZ3;Xis7aninsZ4;Xis7anin525;Xis7and
YisZ6;Xis7anins27;Xis7aninsZ8;Xis7aninsZ9;Xis7anins30;Xis7and
Yis31;Xis7andYis32;Xis7anins33;Xis7anins34;Xis7anins35;Xis7and
Yis36;Xis7anins37;Xis7andY1538;Xis7anins39;Xis7anins4O;Xis7and
Yis41;Xis7anins42;Xis7anins43;Xis7anins44-;Xis7anins45;Xis7and
Yis46;Xis7anins47;Xis7anins48;Xis7anins49;Xis7aninsSO;Xis7and
YisSl;Xis7anins 52;Xis7andYisS3;Xis7aninsS4;Xis7aninsSS;Xis7and
Y1356;Xis7anins 57;Xis7andYis58;Xis7aninsS9;Xis7aninséO;Xis7and
Yis61;Xis7anins62;Xis7anins63;Xis7anins64;Xis7anins65;Xis7and
Yis66;Xis7anins67;Xis7anins68;Xis7anins69;Xis7anins70;Xis7and
Yis71;Xis7anins72;Xis7anins73;Xis7anins74;Xis7anins75;Xis7and
Yis 76;Xis7anins 77;Xis7anins78;Xis7anins79;Xis7anin580;Xis7and
Yi581;Xis7anins82;Xis'l'anins83;Xis7anin384;Xis7anin385;Xis7and
Yi886;Xis7anins 87;Xis7anin388;Xis7anin889;Xis7anins 90;Xis7and
Xis7andYis92;Xis7anins93;Xis7anins94;Xis7adeis95;Xis7and
Xis7anins97;Xis7andYis98;Xis7anin399;Xis7anins 100;Xis7
anins101;Xis7anins102;Xis7anins103;Xis7anins104;Xis7anin5105;
Xis7aninle6;Xis7anins107;Xis7anins108;Xis7anins109;Xis7anins
110;Xis7anins111;Xis7anins112;Xis7anins113;Xis7aninsll4;Xis7
anins115;Xis7anins116;Xis7anins117;Xis7anins118;Xis7anins 119;
Xis7anins 120;Xis7anins121;Xis7anins122;Xis7anins123;Xis7anins
124;Xis7anins125;Xis7anins126;Xis7anins127;Xis7anin3128;Xis7
anins 129;Xis7anins 130;Xis7anins 131;Xis7anins132;Xis7anins 133;
Xis7anins134;Xis7anins135;Xis7anins136;Xis7anins137;Xis7anins
138;Xis7anins139;Xis7anins140;Xis7anins141;Xis7anins142;Xis'/'
anins 143;Xis7anins144;Xis7anins l45;Xis7anins l46;Xis7anins 147;
Xis7anins 148;Xis7anins 149;Xis7anins150;Xis7anin5151;Xis7anins
152;Xis7anins153;Xis7anins154;Xis7anins155;Xis7anins156;Xis7
anins s7anins158;Xis7anins 159;Xis7anins160;Xis7anins 161;
Xis7anins 162;Xis7anins163;Xis7anins 164;Xis7anins165;Xis7anins
166;Xis7anins 167;Xis7anins168;Xis7anins169;Xis7anins170;Xis7
anins171;Xis7anins172;Xis7aninsl73;Xis7aninsl74;Xis7aninsl75;
Xis7anins s7anins 177;Xis7anins l78;Xis7aninsl79;Xis7a11ins
180;Xis7anins181;Xis7anins182;Xis7anin5183;Xis 7 aninSlS4;Xis7
anins s7anins 186;
Xis8aninsl;Xis8aninsZ;XisSanins3;Xi38andYis4;Xis8aninss;Xi38
anin56;XisSanins7;Xis8anin38;XisSanins9;Xis8anins 10;XisSand
Yis11;Xis8anins12;Xi38anins13;XisSanins14;XisSanins15;Xis8and
Yis 16;Xi58anins l7;Xi38anins 18;XisSanins 19;Xis8anin320-,Xis8and
Yile;Xis8aninsZ2;XisSaninsZ3;XisSaninsZ4;XisSanins25;Xi58and
YisZ6;XisSanins27;Xi58anins28;XisSanins29;XisS anins30;XisSand
Yis31;Xis8anins 32;Xis8anins33;XisSanins34;Xis8anins35;Xi58and
Yis36;Xi58anins 37;Xis8anins38;XisSanins39;XisSanins40;XisSand
Yis41;XisSanins42;XisSandYis43;Xi38anins44;Xis8anins45;Xi58and
Yis46;XisSanins47;Xis8anins48;Xis8anins49;XisSaninsSO;Xis8and
YisSl;XisSanin552;Xis8aninsS3;Xi58aninsS4;Xis8anins 55;Xi58and
YisS6;Xis8anins 57;X158anin358;Xis8aninSS9;Xi38anins60;Xi58and
Yis61;Xis8anins62;Xis8anins63;XisSanins64;XisSanins65;Xi38and
Yis66;XisSanins67;Xi58anins68;Xis8anins69;Xis8anins70;XisSand
Yis7l;Xis8anins72;Xis8anins73;XisSanins74;Xi58anins75;Xi58and
Yis76;Xis8anins77;Xi58anins78;XisSanins79;Xis8anins 80;Xis8and
XisSanin582;Xis8anin583;Xi38anin384;Xis8anins 85;Xi88and
Yis 86;XisSanins 87;Xi38anins 88;XisSanins 89;XisSanins 90;Xi38and
Yi591;Xis8anins92;Xis8anins93;Xis8anin594;XisSanins95;Xi38and
Xis8anins97;Xis8anins98;XisSanins99;Xi58anins100;Xi58
anins 101;Xi58anins 102;Xis8anins 103;XisSanins104;XisSanins 105;
XisSanins106;XisSanins107;XisSanins108;Xi38anins109;Xis8anins
110;Xi58anins111;XisSanins112;XisSanins113;XisSanins114;Xi38
anins115;XisSanins116;Xis8anins117;XisSanins118;XisSanins 119;
XisSanins120;XisSanins121;Xi38anins122;Xi38anins123;Xis8anins
124;Xis8anins125;XisSanins126;XisSanins127;Xis8anin5128;Xis8
anins 129;Xis8anins 130;Xi88anins131;Xis8anins132;Xis8anins 133;
Xis8anins134;Xis8anins135;Xis8anins136;Xis8aninsl37;Xis8anins
sSanins139;Xis8aninsl40;XisSanins141;XisSanins142;Xis8
aninsl43;Xis8anins144;Xi88anins 145;XisSanins146;Xissanins147;
ins148;XisSaninsl49;Xi58anins150;XisSanins151;Xis8anins
152;XisSanins153;Xis8anins154;Xi38anins155;Xis8anins156;Xi38
anins157;Xi38anins158;XisSanins159;XisSanins160;Xis8anins 161;
Xis8anin5162;Xi38anins163;Xis8aninsl64;Xi88 anins 165;Xis8anins
166;XisSaninsl67;Xis8anins168;Xis8anins169;Xis8aninsl70;Xis8
anins171;XisSanins172;XisSanins173;XisSanins174;Xi58anins 175;
XisSanins 176;Xis8anins l77;XisSanins 178;XisSanins 179;Xis8anins
180;Xis8a11ins181;Xi58anins182;Xis8anins183;Xis8anins184;Xis8
anins 185;XisSanins 186;
Xis9anins1;Xi59andY1'52;Xis9anins3;Xis9andYis4;Xi39anin85;Xis9
anins6;Xi59andYis7;Xis9anins8;Xis9anin39;Xis9aninle;Xis9and
Yis11;Xis9anins12;Xis9anins13;Xi59aninsl4;Xis9aninslS;Xis9and
Yis16;Xis9anins17;Xis9andY1's18;Xis9aninsl9;Xis9aninsZO;Xi39and
is9aninsZ2;Xis9anin523;Xis9anin324;Xis9aninsZS;XisQand
Yis26;Xis9anins27;Xi59anin328;XisQanins29;Xis9anins3O;Xis9and
Yis31;Xis9anins32;Xis9anins33;Xis9anins34;Xis9anins35;Xi59and
Yis36;Xis9anins37;Xis9anins38;Xis9anins39;Xis9anins40;Xi59and
Yis41;Xis9anins42;Xis9anins43;XisQanins44;Xis9anins45gXis9and
Xis9anins47;Xis9anins48;Xi39anins49;Xis9anins 50;Xis9and
YisSl;Xis9anins 52;Xis9anins53;Xis9aninsS4;Xis9anins55;Xis9and
YisS6;Xis9anins 57;Xis9anins58;Xis9anin359;Xis9anins60;Xis9and
Yis61;Xis9anins62;Xi39anins63;Xis9anin564;XisQanins65;Xis9and
Yis66;Xis9anins67;Xis9anins68;Xis9anins69;Xis9anins70;Xis9and
Yis’ll;Xis9anins72;Xis9anins73;Xis9anins74;Xis9anins75;Xis9and
Xis9anins77;Xis9anins78;Xis9anins79;Xis9anins80;Xi59and
Yis 81;Xis9anins 82;Xi39anins83;Xis9aninSS4;Xis9anins 85;Xis9and
Yis86;Xi39anins87;Xis9andYis88;Xis9anins89;Xis9anins90;XisQand
Yis91;Xis9anins92;Xis9anins93;Xis9anins94;Xis9anins95;Xis9and
Yis96;Xis9anins97;Xis9anins98;Xis9anins99;Xis9anins100;Xis9
aninlel;Xis9anins102;Xis9anins103;Xis9anins104;Xi59aninSIOS;
Xis9anins106;Xis9anins107;Xi39anins108;XisQanins109;Xis9anins
110;Xis9anins111;Xis9anins112;Xis9anins113;Xi39aninsll4;Xis9
3O anins115;Xis9anins116;Xis9anins 117;Xis9anins 118;Xis9anins 119;
XisQanin3120;Xis9anins121;Xis9anins122;Xis9anins123;Xis9anins
124;Xis9anins125;Xis9anins126;Xis9anins127;Xi39anins128;Xis9
anins 129;Xis9anins 130;Xis9anins s9anins 132;Xis9anins 133;
Xis9anins134;Xis9anins135;Xis9anins136;Xis9anins137;Xis9anins
138;Xis9anins139;Xis9anins140;Xis9anins14l;Xis9anin5142;Xis9
anins s9anins 144;Xis9anins 145;Xis9anins 146;X139anins 147;
Xis9aninsl48;Xis9anins s9anins 150;Xis9 anins 151;Xis9anins
152;Xis9anins153;Xi39anins154;XisQanin5155;Xis9 anins156;Xis9
anins 157;Xis9anins 158;Xis9anins 159;Xis9anins 160;Xis9anins 161;
Xis9anins162;Xis9anins163;Xis9anins164;Xis9 anins 165;Xis9anins
166;Xis9anin3167;Xis9anins168;Xis9aninsl69;Xis9 anins170;Xis9
anins 171;Xis9 anins 172;Xis9anins 173;Xis§and‘x’is 174;Xis9andY is 175;
Xis9anins176;Xis9anins177;Xis9aninsl78;Xis9 anins s9a.nins
180;Xis9anins181;Xis9anins182;Xis9anins183;Xis9aninsl84;Xis9
anin3185;Xis9anins 186;
Xis 10anins 1;Xis IOanins2;Xis s3;Xis lOanins 4;Xis 10anins 5;
Xis10anins6;Xis10anins7;Xileanin58;Xis10aninsQ;Xileanins
;Xis 10 anins 11;Xis 10anins 12;Xis s 13;Xi510 anins 14;Xis 10
aninslS;Xis 10 anins 16;Xis 10 anins l7;Xis 10anins 18;Xis 10 anins 19;X
is 10 anins 20;Xis le;Xis 10 anins 22;Xis 10 anins23;Xis10anins
24;Xis 10 anin525;Xis 10anin326;Xis lOaninSZ7;Xis 10 aninsZ8;Xis 10
aninsZ9;Xileanins30;Xis10anins31;Xis10anins32;Xis10anins33;X
is 10 anins 34;Xis 10 anins35;Xis 10 anins 36;Xis 10 anins 37;Xis 10 anins
38;Xis 10 anins39;Xis 10anins40;Xis s41;Xis 10anins42;Xis 10
anins43;Xis 10 anins44;Xis 10 anins45;Xis 10anins46;Xis 10 anins47;X
is 10anins48;Xis 10anins49;Xis 10aninsSO;Xis 10aninsSl;Xis 10anins
52;XileaninsS3;Xis10anins54;Xis10aninsSS;Xis10aninsS6;Xis10
aninsS7;Xi310anin358;Xis10aninsS9;XislOanin560;Xis10anins61;X
is IOanins62;Xis 10anins63;Xis10anin864;Xis 10anin365;Xis lOanins
66;Xis 10 anins67;Xis 10anins68;Xis lOanins69;Xis 10anins 70;Xis 10
anins71;Xis10anins72;XislOanins73;Xis10anins74;Xis10anins75;X
is 10anins76;Xis IOanins77;Xis10anins78;Xis10anins79;Xis lOanins
80;Xis 10 anins 81;Xis 10anins 82;Xis 10anins 83;Xis IOanins 84;Xis 10
anins 85;Xis 10anin586;Xis 10 anins 87;Xis 10 anins 88;Xis 10 anins 89;X
is10anins90;Xis10anins91;Xis10anins92;Xis 10anin393;Xis 10anins
94;Xis 10 anins 95;Xis 10 anins96;Xis 10anins 97;Xis 10anins98;Xis 10
anins 99;Xis 10 anins 100;Xis 10 anins 101;Xis 10 anin5102;Xis 10 anins
103; Xis 10 anins s 10 anins 105;Xis 10 anins 106;Xis 10 anins s
10anins 108;Xis 10 anins 109;Xis 10anin3110;Xis 10 anins s 10 andY
is 112;Xis 10 anins 113;Xis 10 anins 114;Xis 10 anins 115;Xis 10 anin5116;X
W0 2016/1 10584
is 10aninsll7;Xis 10anins 118;Xis s 119;Xis 10 anins 120;Xis 10and
Yis 121;Xis 10anins 122;Xis 10 anins 123;Xis 1021de is 124;Xileanins 125;
Xis 10anins 126;Xis 10 anins 127;Xis 10 anins 128;Xis lOanins 129;Xis 10
anins 130;Xis 10 anins 131;Xis 10anins 132;Xis 10 anins 133;Xis 10anins
134;Xis 10 anins 135;Xis 10 anins 136;Xis 10 anins 137;XisIO anins 138;Xis
anins s s 140;Xis 10 anins 141;Xis 10 anins 142;Xis 10 andY
is 143;Xis 10 anins 144;Xis 10 anins 145;Xis 10 anins 146;Xis 10 anins 147;X
is 10 anins 148;Xis 10 anins 149;Xis 10 anins 150;Xis 10 anins 151;Xis IOand
Yis 152;Xis 10 anins 153;Xis 10 anins 154;Xis 10 aninslSS;Xis 10 anins 156;
Xis 10 anins 157; Xis 10 anins 158;Xis 10 anins 159;Xis 10 anins s 10
anins s 10 anins 162;Xis 10 anins 163;Xis 10anins 164;Xis 10 anins
s 10 anins 166;Xis 10 andY is 167;Xis 10 anins 168;Xis 10 anins 169;Xis
IOaninsl70;X1310anins171;Xis10anins172;Xis10anins173;Xis10andY
is 174;Xis 10 anins 175;Xis 10 anins s 10 anins 177;Xis 10 anins 178;X
is IOanins s 10 anins 180;Xis 10 anins 181;Xis 10 anins 182;Xis 10 and
Yis 183;Xis 10 anins s 10 anins 185;Xis 10 anins 186;
Xisll aninsl;Xisllanin32;Xisll anins3;Xisll ;X1'sll aninsS;
Xisllanins6;Xis 11 anins7;Xis 11 anins8;Xis 11 anin59;Xisll anins
;Xis 11 anins 11;Xi511 anins 12;Xis 11 anins 13;Xis 11 anins 14;Xisll
anins 15;Xisll anins 16;Xisll anins 17;Xisll anins l8;Xisllanins 19;X
isll aninsZO;Xis 11 anins21;Xisll 2;XisllaninsZ3;Xisll anins
24;Xisllanin525;Xisllanins26;Xis11anin327;XisllaninsZS;Xisll
aninsZ9;Xisllanins30;Xis11anins31;Xis11anins32;Xisllanins33;X
isllanins34gXis11anins35;Xisll anins36;Xis11anins37;Xisllanins
38;Xisll anins 39;Xisll anins40;Xis 11 1;Xis 11 anins42;Xis 11
anins43gXisllanins44;Xisllanins45;Xisl1anins46;Xisllanins47;X
is 11 anins48;Xisll anins49;Xisll aninsSO;Xis 11 aninsSI;Xisll anins
52;Xisll anins 53;Xis 11 aninsS4;Xis 11 anins 55;Xisll anins56;Xis 11
anins57;Xisll anin358;XisllandY1359;Xis11 anins60;Xisll anins61;X
3O isllanins62;XisllaninsG3gXis11anins64;Xis11anins65;Xisllanins
66;Xis 11 anin567;Xis 11 anins68;Xis ll anins69;Xis 11 anins 70;Xis 11
anins71;Xis 11 anins72;Xis11 anins73;Xisll anins74;Xisllanins75;X
isll anins76;Xisll anins77;Xis 11 anins78;Xisll anins79;Xis11 anins
80;Xis 11 anins 81;Xis 11 anins 82;Xis llanins83;Xisll anins84;Xis 11
aninsSS;Xis 11 anins86;Xisll anins87;Xis11 anins88;Xisllanins89;X
is 11 anin590;Xis 11 anins91;Xis 11 anins92;Xis 11 anins 93;Xis 11 anins
94;Xis 11 anins95;Xis 11 anins96;Xis 11 7; Xisll anins98;Xisll
anins 99;Xis 11 anins 100;Xis 11 anins 101;Xis 11 deis 102; Xis 11 anins
103;Xisllaninle4;Xi311anin3105;Xis11aninleé;Xis 11aninle7;Xis
11 08;Xisll aninle9;Xisll anins110;Xisll andY is 111;Xisll andY
is 112;Xis 11 anins 113;Xisll l4;Xis 11 anins 115;Xis 11 anins 116;X
i311 anins 117;Xis 11 anins 118;Xis 11 anins 119;Xis 11 anins 120;Xis 11 and
Yisl21;Xis 11 anins122;Xisll anins123;Xis 11 andY is 124;Xis 11 anins 125;
Xis 11 anins 126;Xis 11 anin5127;Xis 11 anins 128;Xis 11 anin5129;Xis11
anin5130;Xis 11 anins 131;Xi311 anins 132;Xis 11 anins 133;Xisll anins
134;Xis 11 anins 135;Xisll anin5136;Xis 11 anins 137;Xis 11 anins 138;Xis
11 anins 139;Xis 11 anins 140;Xis 11 anins 141;Xis11 anins 142;Xis 11 andY
is 143;Xis11 anins 144;Xi311 anins 14S;Xisll anins 146;Xis 11 anins 147;X
1311 deis 148;Xis 11 anins 149;Xis 11 anins s 11 anins s 11 and
Yis 152;Xis 11 anins 153;Xis 11 anins 154;Xis 11 anins 155;Xis 11 deis 156;
Xis 11 anins s 11 anins 158;Xis 11 anins 159;Xis 11 anins 160;Xis 11
anins 161;Xis 11 anins 162;Xis 11 anins 163;Xis 11anins 164;Xisll anins
165;Xis11anins166;Xis11aninsl67;Xis11anin5168;Xisll aninsl69;Xis
11 anins 170;Xis 11 anins 171;Xisll anins 172;Xisll aninsl73;Xis 11 andY
is 174;Xis 11 anins 175;Xis 11 anins 176;Xis 11 anins 177;Xisll anins 178;X
is 11 anins 179;Xis 11 anin5180;Xisll anins 181;Xisll aninsl82;Xis 11 and
Yis 183;Xisll anins 184;Xis 11 anins s 11 deis 186;
Xis 12 anins 1;Xis 12anins2;Xis 12anins3;Xis 123nins4;Xis 12 aninsS;
Xis 12 anins6;Xis 12 anins7;Xis 12 anins 8;Xis 12 anins 9;Xis 12 anins
10;Xis 12 anins 11;Xis IZanins 12;Xis 12 anins 13;Xi312and‘{is l4;Xis 12
anins 15;Xis 12 anins 16;Xis 12 anins l7;Xis 12anins 18;Xi312anins 19;X
is 12anin520;Xis 12 aninle;Xis 12andY1322;Xis 12 anin523;Xis 12 anins
24;Xis 12anin525;Xis 12 anins26;Xis 12 aninsZ7;Xis 12 anins 28;Xi312
aninsZ9;Xis 12 anins 30;Xis 12 anins31;Xis 12 anins 32;Xis 12 anins 33;X
is 534;Xis 12 anins35;Xis 12 anins36;Xis 12anins37;Xis 12 anins
38;Xis 12 anins 39;Xis 12 anins40;Xis 12anins41;XislZanins42;Xis 12
anins43;Xis 12 anins44;Xis s45;Xis 12 anins46;Xis 12 anins47;X
is 12anins48;Xis 12 anins49;Xis s 50;Xis 12aninsSl;Xis 12 anins
52;Xis 12 anins 53;Xis 12 anins 54;Xis 12 aninsSS;Xis 12anins 56;Xis 12
anins 57;Xis 12 anin558;Xis 12anins 59;Xis 12 0;Xis 12anins61;X
W0 2016/1 10584
is 12 anins 62;Xis 12 anins 63;Xis 12 anins 64;Xis 12 anins 65;Xis 12 anins
66;Xis 12 anins67;Xis 12 anins 68; Xis 123nins69; Xis 12 anins70; Xis 12
anins71;Xis 12 anins 72;Xis 12 anins73;Xis 12 anins 74;Xi512anins75;X
is lZanins 76;Xis 12 anins 77;Xis 12 anins78;Xis 12 9;Xi312anins
80;Xis 12 anins 81; Xis 12 anins 82; Xis 12 anins 83; Xis 12 anins 84;Xis 12
anins 85;Xis 12 anins86;Xisl2anins 87;Xis12anins88;XislZanins89;X
is 12 anins90;Xis 12 anins9l;Xis 12 anins 92;Xis 12 anins93;Xis 12 anins
94;Xis 12 andY is 95;Xis 12 anins 96;Xis 12 andY is 97; Xis 12 anins 98; Xis 12
anins 99; Xis 12 anins 100;Xis 12 anins 101; Xis 12 anins 102;Xis 12 anins
103; Xis 12 anins 104;Xis 12 anins 105; Xis 12 anins 106;Xis 12 anins 107; Xis
12 anins 108;Xis 12 anins 109;Xis 12 anins 110;Xis 12 anins s 12 andY
is 112;Xis 12 anins 113; Xis 12 deis 114; Xis 12 anins 115;Xis 12 anins 116;X
is 12 anins 117;Xis 12 anins 118;Xis 12 anins 119;Xis 12 anins 120;Xis 12 and
Yis 121; Xis 12 anins 122; X is 12 anins 123; Xis 12 andY is 124; Xis 12 anins 125;
X is 12 and Yis 126; Xis 12 andY is 127; Xis 12 andY is 128; X is 12 deis 129; Xis 12
‘andY is 130; Xis 12 andY is 131; Xis 12 andY is 132; Xis 12 deis 133; Xis 12 andY is
134; Xis 12 anins 135; Xis 12 anins 136; Xis 12 deis 137; Xis 12 anins 138;Xis
12 andY is 139;Xis 12 anins 140;Xis 12 deis 141; Xis 12 anins 142; Xis 12 andY
is 143;Xis 12 anins 144;Xis 12 deis 145; Xis 12 anins 146;Xis 12 anins 147; X
is 12 anins 148;Xis 12 anins 149;Xis 12 anin8150;Xis 12 anins 151;Xis 12 and
Yis 152;Xis 12 deis 153; Xis 12 deis 154; Xis 12 andY is 155;Xis 12 anins 156;
Xis 12 anins 157;Xis 12 anins 158;Xis 12 anins 159;Xis 12 anins 160;Xis 12
anins 161; Xis 12 anins 162;Xis 12 anins I63; Xis 12 anins 164;Xis 12 anins
s 12 andY is 166;Xis 12 andY is 167; Xis 12 anin5168;Xis 12 anins 169;Xis
12 anins s 12 anins 171;Xis 12 anins 172;Xis 12 anins 173;Xis IZandY
is 174; Xis 12 anins 175; Xis 12 deis 176; Xis 12 anins 177;Xis 12 anins 178; X
is 12 anins 179;Xis 12 anins s 12 anin3181;Xis 12andY15182;Xis 12 and
Yis 183; Xis 12 anins 184; Xis 12 deis 185; orXis 12 and Yis 186.
In one ment, X is 2 and Y is 5. In another embodiment, X is 10 and Y is 164.
In one embodiment, the first binding domain binds to 4-1BB (CD137) and the second binding
domain binds to 0X40 (CD134), wherein, preferably, the binding agent comprises
one or more CDRS or one or more le domains of an antibody AB137_X, wherein X is
selected from the group consisting of 1 to 12, as shown in Table 9, and
one or more CDRs or one or more variable domains of an antibody AB 134_Y, wherein Y is
selected from the group consisting of 1 to 92, as shown in Table 8.
In various ments, X is l and Y is ed from the group consisting of 1 to 92; X is 2
and Y is selected from the group consisting of 1 to 92; X is 3 and Y is selected from the group
consisting of 1 to 92; X is 4 and Y is selected from the group consisting of 1 to 92; X is 5 and Y
is selected from the group consisting of 1 to 92; X is 6 and Y is selected from the group
consisting of 1 to 92; X is 7 and Y is selected from the group consisting of 1 to 92; X is 8 and Y
is ed from the group consisting of 1 to 92; X is 9 and Y is selected from the group
ting of 1 to 92; X is 10 and Y is selected from the group consisting of 1 to 92; X is 11 and
Y is selected from the group consisting of 1 to 92; or X is 12 and Y is ed from the group
consisting of 1 to 92.
In various embodiments,
Xis1aninsl;XisianinsZ;Xis1anins3;Xislanins4;XislaninsS;Xisl
anins6;Xis1anins7;Xislanins8;Xislanins9;Xislanins 10;Xisland
Yisll;Xislanins 12;Xislaninsl3;Xislanins 14; Xislanins 15;Xisland
Yisl6;Xislanins l7;Xisl anins18;Xislanins19;Xislanins20;Xisland
Yis21;Xislanins22;Xisl anin523;Xislanins24; Xislanins 25;Xis 1 and
Yi326;Xislanin527;Xis1anin328;Xis 1 dei529; Xisl anins30;Xisland
Yis31;Xislanins 32;Xislanins33;Xislanins34;Xislanins35;Xisland
Yis36;Xislanin537;Xis l anins38;Xislanins39;Xisl anins40;Xis1and
Xislanins42;Xislanins43;Xislanins44;Xislanins45;Xisland
Yis46;Xislanins47;Xislanins48;Xisl anins49;Xisl anins50;Xisland
YisSl;Xislanins 52;Xis i 3;Xis1aninsS4;Xislanins 55;Xisiand
Yi556;Xislanins 57;Xis1anin358;XislaninsS9;Xislanins60;Xisland
Yis61;Xislanins 62;Xis1anins63;Xis1anins64;Xislanin565;Xis l and
Yi366;Xislanins67;Xislanins68;Xislanins69;Xislanins70;Xisland
Yis71;Xis1anins72;Xislanins73;Xis1anins74;Xislanins75;Xisland
Yis76;Xis1anins77;Xislanins78;Xislanins79;Xislanins80;Xisland
Yi581;Xislanins 82;XislaninsS3;Xis1anins84;Xislanins 85;Xisl and
Yis86;Xis1 anin387;Xis1anins88;Xis1anins89;Xislanins90;Xisland
Yis91;Xislanin392;
XisZanins1;XisZanins2;Xis2anins3;Xi52anins4;Xi52anins5;Xi32
anins6;XisZanins7;XisZandYis8;Xis2anins9;Xi52anins10;Xi52and
W0 2016/1 10584
Yis Zanins 12;Xi32aninsl3;XisZanins14;Xis2anin515;Xi52and
Yis 16;XisZanins l7;XisZanins18;XisZanins 19;XisZaninsZO;XisZand
Yis21;Xis2anin322;XiSZanins23;XisZaninsZ4gXi52anin325;Xi32and
YisZ6;XisZanin327;Xis2aninsZS;XisZaninsZ9;XisZanins30;XisZand
Yis3l;Xi52anins32;Xi52anins33;XisZanins 34;XisZanins35;XisZand
Yis36;XisZaninsS7;XisZanins38;Xi82anins39;Xis2anins40;Xi32and
Yis41;XisZanins42;XisZanins43;XisZanins44;Xi32and‘x’is45;Xis2and
Yis46;Xi52andYi547;XisZandYis48;XisZanins49;XisZanins50;Xis2and
Yis51;XisZaninsSZ;XisZandYisS3;Xis2aninsS4;Xi52aninsSS;Xis23nd
YisS6;XisZanin557;Xis2anins58;Xi32anins 59;XisZanins60;Xi32and
Yis61;Xis2anins62;Xis2anins63;Xi52anin364;Xi32anins65;XisZand
Yis66;Xis2anins67;XisZandYis68;XisZanins69;Xi52anins70;Xi32and
XisZanins72;Xiszanins73;Xis2anins'/4;Xis2anins75;XisZand
Yis76;XisZanins77;Xiszanins78;Xis2anins79;Xis2anins80;Xi52 and
Yis 81;XisZanins 82;Xi32anins83;Xis23nins84;XisZanins85;XisZand
Yis86;Xi82anins87;Xis2anins88;Xis2aninsS9;Xis2anins90;XisZand
Yis91;XisZanins92;
Xis3anins1;Xis3aninsZ;Xis3anins3;Xis3anins4;Xis3aninsS;Xis3
anins6;Xis3anins7;Xis3 ;Xis3anins9;Xis3anins 10;Xis3and
Yis11;Xis3anins 12;Xis3anins13;Xis3aninsl4;Xis3 anins15;Xis3and
Yis16;Xis3anins 3anins18;XisBanins19;Xis3anins20;Xis3and
Yile;Xi53anin522;Xis3aninsZ3;Xis3aninsZ4;Xis3anin525;Xis3and
Yi526;Xis3anin527;Xis3anin328;Xi33anin329;Xis3 anins 30;Xis3and
Yis3l;Xis3anins32;Xis3anins33;Xis3anins34;Xis3anins35;Xis3and
Yi536;Xis3anins37;Xis3anins38;Xis3anins39;Xis3anins40;Xis3and
Yis4l;Xis3anins42;Xis3anins43;XisSanins44;Xis3anins45;Xis3and
Yis46;Xis3anins47;Xi53anins48;Xis3anins49;Xis3anin550;Xis3and
YisSl;Xis3a.nins 52;XisSaninsS3;Xis3anins54;Xis3 anins 55;Xis3and
Yis56;Xis3aninSS7;Xis3anin358;Xis3aninsS9;Xis3anins60;Xis3 and
Yis6l;Xis3anin562;Xis3anins63;Xis3anins64;Xis3anins65gXis3 and
Yi366;Xis3a.nins 67;Xis3anin568;Xis3anins69;Xis3anins70;Xis3and
Xis3anins 72;Xis3anins73;Xis3anins74;Xis3 anins75;Xis3and
Yis76;Xis3anins77;Xis3anins78;Xis3anins79;Xis3 anins 80;Xis3and
YisSl;Xis3anins 82;Xis3anins83;Xis3aninsS4;Xis3 aninsSS;Xis3 and
Yis86;Xi53deis 87;Xis3anins 88;Xis3anins89;Xis3anins90;Xis3and
Xis3anins92;
Xis4aninzs1;Xis4andYisZ;Xis4aninsS;Xis4andY is4;Xis4anins 5;Xis4
anins6;Xis4anins7;Xis42deis8;Xis4anins9;Xis4anins10;Xis4and
Yisll;Xis4anins 12;Xis4aninsl3;Xis4anins 14; Xis4anins 15;Xis4and
Yis16;Xis4anins17;Xis4anins18;Xis4anins19;Xis4anin520;Xis4and
Yis21;Xis4anins22;Xis4aninsZ3;Xis4anins24; Xis4anin525;Xis4and
Yis26;Xis4aninsZ7;Xis4anins28;Xis4anins29; Xis4anins30;Xis4and
Xis4anins32;Xis4anins33;Xis4anins34;Xis4anins35;Xis4and
Yis36;Xis4anins37;Xis4anins38;Xis4anins39; Xis4anins40;Xis4and
Yis41;Xis4anins42;Xis4anins43;Xis4a.nins44; X154 anins45;Xis4and
Yis46;Xis4anins47;Xis4anins48;Xis4anins49; Xis4aninsSO;Xis4and
Yis 51;Xis4anins 4aninsS3gXis4anin354; Xis4anin555;Xis4and
YisS6;Xis4anins 5.7;Xis4anins 4aninsS9; Xis4anins60;Xis4and
Yi561;Xis4anins62;Xis4anins63;Xis4anins64-;Xis4anins65;Xis4and
Yis66;Xis4anins67;Xis4anins68;Xis4anins69; Xis4anins 70;Xis4and
Yis71;Xis4anins72;Xis4anins73;Xis4anins74;Xis4anins75;Xis4and
Yis76;Xis4anins 77;Xis4anins78;Xis4a.nins79;Xis4anins 80;Xis4and
YisSl;Xis4anins 82;Xis4anins 83;Xis4aninsS4;Xis4anin585;Xis4and
Xis4anins 87;Xis4anins 88;Xis4aninsS9;Xis4anins90;Xis4and
Yi591;Xis4anins92;
XisSanins1;XisSanin32;Xis5adeis3;XisSanins4;XisSaninsS;Xis5
;XisSanins7;Xi55aninsS;Xis5anin59;XisSaninle;Xis5and
Yis]1;XisSanins12;XisSaninsl3;XisSaninsl4;Xis5anins15;XisSand
Yis 16;XisSanins 17;XisSaninslS;XisSanins l9;Xis5aninsZO;XisSand
Yile;XisSanins22;XisSanins23;Xis5anin524;XisSaninsZS;Xis5and
YisZ6;XisSanins 27;XisSanin328;Xi35anins29;XisSanins30;Xi55and
Yis31;XisSanins 5anins33;XisSanins34;XisSanins 35;XisSand
Yis36;XisSanins 37;Xis$anins38;XisSanins39;XisSanins40;XisSand
Yis41;XisSanins42;XisSanins43;XisSanins44;XisSanins45;XisSand
Yis46;XisSanins 47;Xi55anins48;XisSanins49;Xis5anin550;XisSand
YisSl;XisSanins 52;Xis$anins 53;XisSaninsS4;XisSanin555gXiSSand
YisS6;XisSanins 57;Xis5anin558;Xis5aninsS9;XisSanins60;XisSand
Yis61;XisSanin362;Xi35anins 63;XisSanin564;Xis5anins 653Xi85and
Yis 66;XisSanins67;XisSanins68;XisSandYis69;XisSanins70;XisSand
W0 2016/1 10584
Yis7l;Xis5anins72;XisSanins73;XisSanins74;XisSanins75;XisSand
Yis76;XisSanins77;XisSanins78;XisSanins79;XisSanin580;Xi35and
Yis81;XisSanins82;Xis§aninsS3;XisSanin884;Xis5aninsSS;XisSand
YisS6;XisSanins 87;Xis$anins88;XisSanins 89;XisSanins90;XisSand
Yis91;XisSanins92;
Xis6aninsl;Xis6aninsZ;Xis6anins3;Xis6anins4;Xis6anins5;Xis6
anins6;Xis6anins7;Xis6anins anin59;Xis6anins10;Xis6and
Yisll;Xi56anins12;Xis6anins13;Xiséaninsl4;Xis6anins15;Xi36and
Yisl6;Xis6anins17;Xis6anins18;Xi56anins19;Xis6anin320;Xis6and
Yis21;Xis6anins22;Xi56anin523;Xis6aninsZ4;Xis6anins25;Xis6and
Xis6anins27;XiSGanin528;Xis6anin529;Xis6anin330;Xis6and
Yis31;Xis6anins32;Xis6anins33;Xis6anins34;Xi36anins35;Xis6and
Yis36;Xis6anins37;Xis6anin338;Xis6anin539;Xi36anins40;Xis6and
Yis4l;Xi36anins42;Xis6anins43;Xis6anins44;Xis6anins45;Xis6and
,_.. (J! Yis46;Xis6anins47;Xiséanins48;XisGanins49;Xis6anins50;Xiséand
YisSl;Xi36anins 52;Xis6anins53;Xis6aninsS4;Xis6anins 55;Xis6and
Yis56;Xis6anins57;Xis6anin558;Xis6aninSS9;Xis6aninsfiO;Xis6and
Yis61;Xis6anins62;Xis6anins63;Xis6anins64;Xis6anins65;Xis6 and
Yi566;Xis6anins67;Xis6anin368;Xis6anins69;Xis6anins 70;Xis6and
Yis71;Xis6anins72;Xis6andYis73;Xis6anins74;Xis6anins 75;Xi56and
Yis76;Xis6anins77;Xis6anins78;Xis6anins79;XisGanins 80;Xis6and
Yis 81;Xis6anins 6andYi383;Xis6anins84;Xis6anins85;Xis6and
Yis 86;Xiséanins 87;Xis6anin388;Xis6anin589;Xi36anins90;Xis6and
Yis91;Xi36anins92;
Xis7anins1;Xis7aninsZ;Xis7anin53;Xis7anins4;Xis7aninsS;Xis7
anin56;Xis7anins7;Xis7aninsS;Xis7anins9;Xis7anins 10;Xis7and
Yis11;Xis7anins12;Xis7anins l3;Xis7anins14;Xis7anins15;Xis7and
Yis 16;Xis7anins 17;Xis7anins18;Xis7anins l9;Xis7anins20;Xis7and
Yis21;Xis7anin322;Xis7anin323;Xis7anin324;Xis7anin525;Xis7and
YisZ6;Xis7aninsZ7;Xis7anins28;Xis7anin829;Xis7anins30;Xis7and
Xis7anins 32;Xis7anins33;Xis7anins34;Xis7anins35;Xis7and
Yis36;Xis7anins 37;Xis7anin538;Xis7anins39;Xis7anins40;Xis7and
Yis41;Xis7anins42;Xis7anins43;Xis7anins44;Xis7anins4S;Xis7and
Yis46;Xis7anins47;Xis7anins48;Xis?anins49;Xis7aninsSO;Xis7and
YisSl;Xis7anins 7aninsS3;Xis7anins54;Xis7anins 55;Xis7and
Yis 56;Xis7anins 57;Xis7anin358;Xis7anins59;Xis7anin360;Xis7and
Yis61;Xis7anins62;Xis7andYis63;Xis7anins64;Xis7anins65;Xis7and
Yi566;Xis7zdeis67;Xis7andYis68;Xis7anins69;Xis7anins70;Xis7and
Yis71;Xis7andYis72;Xis7anins73;Xis7andYis74;Xis7anins75;Xis7and
Yis76;Xis7anins 77;Xis7anins78;Xis7anins79;Xis7anins 80;Xis7and
Yis 81;Xis7anins 82;Xis’?aninsS3;Xis7aninsS4;Xis7anins 85;Xis7and
Yis86;Xis7anins 7anins 88;Xis7aninsS9;Xis7anin390;Xis7and
Yis91;Xis7anins92;
Xis8anins1;Xi38anins2;Xi58anins3;Xis8anins4;Xi38anins5;Xis8
;Xi38anins7;XisSanins8;XisSanins9;Xis8anins 10;Xis8and
XisSanins12;Xis8aninsl3;Xis8anins14;Xis8anins15;Xi38and
Yis16;Xis83nins17;Xis$aninsi8;XisSaninle;XisSanin520;Xis8and
Yis21;Xis8aninsZZ;XisSaninsZ3;XisSaninsZ4;XisSanins25;Xis8and
YisZ6;XisSanins27;XisSanin328;Xis8anin829;Xis8anins30;Xi58and
Yis31;Xis8anins32;Xis8anins33;XisSanins34;XisSanins35;Xi58and
Yis36;XisSanins37;Xis8anins38;Xis8anins39;Xis8anins40;XisSand
Yis41;Xis8anins42;Xis8anins43;Xis8anins44;XisSanins45;Xi38and
Yis46;Xis8anins47;XisSanins48;Xi38anins49;Xi38aninsSO;Xis8and
Yis51;Xis8anin352;Xi38anins53;Xis8aninsS4;Xis8anins 55;XisSa.nd
YisS6;Xis8aninsS7;XisSanin358;Xi58anins 59;XisSanins60;XisSand
Yis61;Xis8anins62;Xis8anins63;XisSanins64;Xi58anins65;Xis8and
Yis66;Xi58anin567;XiSSanins68;XisSanin569;Xi88anins 70;Xi38and
Xis8anins 72;XisSanins73;Xis8anins74;Xis8anins75;Xi38and
Yis76;XisSanins77;Xis8anins78;Xis8anins79;Xis8anins 80;Xis8and
Yis81;XisSanins 82;Xi58anins 83;Xis8aninsS4;XisSanins85;Xis8and
Xis8anins 87;Xi58anins 88;XisSanins89;Xis8anins90;Xi58and
Yis9l;Xi38anins92;
XisQanins1;Xis9aninsZ;Xi59anins3;Xis9anins4;Xis9aninsS;Xis9
anins6;Xis9anins7;Xis9anins8;Xis9anins9;Xis9anins10;Xis9and
Yis11;Xis9anins12;Xis9anins13;Xis9anins14;Xis9aninslS;Xi39and
Yis16;Xis9anins17;Xis9anin518;Xis9anins l9;Xis9aninsZO;Xis9and
Yi521;Xis9anins22;Xis9anins23;Xis9aninsZ4;Xis9andY13253Xis9and
Yis26;Xis9anin327;Xis9anin528;Xis9aninsZ9;Xis9anins 30;Xis9and
Yis31;Xis9anins32;Xi59anins 33;Xis9anin534;Xis9anins35;Xis9and
Yis36;Xis9anins 37;Xis9anins38;Xis9anins39;Xis9anins40;XiS9and
W0 2016/1 10584 2016/050308
Yis41;Xis9anins42;Xis9anins43;Xis9anins44;Xis9anins4S;Xis9and
Yis46;Xis9anins47;Xis9anins48;Xis9anins49;Xis9anin550;Xis9and
Yis51;Xi59anins52;Xis9anins53;Xis9aninsS4;Xis9aninsSS;Xis9and
YisS6;Xis9anins 57;Xi59anins 58;Xis9anins 59;Xis9anins60;Xis9and
Yis61;Xis9anins 9anins63;Xis9anins64;Xis9anins65;Xis9and
Yis66gXis9anins 67;XisQanins68;Xis9anins69;Xis9anins 70;Xis9and
Yis71;XisQanins72;Xi39anins73;Xis9anins74;Xis9anins75;Xi59and
Yis76;Xis9anins77;Xis9anins78;Xi59anins79;Xis9anins 80;Xis9and
YisSl;Xis9anins 82;Xis9anins 83;Xis9aninsS4;Xis9anins 85;Xi39and
Yis 86;Xi39anins 87;Xi39anin588;Xis9anins 9anins90;Xis9and
Yis91;Xis9anins92;
Xileaninsl;Xis10anins2;XisIOanin33;Xis‘10anins4;Xis10aninss;
Xis10anins6;Xis10anins7;Xis10anins8;Xis10anins9;Xis10anins
;Xis 10anins 11;Xis 10 anin512;Xis 10anins 13; Xis 10anins 14;Xis 10
anins 15;Xis 10 anins 16;Xis lOanins 17;Xis 10aninsl8;Xis lOanins 19;X
is 10anin520;Xis IOanin321;Xis IOanin322;Xis 10 anin523;Xis IOanins
24;Xis 10anins25;Xis10anin326;Xi510anin327; Xis 10aninsZS;Xile
aninsZ9;Xis 10anins30;Xis 10anins31;Xileanins32;Xis lOanins33;X
is 10anins34;Xis10anins35;Xis 10anins36;Xis 10 anins37;Xis 10 anins
38;Xis 10 anins 39;Xis 10 anins40;Xis 10 anins41; Xis 10 anins42;Xis 10
anins43;Xis 10 anins44;Xis 10anins45;Xis 10 anins46;Xis 10 7;X
is 10anins48;Xis 10anins49;Xis 10aninSSO;Xis 10 anin551;Xis IOanins
52;Xis loanins 53;Xis 10 anins 54;Xis 10 aninsSS;Xis 356;Xis 10
aninsS7;Xis 10 anins 58;Xis 10 anins 59;Xis 10 anin360;Xis 10 anins6l;X
is 10anins62;Xis s63;Xis IOanins64;Xis 10 anins65;Xis 10 anins
66;Xis 10anins67;Xis10anins68;Xis lOanins69;Xis 10anins70;Xis 10
anins7l;Xis 10anins72;Xis 10anins73;Xis 10anins74;Xis 10 €deiS75;X
is 10anins76;Xis IOanins77;Xis 10 anins78;Xis 10 anins79;Xileanins
80;Xis10anin381;Xis102deis82;Xis10aninsS3;Xis10adeisS4;Xile
anins 85;Xis lOaninsS6;Xis 10anins87;Xis 10andY1588;Xis 10aninsS9;X
is 10anins90;Xis10anins91;Xi310anins92;
Xis11anins1;Xisllanin52;Xisllanins3;Xisllanins4;XisllaninsS;
Xis 11 anins6;Xisllanins 7;Xis 11 anins 8;Xis 11 ;Xisll anins
;Xisll anins 11;Xisl] anins 12;Xisll anins 13;Xis llanins 14;Xisll
anins15;Xisllanins16;Xisllanins17;Xisllanins18;Xisll andY1519gX
isllanins2O;Xis11anin521;Xisll anins22;XisllaninsZ3;Xisll anins
24;Xis 11 anins25;Xis 11 anins26;Xis 11 anins27;Xis 11 aninsZ8;Xis 11
anin529;Xisll anins30;Xisll anins31;Xisll anins32;Xisll anins33;X
is 11 anins34;Xis 11 anins35;Xisll anins36;Xis 11 anins 11 anins
38;Xis 11 anins39;Xis 11 anins40;Xisll anins41; Xis 11 anins42;Xisll
anins43;Xisllanins44;Xisllanins45;Xisllanins46;Xis11anins47;X
is 11 and‘x'is48;Xis 11 anins49;Xisl‘i and‘x’isSO;Xis‘:1 anins 51;Xisli anins
52;Xis 11 andY1553;Xis 11 4;Xis 11 S;Xisll anins56gXis 11
aninsS7;Xisll anin558;Xisll anins 59;Xisll anin560;Xisll anins61;X
is11 anins62;Xisll anins63;Xisll anins64;Xisll anin565;Xisll anins
66;Xis 11 anins67;Xisll anin568;Xisll aninsG9; Xisll anins70;Xis 11
anins71;Xisllanins72;Xis!1anins73;Xi311anins74;Xisllanins75;X
isllanins76;Xisllanins77;Xi311anins78;Xisll anins79;Xisll anins
11 anins81;Xisll andY1582;Xisll aninsS3;Xisll aninsS4;XisIl
aninsSS;Xis11anin386;Xisll anins87gXisllandY1388;Xisllanins89;X
isllanins90;Xisll anins9l;Xisllanins92;
Xis12anins1;Xis123nin32;Xis12anins3;Xis12anins4;Xis12aninsS;
Xis 12 aninsé;Xis 12 anins7;Xis 12 anins 8;Xis 12 ;Xis 12 anins
;Xis 12 anins 11;Xis 12 anins 12;Xis 12anins 13;Xis 12anins 14;Xis 12
anins 15;Xis s 16;Xis 12 anins 17;Xis 1in3 18;Xis lZanins 19;X
is 12 anin320;Xis 12 anins21;Xis l2 anin322;Xis 12 anins23;Xis12anins
24;Xis 525;Xis 12 anins26;Xis 12anins27;Xis lZanin528;Xi312
aninsZ9;Xis 12anins30;Xis12anins31;Xis12anins32;Xis12anins33;X
is 12 aninsS4;Xis 12 anins35;Xis 12 anins36;Xis 12 anins37;Xis 12anins
38;Xis 12 anins 39;Xis 12 anins40;Xis 12 anins41;Xis 12anins42;Xis 12
anins43;Xis12anins44;Xis12anins45;Xis12anins46;Xis12anins47;X
is 12 anins48;Xis 12anins49;Xis 12 anins 50;Xis 12 anins 51;Xis 12 anins
52;Xis 12 anins53;Xis 12aninsS4;Xis 12anins 55;Xi312 anins 56;Xis12
aninsS7;Xis 12 anins58;Xis 12anins 59;Xi512anins60;Xis 12 anins61;X
is 12 anins62;Xis 12anins63;Xis 12 anins64;Xis 12 5;Xis 12 anins
66;Xis 12 anin567;Xis 12 anins68;Xis 12anins69;Xis 12anins 70;Xis 12
anins7l;Xis 12 anins72;Xis 12 anins73;Xis 12anins74;Xis 12 anins75;X
is 12 6;Xis 12 7;Xis 12 anins78;Xis 12 anins79;Xis 12 anins
80;Xis 12 anins 81;Xi312andY1382;Xis 12anin883;Xis12anins 84;Xis 12
W0 2016/1 10584
anins85;Xis 12 anins 86;Xis 12 anins 87;Xis 12 andY is 88;Xis 12 anins 89;X
is 12 anin590;Xis 12 anins 91;orXis 12 anins92.
In one embodiment, X is 2 and Y is 3. In another embodiment, X is 12 and Y is 9.
In one embodiment, the first binding domain binds to 0X40 (CD134) and the second binding
domain binds to CD27, wherein, preferably, the binding agent comprises
one or more CDRs or one or more variable domains of an dy X, wherein X is
selected from the group consisting of 1 to 92, as shown in Table 8, and
one or more CDRs or one or more variable domains of an antibody AB27_Y, wherein Y is
selected from the group consisting of l to 186, as shown in Table 7.
In various embodiments, X is l and Y is ed from the group consisting of 1 to 186; X is 2
and Y is selected from the group ting of 1 to 1.86; X is 3 and Y is selected item the group
consisting of 1 to 186; X is 4 and Y is selected from the group consisting of l to 186; X is 5 and
Y is selected frOm the group consisting of l to 186; X is 6 and Y is selected from the group
consisting of 1 to 186; X is 7 and Y is selected from the group consisting of l to 186; X is 8 and
Y is selected from the group consisting of l to 186; X is 9 and Y is ed from the group
consisting of l to 186; X is 10 and Y is selected from the group ting of l to 186; X is 11
and Y is selected from the group consisting of 1 to 186; X is 12 and Y is selected from the group
consisting of 1 to 186; X is 13 and Y is selected from the group consisting of 1 to 186; X is 14
and Y is selected from the group consisting of l to 186; X is 15 and Y is ed from the group
consisting of 1 to 186; X is 16 and Y is selected from the group consisting of l to 186; X is 17
and Y is selected fi'om the group consisting of 1 to 186; X is 18 and Y is selected fi'om the group
consisting of 1 to 186; X is 19 and Y is selected from the group consisting of 1 to 186; X is 20
and Y is selected fi’om the group consisting of l to 186; X is 21 and Y is selected from the group
consisting of 1 to 186; X is 22 and Y is selected from the group consisting of 1 to 186; X is 23
and Y is selected from the goup consisting of 1 to 186; X is 24 and Y is selected from the group
consisting of 1 to 186; X is 25 and Y is selected from the group consisting of l to 186; X is 26
and Y is selected from the group consisting of l to 186; X is 27 and Y is selected from the group
consisting of l to 186; X is 28 and Y is selected from the group ting of 1 to 186; X is 29
and Y is ed from the group consisting of l to 186; X is 30 and Y is ed from the group
consisting of 1 to 186; X is 31 and Y is selected from the group consisting of 1 to 186; X is 32
and Y is selected from the group consisting of 1 to 186; X is 33 and Y is selected from the group
consisting of 1 to 186; X is 34 and Y is selected fiom the group consisting of 1 to 186; X is 35
and Y is ed from the group consisting of 1 to 186; X is 36 and Y is selected from the group
consisting of 1 to 186; X is 37 and Y is selected from the group consisting of 1 to 186; X is 38
and Y is selected from the group consisting of 1 to 186; X is 39 and Y is selected from the group
consisting of 1 to 186; X is 40 and Y is ed from the group consisting of 1 to 186; X is 41
and Y is selected from the group consisting of 1 to 186; X is 42 and Y is selected from the group
consisting of 1 to 186; X is 43 and Y is selected from the group consisting of 1 to 186; X is 44
and Y is selected from the group consisting of l to 186; X is 45 and Y is selected from the group
consisting of 1 to 186; X is 46 and Y is selected fi‘om the group consisting of 1 to 186; X is 47
and Y is selected from the group ting of 1 to 186; X is 48 and Y is selected from the group
consisting of 1 to 186; X is 49 and Y is selected from the group consisting of 1 to 186; X is 50
and Y is selected from the group consisting of 1 to 186; X is 51 and Y is selected from the group
consisting of l to 186; X is 52 and Y is selected from the group ting of 1 to 186; X is 53
and Y is selected from the group consisting of 1 to 186; X is 54 and Y is selected from the group
consisting of l to 186; X is 55 and Y is selected from the group consisting of 1 to 186; X is 56
and Y is selected from the group consisting of l to 186; X is 57 and Y is selected fi'om the group
consisting of 1 to 186; X is 58 and Y is selected from the group consisting of 1 to 186; X is 59
and Y is selected from the group consisting of 1 to 186; X is 60 and Y is selected from the group
consisting of 1 to 186; X is 61 and Y is selected from the group consisting of 1 to 186; X is 62
and Y is selected from the group consisting of 1 to 186; X is 63 and Y is selected from the group
consisting of 1 to 186; X is 64 and Y is selected from the group ting of 1 to 186; X is 65
and Y is selected from the group consisting of 1 to 186; X is 66 and Y is selected from the group
consisting of 1 to 186; X is 67 and Y is selected from the group consisting of 1 to 186; X is 68
and Y is ed from the group consisting of l to 186; X is 69 and Y is selected from the group
consisting of l to 186; X is 70 and Y is selected from the group consisting of 1 to 186; X is 71
and Y is ed from the group consisting of 1 to 186; X is 72 and Y is ed fiom the group
consisting of 1 to 186; X is 73 and Y is selected from the group consisting of 1 to 186; X is 74
and Y is selected from the group consisting of 1 to 186; X is 75 and Y is selected from the group
consisting of 1 to 186; X is 76 and Y is selected from the group consisting of 1 to 186; X is 77
and Y is selected from the group consisting of 1 to 186; X is 78 and Y is selected from the group
consisting of l to 186; X is 79 and Y is selected from the group consisting of 1 to 186; X is 80
and Y is selected from the group consisting of l to 186; X is 81 and Y is selected from the group
consisting of 1 to 186; X is 82 and Y is selected from the group consisting of 1 to 186; X is 83
and Y is selected from the group consisting of l to 186; X is 84 and Y is selected from the group
consisting of l to 186; X is 85 and Y is selected from the group consisting of 1 to 186; X is 86
and Y is selected from the group ting of 1 to 186 X is 87 and Y is selected from the group
consisting of 1 to 186; X is 88 and Y is selected from the group consisting of l to 186; X is 89
and Y is selected fiom the group consisting of 1 to 186; X is 90 and Y is selected from the group
consisting of 1 to 186; X is 91 and Y is selected from the group consisting of 1 to 186; or X is 92
and Y is selected from the group consisting of 1 to 186.
In various embodiments,
Xislanins l;Xislanins2;Xislanins3;Xis 1. anins4;Xislanins5;Xisl
;Xislanins7;Xisl aninsS;Xisl anins9;Xis1anins 10;Xisland
Yis11;Xislanins 12;Xislanins 13;Xislanins l4;Xislanins 15;Xisland
Yis l6;Xislanins l7;Xis 1 aninsl8;Xis 1 anins l9;Xis1anin320;Xisland
Yis21;Xislanin322;XislaninsZ3;Xislanin524gXislanins25;Xisland
Xislanins27;Xislanin328;XislaninsZ9;Xislanins30;Xisland
Yis31;Xislanins 32;Xis1anins33;Xislanins34;Xisl anins35;Xis1 and
Yis36;XislaninsS7;Xislanins38;Xislanins39;Xisl anins40;Xisl and
Yis41;Xis1anins42;Xislanins43;Xislanins44;Xislanins45;Xisland
Yis46;Xis1anins47;Xislanins48;Xislanins49;XislaninsSO;Xisland
YisSl;Xis l anin552;XislaninsS3;XislaninsS4;XislaninsSS;Xisland
Xislanins 57;Xis 1 anins 58;Xislanin359;Xislanins60;Xis1and
Yis61;Xislanins62;Xislanins63;Xislanins64;Xislanins65;Xisland
Yis66;Xislanins67;XislaninsG8;Xislanins69;Xis1anins70;Xisland
Yis71;Xislanins72;Xislanins73;Xislanins74;Xisl anins75;Xisl and
Yis76;Xislanins 77;Xis1 anins78;Xislanins79;Xis 1 anins80;Xisl and
Yi581;Xislanins 82;Xis1anins 83;Xislanins84;Xis1anins 85;Xisland
YisS6;Xis l anins87;Xis1anins88;Xislanins89;Xislanins90;Xisland
Yis91;Xis1anins92;Xislanins93;Xislanin894;Xis 1 anins 95;Xisland
Xis 1 andY1597;Xis l anins98;Xis 1 aninsQ9;Xis 1 anins100;Xisl
anins 101;Xis 1 anins 102;Xis 1 anins 103;Xis 1 anins 104;Xislanins 105;
Xislaninle6;Xislanins 107;Xis1anins 108;Xis1anins slanins
slaninslll;Xis1anins112;Xislanins113;Xis1aninsll4;Xisl
anins 115;Xis 1 anins ll6;Xisla.ninsll7;Xis 1 anins 118;Xis l anins119;
Xislanins120;Xislanins121;Xis 1anins122;Xisl anin5123;Xis 1 anins
124;Xis1anins 125;Xis 1 anins slanin5127;Xis 1 anin3128;Xisl
andY15129;Xis 1 anins 130;Xislanins s1anins slanins 133;
Xislaninsl34;Xis1anins135;Xislanins 136;Xis1 anins 137;Xis 1 anins
138;Xis 1 anins 139;Xis 1 anins 140;Xis 1 anins 141;Xislanins 142;Xisl
anins slanins 144;Xis 1 anins 145;Xislanins 146;Xis 1 deis 147;
insl48;Xislanins 149;XislaninslSO;Xisl andY is 151;Xislanins
152;Xislanins153;Xislanin3154;Xis1aninslSS;Xis 1 anin5156;Xisl
aninslS7;Xis1 anin5158;Xisl aninslS9;Xislanins160;Xis 1aninsl61;
ins 162;Xis 1 anins 163;Xis 1 anins 164;Xisl andY isl65;Xis1 anins
166;Xislanins167;Xislanins168;Xislaninsl69;Xis1aninsl70;Xisl
anins 171;Xis1anins 172;Xis 1 aninsl73;Xislanins 174;Xis 1 anins 175;
Xis 1 anins 176;Xis 1 anins slanins 178;Xisl andY is 179;Xislanins
180;Xisl anins181;Xis1anins182;Xis1anins183;Xis 1 anin5184;Xisl
anin5185gXislanin3186;
XisZanins1;XisZaninsZ;XisZanins3;XisZandYis4;XisZaninsS;Xi32
anins6;XisZanins7;Xis2andYisS;XisZanins9;XisZanins10;Xi52and
Yis 11;XisZanins 12;Xis2anins 13;XisZanins 14;Xi52 anins 15;Xi32 and
Yis16;Xi52anins17;XisZaninsl8;Xi52anins19;XisZa.nin520;Xi52and
Yile;XisZanins22;XisZanin523;Xis2anin324;XisZanin525;XiSZand
Yi526;XisZaninsZ7;XisZaninsZ8;XisZaninsZ9;XisZanins30;Xis2and
Yis31;XisZanins Zanins33;Xi32anins34;XisZanins35;Xis2and
Yis36;XisZanins 37;XisZanins38;XisZanins39;XisZanins40;XisZand
Yis41;XisZanins42;XisZanins43;XisZanins44;XisZanins45;Xi32and
Yis46;XisZanins47;Xis2anins48;Xi32anins49;Xis2anins 50;Xi82and
YisSl;Xi52anins 52;Xi52aninsS3;XisZaninsS4;XisZanins 55;Xi32and
Yis56;Xi52anins 57;Xi52aninsS8;XisZaninsS9;Xi32anins 60;Xi32and
XisZanins62;Xi32anins63;Xi32anins64;XisZanins65;XisZand
Yis66;Xi32anins 67;Xi52anins68;Xis2anins69;XisZanins 70;Xis2and
Yis71;XisZanins72;XisZanins73;XisZanins’74;XisZanins75;XisZand
Yis76;XisZanins77;XisZanins78;Xis2anins79;XisZanins 80;Xi52and
Yis 81;XisZanins 82;XisZanins 83;XisZanins84;XisZanins 85;XisZand
YisS6;XisZanins Zanin588;Xi52anins 89;Xis2anins90;XisZand
Yis91;Xis2anins92;XisZanins93;Xis2aninsQ4;XisZanin595;Xi52and
XisZanin597;Xi32anins98;Xis2anins99;Xis2anins100;Xi52
anins 101;Xi52anins 102;XisZanins 103;XisZanins 104;XisZanins 105;
XisZanins106;Xis2anins107;Xis2anins108;Xi52anins109;Xi52anins
llO;XisZanins111;Xis2&nins112;Xi82anins113;Xi32anins114;XisZ
anins115;Xi32anins116;XisZanins117;XisZanins118;Xi52aninsll9;
XisZanins120;Xis2anins121;Xi32anins122;Xi32anins123;XisZanins
W0 2016/1 10584
124;Xis2anins 125;Xi32anins126;Xis2anins 52anin3128;Xis2
aninle9;XisZanins130;Xi52anins131;XisZanins132;XisZanins 133;
XisZanins134;Xi32anins135;Xi32anins136;XisZ aninsl37;XisZanins
138;Xis2anins139;Xi52anins140;XisZanins141;XisZanins142;Xisz
anins 143;XisZanins144;XisZanins 145;XisZanins l46;XisZanins 147;
XisZaninsl48;Xi52anins149;XisZanins150;XisZanins151;XisZanins
152;Xis2anins153;Xi52anins154;Xis2aninSlSS;XisZanins156;Xi52
anins 157;Xi32anins 158;XisZanins 159;XisZanins160;Xis2anins 161;
XisZanins162;Xi52anins163;XisZanins164;Xi82aninsl65;XisZanins
166;XisZanins167;XisZanins168;XisZanins169;XisZanins170;Xi52
anins sZanins 172;Xi32anins 173;Xi32anins 174;Xi52anins 175;
Xis2anins176;XisZanins177;XisZanins178;Xi32 anins 179;Xi52anins
180;Xis2anins181',Xis2anins182;Xis2anin3183;XiSZanins184;Xi32
anins 185;XisZanins 186;
Xis3aninsngi53aninsZ;Xis3aninsS;Xis3anins4;Xis3aninsS;Xis3
anins6;Xis3anins7;Xis3anins 8;Xis3anins9;Xis3anins10;Xis3and
Yisll;Xis3anins12;Xis3anins13;Xis3aninsl4;Xis3 anins 15;Xis3and
Yis l6;Xis3anins 17;Xis3anins 18;Xis3anins19;Xi33 0;Xis3and
Yi321;Xis3anins22;Xis3anin523;Xis3aninsZ4;Xis3anin325;Xis3and
YisZ6;Xis3aninsZ7;Xis3anin528;Xis3anin329;Xis3anins30;Xis3and
Yis31;Xis3anins 32;Xis3anin533;Xis3anins34;Xis3 anins35;Xis3and
Yis36;XisS anins37;Xis3anin538;Xis3anins39;Xis3anins40;Xis3 and
Yis41;Xis3anins42;XisSanins43;Xis3anins44;Xis3anins4S;Xi83and
Yis46;Xis3anins47;Xis3anins48;Xis3anins49;Xi53 anins 50;Xis3 and
YisSl;Xis3anin552;Xis3aninsf53gXis3aninsS4;Xis3anin355;Xis3and
Yi356;Xis3anins 57;Xis3aninsS8;Xis3anin559;Xis3anins60;Xis3 and
Yis6l;Xis3anins62;Xis3anins63;Xis3anins64;Xis3anin365;Xis3and
Yis66;Xis3anins 67;Xis3anins68;Xis3anins69;Xi33 anins 70;Xi33and
Yis71;Xis3anins 72;Xis3anins73;Xis3anins74;Xis3anins75;Xis3 and
Yis76;Xis3anins77;Xis3anins78;Xi53anins79;Xis3 anins 80;Xis3and
Xis3anins 82;Xis3aninsS3;Xis3aninsS4;Xis3 anins 85;Xis3and
YisS6;XisSanins87;Xis3andY1588;Xis3anin589;Xis3anins90;Xis3and
Yis91;Xis3aninsQ2;Xis3anins93;Xis3anin594gXis3 anins95;Xis3and
Xis3anins 97;Xis3anins98;Xi53anins99;Xis3anins100;Xi33
anins s3anins 102;Xis3anins 103;Xis3anins 104;Xis3anins 105;
W0 20161110584
Xis3anins 106;Xi33 anins 107;Xis3anins 108;Xis3 andY is s3 anins
110;Xis3aninslll;Xis3anins112;Xis3anins113;Xis 3 aninsll4;Xis3
;Xis3aninsll6;Xis3anins117;Xis3anins118;Xis3aninsll9;
Xis3anin5120;Xi33anins121;Xis3anin_5122;Xis3 andY is 123;Xis3anins
124;Xis3anins125;Xis3anins126;Xis3anin5127;Xis 3 28;Xis3
anins 129;Xis3 anins 130;Xis3anins 13l;Xis3anins 132;Xis3anins 133;
Xis3anin5134;Xi33anins 135;Xis3anins 136;Xis3 anins137;Xis3anins
138;Xis3 anins 139;Xis3 anins l40;Xis3anins 141;Xis 3 aninsl42;Xis3
anins143;Xis3aninsl44;Xis3anins s3aninsl46;Xis3anins 147;
XisSaninsl48;Xis3anins149;Xis3anins150;Xis3 aninslSl;Xi33a.nins
152;Xis3 anins 153;Xis3anins 154;Xis3anin3155;Xis Sanin5156;Xis3
anins157;Xis3aninslS8;Xis3anins 159;Xis3anins l60;Xis3aninsl61;
Xis3anins 162;Xis3anins l63;Xis3anins 164;Xis3 anins 165;Xis3 anins
166;Xis3 anins167;Xis3anins168;Xis3anins 169;Xis3 aninsl70;Xis3
aninsl7l;Xis3anins172;Xis3anins173;Xis3aninsl74;Xis3anins 175;
Xis3aninsl76;Xis3anins s3anins s3aninsl79;Xis3anins
180;Xis3 anins181;Xis3anins182;Xis3anins183;Xis3anin8184;Xis3
anins 185;Xi53 anins 186;
Xis4anins1;Xis4anins2;Xis4anins3;Xis4anins4;Xis4anins 5;Xis4
anins6;Xis4anins7;Xis4anins8;Xis4anins9;Xis4anins10;Xis4and
Yisll;Xis4anins12;Xis4anins13;Xis4aninsl4;Xis4anin315;Xis4and
Yis16;Xis4anins17;Xis4anins18;Xis4anins19;Xis4anins20;Xis4and
Yis21;Xis4anins 22;Xis4aninsZ3;Xis4aninsZ4;Xis4anin525;Xis4and
Yi326;Xis4anins27;Xis4andY1528;Xis4anin329;Xis4anins 30;Xis4and
Yis31;Xis4anins32;Xis4anins33;Xis4anins34;Xis4anins35;Xis4and
Yis36;Xis4anins 37;Xis4anins38;Xis4anins39;Xis4anins40;Xis4and
Yis41;Xis4anins42;Xis4anins43;Xis4anins44;Xis4anins45;Xis4and
Yis46;Xis4anins47;Xis4anins48;Xis4anins49;Xis4andY1's 50;Xis4and
YisSl;Xis4anins 52;Xis4anin353;Xis4aninSS4;Xis4anin555;Xis4and
Yis 56;Xis4anins 57;Xis4anins 58;Xis4andYisS9;Xis4anins60;Xis4and
Yis61;Xis4anins62;Xis4anins63;Xis4aninsG4;Xis4anins65;Xis4a.nd
Yis66;Xis4anins67;Xis4aninsGS;Xis4anins69;Xis4anins70;Xis4and
Yis71;Xis4anins72;Xis4anins73;Xis4anins74;Xis4anins 75;Xis4and
Yis76;Xis4anins77;Xis4anins78;Xis4anins79;Xis4anins 80;Xis4and
Yis 81;Xis4anins 82;Xis4andYis83;Xis4anins84;Xis4anins 85;Xis4and
W0 2016/1 10584
Yis 4anins 87;Xis4anins 88;Xis4anins 89;Xis4anins90;Xis4and
Yi591;Xis4anins92;Xis4anins93;Xis4anins94;Xis4anins95;Xis4and
Yis96;Xis4anins97;Xis4andYis98;Xis4anins99;Xis4anins100;Xis4
anins101;Xis4anins102;Xis4anins103;Xis4anins 104;Xis4anins 105;
Xis4anins106;Xis4anins107;Xis4anins108;Xis4anins109;Xis4anins
110;Xis4anins111;Xis4anins112;Xis4anins113;Xis4anins114;Xis4
anins115;Xis4anins116;Xis4anins 117;Xis4anins118;Xis4anins119;
Xis4anins120;Xis4anins121;Xis4anins122;Xis4anins123;Xis4anins
124;Xis4anins125;Xis4anins126;Xis4anins127;Xis4anins]28;Xis4
anins129;Xis4anins130;Xis4anins13l;Xis4anins132;Xis4aninsl33;
Xis4anins 134;Xis4anins 135;Xis4anins 136;Xis4anins s4anins
138;Xis4anins139;Xis4anins140;Xis4anins141;Xis4anins142;Xis4
andY is 143;Xis4aninsl44;Xis4anins145;Xis4anins146;Xis4anins 147;
Xis4aninsl48;Xis4anins149;Xis4anins150;Xis4anins151;.Xis4anins
152;Xis4and‘{is153;Xis4anciYis154;Xis4anins155;Xis4anin5156;Xis4
anins 157;Xis4anins 158;Xis4anins 1S9;Xis4anins 160;Xis4anin5161;
Xis4anins162;Xis4anins163;Xis4anins 164;Xis4anins165;Xis4anins
166;Xis4anins167;Xis4anins168;Xis4anins169;Xis4aninsl70;Xis4
anins 171;Xis4anins 172;Xis4anins 173;Xis4anins174;Xis4anins 175;
Xis4aninsl76;Xis4anins177;Xis4anins178;Xis4anins179;Xis4anins
180;Xis4anins181;Xis4anins182;Xis4anins183;Xis4anins184;Xis4
anin3185;Xis4anins 186;
XisSanins1;XisSaninsZ;XisSanins3;XisSanins4;XisSan<iYisS;XisS
anins6;XisSanins7;XisSanins8;XisSanins9;Xis5anins10;Xis$and
Xis5anins12;Xis5anins13;XisSanins14;Xis$aninsl§;XisSand
Yi516;XiSSanins17;XisSa.ninsl8;XisSanins19;XisSanins20;XisSand
Yi521;XiSSanin522;XiSSaninsZ3;XisSaninsZ4;XisSanins25gX1'sSand
YisZ6;Xis5anin527;Xis5aninsZS;XisSaninsZ9;Xis5anins30;XisSand
Yis31;XisSanins 32;XisSanins33;XisSanins34;XisS anins35;XisSand
Yis36;XisSanins 37;Xis5anins38;XisSanins39;Xis5anins40;XisSand
Yis41;XisSanins42;XisSanins43;Xis5anins44;XisSanins45;XisSand
XisSanins47;XisSanins48;XisSanins49;XisSaninsSO;XisSand
Yis 51;XisSanins 52;XisSanin353;Xi35anins 54;XisS 5;Xi55and
YisS6;XisSaninsS7;XisSaninsS8;XisSanin859;Xi55anins60;XisSand
Yis61;XisSanins62;Xis5anins63;Xis5anins64;XisSanins65;XisSand
Yis66;XisSanins67;XisSanins68;XisSanins69;XisSanins 70;XisSand
Yis71;XisSanins72;XisSanins73;Xis5anins74;XisSanins75;XisSand
XisSanins77;XisSanins78;XisSanins79;XisSaninsSQXiSSand
Yi581;Xis5anins 82;Xi35anins83;Xis5anins84;XisSanin385;XiSSand
Yis 86;Xis5anins 87;XisSanins 88;XisSanins 89;XisSanins90;XisSand
Yis91;XisSanins92;Xis5anins93;XisSanins94;Xis5aninsQS;XisSand
Yi396;XiSSanins97;XiSSaninsQS;XisSanins99;XisSanin5100;Xi55
anins101;XisSanins102;XisSanins103;XisSanins104;XisSaninleS;
XiSSanins106;XisSanins107;Xis$anins108;XisS anins 109;XisSanins
llO;XisSanins 111;XisSanins 112;XisSanins 113;XisS aninsll4;XisS
aninsllS;XisSanins116;XisSanins117;XisSanins118;Xis5aninsll9;
XisSanins 120;Xis5anins 121;Xis$anins 122;XisS anins 123;Xis$anins
124;Xis53nins125;Xis$anins126;Xis$aninle7;Xis 5 anin8128;Xis-.5
anin5129;Xis5anins 130;Xis$anins131;XisSanins 132;Xis5anins 133;
insl34;XisSanins135;XisSanins136;XisS anins 137;XisSanins
138;XisSanins139;XisSanins l40;XisSanins141;XisSaninsl42;XisS
aninsl43;XisSanins 144;XisSanins145;XisSanins 146;XisSanins 147;
XisSanins 148;Xis$anins sSanins 150;XisSanins 151;XiSSanins
152;Xis5anins153;XisSanins154;Xis5anins155;Xi55anins156;Xis5
anins 157;XisSanins 158;Xis5anins 159;XiSSanins 160;XisSanins 161;
XisSaninsl62;XisSanins163;XisSanins164;XisSanins165;XisSanins
l66;XisSanins167;XisSanins168;XisSanin3169;XisS anins l70;XisS
71;XisSaninsl72;XisSanins173;XisSaninsl74;Xis5aninsl7S;
XisSanins176;XisSanins177;XisSanins178;XisSaninsl79;XisSanins
180;XisS anin3181;Xis5anins182;Xi35anins183;Xis5aninsl84;XisS
anins 185;XisS deis 186;
Xis6anins 1;Xis6andYisZ;Xis6anins3;X136anins4;Xis6aninsS;Xis6
anins6;Xis6anins7;Xis6anins8;Xisfianins9;Xis6anins10;Xis6and
Xis6anins12;Xis6anins13;Xis6anins14;XisGaninslS;Xis6and
Yisl6;Xis6anins17;Xis6anins18;Xis6anins19;Xis6anin520;Xis6and
Yi521;Xi36anin322;Xis6aninsZ3;Xis6aninsZ4;Xis6anins25;Xi56and
YisZ6;Xis6anins27;Xis6anin328;Xi56anin329;Xis6anins 30;Xiséand
Yis31;Xis6anins32;X136aninsS3;Xis6anins34;Xisfianins35;Xis6and
Yis 36;Xis6anins 37;Xis6andYi338;Xi86anins39;Xis6anins 40;Xis6and
Yis41;Xis6andYis42;XiséandYis43;Xiséanins44;Xis6anins45;Xis6and
W0 2016/1 10584
Yis46;XisGanins47;Xis6anins48;Xis6anins49;Xis6anin350;Xis6and
YisSl;Xis6anin352;Xis6andYi553;Xis6anins54;Xis6aninsSS;Xis6and
YisS6;Xis6aninsS7;Xis6andYisSS;Xis6aninsS9;Xis6anins60;Xiséand
Yis61;Xiséanin562;Xi56anins63;Xis6anin564;Xis6anins65;Xis6and
Yi566;Xis6anins67;Xis6anins68;Xis6anin569;Xis6anins70;Xis6and
Yis71;Xis6anins72;Xis6anins73;Xis6anins74;Xi56anins75;Xis6and
Yis76;Xiséanins 77;Xis6anins78;Xis6anins79;Xi36anin580;Xis6and
YisSl;Xis6anins 82;Xis6anins83;Xis6anins84;XisGanin385;Xiséand
Xi56anins87;Xis6anins 88;Xi56anins89;Xis6anins90;Xis6and
Yis91;Xis6anins92;Xi56anins93;Xis6anins94;Xis6anins95;Xis6and
Yis96;Xis6aninsQ7;Xiséanins98;Xi36anins99;Xiséanins100;Xi56
anins101;Xis6anins102;Xi56anins103;Xis6anins104;XiséaninleS;
Xis6anins106;Xis6anins107;Xis6anins108;Xis6anins109;Xis6anins
110;Xi56anins111;XisGanins112;Xis6anins113;Xis6anins114;Xis6
anins115;Xis6anins116;Xis6anins117;Xis6anins118;Xis6aninsll9;
Xis6anins120;Xis6aninsl21;Xis6anins122;Xis6anins123;Xis6anins
124;Xiséanins125;Xis6anins126;Xis6anins127;Xis6anin3128;Xis6
anin5129;Xis6anins130;Xiséanins131;Xi56anins132;Xi36aninsl33;
Xis6anins134;Xi56anins135;Xis6anin3136;Xis6anins137;Xis6anins
138;Xiséanins139;Xi56anins140;Xis6aninsl41;Xis6anins142;Xis6
anins 143;Xis6anins 144;Xis6anins 145;Xis6 anins 146;Xi56anins 147;
Xis6aninsl48;Xis6anins149;Xis6anins150;Xis6anins151;Xis6anins
152;Xi56anins153;Xis6anins154;Xis6anins155;Xis6aninslS6;Xis6
anins 157;Xis6anins 158;Xis6anins s6anins 160;Xis6anins 161;
ins 162;Xis6anins 163;Xi56anins l64;XisGanins165;Xis6anins
166;Xis6anins167;Xis6anins168;Xis6anins169;Xis6anins170;Xis6
anins 171;Xis6anins s6anins 173;Xi36anins174;Xi36anins 175;
Xis6anins176;Xis6anins177;Xiséanins178;Xis6anins179;Xis6anins
180;Xis6anins181;Xis6anins182;Xis6anins183;Xis6aninsl84;Xis6
anins 185;Xis6anins 186;
Xis7anins1;Xis7aninsZ;Xis7anins3;Xis7anins4;Xis7aninsS;Xis7
;Xis7anins7;Xis7anins8;Xis7anins9;Xis7anins10;Xis7and
Yisll;Xis7anins12;Xis7anins13;Xis7anins14;Xis7anins15;Xis7and
Yis16;Xis7anins17;Xis7anins18;Xis7’anins19;Xis7anin820;Xis7and
Yile;Xis7anins22;Xis7anin323;Xis7anins24;Xis7anin525;Xis7and
Yis26;Xis7anin827;Xis7anins28;Xis7aninsZ9;Xis7anins30;Xis7and
Yis31;Xis7anins32;Xis7anins33;Xis7anins34;Xis7anins35;Xis7and
Yis36;Xis7anins 37;Xis7anins38;Xis7anins39;Xis7anins40;Xis7and
Yis41;Xis7anins42;Xis7anins43;Xis7anins44;Xis7anins45;Xis7and
Yis46;Xis7anins47;Xis7anins48;Xis7anins49;Xis7anin550;Xis7and
YisS];Xis7anins 52;Xis7aninsS3;Xis7anins54;Xis7aninsSS;Xis7and
Yi356;Xis7anins 5,7;Xis7aninsSS;Xis7anin859;Xis7anins60;Xis7and
Yis61;Xis7anins62;Xis7anins63;Xis7anins64;Xis7anins65;Xis7and
Yis66;Xis7anins67;Xis7anins68;Xis7anins69;Xis7anins70;Xis7and
Yis71;Xis7anins72;Xis7anins73;Xis7anins74;Xis7anins75;Xis7and
Yis76;Xis7anins77;Xis7anins78;Xis7anins79;Xis7anins80;Xis7and
Yis81;Xis7anins82;Xis7anins83;Xis7anins84;Xis7anins85;Xis7and
Yi386;Xis7anin387;Xis7anins88;Xis7andY1389;Xis7anins90;Xis7and
Yis9l;X137anins92;Xis7anins93;Xis7andYi594;Xis?anin595;Xis7and
Yis96;Xis7anins97;Xis7anins98;Xis7anins99;Xis7anins100;Xis7
anins 101;Xis7anins 102;Xis7anins103;Xis7anins104;Xis7aninleS;
Xis7anins106;Xis7anins107;Xis7anins108;Xis7aninle9;Xis7anins
110;Xis7anins111;Xis7anins112;Xis7anins113;Xis7aninsll4;Xis7
aninsllS;Xis7anins 116;Xis7anins117;Xis7anins118;Xis7anins119;
Xis7anins 120;Xis7anins121;Xis7anins122;Xis7anins123;Xis7anins
124;Xis7anins125;Xis7anin3126;Xis7anins127;Xis7anin5128;Xis7
anins129;Xis7anins130;Xis7anins131;Xis7anins132;Xis7anins 133;
Xis7anins134;Xis7anins135;Xis7anins136;Xis7anins 137;Xis7anins
138;Xis7anins139;Xis7aninsl40;Xis7anins141;Xis7anins142;Xis7
anins s7anins l44;Xis7anins 145;Xis7anins146;Xis7anins 147;
Xis7anins148;Xis7anins149;Xis7anins150;Xis7anins151;Xis7anins
152;Xis7anins153;Xis7anins154;Xis7anins155;Xis7anins156;Xis7
anins 157;Xis7anins 158;Xis7anins s7a;nins 160;Xis7anins 161;
Xis7anins162;Xis7anins163;Xis7anins164;Xis7anins16S;Xis7anins
l66;Xis7anins167;Xis7anins168;Xis7anins169;Xis7aninsl70;Xis7
71;Xis7anins172;Xis7anins173;Xis7aninsl74;Xis7aninsl7S;
Xis7anins l76;Xis7anins177;Xis7anins178;Xis7anins179;Xis7anins
180;Xis7anins181;Xis7anins182;Xis7anins183;Xis7anins184;Xis7
anins 185;Xis7anins 186;
W0 2016/1 10584
Xis8anins1;Xis8aninsZ;Xis8anins3;XisSandYis4;XisSaninsS;Xis8
anins6;Xi58anins7;XisSanins 8;Xi58anins9;Xis8anins10;Xis8and
Yisll;Xis8anins12;Xis8anins13;Xi38anins14;XisSaninslS;Xi88and
Yis 16;XisSanins 8anins18;Xi58anins19;XisSaninsZO;Xi38and
Yile;XisSaninsZ2;Xis8&nins23;Xi58anin324;Xi38aninsZS;Xi38and
YisZ6;Xis8&1deis27;Xis8anins28;Xi58anin529;Xis8anins30;XisSand
Yi531;Xis8anins32;Xis83nins33;Xis8anins34;XisSaninsSS;XisSand
Yis36;XisSanins37;XisSanins 38;XisSaninsB9;Xis8anins40;XisSand
Yis41;Xis8anins42;Xis8adeis43;XisSanins44;Xis8anins45;Xi38and
Yis46;XisSanins47;Xis8anins48;Xi58anins49;Xis8aninsSO;Xis8and
YisSl;XisSanins 52;Xis8anin353;Xis8anin354;Xis8adeis55;XisSand
Yis56;Xi88anin557;Xi58anins 58;Xis8aninsS9;XisSanins60;Xi58and
Yis61;Xis8anins62;Xis8anins63;XisSanins64;Xis8anins65;Xi38and
Yis66;Xis8anin567;Xis8andYis68;XisSaninsfi9;Xi38anins70;XisSand
Yis71;Xis8anins Sanins73;Xi58anins74;Xis8anins75;Xi58and
Yis76;XisSanins77;XisSanins78;XisSanins79;XisSaninsSO;Xi58and
YisSl;XisSanins 82;XisSanins83;XisSanins84;Xi58anins85;Xis8and
YisS6;Xi38anins 87;XisSanins88;Xis8andYisS9;XisSanins90;Xis8and
YisQl;XisSanins92;Xis8anins93;XisSanins94;Xis.8anins95;XisSand
Xi38anins97;Xis8anins98;XisSanin399;XiSSanins100;Xi38
anins sSanins 102;Xis8anins 103;Xi58anins lO4;XisSanins 105;
XisSanins106;Xi58anins107;Xis8anins108;Xi38anins109;Xi58anins
110;XisSanins 111;Xis83nin5112;Xi38anins113;Xis8anins 114;Xi38
anins115;Xi38anins116;XisSanins117;Xi58a11insll8;Xi58aninsll9;
XisSanins120;XisSanins121;Xis8anins122;Xi58anins123;Xi58anins
124;Xi58anins125;XisSanins126;XisSanins127;Xis8anin3128;Xis8
29;XisSanins130;Xis8anins131;Xis8anins132;Xi38anins 133;
Xis8anins134;Xis8aninsI35;Xis8anins136;Xi38anins 137;Xi38anins
138;Xi58anins139;Xi38anins140;XisSanins141;Xis8anins142;Xis$
anins 143;Xis8anins 144;Xi58anins 145;XisSanins 146;Xi58anins 147;
Xis8anins148;Xi58anins149;XisSanins150;XisSaninslSl;Xi58anins
152;Xis8anins153;XisSaninslS4;Xi58anins155;XisSanins156;XisS
anins157;Xis8anins158;Xi58anins 159;XisSanins160;XisSanins 161;
XisSanins162;Xi58anins163;Xi38anins164;Xi88anins165;Xis8anins
166;XisSanins167;Xis8anins168;Xis8anins169;Xi38anins170;Xi58
anins 171;Xi58anins 172;XisSanins s8anins 174:Xis8anins 175;
Xis8anins176;XisSanins177;XisSanins178;Xi38 anins 179;Xi38anins
180;Xi38anins181;Xi38anins182;Xis83nin3183;Xis 8 anin3184;Xi58
aninslSS;Xi58aninsl86;
Xis9anins1;Xis9anins2;Xis9anins3;Xis9andY is4;Xi39aninSS;Xis9
anins6;Xis9anins7;Xis9anins8;Xis9anins9;Xis9anins10;Xis9and
Yis11;Xis9anins12;Xis9anins13;Xis9and‘1’is14;Xis9anins15;Xis9and
Yis16;Xis9aninsl7;Xis9anins 9anins19;Xis9aninsZO;Xis9and
Yile;X139anin522;Xis9anins23;Xis9anin324;Xis9anin525;Xis9and
Yis26;Xi59anins27;Xis9anin828;Xis9anin829;Xis9anins 30;Xis9and
Yis31;Xis9anins32;Xi59anins33;Xi39anins34;XisQanins 35;Xis9and
Yi336;Xis9anins 37;Xis9anins38;Xis9anins39;XisQanins40;Xi59and
Yis41;Xis9anins42;Xis9anins43;Xis9anins44;Xis9anins4S;Xis9and
Yis 46;Xis9anins47;Xi39anins48;Xis9anins49;Xis9anins50;Xis9and
Yi551;Xis9anins 52;XisQaninsS3;Xis9anins 54; Xis9anins 55;Xis9and
Yis56;Xis9aninsS7;Xi59anin558;Xis9anins 59; Xis9anins 60;Xis9and
XisQanins62;XisQanins63gXi39anins64;XisQanins 65;Xis9and
Yis66;Xis9anins67;Xi39anin368;Xi39anins69;Xis9anins70;Xi39and
Yis71;Xis9anins 72;Xis9andYis73;Xis9anins74;Xis9anins75;Xis9and
Yis76;Xis9anins77;Xis9anins78;Xis9anins79;Xis9anins 9and
Yis 81;Xi39anins 82;Xis9anins 83;Xis9anin384; XisQanins 85;Xi39and
YisS6;Xis9aninsS7;Xis9anin588;Xis9anins 89;Xis9anins 90;Xis9and
Yis91;Xi39anin592;Xi39anins93;Xis9anins94; Xis9anins95;Xis9and
Yis96;Xis9anins97;Xis9anins98;Xis9anins99;Xis9anins100;Xis9
anins 101;Xi39anins 102;Xis9anins 103;Xis9anins lO4;Xis9anins 105;
Xis9anins106;Xi59anins107;Xis9anins108;Xis9anins109;Xis9anins
110;Xis9anins111;Xis9anins112;Xis9anins113;Xis9anins114;Xis9
anins115;Xis9anins116;Xis9anins117;Xis9anins118;Xis9anins119;
Xis9anins120;Xis9anins121;Xis9anins122;Xis9anins123;Xi59anins
124;Xis9anins125;Xis9anins126;Xis9anins127;Xis9anins 128;Xis9
anins129;Xi39anins130;Xis9anins s93nins132;Xis9anins133;
Xis9aninsl34;Xis9anins13S;Xi59anins136;Xis9anins137;Xis9anins
s9anins139;Xis9anins140;Xis9anins141;Xis9anins142;Xis9
anins143;Xis9anins144;Xis9anins 145;XisQanins146;Xis9anins147;
Xis9aninsl48;Xis9anins149;Xis9anins150;Xis9anins151;Xis9anins
W0 2016/1 10584
152;Xis9a_nins153;Xis9anins154;Xis9anins155;Xis9anins156;Xis9
anins 157;Xis9anins 158;Xi59anins 159;Xis9anins 160;Xis9a.nins I61;
Xis9anins 162;X1398_nins 163;Xis9anins 164;Xis9anins165;Xis9anins
166;Xis9anins167;Xis9anins168;Xi39anins 169; Xis9aninsl70;Xis9
anins 171;Xi89anins172;Xi89anins 173;Xis9anins 174;Xis9anins 175;
insl76;Xi39anins 177;Xi59anins178;Xis9anins 179;Xis9anins
180;Xis9anins 181;Xis9 anins 182;Xis9anins 183; Xis9anins 184;Xis9
anins 185;Xis9anins 186;
Xis 10 anins 1;Xis 10aninsZ;Xis lOanins3;Xis 10anins4;Xis 10aninsS;
XileaninsG;Xis 10anins7;Xis10anins8;Xileanins9;Xis10anins
;Xis IOanins11;Xileanins12;Xileanin513;Xis10aninsl4;Xile
aninslS;Xis 10anins 16;Xis10anins17;Xis10anins 18;Xileanin319;X
is IOanin320;Xis 10anins21;Xis 10anin522;Xis 10aninsZ3;Xis 10anins
24;XislOanin325;Xis10anin826;Xis10aninsZ7;XislOaninsZS;Xile
anin329;Xis 10 anins30;Xis 10 1;Xis 10 anins32;Xis 10 anins33;X
is lOanins34;Xis 10anins35;Xis 10anins36;Xis 10 anins37;Xis 10 anins
38;Xis lOanins39;Xis 10 anins40;Xis 10anins4ngis 10anins42;Xis10
3;Xis 10anins44;Xis10anins45;Xis lOanins46;Xis103nins47;X
is lOanins48;Xis IOanins49;Xis 10aninsSO;Xis 103ninsSl;Xis s
52;Xis lOaninsS3;Xis 10 aninsS4;Xis lOanins SS;Xileanins 56;Xis 10
aninsS7;Xis 358;Xis10aninsS9;Xis10anin360;Xis lOanin861;X
is 10andY1562;Xis10anins63;Xis 10anins64;XisIOanins65;Xis lOanins
66;Xis s67;Xis 10anins 68;Xis 10anins69;Xis 10anins703Xis 10
1;Xis10anins72;Xis10anins73;Xis10anins74;Xis10anins75;X
is 103nins76;Xis10anins77;XislOanins78;Xis 10anins79;Xis 10anins
80;Xis IOanin581;Xis10anin582;Xis10anins83;Xis lOaninsS4;Xile
aninsSS;XileaninsS6;Xis10aninsS7;Xis10anins88;Xileanin389;X
is 10anins 90;Xis 10anins91;Xis 10anin592;Xis lOanins93;Xis 10anins
94;Xis 10anin895;Xis 10 anins96;Xis 10anins 97;Xis IOanins98;Xis 10
anins99;Xis 10anins100;Xis10anins101;Xileanin3102;Xis10anins
103;Xis 10 anins 104;Xis 10 anins 105;Xis 10 anins s 10 anins 107;Xis
IOanin5108;Xis s 109;Xis 10anins110;Xis10aninslll;Xis 10andY
Xis10anins113;Xis10anins114;Xis10anins115;Xileaninsll6;X
is 10 anins 117;Xis 10 anins 118;Xis 10 anins 119;Xis 10 anins s Wand
Yis 121;Xis 10 anins 122;Xis 10 anins 123;Xis 10 anins 124;Xis 10 deis 125;
W0 2016/110584
Xis 10 anins 126;Xis 10 anins 127;Xis 10 anins 128;Xis 10 anins 129;Xis 10
anins 130;Xis 10 anins 131;Xis 10 anins 132; Xis 10 deis 133; Xis 10 anins
134;Xis 10 anins 135;Xis 10 anins s 10 anins 137;Xis 10 anins 138;Xis
anins 139;Xis lOanins 140;Xis 10anins 141;Xis 10 andY is 142;Xis 10 andY
is s 10 deis 144; Xis 10 anins 145;Xis 10 anins 146;Xis 10 anins 147;X
is 10anins 148;Xis 10 anins 149;Xis 10 anins 150;Xis 10 anins 151;Xis lOand
Yis s 10 anins 153;Xis 10 anins 154;Xis 10 andY is 155; Xis 10 anins 156;
Xis 10 anins 157;Xis 10 anins 158;Xis 10 anins 159;Xis 10 anins 160;Xis 10
anins 161; Xis 10anins 162;Xis 10 anins 163;Xis 10anins s 10 anins
165;Xis 10 anins 166;Xis 10 anins s 10 anins 168;Xis 10 anins s
anins 1.70;Xis 10 anins 171;Xis 10 anins 172;Xis 10 andY is 173; Xis 10 andY
is 174;Xis 10 anins s ‘IOanins 176;Xis ‘10 anins s 10 anins 178;X
is 10 anins 179;Xis 10 anins 180;Xis 10 anins 181;Xis 10 anins 182;Xis 10 and
Yis 183;Xis 10 anins 184; Xis 10 anins 185;Xis 10 andY is 186;
Xisllaninsl;Xis11aninsZ;Xisllanin33;Xis11anins4;XisllaninsS;
Xis 11 anins 6;Xisll anins7;Xis 11 aninsS;Xis 11 anins9;Xisll anins
;Xis 11 anins 11;Xis 11 anin312;Xis 11 anins 13;Xisll anins 14',Xis ll
anins15;Xisllaninsl6;Xisllanins17;Xisllaninsl8;Xi311aninsl9;X
is 11 aninsZO;Xis 11 anin521;Xis 11 anin522;Xis 11 aninsZ3;Xis 11 anins
24;Xis 11 5;Xis 11 anin326;Xis 11 anin327;Xis11 anin528;Xisll
anins29;Xis 11 anins30;Xisll anins3l;Xis 11 anins32;Xisll anins33;X
is 11 anins34;Xis 11 anins35;Xis 11 anins 36;Xis 11 anins37;Xis 11 anins
38;Xis 11 anins39;Xis 11 anins40;Xis 11 anins 41;Xis 11 anins42;Xisll
anins43;Xis 11 anins4—4;Xisll 5;Xisll anins46;Xisll anins47;X
is 11 anins48;Xis 11 anins49;Xisll O;Xis 11 anins 51;Xis 11 anins
52;Xis 11 anins 53;Xis 11 anins 54;Xis 11 anins 55;Xis 11 anins 56;Xis 11
aninsS7;Xis 11 aninsS8;Xis 11 aninsS9;Xis 11 aninséO;Xis 11 anins61;X
i311anin562;Xis11anins63;Xisllanins64;Xis11anin565;Xisllanins
66;Xis 11 anins 67;Xis 11 anins68;Xisll anins 69;Xis11 anins 70;Xis 11
anins71;Xis11anins72;Xisll anins73;Xisll anins74;Xisll anins75;X
i511 anins76;Xis11anins77;Xisll 8;Xisll anins79;Xis 11 anins
80;Xis 11 anins 81;Xis 11 anins 82;Xis 11 anins 83;Xisll anins 84;Xisll
anins85;Xis 11 anins 86;Xisll anins 87;Xis 11 anins 88;Xis 11 anins89;X
i511 anins90;Xis 11 anin391;Xis 11 anins92;Xisll andY1393;Xis 11 anins
94;Xis 11 anins 95;Xis 11 anins 96;Xis 11 anins97;Xis11 anins 98;Xisli
W0 2016/1 10584
anins99;XisllaninleO;Xis11anins101;Xislla.nin3102;Xisllanins
103;Xis11aninle4;Xis11aninleS;Xisllanins106;Xisllaninle7;Xis
11anins108;Xisllanins109;Xisllanins110;Xisll aninslll;XisllandY
i5112;Xisll anins 113;Xis 11 anins 114;Xis11 anins 115;Xisll l6;X
is 11 anins 117;Xis 11 anins 118;Xis 11 anins 119;Xis 11 anins 120;Xis 11 and
Yi3121;Xis 11 anins 122;Xisll anins 123;Xis 11 aninle4;Xis 11 deis 125;
Xis 11 anins 126;Xis 11 anins 127;Xis 11 ‘1’15128;Xi311anin5129gXisll
anins 130;Xis 11 anins 131;Xisll anins 132;Xisll anins 133;Xisll anins
134;Xisll anins 135;Xisll anins 136;Xis11 37;Xisll anins 138;Xis
11 anins 139;Xis 11 anins 140;Xis 11 anins 141;Xisll anins 142;Xis11 andY
is 143;Xi311 anins 144;Xis 11 anins 145;Xis 11 anins 146;Xisll anins 147;X
is llanins148;Xisllaninsl49;Xisllanin8150;Xis llanins 151;Xis11 and
Yis152;Xis11 S3;Xis 11 54;Xis 11 anins 155;Xis11 anins 156;
Xis 11 anins is 11 anins 158;Xis 11 anins 159;Xis 11 anins 160;Xis 11
anins 161;Xis 11 anins 162;Xis 11 anins sllanins 164;Xisll anins
sll anins 166;Xis11anins 167;Xisll anins 168;Xis11 anins s
11 anins 170;Xisll anins 171;Xisll anins 172;Xisll aninsl73;Xisll andY
is 174;Xisll anins s 11 anins 176;Xis 11 anins 177;Xis 11 anins 178;X
is 11 anin5179;Xisll anins 180;Xis11 anins 181;Xis llanins 182;Xislland
Yis 183;Xis11 anins 184;Xisllanin5185;Xisll anins 186;
Xis 12anins 1;Xis 12anin52;Xis 12anins3;Xis 12anins4;Xis 12 3.11in55;
Xis 12anins6;Xis lZanins7;Xis 12 anins 8;Xis 12 anin59;Xi812 anins
;Xis 12anins 11;Xis 12 anins 12;Xis 12 anins 13;Xis s 14;Xis 12
anins 15;Xis lZaninsl6;Xis 12 anins 17;Xis 12anin518;Xis lZaninsl9;X
is IZanin320;Xis 12aninSZI;Xis 12 anin522;Xis 12 anins23;Xi312 anins
24;Xis s25;Xis 123ninsZ6;Xis12anin327;Xis 12anin328;Xis 12
anin529;Xis 123nins30;Xis12anins31;Xis12 anin332;Xis 12 anins33;X
is 12 anins34;Xis 12anin335;Xis 12anins36;Xis 12anins37;Xis 12 anins
38;Xis l2anins 39;Xis 123nins40;Xis 12 anins4l;Xis IZanins42;Xis 12
anins43;Xis 12 anins44;Xileanins45;Xis 12 anins46;Xis12anins47;X
is 12 anins48;Xis 123nins49;Xis 12 anins 50;Xis 12 aninsSl;Xis 12 anins
52;XileaninsS3;Xis12anin554;Xis12anin355;Xis12aninSS6;Xis 12
7;Xis12anin558;Xisl2aninsS9;Xis12adeis60;Xis 12 anins61;X
i312 anins62;Xis 12 aninsG3;Xis 12 anins 64;Xis 12anins65;Xis 12 anins
66;Xis 12 anins67;Xis 12 anins68;Xi512 anins69;Xis 12 anins70;Xis 12
anins 71;Xis 12 anins 72;Xis 12 anins 73;Xis 12 andY 1374; Xis 12 aninS 75;X
is 12anins76;Xis s77;Xis 12anins78;Xis IZandY is 79;X1312 anins
80;Xis 12 anins 81;Xis 12 anins 82;Xis 12 anins 83;Xis 12 anins 84;Xis 12
S;Xisl2anins86;Xis12andY1387;Xis12anin588;Xis12andY1389;X
is 12anin890;Xis 123nins91;Xis 592;Xis 12 andY 1593;Xi512anins
94;Xis 12 anins 95;Xis 12 anins96;Xis 12 anins97;Xis 12 anins98;Xis 12
an Yis99;Xis 12adeis 100;Xis 12anins 101;Xis 12am1Yis 102;Xis 12anins
103;Xis 12 anins 104;Xis 12 anins 105;Xis 12 aninle6;Xis12andY15107;Xis
12 anins 108;Xis 12 anins 109;Xis 12 anins 110;Xis 12 anins 111;Xis 12 andY
is s 12anins 113;Xis 12anins 114;Xis 12 anins 115;Xis 12anins 116;X
is 12 anins 117;Xis 12 anins 118;Xis 12 anins 119;Xis 12 anins 120;Xis 12 and
Yis s 12 anins 122;Xis 12 anins 123;Xis 12 andY is 124; Xis 12 anins 125;
Xis 12 anins 126;Xis 12 anins 127;Xis 12 anins 128;Xis 12 anins 129;Xis 12
anins 130;Xis 12 anins s 12 anins 132;Xis 12 anins 133;Xis 12 anins
s 12 anins 135; Xis 12 anins 136;Xis 12 anins s 12 anins 138;Xis
12 anins 139; Xis 12 anins 140;Xis 12 anins 141;Xis 12 anins 142;Xis 12 andY
is 143;Xis 12 anins 144;Xis 12 anins s 12 anins 146;Xis 12 anins 147;X
is 12 anins 148;Xis 12 anins 149‘,Xis 12 anins 150;Xis 12 anins is 12 and
Yis152;Xis12anins153;Xis12anins154;Xis 12 anin5155;Xi5123ndY13156;
Xis 12 anins 157;Xis 12 anins s 12 anins 159; Xis 12 deis 160; Xis 12
anins 161;Xis 12 anins 162;Xis 12 anins 163;Xis 12 anins 164;Xis 12 anins
165;Xis 12 anins 166;Xis 12 anins 167;Xis 12 anins 168;Xis 12 anins 169;Xis
12 anins 170;Xis 12 anins 171;Xis 12 anins 172;Xi512 anins 173;Xis 12 andY
is 174;Xis 12 anins 175;Xis 12 anins 176;Xis 12 anins 177;Xis 12 anins 178;X
is 12 anins 179;Xis 12 anins 180;Xis 12 anins 181;Xis 12 andY is 182;Xis 12 and
Yis 183;Xis 12 anins 184;Xis 12 anins 185;Xis 12 anins 186;
Xis 13 anins 1;Xis 13 aninsZ;Xis 13 anins3;Xis 13 anins4;Xis 13 aninsS;
Xis 13 anins 6;Xis 13 anins 7;Xis 13 anins 8;Xis 13 anin39;Xis 13 anins
;Xis 13 anins 11;Xis 13 anins 12;Xis 13 anins 13;Xis 13 anins 14;Xis 13
anins 15;Xis 13 anins 16;Xis 13 anins 17;Xis 13 anins 18;Xis 13 anins 19;X
is 13 anin820;Xis 13 anin521;Xis 13 anins 22;Xis 13 anin523;Xis 13 anins
24;Xis 13 anins 25;Xis 13 aninsZ6;Xis 13 anin527;Xis 13 anins 28;Xis 13
anin329;Xis 13 anins30;Xis 13 anins 31;Xis 13 anins32;Xis 13 anin533;X
is 13 anins34;Xis 13 anins35;Xis 13 anins 36;Xis 13 anins37;Xis 13 anins
38;Xis 13 anins39;Xis 13 anins40;Xis 13 anins 41;Xisl3 anins 42;Xis 13
W0 2016/1 10584
anins43;Xis 13 anins44;Xis 13 anins45;Xis 13 andY is46;Xis 13 anins47;X
is 13 anins48;Xis 13 anins49;Xis 13 anins 50;Xis 13 anins 51;Xis 13 anins
52;Xis 13 aninsS3;Xis 13 aninsS4;Xis 13 anins 55; Xis 13 aninsSé;Xis 13
aninsS7;Xis13 aninsSS;Xisl3 anins 59;Xis 13 anins60;Xisl3andY1361;X
is 13 anins62;Xis 13 anins63;Xis 13 anins64;Xis 13 anins65;Xis 13 anins
66;Xis 13 anins67;Xis 13 anins 68;Xis 13 aninsfi9; Xis 13 0;Xis l3
anins7l;Xis 13 anins72;Xis 13 anins 73;Xis 13 anins74;Xis13anins75;X
is 13 6;Xis 13 anins77;Xis 13 anins78;Xis 13 anins79;Xis13anins
80;Xis 13 anins 81;Xis 13 anins 82;Xis l3 aninsS3; Xis 13 anins84;Xis 13
5;Xis 13 anins86;Xis 13 anins 87;Xis 13 anins88;Xis 13 anins89;X
is 13anins90;Xis13anins91;Xis 13 anins92;Xis 13 anins93;Xisl3 anins
94;Xis13 aninsQS;Xis 13 anin596;Xis 13 aninsQ'l; Xis 13 andY1598;Xis 13
andY1s99;Xis 13 anins 100; Xis 13 andY is 101;Xis 13 anin3102;Xis 13 anins
103;Xis 13 anins 104;Xis 13 anins 105;Xis13 anins 106;Xis 13anins107;Xis
13 anins 108;Xis 13 anins 109;Xis 13 deis 110;
Xis 13 anins 111;Xis 13 anins 112;Xis 13 anins 113;Xis 13 l4;Xis 13
anins 115;Xis 13 anins 116;Xis 13 anins117;Xisl3anin5118;Xis 13 anins
119;Xis 13 anins 120;Xis 13 anins121;Xis 13 anins 122;Xis 13 anins 123;Xis
13 anins 124;Xis 13 anins 125;Xis 13 anins 126;Xis 13 anins 127;Xis 13 andY
is 128;Xis 13 anins 129;Xis 13 anin5130;Xis 13 anins 131;Xis 13 anins 132;X
is 13 anins 133;Xis 13 anins 134;Xis 13 anins s 13 anins 136;Xis 13 and
Yis 137;Xis 13 anins 138;Xis 13 anins 139;Xis 13 anins sl3 anins 141;
X1313 anins 142; Xis 13 andY is 143;Xis 13 anins 144;Xis 13 anins 145;Xis 13
anins 146;Xis 13 anins147;Xis 13 anins 148;Xis 13 anins 149; Xis 13 anins
150;Xis 13 anins 151;Xis 13 anins 152;Xis 13 andY13153;Xis13anins 154;Xis
13 anins 155;Xis 13 anins 156;Xis 13 anins 157;Xis 13 anins 158;Xis 13 andY
is 159;Xis 13 anins 160;Xis 13 anins161;X1313 anins 162;Xis 13 anins 163;X
1513 anins 164;Xis 13 anins 165;Xis 13 anins 166;Xis 13 anins 167;Xis 13 and
Yis s 13 anins 169;Xis 13 anins 170;Xis 13 anins 171;Xis 13 anins 172;
Xis 13 anins 173;Xis 13 anins s 13 anins 175;Xis 13 anins 176;Xis 13
anins 177; Xis 13 anins 178;Xis 13 anins 179;Xis 13 180;Xis 13 anins
181;Xis 13 anins 182;Xis 13 anins s 13 aninsl84;Xis 13 anin5185;Xis
13 deis 186;
Xis s 1;Xis 14anins2;Xis 14anins3;Xisl4anins4;Xis 141311in55;
Xis 14 anins6;Xis 14 anins7;Xis 14anins 8;Xis 14 anins9;Xis l4anins
;Xis l4 aninsll;Xis 14anins 12;Xis 14anins 13;Xis 14 anins14;Xis 14
anins 15;Xis 14anins 16;Xis 14anins 17;Xis 14anins 18;Xis 14a11ins 19;X
is SZO;Xis 14anins21;Xis 14anin322;Xis 14andY is i4anins
24;Xis 14 andY1325;Xis 14anin326;Xis 14anins27;Xis 14 anins28;Xi_s 14
9;Xis 14 anins30;Xis 14anins31;Xis 14 anins32; Xis 14 anins33;X
is 14anins34;Xis 14anins35;Xis l4anins36;Xis 14andY is 37;Xis 14 anins
38;Xis 14 anins 39;Xis 14anins40;Xis 14anins41', Xis 1.4 anins42;Xis 14
anins43;Xis 14 4;Xis 14 anins45;Xis 14 andY is46; Xis s47;X
is s48;Xis 14anins49;Xis 14 anins 50;Xis 14 andY is 51;Xis 14 anins
52;Xis 14 anins 53;Xis 14 anins 54;Xis l4anins55; Xis 14 anins56;Xis 14
aninsS7;Xis 14 aninsSS;Xis 14anins 59;Xis 14anins60;Xis 14 anin361;X
is l4anins62;Xis 14anins63;Xis 14aninsG4;Xis 14 aninséS;Xis s
66;Xis 14anins 67;Xis 14 anins 68;Xis 14 anins 69', Xis 14 anins70;Xis 14
anins71;Xis 14 anins72;Xis 14anins 73;Xis 14 anins 74; Xis 14 anins75;X
is 14anins76;Xis 14anins77;Xis l4anins78;Xis 14 anins79;Xis 14anins
80;Xis l4 anins81;Xis 14anins82;Xis l4anins 83; Xis 14 anins 84;Xis 14
aninsSS;Xis14anin586;Xis14anins87;Xis14anins88;Xis14aninsS9;X
is 14 anins90;Xis 14 anins91',Xis 14 2;Xis 14 anins93;Xis 14 anins
94;Xis 14 anins95;Xis 14anins96;Xis 14anin597; Xis l4anins98;Xis 14
anins 99;Xis 14 anins 100;Xis 14 anins 101;Xis 14anins 102;Xis 14 anins
103;Xis 14 anins 104;Xis 14 anins 105;Xis 14 anins 106;Xis 14 anins 107;Xis
14 anins 108;Xis 14 anins 109;Xis s 110;Xis 14anins 111;Xis 14de
is 112;Xis14aninsll3;Xis14anins114;Xisl4anins115;Xisl4anins116;X
is 14 aninsll7;Xis 14 anins 118;Xis 14 aninsll9;Xis 14anins 120;Xis 14and
Yis 121;Xis 14 anins 122;Xis 14 anins 123;Xis 14 anins 124;Xis 14 anins 125;
Xis 14 anins 126;Xis 14 deis 127; Xis 14anins 128; Xis 14 deis 129; Xis 14
anins 130;Xis 14 anins 131;Xis 14 anins 132;Xis 14 anins 133;Xis 14 anins
134;Xis 14 anins 135;Xis 14anins s 14 anins137;Xis 14anins 138;Xis
14 anins 139;Xis 14 anins 140;Xis 14 anins 141;Xis l4anins 142;Xis 14andY
is 143;Xis 14 anins 144;Xis 14 anins 145;Xis 14 anins 146;Xis 14 anins 147;X
is 14 anins 148;Xis s 149;Xis 14 anins 150;Xis 14 anins 151;Xis 14 and
Yis152;Xis14anins153;Xis14anins154;Xisl4anins155;Xisl4anins 156;
Xis 14 anins 157; Xis 14 deis 158; Xis 14 deis 159; Xis 14 anins 160;Xis 14
anins 161;Xis 14 anins 162;Xis 14 anins 163;Xis 14 anins 164;Xis 14 anins
165;Xis 14 anins 166;Xis 14 anins 167;Xis 14 anins 168;Xis 14 anins 169;Xis
W0 2016/1 10584
14 anins 170;Xis 14 anins 171;Xis 14 anins 172;Xis 14 anins 173;Xis 14 andY
is 174;Xis 14 anins 175;Xis 14 anins 176;Xis 14 anins 177;Xis 14 anins 178;X
is 14anins 179;Xis 14 anins 180;Xis 14anins 181;Xis 14 anins 182;Xis 14 and
Yis183;Xis14aninsl84;Xisl4andY1's185;Xis14anins186;
Xis 15 anins 1;Xis 15 aninsZ;Xis 15 anins 3;Xis 15 anins4;XislSanins5;
Xis 15 anins6;Xis 15 anins 7;Xis 15 anins 8;Xis 15 anin59;Xis 15 anins
;Xis 15 anins 11;Xis 15 anins 12;Xis 15 deis 13; Xis 15 anins 14;Xis 15
anins 15;Xis 15 anins 16;Xis 15 anins 17;Xis s 18;Xis 15 anins 19;X
is 15 aninsZO;Xis 15 anins21;Xis 15 andY1322;Xis 15 anin323;Xi315 anins
24;Xis 15 aninsZS;Xis 15 aninsZ6;Xis 15 anins 27; Xis 15 8;Xis 15
andY1329;Xis15anins30;Xis15andY1331;Xis15anins32;Xis15anins33;X
is 15 aninsS4;Xis 15 5;Xis 15 anins36;Xis 15 7;Xis 15anins
38;Xis 15 anins39;Xis 15 anins 40;Xis 15 anins41;Xis 15 anins42;Xis 15
anins43;Xis 15 anins44;Xis 15anins45;Xis15anins46;Xis 15 anins47;X
is 15 anins48;Xis 15 9;Xis 15 aninsSO;Xis 15 aninsSl;XislS anins
52;Xis 15 anins 53;Xis 15 anins 54;Xis 15anins 55; Xis 15 anins56;Xis 15
aninsS7;Xis 15 anin358;Xis 15 anins 59;Xis 15 anins60;Xis 15anin361;X
islS anin362;Xis 15 anins63;Xis 15 4;Xis 15 anins65;Xis 15 anins
66;Xis 15 anins 67;Xis 15 aninsé8;Xis 15 anins69;Xis 15 anins70;Xis 15
anins71;Xis 15 anins72;Xis 15 anins 73;Xis 15 anins74;Xis15 anins75;X
is 15 anins76;Xis 15anins77;Xis 15 8;Xis 15 anins79;Xis 15 anins
80;Xis 15 anins 81;Xis 15 anins82;Xis 15 anins83;Xis 15 anins 84;Xis 15
anins 85;Xis 15 anins 86;Xis 15 anins 87;Xis 15 anin388;Xi315 anins89;X
is 15anins90;Xis 391;Xis 15 anins92;Xis 15 anins93;Xis 15 anins
94;Xis 15 anins95;Xis 15 anins96;Xis 15 anins 97;Xis 15 anins 98;Xis 15
anins 99;Xis 15 anins 100; Xis 15 anins101;Xis 15 anins 102;Xis 15 anins
s 15 anins 104;Xis 15 anins 105;Xis 15 anins 106;Xis 15 anins 107;Xis
anins 108;Xis 15 anins 109;Xis 15 anins 315 anins 111;Xis 15 andY
is s 15 anins113;XisISanin5114;Xis 15 anins 115;Xis 15 aninsll6;X
is 15 anins 117;Xis 15 anins 118;Xis 15 anins 119;Xis 15 anins 120;Xi315 and
Yis 121;Xis 15 anins 122;Xis15 anins 123;Xis 15 anins 124;Xis 15 deis 125;
X1315 andY15126;Xis15 deis 127; Xis 15 anins 128;Xis 15 anins 129; Xis 15
andY13130;Xis ISanins131;Xis 15 anins 132;Xi315andY13133;X1315 anins
134;Xis 15 anins 135;Xi515 anins 136;Xis 15 anins 137;Xis 15 anins 138;Xis
15 anins 139‘,Xis 15 anins 140;Xis 15 anins 141;Xis 15 anins 142;Xis 15 andY
is 143;Xis 15 anins 144;Xis15 anins 145;Xis 15 anins 146;X is 15 anins 147;X
is 15 anins 148;Xis 15 anins 149;Xis 15 anins 150;Xis 15 anins 151;Xis 15 and
Yis 152;Xis 15 anins 153;Xis 15 anins 154;Xis 15 andY is 155; Xis 15 deis 156;
X1315 anins 157; Xis 15 anins 158;Xis 15 anins 159;X1315 anins 160;Xis 15
anins 161; Xis 15anins 162;Xis 15 anins 163;Xis15 anins 164;Xis 15 anins
165;Xis 15 anins s 15 anins 167;Xis 15 anins 168;Xis 15 anins 169;Xis
anins 170;Xis ‘15 anins 171;Xis 15 anins 172;Xis 15 andY is 173;Xis 15 andY
is 174;Xis 15 anins175;Xis15anins176;Xi315anins177;XislS anins 178;X
is 15 anins 179;Xis15 anins 180;Xis 15 anins 181;Xis 15 anins 182;Xis 15 and
Yis 183;Xis 15 anins184;Xis 15 andY13185;Xis 15 deis 186;
Xis16aninsl;Xis16aninsZ;Xis16anins3;Xisl6anins4;Xis16aninsS;
Xis s6;Xis 16 anins7;Xis s 8;Xis 16 anins 9;Xis 16 anins
;Xis 16anins11;Xis 16anins 12;Xis l6anins 13; Xis 16 anins 14;Xis 16
aninslS;Xis 16 anins 16;Xis 16anins 17;Xis 16 anin818;Xis 16anins 19;X
is 520;Xis le;Xis l6anins22;Xis 16 3;Xis 16 anins
24;Xis l6anin825;Xis 16aninsZ6;Xis 16 aninsZ7; Xis 16 andY1528;Xis 16
aninsZ9;Xis16aninsSO;Xis16anins3l;Xis16anins32;Xis16anins33;X
is 16 anins34;Xis 16anins 35;Xis 16 anins 36;Xis 16 anins37;Xis 16 anins
38;Xis 16anins 39;Xis l6anins40;Xis l6anins41; Xis 16 anins42;Xis 16
anins43;Xis16anins44;Xis16anins45;Xis16anins46;Xis16anins47;X
is 16 anins48;Xis 16anins49;Xis sSO;Xis 16 aninsSl;Xis 16anins
52;Xis 16 anins 53;Xis s54;Xis 16anins 55;Xis 16 6;Xis 16
aninsS7;Xisl6anins 58;Xis l6 aninsS9;Xis s60;Xis 16 anins61;X
is 16 anins 62;Xis 16anins63;Xis 16 anins64;Xis 16 anins65;Xis l6anins
66;Xis 16 andY1567;Xis 16 anins68;Xis 163nins69;Xis ‘6anins 70;Xis 16
anins71;Xis l6 2;Xis l6anins73;Xis 16anins 74;Xis 16 anins75;X
is16anins76;Xis16anins77;Xis16anins78;Xis16anins79;Xis16anins
80;Xis 16 anins 81;Xis 16anins 82;Xis 16 anins 83;Xis 16anins 84;Xi316
anins85;Xis 16anins86;Xis 16anins87;Xis 16 andY1388;Xis 16anins89;X
3O is 16anins90;Xis 162deis91;Xis 16anins92;Xis 16 anins93;Xis 16anins
94;Xis 16 anins95;Xis 16anins96;Xis 16anins97;Xis l6anins 98;Xis 16
anins99;Xis 16 anins 100;Xis 16 anins 101;Xis 16 aninleZ; Xis 16anins
103;Xis 16 anins 104;Xis 16 anins 105;Xis 16 anins106;Xis 16 anins 107;Xis
16 anins 108;Xis 16 anins 109;Xis 16anins 110;Xis 16 anins 111;Xis 16 andY
i3112;Xis16anins113;Xi516anins114;Xis]6anins115;Xis16aninsll6;X
W0 2016/1 10584
is 16anins 117;Xis 16anins 118;Xisl6andY1's 119;Xis s 120;Xis l6 and
Yis 121;Xis 16 anins 122;Xis 16 anins 123;Xis 16 anins 124;Xis 16 anins 125;
Xis 16 anins s 16 deis 127; Xis 16 andY13128gXis 16 anins 129;Xis 16
anins 130;Xis 16 anins 131;Xis 16 anins 132;Xis 16 anins 133;Xis 16 anins
s 16 anins 135;Xis 16 anins 136;Xis 16 deis 137; Xis 16 anins 138;Xis
16 anins 139;Xis 16 anins 140;Xis 16 anins 141;Xis 16 anins 142;Xis 16 andY
is 143;Xis 16. anins 144;Xis 16 anins 145;Xis 16 anins s 16 anins 147;X
is 16anins 148;Xisl6 anins 149;Xis 16 anins s 16 anins 151;Xis l6 and
Yis 152;)(1316 anins 153;Xis 16 anins 154;Xis 16 anins 155;Xis 16:111in5 156;
Xis 16 anins 157;Xis 16 anin5158gXis 16 anins s 16 anins 160;Xis 16
anins 161; Xis 16 deis 162; Xis 16 anins 163;Xis 16 anins 164;Xis 16 anins
165;Xis 16 anins 166;Xis 16anins 167;Xis 16 anins 168;Xis 16 anins 169;Xis
16anins 170;Xis 16 anins 171;Xis 16 anins 172;Xis 16 anins 173;Xisl6 andY
is I74;Xis 16 anins 175;Xis 16 anins 176;Xis 16 anins 177;Xis 16 anins 178;X
is 16 anins 179;Xis 16 anins 180;Xis 16 anins 181;Xis 16 anins s 16 and
Yis 183;Xis 16 anins 184;Xis 16 anins 185;Xis 16 deis 186;
Xis 17anins ngis 17 aninsZ;Xis 17anins3;Xis 17 anins4;Xis sS;
Xis 17anins6;Xis l7anins7;Xis 17 anin38;Xis 17 andY139gXis 17 anins
;Xis 17anins 11;Xis 17 anins 12;Xis s 13;Xis 17anins 14;Xis 17
anins 15;Xis 17anins 16;Xis17anins 17;Xis 17anins l8;Xis 17anins19;X
is 17anin520ins l7aninle;Xis 17 anin322;Xis 17aninsZ3;Xis 17anins
24;Xis 17anins25;Xis 17 anin526;Xis sZ7;Xis 17andY1328;Xis 17
anin829;Xis17aninSSO;Xis17anin531;Xis17anins32;Xis17anins33;X
is 17anins34;Xis 17anins35;Xis17anins36;Xis17anins37;Xisl7anins
38;Xis 17anins 39;Xis 17anins40;Xis 17 anins41;Xis 172deis42;Xis 17
anins43;Xis 17 anins44;Xis 17 anins45;Xis 17 anins46;XisI7 anins47;X
is s48;Xis17anins49;Xis17aninsSO;Xis 17aninsSl;Xisl7anins
52;Xis l7aninsS3;Xis 17 aninsS4;Xis 17 anins55;Xis 17aninsS6;Xis 17
anins 57;Xis 17 anins 58;Xis 17 anins 59;Xis 17 anins 60;Xis 17 anin361;X
is l7anins62;Xis 17anins63;Xis 17 anins64;Xis s65;Xis 17 anins
66;Xis l7anins67;Xis 17 anins 68;Xis 17 anins 69;Xis 17anins70;Xis 17
anins71;Xis 17anins72;Xis17anins73;Xis l7anins74gX1's 17anins75;X
is 17 anins76;Xis 17 anins77;Xis 17 anins78;Xis 17anins79;Xis 17 anins
80;Xis 17anins81;Xis 17 anins 82;Xis 17 anins 83;Xis 17anins 84;Xis l7
anins85;Xis17andY1386;Xis17aninSS7;Xis17anin388;Xis17aninsS9;X
is l7anin890;Xis 17anins91;Xis17anins92;Xis 17 andY is 93; Xis 17 deis
94; Xis 17anins95; Xis 17anins96;Xis 17 anin397; Xis 17 anins98; Xis 17
anins 99; Xis 17 anins 100;Xis 17 anins 101; Xis 17 deis 102; Xis 17 anins
103;Xis 17 anins 104;Xis17 anins 105;Xis 17 anins 106;Xis 17 anins 107;Xis
17 anins 108;Xis 17 anins 109;Xis 17 anins 110;Xis 17 andY is 111;Xis 17andY
is 112;Xis 17 anins 113;Xis 17 anins s 17 anins 115;X is 17 anins 116;X
is 17 anins 117;Xis 17 anins 118;Xis 17 anins119;Xis 17 anins 120;Xis 17 and
Yis 121;Xis 17 anins 122;Xis 17 anins 123;Xis 17 andY is 124; Xis 17 anins 125;
X is 17 andY is 126; Xis 17 deis 127; Xis 17 anins 128; Xis 17 andY is 129; Xis 17
deis 130; Xis 17 anin3131;Xis 17 anins s s s 17 anins
134; Xis 17 anins 135; Xis 17 anins 136; Xis 17 anins 137; Xis 17 anins 138; Xis
17 anins 139;Xis 17 anins 140;Xis 17 anins s 17 anins 142;Xis 17 andY
is 143; Xis 17 anins 144;Xis17 anins 145;Xis 17 anins 146;Xis 17 anins 147;X
is 17 anins 148;Xis 17 anins 149;Xis 17 anins 150;Xis 17 anin3151;Xis 17 and
Yis 152; Xis 17 anins 153;Xis 17 anins 154;Xis 17 andY is 155; Xis 17 anins156;
Xis 17 deis 157; Xis 17 anin3158;Xis 17 anins 159; Xis 17 anins 160; Xis 17
anins 161;Xis 17 anins 162; Xis 17 anins 163;Xis 17 anins 164;Xis 17 anins
165; Xis 17 anins 166;Xis 17 anins167;Xis 17 anins 168; Xis 17 anins 169;Xis
17 anins 170;Xis 17 anins 171;Xis 17 anins 172;Xis 17anins 173;Xis 17 andY
is 174; Xis 17 anins 175; Xis 17 anins 176; Xis 17 deis 177; Xis 17 andY is 178; X
is 17 anins 179;Xis 17 anins 180;Xis 17 anins 181;Xis 17 anins 182;Xis l7 and
Yis s 17 anins 184;Xis 17 anins s 17 anins 186;
Xis 18 anins 1;Xis 18 anins 8 anin53;Xis '18 anins4;Xis 18 aninsS;
Xis 18 anins 6;Xis 18 anins7;Xis 18 anins 8;Xis 18 anins 9;Xis 18 anins
10;Xis 18 anins 11;Xis 18 anins 12;Xis 18 anins 13;Xis 18 anins 14;Xis 18
anins 15;Xis 18 anins 16;Xis 18 anins 17;Xis 18 anins 18;Xis 18 anins 19;X
is 18 anin320;Xis 18 anin521;Xis 18 anins 22;Xis 18 anins23;Xis 18 anins
24;Xis 18 anins25;Xis 18 6;Xis 18 anins27;Xis 18 anins 28;Xis 18
aninsZ9;Xis 18 anins 30;Xis 18 anins 31;Xis 18 anins32;Xis 18 anins33;X
is 18 aninsS4;Xis 18 anins 35;Xis 18 anins36;Xis 18 anins 37;Xis 18 anins
38;Xis 18 anins 39;Xis 18 anins 40;Xis 18 anins 41;Xis 18 anins 42;Xis 18
anins43;Xis 18 anins44;Xis 18 anins45;Xis 18 anins46;Xis 18 anins47;X
is 18 anins48;Xis 18 anins49;Xi318 anins 50;Xis 18anins 51;Xis 18 anins
52;Xis 18 anins 53;Xis 18 deis 54; Xis 18 anins 55;Xis 18 aninS 56;Xis 18
aninsS7;Xis 18 anins58;Xis 18 anins 59;Xis 18 anins60;Xis 18 anins61;X
2016/050308
is 18 andY1562;Xis 18 anins63;Xis l8anins64;Xis 18 anins65;Xis 18 anins
66;Xis 18 anins 67;Xis 18 anins68;Xis l8 anins69;Xis 18 anins 70;Xis 18
anins71;Xis 18 anins 72.;Xis 18 anins 73;Xis 18 andY is 74;Xis 18 anins 75;X
is 18 6;Xis 183nins77;Xis 18anins78;Xis 18 anins 79;Xis 18 anins
80;Xis 18anins 81;Xis 18 anins 82;Xis 18anins 83; Xis 18 4;Xis 18
anins 85;Xis 18 aninsS6;XislSaninsS7;Xis 18 andY is 18aninsS9;X
is 18 anins90;Xis 18 anins91;Xis 18anins92;Xis 18 aninsQ3;Xisl8 anins
94;Xis 18 anin595;Xi518anins96;Xis 18anins97;Xis 18 anins98;Xis 18
anin599;Xi318anins100;Xis18anins101;Xisl8anins102;Xi3182deis
103;Xis 18 anins s 18 anins 105;Xis 18 anins 106;Xis l8anins 107;Xis
18 anins 108;Xis 18 anins 109;Xis 18 anins 110;Xis 18 anins 111;Xis 18 andY
is 112;Xis 18 anins 113;Xis 18 anins 114;Xis 18 anins 115;Xis 18 anins 116;X
is 18 anins 117;Xis 18 anins s 18 anins 119;Xis 18 anins 120;Xis 18 and
Yis 121;Xis 18 anins 122;Xis 18 anins 123;Xis 18 anins 124;Xis 18 deis 125;
Xis 18 anins 126;Xis 18 anins 127;Xis 18 anins 128;Xis 18 anins 129;Xis 18
anins 130;Xis 18 anins s 18 anins 132;Xis 18 deis 133; Xis 18 anins
134;Xis 18 anins 135;Xis 18 anins 136;Xis 18 aninS 137;Xis 18 anins138;Xis
18:111in5 139;Xis 18 anins 140;Xis 18 anins 141;Xis 18 anins s 18 andY
is 143;Xis 18 anins 144;Xis 18 anins 145;Xis 18 anins 146;Xis 18 anins I47;X
is 18 anins 148;Xis 18 anins 149;Xis 18 anins 150;Xis 18 anins 151;Xis 18 and
Yi5152;X1318 anins 153;Xis 18 anins154;Xis 18 anins 155;Xis 18 anins 156;
Xis 18 anins 1.57;Xis 18 anins 158;Xis 18 anins 159;Xis 18 anins s 18
deis 161; Xis 18 anins 162;Xis 18 anins 163;Xis 18 anins 164;Xis 18 anins
165;Xis 18 anins 166; Xis 18 anins 167;Xis 18 anins s18 anins 169;Xis
18 anins 170;Xis 18 aninsl71;Xis 18 anins 172;Xis 18 aninsl73;Xis18andY
is 174;Xis 18 anins 175;Xis 18 anins 176;Xis 18 anins 177;Xis 18 anins 178;X
is 18 anins 179;Xis 18 anins 180;Xis 18 anins 181;Xis 18 anins s 18 and
Yis183;Xis18anins184;Xis18anins185;Xis18aninsl86;
Xis19aninsl;Xis19aninsZ;Xis19anins3;Xis19anins4;Xisl9anin55;
3O Xis 19 anins6;Xis 19 anins7;Xis 19anin38;Xis 19anins 9;Xis 19 anins
;Xis 19 anins 11;Xis 19anins 12;Xis 19 anins 13;Xis 19anins 14;Xis l9
aninslS;Xisl9anins16;Xisl9anins17;Xis19anin518;Xisl9aninsl9;X
is l9anin520;Xis19andY1'321;Xis19anin522;Xis 19anins23;Xi519anins
24;Xis l9anin525;Xis l9anins26;Xis 19andY1327;Xis19aninSZ8;Xis 19
anins29;Xis l9 anins30;Xis 19 anins31;Xis 19anins 32;Xis 19 anins33;X
is 19 anins 34;Xis 19 anins 35;Xis 19anins 36;Xis 19 andY is 37;Xis 19 anins
38;Xis 19 anins 39;Xis 19 anins40;Xis 19 anins 41; Xis 19 anins42;Xis 19
anins 43;Xis 19 anins44;Xis 19 anins45;Xis 19 anins 46; Xis 19 anins47;X
is 19 anins48;Xis 19 anins49;Xis 19 aninsSO;Xis 19 andY is 51;Xisl9 anins
52;Xis 19 anins 53;Xis 19 anins 54;Xis 19 anins 55; Xis 19 aninsS6;Xis 19
aninsS7;Xis l9 8;Xis 19 anins 59;Xis 19 anins60; Xis 19 anins61;X
is 19 anins 62;Xis 19and‘1’is 63;Xis 19 anins64;Xis 19 andY is 65;Xis 19 anins
66;Xis 19 andY is 67;Xis 19 anins 68;Xis 19 andY is 69; Xis 19 anins 70;Xis 19
anins71;Xis 19 2;Xis 19anins73;Xis 19anins74; Xis 19 anins75;X
is 19 anins76;Xis 19 anins77;Xis 19anins78;Xis 19 anins 79;Xisl9 anins
80;Xis 19 anins 81;Xis 19 anins 82;Xis 19 anins83; Xis 19 aninsS4;Xis 19
anins85;Xis 19 anins 86;Xis 19 anins 87;Xis 19anins 88; Xis 19 aninsS9;X
is 19 anins90;Xis 19 1;Xis 19 anins92;Xis 19 andY is93;Xis 19 anins
94; Xis 19 anins 95; Xis 19 anins 96;Xis 19 anins 97;Xis 19 anins98;Xis 19
anins 99;Xis 19 anins 100;Xis 19 anins 101;Xis 19 anins 102;Xis 19 anins
103;Xis 19 anins 104; Xis 19anins 105; Xis 19 anins 106; Xis 19 anins 107;Xis
19anins 108;Xis 19 anins 109;Xis 19 anins 110;Xi519anins 111;Xis 19andY
is 112;Xis 19 anins 113;Xis 19 anins 114;Xis 19 anins 115;Xis 19 anins 116;X
is 19 anins 117;Xis 19 anins 118;Xis 19 anins 119;Xis 19 anins 120;Xis 19and
Yis 121;Xis 19 anins 122;Xis 19 anins 123;Xis 19 anins 124;Xis 19 anins 125;
Xis 19 deis 126; Xis 19 deis 127; Xis 19 and Yis 128; Xis 19 deis 129; Xis 19
anins 130;Xis 19 anins 131;Xis 19 anins 132;Xis 19 anins 133;Xis 19 anins
134;Xis 19 anins 135;Xis 19 anins 136;Xis 19 anins 137;Xis 19 anins s
19 anins 139;Xis 19 anins 140;Xis 19 anins 141; Xis 19 anins 142;Xis 19 andY
is 143; Xis 19 and Y is s 19 anins 145; Xis 19 anins 146;Xis 19 anins 147;X
is 19 anins 148;Xis 19 anins 149;Xis 19 anins 150;Xis 19 anins s 19 and
Yis 152;Xis 19 anins s 19 anins s 19 anins 155;Xis 19 deis 156;
Xis 19 anins 157;Xis 19 anins 158; Xis 19 anins 159;Xis 19 anins 160;Xis 19
anins 161;Xis 19anins 162;Xis 19 anins 163;Xis 19 anins 164;Xis 19 anins
165; Xis 19 deis 166; Xis 19 deis 167; Xis 19 anins 168; Xis 19 andY is 169; Xis
19 anins 170;Xis 19 anins 171;Xis 19 anins 172;Xis 19 anins 173;Xis l9 andY
is s 19 deis 175; Xis 19 anins 176;Xis 19 andY is s 19 anins 178;X
is 19 anins 179;Xis 19 anins 180;Xis 19 anins 181;Xis 19 anins 182; Xis 19 and
Yis 183;Xis 19 anins 184;Xis 19 anins 185;Xis 19 anins 186;
Xiszoanins1;XisZOanins2;XisZOanins3;XisZOanins4;Xis20anins5;
XisZOanins6;Xi520anins7;XisZOanins8;Xis20 anin39;Xis20anins
IO;XisZOanins 11;Xis20anins12;Xi320anins 13; Xis 20anins 14;Xi520
anins15;Xi320anins16;XisZOaninsl7;Xi520anins18;Xi520anins 19;X
is20aninsZO;Xis20anin521;Xi320anins22;Xis20 aninsZ3;XisZOanins
24;Xi520anin525;Xis20anin526;Xis20anins27;XisZOanins28;Xis20
anin529;Xis20anins30;XisZOanins31;Xi320anins32;Xis20anins33;X
1320andYis34;Xis20anins3S;XisZOanins36;Xis20 anins37;Xi520anins
38;Xi520 anins 39;XisZOanins40;Xis20anins41;Xis20anins 42;Xis20
anins43;Xi520anins44;Xi520anins45;Xis20anins46;Xis20anins47;X
isZOanins48;XisZOanins49;Xi520andYisSO;Xi320 aninsSl;XisZOanins
52;Xi320anins53;Xis20aninsS4;Xi520anins55;Xis20anins56;Xis20
anins57;Xis20aninsSS;Xi320andYisS9;Xi520andYiséO;Xis20anin561;X
isZOanins62;XisZOanins63;Xis20anins64;Xis20 5;XisZOanins
20 anins 67;XisZOanins68;Xis20anins 69;Xi320anins 70;XisZO
anins71;Xi320anins72;Xi820anins73;XisZOanins74;Xis20anins75;X
isZOanins76;XisZOanins77;Xis20anins78;XisZOanins79;XisZO anins
80;Xi320 anins Sl;XisZOanins 82;Xi520anins83;XisZOanins 20
anin385;Xi520anins86;Xi520anin387;Xis20anins88;Xis20anins89;X
isZOanins90;Xis20anins91;Xi320anins92;Xis20 anins93;XisZOanins
94;Xis20 anins 95;Xis20anins96;Xis20anins97;XisZOanins 98;Xi520
anins99;Xi520anins100;Xis20anins101;Xi520anins102;XisZOanins
103;Xis 20 anins 104;Xis 20 anins 105;Xis 20 anins 106;Xis 20 anins 107;Xis
20anin5108;Xi820anins109;Xis20aninsllO;Xis20anins111;Xi320andY
is112;Xis20anins113;Xis20anins114;Xi520anins 115;XisZOaninsll6;X
isZOanins117;Xi820anins118;XisZOanins119;Xi820anins120;Xis20and
Yis 121;Xis 20 anins 122; Xis 20 anins s 20 anins 124;Xis 20 deis 125;
Xis 20 anins 126;Xis 20 anins 127;Xis 20 anins s 20 andY is 129; Xis 20
anins 130;Xi320 anins 131;Xis 20 anins 132;Xis20anins s 20 anins
134;Xis 20 anins 135;Xis 20 anins 136;Xis 20 anins 137;Xis 20 anins I38;Xis
20anin5139;Xi520anins140;Xi320anins141;XisZOanins142;Xis20andY
is 143;Xis 20 anins 144;Xis20 anins 145;Xis 20 anins 146;Xis 20 anins 147;X
i320 anins I48;Xis 20 anins 149;Xis20anin3150;Xis 20 anins 151;Xis20 and
Yis s 20 anins 153;Xis 20 anins 154;Xis 20 anins s 20 anins 156;
XisZOanins157;Xis20anins158;Xis20anins159;Xi320anins160;Xis20
WO 10584
anins 161;Xis 20 anins 162;Xis 20 anins 163;Xis 20 anins 164;Xis20 anins
165;X is 20 deis 166; Xis 20 andY is 167; Xis 20 andY is 168; Xis 20 anins 169; Xis
20anins 170;Xi320aninsl71;XisZOanins l72;XisZO anins 173;X1520andY
is 174;Xis 20 anins 175; Xis 20 anins 176; Xis 20 anins 177; X is 20 anins 178;X
isZOanins 179;XisZOanins180;Xi320anins 181;Xis 20 anin3182;Xi320and
Yis183;Xi320anins184;Xi320anins185;Xi320anins186;
Xis21aninsl;Xis21anins2;Xi321anins3;Xis21anins4;XileaninsS;
X1321anins6;Xis21anins7;Xis21aninsS;Xis21 anins9;Xile anins
;Xi521aninsll;Xis2lanins12;Xis21aninsl3;Xi321aninsl4;Xis21
aninslS;Xi521aninsl6;Xi521aninsl7;XileandYi518;Xi521aninsl9;X
insZO;Xileanin521;Xi521anins22;Xi521anin323;Xi521 anins
24;Xi521 anin325;Xis 21 anins26;Xile 7; Xile anin328;Xi521
anins29;Xis21anins30;Xis21anins31;Xi521anin532;Xis21anin333;X
i521anin534;Xis21anins35;Xi521anins36;Xis21anins37;Xileanins
38;Xileanins39;XisZI anins40;Xi521anins41;Xi521anins42;Xi521
anins43;Xi321anins44;Xileanins45;Xi521anins46;Xis21anins47;X
is21anins48;Xis2lanins49;Xi521aninsSO;Xi321anins51;Xi521anins
52;Xi321aninsS3;XileaninsS4;Xi521aninsSS;Xis21anin556;Xi521
aninsS7;Xis21aninsS8;Xis21aninsS9;Xileanins60;Xis21anin361;X
i321anins62;Xi521anins63;Xileanins64;Xi821 anins65;Xi521anins
66;Xileanins67;Xi521anins68;Xis21anin569;Xi321anins70;Xile
an Yis71;Xi521anins72;Xi321anins73;Xis21anins74;Xis21anins75;X
i521anins76;Xileanins77;Xi521anins78;Xis21 anins79;Xi521anins
80;XileaninsSl;Xileanin382;Xi521anin383;Xileanins84;Xis21
andY is 85;Xis21 mlins 86;Xis 21 andY is 87; Xis 21 anins 88;Xis 21 anins 89;X
i521anins90;Xis21anin591;Xi321anins92;Xis21anins93;Xi521anins
94;Xileanins95;Xi321anins96;Xis21anins97;Xileanins98;Xis21
anins 99; Xis 21 deis 100; Xis 21 anins 101; Xis 21 anins 102; Xis 21 anins
103; Xis 21 anins 104; Xis 21 anins 105; Xis 21 andY is 106; Xis 21 andY is 107; Xis
21anins108;Xi521anin3109;Xis21aninsllO;Xi821anins111;Xis2landY
is112;Xis2lanins113;Xi321aninsll4;Xileanins115;Xis21 16;X
i521 aninsll7;Xis21 anin5118;Xi521anins119;Xi821anin5120;Xi821 and
Y is 121;Xis 21 anins 122;Xis 21 deis 123; Xis 21 anins 124;Xis 21 anins 125;
Xis 21 deis 126; Xis 21 anins 127; Xis 21 andY is 128; X is 21 andY is 129; X is 21
anins 130;Xis 21 deis 131; Xis 21 anins 132;Xis 21 anins 133;Xis 21 anins
W0 2016/1 10584
134;Xis 21 anins 135;Xis 21 anins 136; Xis 21 anins 137;Xis 21 anins 138;Xis
21 anins 139;Xi521 anins 140;Xis 21 anins 141;Xi321 anins 142;Xi521 andY
is 143;Xis 21 anins 144;Xis 21 anins 145;Xis 21 anins 146;Xis 21 anins 147;X
is 21 anins 148; Xis 21 anins 149;Xis 21 anins 150;Xis 21 anins 151;Xis 21 and
Yis 152;Xis 21 anins 153;Xis 21 anins 154;Xis 21 anins 155;Xis 21 anins 156;
Xis 21 anins 157;Xis 21 anins 158;Xis 21 anins s 21 anins 160;Xi821
anins 161; Xis 21 anins 162; Xis 21 deis 163; Xis 21 anins 164;Xis 21 anins
165;Xis 21 anins 166;Xis 21 anins 167;Xis 21 anins 168;Xis 21 anins 169;Xis
21 anins 170;Xi521 anins 171;Xis 21 anins 172;Xis 21 anins 173;Xi521 andY
is 174;Xis 21 anins 175;Xis 21 anins 176;Xis 21 aninS 177;Xis 21 aninS 178;X
is 21 anins 179;Xis21 anins s 21 anins s 21 anins 182;Xis21 and
Yis 183;Xis 21 anins 184;Xis 21 anins 185;Xis 21 deis 186;
nins1;Xis22anin32;Xis22anin33;Xis22anins4;Xis22anins5;
XisZZanin56;X1322 anins 7;Xis22 anins 8;Xis22 anins9;Xis22anins
..¢ 9'] 10;Xis 22 anins 11;Xis 22 anins 12;X1322 anins 13; Xis 22 anins 14;Xis 22
anins 15;Xis22anins16;Xi522anins 17;Xis22anins 18;Xis22anin519;X
isZZaninsZO;Xi322anins2l;Xis22 anins22;Xi322 anin323;Xi822andY1's
24;Xi322 anin525;Xi522 anins26;Xi522andYi527;X1922 anin528;Xi322
aninsZQ;Xis223nins30;Xis22anins31;XisZ2 anins32;Xis22 anins33;X
i322anins34;Xis22anins35;Xi522 6;Xis22anins37;Xis22 anins
38;Xis22anins 39;Xis 22 anins40;Xis 22 1;Xi322 anins42;Xis22
3;Xi322andYis44;Xi322 anins45;Xis22 anins46;Xi522 anins47;X
is223nins48;Xi522 anins49;Xi322 anins 22 aninsSl;Xis 22anins
52;Xis22anins 53;Xis22 anins 54;Xis22 anin355;Xi322 anins 56;Xi322
aninsS7;Xi322 anin558;Xi522 anins 59;Xi322anin360;Xis22anins61;X
ins62;Xi522anins63;XisZZanins64;Xis22 anins65;Xis22 anins
66;Xi322anins67;Xis22 anins 68;Xis 22 9;Xis22 anins 70;Xi522
anins71;XisZ2anins72;Xi322 anins 73;Xis22 4;Xi322anins 75;X
i822 anins76;Xi822anins77;Xi522 anins78;Xis22anins79;Xi822anins
80;Xi522anins 81;Xi822 anins 82;Xis 22 anins 83;Xis22 anins 84;Xi522
aninsSS;Xis22aninsS6;Xi522 anins87;X1822anin588;Xis22anins89;X
i322anins90;XisZZanins91;Xi522anins92;Xis22anins93;Xis22anins
94;Xi522 anins 95;Xi522 anins96;Xis 22 anins 97;Xi322 anins98;Xis22
anin399;Xis22anins100;Xi3223nins101;Xi322anins102;Xi322anins
103;Xis 22 deis 104; Xis 22 anins 105;Xis 22 anins 106;Xis 22 anins 107;Xis
2016/050308
22anin5108;Xis223nins109;Xi522anins110;Xi822 andY is 111;Xi322 andY
is 112;Xi522anins113;Xis22anins 114;Xis22anins 115;X is22 anins 116;X
is 22 anins 117;Xi322 anins 118;Xis 22 anins 119;Xis 22 and Yis 120;Xis 22 and
Yis 121;Xis 22 anins 122;Xis 22 anins 123;Xis 22 andY is 124; Xis 22 anins 125;
Xis 22 deis 126; Xis 22 andY is 127; Xis 22 anins 128;Xis 22 anins 129;Xis 22
;Xis22anins131;Xi522anins132;Xi522anins 133;Xis22anins
134;Xis 22 anins 135;Xis 22 anins 136;Xis 22 anins 137;Xis 22 anins 138;Xis
22anins139;X1522anins140;Xis22anins141;Xi522 andY is 142;Xis 22 andY
is s 22 anins 144;Xis 22 anins 145;Xis 22 anins 146;X is 22 anins 147;X
i522 anins 148;X1522 anins 149;Xis 22 anins 150;Xis 22 aninslSl;Xi522 and
Yis 152;Xis 22 anins 153;Xis 22 anins 154;Xis 22 andY is 15S;Xis 22 anins 156;
Xis 22 anins 157;Xis 22 and Y is 158; Xis 22 andY is 159;Xis 22 anins 522
anins 161;Xis 22 anins 162;Xis 22 anins 163;Xis22 anins 164;Xis22 anins
s 22 anins 166;Xis 22 anins 167;Xis 22 anins 168;Xis 22 anins 169;Xis
22 aninsl70;Xi522 anins 171;Xis22 anins 172;Xis 22 anins 173;Xis 22 andY
is 174;Xi322 anins 175;Xis 22 anins 176;Xis 22 anins 177;Xis 22 anins 178;X
is22 anins 179;Xis 22 anins 180;Xis 22 anins 18];Xis 22 anins 182;Xis22 and
Yis 183;Xis 22 anins 184;Xis 22 anins 185;Xis22 anins 186;
Xis23anins1;Xi323anin52;Xi823 anins3;XisZ3 anins4;Xis23 aninsS;
Xis23 anins6;Xis 23 anins 7;Xi323 anins 8;Xis23 anins9;XisZ3 anins
;Xis23 anins 23 anins 12;Xi323 anins 13; Xi323 anins 14;Xi523
anins15;Xi823 anins 23 anins17;Xi323a.nins18;Xi523anin519;X
is 23 anin520;Xis 23 anins 21;Xi523 anin522;Xis 23 aninsZ3;Xis 23 anins
24;Xi523 anin325;Xis23 anin326;Xis23 anins27;Xi523 anins28;XisZ3
anins29;XiSZ3 andY is 30;Xis23 1;Xi323 anins 32;Xi523 anins33;X
1823 anins34;Xi323 anins35;XisZ3 6;Xi523 anin537;Xi523 anins
38;Xis 23 anins39;Xis23 anins40;Xis23 1;XisZ3 anins42;XisZ3
anins43;Xi523 anins44;Xi523 anins45;XisZ3 anins46;Xi323 anins47;X
i323 anins48;Xis 23 anins49;Xis23 aninsSO;Xi823 anins 51;Xis 23 anins
52;Xis 23 anins 53;Xi523 aninsS4;Xi323 anins 55;Xis23 anins 56;Xis23
anins 57;Xis23 anins 58;X1323 andY1359;Xi523 anins60;Xis23 1;X
i523 anins 62;Xis 23 anins63;Xis 23 anin564;Xis 23 anins65;Xis 23 anins
23 aninsé7;Xi323 anins68;Xi523 anins 69;Xi523 anins 70;Xi323
anins7l;Xis 23 anins72;Xis23 anins73;Xi523 anins 74;Xi523 anins 75;X
is 23 anins 76;Xis 23 anins77;Xis23 anins 78;X1823 anins 79;Xis 23 anins
W0 20161110584
80;Xi323 anins 81;Xis 23 anins 82;Xis23 anins83; Xi523 aninsS4;Xis23
anins 23 anins 86;Xi323 anins 87;Xi323 anins 88;Xis23 anins 89;X
is23 anins90;Xis23 anins9ngis23 anin592;Xi523 aninsQ3;Xis23 anins
94;Xi523 anins95;Xi323 anins96;Xis23 anins97; Xi323 anins98;XisZ3
anins 99;Xis 23 anins s 23 anins s 23 anins 102;Xis 23 anins
103;Xis 23 anins 104;Xis 23 anins 105;Xi323 anins 106;Xis 23 anins 107;Xis
23 anins 108;Xi323 anins 109;Xis23 anins 110;Xi523 anins 111;Xis23 andY
i3112;Xi523anins113;Xis23 anins 114;Xi523 anins 115;Xis23 anins 116;X
i523 anins 117;X1523 18;Xi523 anins119gXis 23 anin5120;Xis23 and
Yis 121;Xis 23 anins 122;X1's 23 anins 123;Xis 23 anins 124;Xis 23 anins 125;
Xis 23 anins 126;Xis 23 deis 127; Xis 23 anins 128;Xis 23 anins 129; Xis 23
anins 130;Xis 23 anins 131;Xis 23 anins 132;Xis 23 anins 133;Xi523 anins
134;Xis 23 anins 135;Xis 23 anins 136;Xis 23 anins 137;Xis 23 anins 138;Xis
23 anins s 23 anins I40;Xis 23 anins 141;Xis 23 anins 142;Xis23 andY
is 143; Xis 23 deis 144; Xis 23 anins 145;Xis 23 anins 146;Xis 23 anins 147;X
is23 anins 148;Xi323 anins 149;Xis 23 anins 150;Xis 23 anins 151;Xi323 and
Yis 152;Xi323 anins 153;Xi523 anins 323 anin5155;Xis23 deis 156;
Xis 23 anins s 23 anins 158;Xis 23 anins 159;Xis 23 anins 160;Xis 23
anins 161;Xis 23 anins 162;Xis 23 anins 163;Xis 23 anins 164;Xis 23 anins
165;Xis 23 anins s 23 anins 167;Xis 23 anins 168;Xis 23 anins 169;Xis
23 anins 170;Xis 23 anins 171;Xis 23 anins 172;Xis 23 anins s 23 andY
is 174;Xis 23 anins s 23 anins 176;Xis 23 anins 177;Xis 23 anins178;X
is23 anins 179;Xis23 anins 180;Xis 23 anin3181;Xis 23 aninslS2;Xi523 and
Yis 183;Xis 23 anins 184;XisZ3anins185;Xis23anin3186;
Xi324anins1;Xis24anins2;Xis24anins3;Xi324anins4;Xi524aninsS;
XisZ4anins 6;Xis24 anins 7;XisZ4anins 8;Xis24 anins 9;XisZ4anins
;Xi324anins11;Xis24anins12;Xi324anins13;Xis24aninsl4;Xis24
anins 15;Xi524anins 16;Xi524anins 17;Xi824anins18;Xi524anins 19;X
is24anins20;Xis24anins21;Xi524anins22;Xi524anin323;XisZ4anins
24;Xis24anins 25;Xis24andYi826;Xis24anins27;Xis 24anin328;Xi524
anin529;Xi524andYi330;Xis24anins31;Xi524anins32;Xis24anins33;X
is24anins34;Xi524anins35;Xis24anins36;Xis24anins37;Xi524anins
38;Xis24anins 24anins40;Xis24 anins4l;Xis24anins42;Xis24
anins43;Xis24anins44;Xis24anins45;Xi324anins46;Xis24anins47;X
is24andYis48;Xi324anins49;Xi524anins 50;Xis24anins51;XisZ4anins
2016/050308
52;Xis 24 anins 53;Xi324anins 54;Xis 24 anins 55;Xis 24 anin356; Xis 24
anins 57;Xis 24 anins 58;Xi524 anins 59;XisZ4anins 60; Xis24 anins 61;X
is 24 anins 62;Xis 24anins63;Xis24anins 64;Xis 24andY is 65;Xi524 anins
66; Xis 24 anins 67; Xis 24 anins 68; X is 24 anins 69; Xis 24 anins 70; Xis 24
anins 71;Xis 24anins72;Xis24anins 73;Xi524 andY is 74; Xisz4 anins75;X
i524 anins 76;Xis 24anins77;Xis24anins78;Xis 24andY is 79;Xi324 deis
80; X is 24 and Y is 81; Xis 24 and Y is 82; X is 24 and Y is 83; X is 2.4 andY is 84; X is 24
andY is 85;Xis24 anins 86;Xis24anins 87;Xis24 andY 1388; Xis24 anins 89;X
is 24 anins 90;Xis24 anins91;Xis24 anin392;Xi524andY is 93;Xis24 deis
94; Xi524 anins 95;Xis 24 anins 96;Xi524 anins 97; Xi524 anins 98;Xis 24
anins 99; Xis 24 deis 100; Xis 24 anins 101; Xis 24 deis 102; Xi524 deis
103; Xis 24 and Yis 104; X is 24 andY is 105; X is 24 andY is 106; X is 24 and Yis 107; Xis
24 anins 108;Xi524 anins 109;Xi824 anins110;Xi524 anins “1;Xis 24 andY
is 112;Xis 24 anins s.24anins is 24anins 115;Xi324an-:1Yis 116;X
i524anins 117;Xi324 anins 118;Xi524 anins 119;Xis 24 anins 120;Xis 24and
Yis 121; Xis 24 anins 122;Xis 24 anins 123; Xis 24 andY is 124; Xis 24 3.11in8 125;
X is 24 andY is 126; Xis 24 anins 127; Xis 24 andY is 128;Xis 24 andY is 129; X is 24
anins 130;Xis 24 anins 131;Xis 24 anins 132;Xis 24 anins 133;Xis 24 deis
134; Xi524 anins 135;Xis 24 anins 136;Xis 24 anins 137;Xis 24 anins 138;Xis
24 deis 139; Xis 24 anins 140;Xis 24 deis 141; Xis 24 anins 142; Xis 24 andY
is 143; Xis 24 anins 144; Xis 24 anins 145;Xis 24 anins 146;Xis 24 anins 147;X
is 24 anins 148;Xis 24 anins 149;Xis 24 anins 150;Xis 24 anins 151;Xis 24 and
Yis 152;Xis 24 anins 153;Xis 24 anins 154;Xis 24 anins 155;Xis 24 deis 156;
Xis 24anins 157;Xis 24 anins 158;Xis 24 anins 159; Xis 24 deis 160; Xi324
anins 161;Xis 24 anins 162;Xis 24 anins s 24 anins s 24 anins
165;Xis 24 anins 166;Xis 24 anins 167;Xis 24 anins s 24 anins 169;Xis
24 anins 170; Xis 24 andY is 171;Xis 24 anins 172; Xis 24 deis 173; Xis 24 andY
is 174; Xis 24 anins 175;Xis 24 anins 176; Xis 24 anins s 24 anins178;X
is 24 deis 179; Xis 24 anins 180;Xis 24 anins s 24 deis 182; Xis24 and
Yis 183;Xis 24 anins 184;Xis 24 anins 185;Xis 24 anins 186;
XisZS anins 1;Xis 25 anins 2;Xis 25 anins3gXis 25 anins4;Xi325 aninsS;
Xis 25a11ins 6;Xis 25 anins 7;Xis 25 anins 8; Xis25 anins 9; Xis 25 anins
;Xi325 anins 11;Xis 25 anins 12;Xis 25 anins 13;Xi525 anins 25
anins15;Xi325 anins 16;Xi325 anins 17;Xis25 anin318;Xis 25 anins 19;X
is25 anin320;Xis 25 anins21;Xis25 anins22;XisZS anins23;Xis 25 anins
24;Xi325 anins 25;Xi325 6;Xis25 anins27; Xis25 anin328;Xi525
anin329;Xis25anins30;Xis25 anins31;Xis25 2;Xis25 anins33;X
1825anins34;Xi325andYis35;Xis25anins36;XisZS anins37;Xi325 anins
38;X1325 anins39;Xis 25 anins40;XisZS anins41; XisZS anins42;XisZS
anins43;Xi525 4;XisZS anins4S;Xi325 anins46;XisZS anins47;X
i325 anins48;Xis25 anins49;Xi325 anins50;Xi325 aninsSl;Xis25 anins
52;Xis25anins53;XisZSaninsS4;Xi325aninsSS; Xis25a11in556;Xis25
aninsS7;Xi325 anins 58;Xis25 anins 59;Xi525 anin360;Xi325 anins 61;X
i525 anins62;Xi825 anins63;Xis253ninsé4;Xis25 anins65;Xi325anins
25 anins67;Xis25 anins68;Xis25 anins69; XisZS anins 70;Xi325
anins7l;Xi525anins72;X1825 anins 73;Xis25anins74;Xi325 anins75;X
i325 anins76;Xi525 anins 77;Xi325anins78;Xi325 anins79;Xis25anins
80;X1325 aninsSl;Xis25 aninsS2;Xis25 anins 83; Xi825 anins 84;Xi525
anins 85;Xis25 anins 86;Xi825 anins 87;Xis 25 anins 88;Xi325 anin589;X
i325 anins90;Xis25 anins91;Xis25 anins92;Xis25 anin593;Xis25anins
94;X1325 anins95;Xis25 anins96;Xi325 anins97; Xis25 anins 98;Xi325
anins 99; XisZS anins 100;Xis 25 anins 101;Xi525 anins 102;Xi325 anins
103;Xis 25 anins 104;Xis 25 anins 105;Xis 25 anins s 25 anins 107;Xis
anins 108;Xi525 anins 109;Xi325 anins 110;Xis25 11;Xi525andY
is 112;Xis25 anins 113;Xis25 anins 114;Xis 25 anins 115;Xis25 anins 116;X
is 25 aninsll7;Xi525 18;Xis25 anins 119;Xis 25 anins 525 and
Yis 121;Xis 25 anins 122;Xis 25 anin5123;X1325 andY is 124;Xis 25 anins 125;
Xis 25 anin3126;Xis 25 deis 127; Xis 25 anins 128; Xis 25 anins 129;Xis 25
anins 130; Xis 25 anins 131;Xi325 anins 132;Xi525 anins s 25 anins
134;Xis 25 anins 135;Xis 25 anins 136;Xis 25 anins 137;Xis 25 anins 138;Xis
anins 139;Xis 25 anins 140;Xi825 anins 141;Xi825 anins 142;Xis 25 andY
is 143;Xis 25 anins 144;Xis 25 anins 145;Xis 25 anins 146;Xis 25 anins 147;X
is 25 anins 148;Xis 25 anins s 25 anins 150;Xis 25 anins 151;Xis25 and
Yis 152;Xis 25 anins 153;Xis 25 anins s 25 anin5155;Xi825 deis 156;
Xis 25 anins 157;Xis 25 anins 158;Xis 25 anins 159;Xis 25 deis 160; Xis 25
anins 161;Xis 25 anins 162;Xi525 anins s 25 anins 164;Xis 25 anins
165; Xis 25 anins I66;Xis 25 anins 167;Xis 25 anins168;Xis25anin8169;Xis
anins 170;Xi525 anins s 25 anins 172;Xi825 anins 173;Xis 25 andY
is 174;Xis 25 anins 175;Xis 25 anins 176;Xis 25 anins 177;Xis 25 anins 178;X
is 25 anins 179;Xis25 anins 18O;Xi525 anin3181;Xis 25 and Yis 182;Xis 25 and
Y,is183;Xis25anins184;Xi525anins 185;Xi525anins 186;
Xis26anins1;Xis26anins2;Xis26anins3;Xis26anins4;Xis26aninsS;
XisZ6anins 6;Xi526anins7;Xi326anins 8;Xis 26 andY is9;Xi326 anins
;Xis 26anins 11;Xi326 anins 26anins 13; Xi526 anins 14;Xi326
anins 15;Xi526anins16;Xis26anins 17;Xis26andY is 18; XisZ6anins 19;X
is 26 anins 20;Xis 26 anins 21;Xis 26 anin522gXis 26 andY is 23;Xi526 and‘x’is
24;Xi3263nin525;Xi526 anins26;Xis26 anins27; Xis26 anin528;Xis26
andYi329;Xi526anins30;XisZ6anins3l;Xis26andYi532;Xi526anins33;X
is 26 anins34;Xis 26 5;Xis26 6;Xis 26 andY is37;Xi526 anins
38;XisZ6andYis39;Xi526anins40;Xi326anins41;XisZGanins42;Xis26
andYis43;Xi526anins44;XisZ6anins45;Xi326anins46; XisZéanins47;X
i526anins48;Xis 26 anins49;Xis26anins50;Xis26 andY is 51;Xis26 anins
52;Xis26anins 53;Xis.26anins Z6aninsSS; Xi826 aninsS6;Xi526
anins 57;Xis 26 anins 58;Xi326 anins 59;Xi326 anins 60;Xis 26 anins61;X
ins62;Xi326 anins63;Xis26anin364;Xis 26 anin565;Xis26anins
66;Xi526anins67;Xi526 anins68;Xi326 anins 69;XisZ6anins70;XisZ6
anins 71;Xis 26 anins 72;Xis26 anins 73;Xis 26 anins 74;Xis 26 anins 75;X
is26anins76;Xis26deis77;Xi326anins78;X1526anins79;Xi526anins
80;Xi526anins 81;Xis26anin582;Xi326 anins 26 anins 84;Xi326
anins 85;Xis 26 anins 86;Xi826 anins 87;Xi326 anins 26 anins 89;X
i826anin890;Xi326 anins91;Xi526anins92;Xi526 3;XisZ6anins
94;XisZ6anins 95;Xis26anins96;Xi526anins97;XisZ6anins98;XisZ6
anins 99;X1926 anins 100;Xis 26 anins 101;Xis 26 anins 102;Xis 26 anins
103;Xis 26 anins 104;Xis 26 anins s 26 anins 106;Xis 26 anins 107;Xis
26anins108;Xi326anins109;Xi526anins110;XisZ6anins111;X1826andY
is112;Xis26anins113;Xi326anins114;XisZ6anins115;Xis26aninsll6;X
i526anins117;Xi526anins118;Xis26anins119;Xis26anins120;Xis26and
Yis 121;Xis 26 anins 122;Xis 26 anins 123;Xis 26 anins 124;Xis 26 deis 125;
Xis 26 anins 126;Xis 26 anins 127;Xis 26 anins 128; Xis 26 anins 129;Xis 26
anins 130;Xis 26 anins 131;Xis 26 anins 132;Xis 26 anins 133;Xis 26311in5
134;Xis 26 anins 135;Xis 26 anins 136;Xis 26 anins 137;Xi326 anins 138;Xis
26 anins 139;Xis26 anins 140;Xis26 anins 141;Xis 26 anins 142;Xis 26 andY
is 143;Xis 26 anins 144;Xis 26 anins 145;Xis 26 anins 146;Xis 26 anins 147;X
is 26 anins 148; Xis 26 anins 149;Xis 26 deis 150; Xis 26 anins 151; Xis 26 and
Yis 152;Xis 26 anins 153;Xis 26 anins 154;Xis 26 anins s 26 deis 156;
Xis 26 deis 157; Xis 26 anins 158;Xis 26 anins 159; Xis 26 anins 160;Xis 26
anins 161;Xis 26 anins 162;Xis 26 anins 163;XisZ6 anins 164;Xi526 anins
165;Xis 26 anins 166;Xis 26 anins 167;Xis 26 anins 168;Xis 26 anins 169;Xis
26anins170;Xis26anins171;XisZ6anins172;XisZ6anins173;Xi326andY
is 174;Xis 26 anins 175;Xis 26 anins s 26 anins 177;Xis 26 anins 178;X
is 26 anins 179;Xi326 aninsl80;Xis 26 anins 181;Xis 26 anins 182;Xis 26and
YislS3;Xis’26anins184;Xis26anins185;Xi526aninsl86;
XisZ7anins1;Xis27anin32;Xi527anins3;Xis27anins4;XisZ7aninsS;
XisZ7anins 6;Xi827 anins7;Xi327 anins 7 anins9;Xi527anins
;Xi527anins11;Xi327anins12;Xis27anins13;Xi327aninsl4;Xis27
anins15;Xis27anin316;Xi327anins17;Xi527anins18;,XisZ7anins19;X
i327 anins20;Xis27 aninle;XisZ7anins22;Xis27 anins23;Xis27 anins
27 anins25;Xis27anin526;Xi327anin527; Xi327anin328;Xis27
9;Xi527anins30;XisZ7anins31;XisZ7anins32;XisZ7anins33;X
is27anins34;Xis27anins35;Xi327anins36;Xi327 anins37;Xis27anins
38;Xi527anin539;Xis27anins40;Xi827anins4l;XisZ7anins42;XisZ7
anins43;Xis27 anins44;Xis27anins45;Xis27anins46;XisZ'l anins47;X
i527 anins48;Xis27 9;Xi327anin550;Xi527 aninsSl;XisZ7 anins
52;Xis 27 anins 53;Xis27aninsS4;Xi527anins Z7anins 56;Xi327
aninsS7;XisZ7aninsS8;Xi827aninsSQ;XisZ7anin360;Xis27 anin561;X
isZ7anins62;Xis27 anins63;Xi327anins64;Xi327 anins65;XisZ7anins
66;Xis 27anins 67;Xi527anins68;XisZ7anins69;Xis27 anins 70;Xi327
anins71;Xis27 anins72;Xis27anins73;Xis27anins74;XisZ7anins75;X
i527anins76gXi527anins77;Xi327anins78;X1527anins79;Xis27anins
80;Xis27 anin381;Xi527 anins 82;Xis27anins 83;Xi327 anins 84;Xi527
anin585;Xi527 anin386;Xi327anins87;Xis27 aninsS8;Xi327anin389;X
i527 anins 90;XisZ7anins 91;Xi527 anins92;Xis27anins93;XisZ7anins
27 aninsQS;Xi527anins96;Xi327 anins97;XisZ7anins98;Xis27
anin399;Xi327anins100;XisZ7anins101;Xis27anins102;Xis27anins
103;Xis 27 anins 104;Xis 27 anins 105; Xis 27 anins 106;Xis 27 anins 107;Xis
27anins108;Xi327anins109;Xis27anins110;Xi527anins111;Xis27andY
i5112;Xi827anins113;Xis27anins114;Xi327anins115;XisZ7aninsll6;X
i527anins 117;Xi327anin5118;Xi327 anins 119;Xis27anins 120;Xi527 and
Yis 121;Xis 27 anins s 27 anins 123;Xis 27 anins 124;Xis 27 anins 125;
Xis 27 anin5126;Xis 27 andY is 127; Xis 27 anins 128;X is 27 anins 129;Xis 27
aninslSO;Xis 27 anins 131;Xis 27 anins 132;Xis 27 anins 133;Xi527 anins
134;Xis 27 anins135;Xis27anins136;Xi327anins137;Xis 27anins s
27 anins 139;Xis 27 anins 140;Xis 27 anins 141;Xis 27 andY is 142;Xis 27 andY
is 143; Xis 27 anins 144;Xis 27 anins 145;Xis 27 anins 146;X is 27 anins 147;X
is 27 anins 148;Xis 27 anins 149;Xis 27 anins 150;Xis 27 and Yis 151;Xis 27 and
Yis s 27 anins 153;Xi527 anins 154;Xis 27 anins 155; Xis 27anins 156;
Xis27 anins 157;Xis 27 anins 158;Xi327 anins 159;Xis 27 anins 160‘,Xis 27
anins161;Xi527aninsl62;XisZ7anins163;Xi527anins164;XisZ7anins
165;Xis 27 anins 166; Xis 27 anins 167;Xis 27 anins 168;Xis 27 anins 169;Xis
27 anins 170;Xi527 andY is 171;Xi527 anins 172;Xi827 andY is 173;Xis 27 andY
is 174; Xis 27 anins 175;Xis 27 anins 176;Xis 27 anins 177;Xis 27 anins 178;X
is 27 anins 179;Xis 27 anins 180;Xis 27 anin8181;Xis 27 anins182;Xis27 and
Yis 183;Xis 27 anins 184;Xis 27 anins s 27 anins 186;
nins1;X1528aninsZ;Xi528anins3;XisZSanins4;Xis28aninsS;
Xis28anins 8 anins7;XisZ8anins 8;Xis28 ;Xis28 anins
;Xi328 anins 11;Xis28 anins 12;Xis28 deis 13; Xi528 anins 14;Xis28
anins15;Xi528anins16;Xi328aninsl7;Xis28anins18;Xi528a_nin319;X
is28aninsZO;Xi328 1;Xi528 anin522;Xis28 anin523;Xis28 anins
24;Xis 28 anin525;Xi328 anin326;Xi328 anins27;XisZ8 anins28;Xi328
anin329;Xi528 0;XisZSanins31;Xi528 anins32;Xi328 anins33;X
i328anins34;Xi528 anins35;Xi528anins36;Xis28 7;Xi528 anins
38;Xis28anins39;Xi328anins40;Xis28anins41;Xi328anins42;Xi328
anins43;Xis28 anins44;Xi328anins45;Xis28anins46;Xis28anins47;X
1328 anins48;Xis 28 anins49gXis28 anins 50;Xis28 anins 51;Xis28 anins
52;Xi328 aninsS3;Xi328 aninsS4;Xi328 anin355;Xi528 anins 56;Xi528
aninS 57;Xis 28 anins 28 anins 59;Xis28 anins60;Xis28 anins61;X
1528 anins62;X1528 anins63;Xis28 aninsé4;Xis28 anin565;Xis28 anins
66;Xi528anins67;Xis28 anins68;Xis28 anins 69;Xi528anins 70;Xis28
anins71;Xi328 anins72;Xis28anins73;Xis28anins74;Xis28 anins75;X
i528 anins76;Xi528 anins77;Xis28 anins78;Xis28 anins79;Xi328 anins
80;Xi528anins 28 anins 82;X1328 anins 83;Xi528 anins 84;Xi528
anins 85;Xis28 anins 86;Xis28 anins 87;Xi328 anins88;Xi528 anins89;X
i328 anins90;Xis28 anins91;X1828 anins92;XisZSanin593;Xis28 anins
94;Xis28 anins 95;Xi328 anins96;Xi528 anins 97;XisZSanins 98;Xi328
2016/050308
anins 99; Xis 28 anins 100;Xis 28 anins 101;Xis 28 anins 102;Xis 28 anins
103;Xi328anins104;Xis28.anins105;Xi828anins106;Xi328anins107;Xis
28 anins 108;Xis28 anins 109;Xis 28 anins 110;Xi528 anins 111;Xis 28 andY
is 112;Xis28anins 113;Xi328 anins 114;Xis28 anins 115;Xi528 anins 116;X
is 28 anins 117;Xi328 anins 118;Xis 28 anins 119;Xis 28 anins 120;Xis 28 and
Yis 121;Xis 28 anins 122;Xis 28 anins 123;Xis 28 andY is 124;Xis 28 anins 125;
Xis 28 deis 126; Xis 28 anin3127;Xi328 anins 128;Xis 28 anins 129;Xis 28
anins s28 anins 131;Xi328 anins 132;Xi528 anins 133;Xi328 anins
134;Xi528 aninsl35;Xi528 anins I36;Xi328 anins 137;Xis 28 anins 138;Xis
28 anins 139;Xis 28 anins 140;Xis 28 anins 14I;Xis 28 anins 142;Xis 28 andY
is 143;Xis 28 anins 144;Xis 28 anins 145;Xis 28 anins 146;Xis 28 anins 147;X
is 28 anins s28 anins 149;Xis 28 anins 150;Xis 28 anins 151;Xi328 and
YislSZ;Xis 28 anins 153;Xi528 anins 154;Xis28 SS;Xis 28 deis 156;
Xis 28 anins 157;Xis 28 anins 158;Xis28 anins 159;Xis 28 anins 160;XisZ8
anins 161;Xis 28 anins 162;Xis 28 anins s 28 deis 164; Xis 28 anins
165;Xis 28 anins 166;Xis 28 anins 167;Xis 28 anins 168;Xi528 anins 169;Xis
28 anins 170;Xis 28 anins 17I;Xis 28 anins 172;Xi328 anins 173;Xi528 andY
is 174;Xis 28 anins 175;Xis 28 anins 176;Xis 28 anins 177;Xis 28 anins 178;X
is 28 anins s 28 anins 180;Xis 28 anins 181;Xis 28 anins 182;Xis 28 and
Yis s 28 anins184;Xis28 anins s 28 deis 186;
Xi329anins1;Xis29anins2;Xis29anins3;Xi529anins4;Xi329anins5;
XisZ9anins6;Xi329anins7;Xis29anins8;Xis29 aninsQ;XisZ9anins
;Xis29anins 11;Xi329anins12;Xis29aninsl3;Xis29anins 14;Xi529
anins 15;Xis29anins 16;Xi329anins l7;Xi329anin318;Xisz9 anins 19;X
is29anins20;Xis29aninle;Xis29 anin322gXi329anins23;XisZ9anins
24;Xi329 anins25;Xi329anin326;Xis29 anin827;Xi529 anin528;Xi329
anins29;Xis29 anins30;XisZ9anins31;Xis29anins32;Xis29 anins33;X
is29anins34;Xis29anins35;XisZ9 anins36gXis29anins37;Xis29 anins
38;Xi529 anins 39;Xis29anins40;Xi529anins4l;Xis29 anins42;Xis29
anins43;Xi329anins44;Xi529andYis45;Xi529andYis46;XisZ9anins47;X
i329anins48;Xi529anins49gXi329anins 50;Xi329 aninsSngi529anins
29 anins 53;Xi829anins 54;Xis29anins55;Xi529 aninsS6;XisZ9
anins57;Xi529anins58;Xi329anin359;Xis29anins60;Xi529anins61;X
i329anins62;Xis29anins63;Xis29anins64;Xis29a11ins65;X1329 anins
66;Xis29 anins67;Xis29anins68;Xis29anins69;Xis29anins70;XisZ9
W0 20161110584
anins7l;Xi529 anins 72;Xis29 anins73;XisZ9 andY is 74; X1529 anins75;X
is29anins76;XisZ9anins77;Xis29anins78;Xis29andY is 79;Xis29 anins
80;Xis 29anins 81;Xis 29 anins 29 anins 83; Xi529 anin584;Xi329
anins 85;Xis29 anins 86;XisZ9anins 87;Xis 293.de is 88; Xi329 aninsS9;X
is29 anins 90;Xis29 anins91;Xi329 anins92;Xis29 andY is 93;Xi529 anins
94;Xi529anins95;Xis29anins96;Xi529anin897; Xi529 anin598;Xi529
anins 99; Xis 29 anins s 29 deis 101.; Xis 29 anins 102; Xis 29 anins
103;Xis29anins104;Xi329anins105;Xis29anins106;Xi329anins107;Xis
29 anins 108;Xis 29 anins 109;Xi329 anins 110;Xis 29 anins lll;Xis29 andY
is 112;Xis 29anins 529anins 114;Xis 29anins 115;Xis 29 anins 116;X
is 29 anins 117;Xis29 anins 118;Xi529 anins 119;Xis 29 anins 120;Xi529a.nd
Yis 121;Xis 29 anins 122;Xis 29 anins 123;Xis 29 andY is 124; Xis 29 anins 125;
Xis 29 deis 126', Xis 29 anins 127;Xis 29 anins 128;Xis 29 anins 129;Xis 29
anins s 29 anins 131;Xis 29 anins 132;Xis29 anins 133;Xi529 anins
134;Xis 29 anins 135;Xi329 anins 136;Xi329 anins 137; Xis 29 anins 138;Xis
29 anins s 29 anins 140;Xis29 anins 141;Xis29 anins 142;Xis 29andY
is 143;Xis 29 anins 144;Xis 29 anins 145;Xis 29 anins 146;Xis 29 anins 147;X
1329 anins 148;Xis 29 anins 149;Xis 29 anins 150;Xis 29 aninslSl;Xis 29 and
Yis 152;Xi329 anins 153;Xis 29 anins 154;Xi329 anins 155;Xis 29 deis 156;
Xis 29 anins s29 anin5158;Xi529 anins 159;Xis 29 anins 160;Xis29
anins 161;Xis 29 anins 162;Xis 29 anins 163;Xis 29 anins 164;Xis 29 anins
165;Xis 29 anins 166;Xis 29 anins 167;Xis 29 aninsl68;Xis 29 anins 1169;Xis
29 anins s 29 anins 171;Xi329 anins 172;Xi329 anins 173;Xi529 andY
is 174;Xis 29 anins 175;Xis 29 anins 176;Xis 29 anins s 29 anins 178;X
is29 anins ‘179;Xis 29 aninslSO;Xi329 anins s 29 anins 182;Xi529 and
Yis 183;Xis29 anins 184;Xis29 anins 185;Xis 29 anins 186;
Xis30anins1;Xis30anins2;Xis30anins3;Xis303nins4;Xis3Oanin35;
Xis 30anins6;Xis30 anins7;Xi830a.nins 8;Xis 30anins9;Xis30anins
;Xis30anins11;Xis30anins12;Xi330anins13;Xis30anins 30
anins 15;Xis 30anins 16;Xis30 anins 17;Xis 30 anins 18;Xis 30 anins 19;X
ins20;Xis30anins21;Xis30anins22;Xis30andY1523;Xis 30anins
24;Xis 30anin825;Xis30anins26;Xis 30anin527;Xis30anins 28;Xis30
anins29;XisSOanins30;Xis30anins31;Xis30anins32;Xis30anins33;X
is30anins34;Xis 30anins35;Xis30andY'1536;Xis30anins37;Xis 30anins
38;Xis30anins 39;XisBOanins40;Xis30anins41;Xis30anins 42;Xis30
W0 2016/1 10584
anins43;Xis30anins44;XisSOanins45;Xis30 andY is46;Xis30anins47;X
is 30anins48;Xis 30 anins49;Xis 30 aninsSO;Xis30 anins 30anins
52;Xis30anins 53;Xis30anins 54;Xis30anins 55;Xis30aninsS6; Xis30
anins 57;Xis30anins 58;Xis30 anins 59;Xis30 0;Xis 30 anins61;X
is 30 anins62;Xis 30anins 63;Xis 30anins 64; Xis 30 anins65;Xi530anins
66;Xis 30 anins67;Xis30 aninsfi8;Xis 30 deis 69; Xis 30 anins 70;Xis 30
anins71;Xis30 anins72;Xis 30anins 73;Xis 30andY is74;Xis30anins 75;X
1330 anins76;Xis 30 anins77;Xis3O anins 78;Xis 30 anins79;Xis30anins
80;Xis 30 anins 81;Xis s 82;Xis 30 anins 83; Xis 30 anins 84;Xis 30
anins 85;Xis30anins 86;Xis 30 anins 87;XisSOanins 88;Xis 30 aninsS9;X
is 30anins 90;Xis30 anins 91;Xis 30 anins 30 anins93;Xis 302111in3
94;Xis 30anin395;Xis 30 anins 96;Xis 30 deis 97; Xis 30 anins 98;Xis 30
anins 99; Xis 30 anins 100;Xis 30 anins 101;Xis 30 anins 102;Xis 30 anins
103;Xis 30 deis 104; Xis 30 anins105;Xis 30 anins s 30 anins 107; Xis
30 anins 108;Xis 30 anins 109;Xis 30 anins 110;Xis 30 anins 111;Xis30 andY
is 112;Xis 30anins 113;Xis30 anins 114;Xis 30 anins 115;Xis 30 anins 116;X
is30anins117;Xi530anins118;Xis30anins119;Xis 30 anins 120;Xis30 and
Yis 121; Xis 30 anins 122;Xis 30 anin3123;Xis 30 anins 124;Xis 30 andY is 125;
Xis 30 anins 126;Xis 3O andY is 127;Xis 30 andY is 128;Xis 30 anins 129;Xis 30
anins I30;Xis 30 anins 131; Xis 30 anins 132; Xis 30 anins 133;Xis30 anins
134; Xis 30 anins 135; Xis 30 anins 136;Xis 30 anins 137; Xis 30 anins138;Xis
anins 139;Xis 30 anins 140;Xis 30 anins s 30 anins 142;Xis 30 andY
is 143;Xis 30 deis 144; Xis 30 deis 145; Xis 30 anins 146;Xis 30 andY is 147;X
is 30 anins 148;Xis 30 anins 149;Xis 30 anins 150;Xis 30 3.11in3 s 30 and
Yis 152; Xis 30 anins 153; Xis 30 anins 154; Xis 30 anins 155; Xis 30 anins 156;
Xis 30 anins 157;Xis 30 deis 158; Xis 30 anins159;Xis 30andY is 160; Xis 30
anins 161;Xis 30 anins 162;Xis 30 deis 163; Xis 30 anins 164;Xis 30 anins
165;Xis 30 anins 166;Xis 30 anins 167;Xis 30 anins 168;Xis 30 anins l69;Xis
anins 170;Xis 30anins 171;Xis 30anins 172;Xis 30anins 173; Xis 30 andY
is 174; Xis 30 deis 175; Xis 30 deis 176; Xis 30 anins 177;Xis 30 anins 178; X
is 30 anins 179;Xis 30 anins 180;Xis 30 anins 181;Xis 30 anins s 30 and
Yis 183;Xis 30 anins 184;Xis 30 anins 185;Xis 30 deis 186;
Xis 31 anins 1;Xis 31 anins2;Xis 31 anins 1 anins4;Xis 31 anins 5;
Xis 31 anins 6;Xis31 anins 7;Xis 31 anins 8; Xis 31 anins 9;Xis 31 deis
10; Xis 31 anins 11;Xis 31 anins 12;Xis 31 anins 13;Xis 31 anins 14;Xis 31
WO 10584
anins 15;Xis31anins16;Xis31aninsl7;Xis31anins18;Xis31anins 19;X
i331anin320;Xis31anin321;Xis31anin322;Xis31anins23;Xis3lanins
24;Xis 31 anins 25;Xis31 anin526;Xis31 aninsZ7; Xis3l anins28;Xis31
andY1529;Xis31anins30;Xis31anins31;Xis31anins32;Xis31anins33;X
isBlanins34gXis3lanins35;Xis31anins36;Xis31anins37;Xis3lanins
38;Xis31 anins 31 anins40;Xis 31 anins41; Xis 31 anins42;Xis31
anins43;Xis31anins44;Xis31anins45;Xi331anins46;Xis3lanins47;X
is31anins48;Xi531anins49;Xis31anin350;Xis31anins51;Xis31anins
52;Xis 31 anins 53;Xis31 anins 54;Xis31 aninsSS; Xis31 anin356;Xis3l
aninsS7;Xi831anins58;Xis31aninsS9;Xis31anins60;Xis31anins61;X
i331anins62;Xis31anins63;Xis3lanin864;Xis31anins65;Xis31anins
66;Xis31anins67;Xi531anins68;Xis31anins69;Xis31anins70;Xis31
anins71;Xis31anins72;Xis31anins73;Xis31anins74;Xis3lanins75;X
is 31 anins 76;Xis 31 anins 77;Xis 31 anins78;Xis 31 anins 79;Xis31 anins
80;Xis31anins81;Xis31anin582;Xis31anin583;Xis31aninsS4;Xis31
aninsSS;Xis31 6;Xis31anin387;Xis31anin388;Xis31anins89;X
is31anins90;Xis31anin591;Xi331anins92;Xis31anins93;XisSlanins
94;Xis 31 anins95;Xis31 anins96;Xis 31 deis 97; Xis 31 anins98;Xis 31
anins 99;Xis 31 anins 100;Xis 31 anins 101;Xis 31 anins 102;Xis 31 anins
103;Xis 31 anins 104;Xis31anins105;Xis31anins106;Xis3lanin8107;Xis
31 anins 108;Xis31 aninle9;Xis 31 anins 110;Xis31 anins 111;Xi331 andY
is 112;Xis 31 aninsll3;Xis3l anins 114;Xis31 anins 115;Xis31 anin5116;X
is 31 anins s 31 anins 118;Xis 31 anins 119;Xis 31 anins s 31 and
;Xis31anins122;Xis3lanins123;Xis31anin5124;Xis31aninleS;
Xis 31 anins 126;Xis 31 anins 127;Xis 31 anins 128; Xis 31 anins 129;Xis 31
anins s 31 anins 131;Xis 31 anins 132;Xis 31 anins 133;Xis 31 deis
134; Xis 31 anins 135;Xis 31 anins 136;Xis31 anins 137;Xis 31 anins 138;Xis
31 anins 139;Xis 31 anins 140;Xis 31 anins 141;Xis31 anins 142;Xis 31 andY
is 143;Xis 31 anins 144;Xis 31 anins 145;Xis 31 anins 146;Xis 31 anins 147;X
is 31 anins 148;Xis 31 anins 149;Xis 31 anins 150;Xis 31 anins 151;Xis 31 and
Yis 152;Xis 31 anins 153;Xi531 anins 154;Xis 31 anins 155;Xis 31 anins 156;
Xis 31 anins 157;Xis 31 anins 158;Xis 31 anins 159; Xis 31 anins 160;Xis 31
anins 161;Xis 31 anins 162;Xis 31 anins s 31 anins 164;Xis 31 anins
165;Xi531anins166;Xis31anins167;Xis31aninsl68;Xis31andY13169;Xis
31 anins 170;Xis 31 anins 171;Xis 31 anins 172;Xis31 anins 173;Xis 31 andY
W0 2016/1 10584
is s31 anins 175;Xis 31 anins 176;Xis 31 anins 177;Xis 31 anins 178;X
is 31 anins 179;Xis 31 anins s 31 anins 181;Xis 31 anins 182;Xis 31 and
Yis 183;Xis31 anins 184;Xis 31 anins 185;Xis 31 deis 186;
Xis3Zanins1;Xis32anin52;Xis32anins3;Xis32anins4;Xis32aninsS;
Xis32311ins6;Xis32anins7;Xis 32 anins8;Xis32 anins 9;Xis323nins
;Xis32anins 11;Xis32anins 12;Xis 32 deis 13; Xis32 anins 14;Xis32
anins15;Xis32anins16;Xis32anins17;Xis32anins18;Xis32aninsl9;X
insZO;Xis 32anins21;XisSZaninsZZ;Xis32 anin323;Xis32anins
24;Xis32 anins 25;Xis32 aninsZ6;Xis32anins 27;Xis 32aninsZS;Xis 32
anin329;Xis32 anins 30;Xis32 anins3l;Xis 32 anins32;Xis32 anins33;X
i332 4;Xis 32aninsBS;Xis 32 anins36;Xis32 aninsB?;Xis32 anins
38;Xis32 anins39gXis 32 anins40;Xis 32 anins41;Xi332anins42;Xis32
43;Xis32anins44;Xi832 anins4S;Xis 32 anins46;Xis32anins47;X
is 32 anins48;Xis 32 anins49;Xis32 anins 50;Xis 32 anins 51;Xis 32 anins
32 anins 53;Xis 32 aninsS4;Xis 32 anin855;Xis 32 aninsS6;Xis32
anins 57;Xi532 anins 58;Xis32 aninsS9;Xis 32anins60;Xis32 anins61;X
is32 anins62;Xis32 anins63;Xis32anin564;Xis32 anin865;Xis32anins
66;Xis32 7;Xis 32andY1568;Xis32anins 69;Xis32anins70;Xis32
1;Xis 32 anins72;Xis32 anins 73;Xis 32 anins74;Xis32 anins75;X
is32anins76;Xi332 anins77;Xis32 anins78;X1332 anins79;Xis32 anins
80;Xis32anins81;Xis32anins 82;Xis 32 anins 83;Xis 32 4;Xis32
aninsSS;Xis32 anins86;Xis32a.nins87;Xis323nins88;Xis32aninsS9;X
i332 anins90;Xis32 anins91;Xi332 anins92;Xis32 anins93;Xis32anins
94;Xis 32 anins 95;Xis 32 anins 96;Xis 32 anins 97;Xis 32 andY is 98;Xis 32
anins99;Xis 32 anins 100;Xis 32 anins 101;Xis 32 anins 102;Xis32 anins
103;Xis 32 anins 104;Xis 32 anins 105;Xis 32 anins 106;Xis 32 anins 107;Xis
32anins108;Xis3Zanins109;Xis32anins110;Xis32anins111;Xis32andY
is112;Xi332anins113;Xis32anins114;Xis323nins 115;Xis322dei3116;X
is32 anins 117;Xis 32 anins 118;Xis32 anins s 32 anins 120;Xis 32 and
Yis 12];Xis 32 anins 122;Xis32 anins 123;Xis32 anins 124;Xi332 anins 125;
Xis 32 anins 126;Xis 32 andY is 127;Xis 32 anins s 32 anins 129;Xis 32
anins 130;Xis 32 anins 131;Xis 32 anins I32;Xis 32 anins 133;Xis 32 anins
134;Xis 32 anins 135;Xis 32 anins 136;Xis 32 anins 137;Xis 32 anins 138;Xis
32anins 139;Xis 32 anins 140;Xis 32 anins 141;Xis32 anins 142;Xis 32 andY
is 143;Xis 32 deis 144; Xis 32 anins 145;Xis 32 anins 146;Xis 32 anins 147;X
W0 10584
is 32 anins 148;Xis 32 anins 149;Xis 32 anins 150;Xis 32 and Yi5151;Xis 32 and
Yis 152;Xis 32 anins 153;Xis32 anins 154;Xis 32 anins 155; Xis 32 anins 156;
Xis 32 anins 157;Xis 32 anins 158;Xis 32 anins 159;Xis 32 anins 160;Xis 32
anins s 32 anins 162;Xis 32 anins 163;Xis 32 anins 164;Xis 32 anins
165;Xis 32 anins 166; Xis 32 anins 167;Xis 32 anins 168;Xis 32 anins 169;Xis
32 anins 170;Xis 32 anins 171;Xis 32 anins 172;Xis 32 andY is 173;Xis 32 andY
is 174; Xis 32 anins 175; Xis 32 anins 176;Xis 32 anins 177;Xis 32 anins 178;X
is 32 anins 179;Xis 32 anins 180;Xis 32 anins 181;Xis 32 anins 182;Xis 32 and
Yis 183;Xis 32 anins 184;Xis 32 anins 185;Xis 32 aninslS6;
Xis33 anins 1;Xis33 aninsZ;Xis33 anins3;Xi533 anins4;Xis33 aninsS;
X1333 anins6;Xis 33 anins7;Xisl33 anins 8;Xis 33 anins9;Xis33 anins
;Xis 33 anins 11;Xis33 anins 33 deis 13; Xis 33 anins 14;Xis33
aninslS;Xis33 anins 33 anins 17;Xis 33 deis 18; Xis 33 anins 19;X
1533 anin820;Xis33 aninle;Xis33 2;Xis33 aninsZ3;Xis33 anins
24;Xis33 anins25;Xis 33 anin526;Xis 33 anins27; Xis33 anin528;Xis33
anin329;Xis33 anins30;Xis 33 anins3l;Xis33 anins 32;Xis33 anins33;X
i333 anins34;Xis33 anins35;Xis33 anins36;Xis33 anin337;Xi333 anins
38;Xis 33 anins 39;Xis 33 anins40;Xis 33 deis 41; Xis 33 anins42;Xis 33
anins43;Xis 33 anins44;Xis33 anins45;Xis33 anins46;Xis33 anins47;X
is 33 anins48;Xis 33 anins49;Xis 33 aninsSO;Xis 33 anins 51;Xis 33 anins
33 aninsS3;Xis33 anins 54;Xis33 anins 55;Xis 33 anins 56;Xis33
anins57;Xis33 anin558;Xis33 aninsS9;Xis33 anins60;Xis33 anins61;X
i333 anins62;Xis33 anin563;Xis33 anins64;Xis33 anins65;Xis 33 anins
66;Xis 33 anins 67;Xis33 anins68;Xis33 anins69;Xis33 anins70;Xis33
anins71;Xis 33 2;Xis33 anins 73;Xis33 anins74;Xi" 33 "~1in5 7S;X
i533 anins76;Xis 33 anins 77;Xis 33 anins78;Xis 33 anins 79;Xis 33 anins
80;Xis 33 anins 81;Xis33 anins 82;Xis33 anin883;Xis33 anins 84;Xis33
anins85;Xis 33 anins86;Xis33 anin387;Xis 33 anins 88;Xis 33 9;X
is 33 0;Xis 33 anins91;Xis 33 anins 33 anins93;Xis 33 anins
94;Xis33 anins95;Xis33 anins96;Xis33 anins97;Xis33 anins 98;Xis33
andY is 99; Xis 33 anins 100;Xis 33 anins 101;Xis 33 deis 102; Xis 33 anins
103;Xis 33 anins 104;Xis 33 anins 105;Xis 33 anins 106;Xis 33 andY is 107;Xis
33 anins s 33 anins 109;Xis33 anins 110;Xis33 anins 111;Xi333 andY
is 112;Xis 33 anins 113;Xis 33 anins 114;Xis 33 anins 115;Xis 33 anins 116;X
is 33 anins 117;Xis 33 anins 118;Xis33 anins s 33 anins 120;Xis 33 and
W0 2016/1 10584
Yis 121; Xis 33 anins s 33 anins 123;Xis 33 anins 124;Xis 33 deis 125;
Xis 33 anins 126;Xis 33 deis 127; Xis 33 anins 128;X is 33 anins 129;Xis 33
anins 130;Xis 33 anins 131;Xis 33 anins s 33 anins 133;Xis 33 anins
134;Xis 33 anins 135;Xis 33 anins 136;Xis 33 anins 137;Xis 33 anins 138;Xis
33 anins 139;Xis 33 anins 140;Xis 33 anins s 33 anins 142;Xis33 andY
is s 33 anins 144;Xis 33 anins 145; Xis 33 anins 146;Xis 33 anins 147;X
is 33 anins 148;Xis 33 anins 149;Xis 33 anins 150;Xis 33 anins lSEgXis 33 and
Yi5152;Xis33 anins 153;Xis 33 anins s 33 anins 155;Xis 33 anins 156;
Xis 33 anins 157;Xis 33 anins s 33 anins 159;Xis 33 anins160;Xis33
anins s 33 anins 162;Xis 33 anins 163;Xis 33 anins 164;Xis 33 anins
165;Xis 33 anins 166;Xis 33 anins 167; Xis 33 anins 168;Xis 33 anins 169;Xis
33 anins 170;Xis33 anins s 33 anins 172;Xis 33 anins 173;Xis 33 andY
is 174;Xis 33 andY is 175;Xis33 anins 176;Xis 33 anins 177;Xis 33 anins 178;X
is 33 anins 179;Xis 33 anins 180;Xis 33 anins 181;Xis 33 anins 182;Xis 33 and
Yis s 33 anins 184;Xis 33 anins 185;Xis 33 anins 186;
Xis34 anins 1;Xis 34 anin32;Xis34 anins3;Xis34anins4;Xis 34aninsS;
Xis34anins 6;Xis 34anins7;Xis34anins 8;Xis34 anins9;Xis34anins
;Xis34anins11;Xis34anins12;Xis34anins13;Xis34anins14;Xis34
anins 15;Xis 34 aninsl6;Xis 34anins s 34 anins 18;Xis34anins 19;X
is 34anins20;Xis34aninle;Xis34anin522;Xis34aninsZ3;Xis34anins
24;Xis 34anin325;Xis34 anins 26;Xis 34 anins27;Xis34anin328;Xis34
aninsZ9;Xis 34anins30;Xis34 anins31;Xis34 anins 32;Xi334 anins33;X
is34anins34;Xis 34anins 35;Xis 34 anins 36;Xis 34anins37;Xis34anins
38; Xis 34 andY is 39; Xis 34 anins 40; Xis 34'anins 41;Xis 34 anins 42; Xis 34
andYis43;Xis34anins44;Xis34 andYis45;Xis34anins46;Xis34andYis47;X
is34anins48;Xis34anins49;Xis34aninsSO;Xis34aninsSl;Xis34anins
52;Xis34aninsS3;Xis34anins 54;Xis 34anins 55;Xis34aninsS6;Xis34
anins 57;Xis34anins 58;Xis34 anins 59;Xis34anins60;Xis34 anin561;X
is34anins62;Xis34anin363;Xis34anins64;Xis34anins65;Xis34anins
66;Xis34anins 67;Xis 34anins68;Xis 34anins 69;Xis34anins70;Xis34
anins71;Xis34anins72;Xis34anins73;Xis34anins74;Xis34anins75;X
is34anins 76;Xis 34anins77;Xis34 anins78;Xis34anins79;Xis 34anins
80;Xis34anins 81;Xis 34anins 82;Xis34 anins83;Xis34anins 84;Xis 34
anin385;Xis 34anins 86;Xis34anins 87;Xis34anins88;Xis34anins89;X
is34anins90;Xis 34anins91;Xi534 anins92;Xis34anins93;Xis34 anins
W0 2016/110584
94;Xis 34 anins 95;Xis 34anins96;Xis34anins97; Xis34 anins98;Xis34
9;Xis34anins100;Xis34anins101;Xis34anins102;Xis34anins
s 34 anins 104;Xis 34 and Y is s 34 anins 106;Xis 34 anins 107;Xis
34anins108;Xis34anins109:,Xis34anins11,0;Xis34anins111;Xis34m1dY
is112;Xis34anins113;Xis34anins114;Xis34anins 115;Xis34anins 116;X
is 34 anins 117;XisS4anins 118;Xis 34anins 119;Xis 34 and Yis 120;Xis 34and
Yis 121; Xis 34 and Y is 122;Xis 34 anins 123;Xis 34 andY is 124; Xis 34 anins 125;
Xis 34 anins 126;Xis 34 anins 127;Xis 34 andY is 128; Xis 34 anins 129;Xis 34
anins130;Xis34anins131;Xis34anins132;Xis34anins133;Xis34anins
134;Xis 34 anins 135;Xis 34 anins 136;Xis 34 anins 137;Xis 34 anins 138;Xis
34anins139;Xis34anins140;Xis34anins141;Xis34anins142;Xis34andY
is 143; Xis 34 andY is 144; Xis 34 anins 145; Xis 34 anins 146;X is 34 anins 147;X
is 34 anins 148;Xis 34 anins 149;Xis 34 anins 150;Xis 34 anins s 34 and
Yis 152;Xis 34 anins 153;Xis 34 anins 154;Xis 34 anins 155; Xis 34 anins 156;
Xis 34 deis 157; Xis 34 anins 158;Xis 34 deis 159; Xis 34 anins 160;Xis 34
anins 161;Xis 34 anins 162;Xis 34 anins 163;Xis 34 anins 164;Xis 34 anins
165;Xis 34 anins s 34anins 167;Xis34 anin5168;Xis 34 anins 169;Xis
34anins170;Xis34anins171;Xis34anins172;Xis34anins173;Xis34andY
is 174;Xis 34 anins 175;Xis 34 anins 176;Xis 34 anins 177;Xis 34 anins 178;X
is 34anins 179;Xis 34anins 180;Xis 34 anins 181;Xis 34anins 182;Xis 34 and
Yis 183;Xis34anins184;Xis34anins 185;Xis34anins 186;
Xis35anins 1;Xis 35 ;Xi335 anins3;Xis35 anins4;Xis35 aninsS;
Xis35anins 6;Xis35 anins7;Xis 35 anins8;Xis35 ;Xis 35anins
;Xis35 anins 11;Xis35 anins 12;Xis35 anins 13;X1835 anins 14;Xis35
aninslS;Xis35 anin516;Xis35anins17;Xis35anins18;Xi535aninsl9;X
i535 anin520;Xis35 ];Xis35 aninsZZ;Xis35aninsZ3;Xis35 anins
24;Xis35 anin325;Xis3S anins26;Xis 35anin527;Xi5353nins 28;Xis35
aninsZ9;Xis 35 anins 30;Xis 35 anins31;Xis 35 anins32;Xis 35 anins 33;X
i335 anins34;Xi535anins35;Xis35 anins36;Xis35 anins37;Xi335 anins
38;Xis 35 anins 39;Xis35 anins40;Xi335 anins41;Xis35 anins 42;Xis35
anins43;Xis 35 anins44;Xis35 anins45;Xis35 anins46;Xis 35 anins47;X
is 35 anins48;Xis35 anins49;Xis35 aninsSO;Xis35anins51;Xis35 anins
52;Xis35 anins 53;Xi835 anins 54;Xis 35 anins 35 anins 56;Xis35
anins57;Xis35 anin558;Xis35 aninsS9;Xis35 anin560;Xis35 anins61;X
i535 2;Xis35anin863;Xis35 anins64;Xis35 anin365;Xis 35 anins
W0 2016/110584
66; Xis 35 andY is 67; Xis 35 anins 68;Xis 35 anins 69; Xis 35 deis 70; Xis 35
anins71;Xi835 anins72;Xis35 3;Xis35 anins74;Xis35anins75;X
i335 anins76;Xis3S anins77;Xis35 anins78;Xis35 anins79;Xis35 anins
80;Xis 35 anins 81; Xis 35 anins 82;Xis 35 anins 83; Xis 35 anins 84; Xis 35
anins85;Xis35 anins86;Xis35 anins 87;Xis35andYis88;Xis35anins 89;X
is35 0;Xis35 anins91;Xis35 anins 92;Xis35 anins93;Xis35 anins
94;Xis 35 anins95;Xis35 anins96;Xis35anin597;Xis35andY1598;Xi335
anins 99;Xis 35 anins s 35 anins s 35 andY is 102;Xis 35 anins
103;Xis 35 anins 104;Xis 35 anins 105;Xis 35 anins s 35 anins 107;Xis
35 anins 108;Xis35 anins 109;Xis35 anins 110;Xis35 anins111;Xis35andY
is s35anins ll3;Xis35anins114;Xis35anins 115;Xis35anins 116;X
is 35 anins 117;Xis 35 anins 118;Xis 35 andY‘sli9;Xis 35 anins 120;Xis 35 and
Yis 121;Xis 35 anins 122;Xis 35 anins 123;Xis 35 anins 124;Xis 35 anins 125;
Xis 35 anins 126;Xis 35 anins 127;Xis 35 anins 128;Xis 35 deis 129; Xis 35
anins 130;Xis 35 anins s 35 anins 132;Xis 35 anins 133;Xis 35 anins
134;Xis 35 anins 135;Xis 35 anins 136;Xis 35 anins 137;Xis35 anins 138;Xis
anins 139;Xis 35 anins 140;Xis 35 anins 141;Xis 35 anins 142;Xis35 andY
is 143; Xis 35 deis 144; Xis 35 deis 145; Xis 35 anins 146; Xis 35 anins147;X
is 35 anins 148;Xis 35 anins 149;Xis 35 anins 150;Xis 35 anins 151;Xis 35 and
Yis 152;Xis 35 anins 153;Xis 35 anins s 35 anins s 35 deis 156;
Xis 35 anins 157;Xis 35 deis 158; Xis 35 anins 159;Xis 35 anins 160;Xis 35
anins 161;Xis 35 anins 162;Xis 35 anins 163;XiS35 anins 164;Xis35 anins
165;Xis 35 anins 166;Xis 35 anins 167;Xis 35 anins 168;Xis 3S anins169;Xis
anins 170;Xis 35 anins 171;Xis 35 anins 172;Xis 35 anins 173;Xis 35 andY
is 174;Xis 35 anins 175; Xis 35 anins 176;Xis 35 anins 177;Xis 35 anins178;X
i335 anins 179;Xis 35 anins 180;Xis 35 anins 181;Xis 35 anins 182;Xis35 and
Yis 183;Xis 35 anins 184;Xis 35 anins s 35 anins 186;
nins1;Xis36aninsZ;Xis36anins3;Xis36anins4;Xis36aninsS;
Xis36anins 6;Xis 36anins 7;Xis36anins 8;Xis36 anins 9;Xis36 anins
10;Xis36 anins 11;Xis36 anins 12;Xis 36anins 13;Xis36anins 14;Xis 36
anins15;Xis36anins16;Xis36anins17;Xis36anins18;Xis36anins19;X
is36 aninsZO;Xis36aninsZ];Xis36anins22;Xis36anins23;Xis36anins
24;Xis36 anins 25;Xis36 aninsZ6;Xis36anins27;Xis 36anins 28;Xis36
anins29;Xis 36anins 30;Xis36 anins31;Xis 36anins32;Xis36anins33;X
is36anins34;Xis36 anin535;Xis36anins36;Xis36anin537;Xis36 anins
W0 2016/110584 2016/050308
38; Xis 36 anins 39;Xis 36 anins40; Xis 36 anins41; Xis36 anins42;Xis36
anins43;Xis36 anins44;Xis36 anins45;Xis36 andY i346; Xis36anins47;X
is 36 anins48;Xis36 anins49;Xis 36 O;Xis36 andY is 51;Xis36 2111in5
52; Xis 36 anins 53;Xis 36 anins 54;Xis36 anins 55; Xis36 anins 56;Xis 36
anins 57;Xis 36anins 58;Xis 36 aninsS9;Xis36 andY is 60; Xis 36 anins 61;X
i336 anins 62;Xis 36 anin563gXis36 anins64;Xis 36 andY is65;Xis36anins
66; Xis 36 anins 67;Xis 36 anins 68;Xis 36 anins 69; Xis36 anins70;Xis36
anins71;Xis 36 anins72;Xis36anins73;Xis36 anins74; Xis 36 anins75;X
i836 anins 76;Xis 36anins 77;Xis 36 anins78;Xis 36 andY is 79;Xis36 deis
80; Xis 36 anins 81;Xis 36 anins 82;Xis 36 deis 83; Xis 36 anins 84;Xis 36
anins 85;Xis 36 anins 86;Xis36anins 87;Xis 36 anins 88; Xis36anins 89;X
is 36 anins 90;Xis 36 anins 91;Xis 36anins92;Xis 36 andY is 36 anins
94;Xis36 anins 95;Xis 36 anins96;Xis 36 deis 97; Xis 36 anins98;Xis 36
andY is 99; Xis 36 andY is 100; X is 36 andY is 101; X is 36 andY is 102; Xis 36 deis
103; Xis 36 anins 104; Xis 36 andY is 105;Xis 36 anins 106;Xis 36 anins 107;Xis
36 anins 108;Xis 36 aninle9;Xi336anins110;Xis36anins111;Xis36andY
is s36 anins 113;Xis 36anins 114;Xis 36anins s36 anins 116;X
i836 anins 117;Xis 36 anins 118;Xis36 anins 119;Xis 36 anins 120;Xis 36 and
Yi3121;Xis 36 anins 122;Xis 36 anins s 36 anins 124; Xis 36 anins 125;
Xis 36 andY is 126; Xis 36 anins 127; Xis 36 andY is 128; X is 36 andY is 129; Xis 36
anins 130; Xis 36 anins 131;Xis 36 anins 132; Xis 36 anins 133;Xis36 deis
134; Xis 36 anins 135; Xis 36 anins 136; Xis 36 andY is 137; Xis 36 anins 138;Xis
36 anins 139;Xis 36 anins 140;Xis 36 anins 141;Xis 36 anins 142;Xis 36 andY
is 143; Xis 36 anins 144;Xis 36 andY is 145; Xis 36 anins 146;Xis 36 anins 147;X
is 36 anins 148;Xis 36 anins 149;Xis 36 anins 150;Xis 36 anins 151;Xis 36 and
Yis 152; Xis 36 anins 153; Xis 36 anins 154; Xis 36 2111in5 155; Xis 36 anins 156;
Xis 36 anins s 36 anins 158;Xis 36 anins 159;Xis 36 anins 160;Xis 36
anins 161;Xis 36 deis 162; Xis 36 anins 163;Xis 36 anins 164;Xis 36 anins
165; Xis 36 anins 166; Xis 36 anins 167; Xis 36 anin5168;Xis 36 andY is 169; Xis
36 anins 170;Xis 36 anins 171;Xis 36 anins 172;Xis 36 anins 173; Xis 36 andY
is 174;Xis 36 anins 175;Xis 36 anins 176;Xis 36 anins 177;Xis 36 anins 178;X
is 36 anins s 36 anins s 36 anins 181;Xis 36 anins 182;Xis 36 and
Yis 183;Xis 36 anins 184;Xis 36 anins 185;Xis 36 anins 186;
Xis 37 anins 1;Xis 37 aninsZ;Xis 37 anins 3;Xis37 anins4;Xis 37 aninsS;
Xis37 anins 6;Xis37 anins7;Xis37 anins 8;Xis37 anins9;Xis 37anins
W0 10584
;Xis37anins11;Xis37aninsl2;Xis37anins13;Xis37aninsl4;Xis37
anins 15;Xis 37 anins 16;Xis37 anins l7;Xis 37 anins 18;Xis37 anins 19;X
is 37anins20;Xi337anin321;Xis37anins22;Xis37 aninsZ3;Xis37anins
24;Xis 37 anin525;Xis37 anin326;Xis37aninSZ7;Xi337anin328;Xis37
anins29;Xis37anins30;Xis37anins31;Xis37 anins32;Xis37anins33;X
is37anins34;Xis37anins35;Xis37anins36;Xis37 anins37;Xis37anins
38;Xis37 anins 39;Xis37anins40;Xis 37anins41;Xis 37 anins42;Xis37
anins43;Xis 37 anins44;Xis37 anins45;Xis 37 anins46;Xis37 anins47;X
is37anins48;Xis37anins49;Xis37aninsSO;Xis37 aninsSl;Xis37 anins
52;Xis 37 aninsS3;Xis37anins 54;Xis37anins 55;Xis 37 anins 56;Xis37
andYis57;Xis37anin558;Xis37aninsS9;Xis37 anins60;Xis37anins61;X
is37anins62;Xis37anins63;Xis37anins64:Xis37 anins65;Xis37anins
37 anins67;Xis37 anins68;Xis37 anin369;Xis 37 anins70;Xis37
anins71;Xis37anins72;Xis37anins73;Xis37anins74;Xi337anins75;X
is37anins76;Xis37anins77;Xis37anins78;Xis37anins79;Xis37 anins
80;Xis37 anins 81;Xis37 anin382;Xis37anin883;Xis37 anins 84;Xis37
anins85;Xis37aninsS6;Xis37 anins 87;Xis37anins 88;Xis37anin589;X
is37andYis90;Xis37anins91;Xis 37anins92;Xis37a;nins93;X1537 anins
94;Xis 37 anins95;Xis37anins96;Xis37anins97;Xis37 anins 37
anins 99; Xis 37 anins100;Xis 37 anins 101; Xis 37 anins s 37 deis
103; Xis 37 anins 104;Xis 37 anins 105;Xis 37 anins 106;Xis 37 anins 107;Xis
37anin8108;Xis37anins109;Xis37anins110;Xis37anins111;Xis37andY
is112;Xi837anins113;Xis37anins114;Xis37anins115;Xis37anins116;X
is 37anins 117;Xis 37 anins 118;Xis37 anins 119;Xis 37 anins 120;Xis37and
Yis 121;Xis 37 anins 122;Xis 37 anins s 37 anins 124;Xis 37 deis 125;
Xis 37 deis 126; Xis 37 anins127;Xis 37 anins 128;Xis 37 anins 129; Xis 37
anins 130; Xis 37 anins 131;Xis 37 anins 132;Xis 37 deis 133; Xis 37 anins
134; Xis 37 anins 135;Xis 37 anins 136;Xis 37 anins 137;Xis 37 anins 138;Xis
37 anins 139;Xis37 anins 140;Xis 37anins 141;Xis 37 anins 142;Xis 37 andY
is s 37 anins 144;Xis 37 anins 145;Xis 37 anins 146;Xis 37 anins 147;X
is 37 anins s 37 anins s 37 anins 150;Xis 37 anins 151;Xis37 and
Yis 152;Xis 37 anins 153;Xis 37 anins 154;Xis 37 anins 155;Xis 37 deis 156;
Xis 37 anins 157;Xis 37 anins s 37 anins 159;Xis 37 anins 160;Xis 37
anins 161;Xis 37 anins 162; Xis 37 anins 163;Xis37 anins 164;Xis 37 anins
165;Xis 37 anins 166; Xis 37 anins 167;Xis 37 anins I68;Xis 37 anins 169;Xis
W0 2016/110584
37 anins 170;Xis 37 anins 171;Xis 37 anins 172;Xis 37 andY is 173;Xis37 andY
is 174;Xis 37 anins 175;Xis 37 anins 176;Xis 37 anins 177;X is 37 anins 178;X
is 37 anins 179;Xis 37 anin3180;Xis 37 anins 181;Xis 37 anins 182;Xis 37 and
Yis 183;Xis 37 anins 184;Xis 37 anins 185;Xis 37 anins 186;
Xis38anins1;Xis38aninsZ;Xis38anin33;Xis38anins4;Xi538aninSS;
Xis38’anins 6;Xis38 anins 7;Xis38 ;Xis38 anins 8 anins
;Xis38 anins 11;Xis 38 anins 12;Xis 38 anins 13; X1338 anins 14;Xis38
anins 15;Xis 38 anins 16;Xis38 anins 17;Xis38 anins 18;Xis 38 anins 19;X
is38anin520;Xis38 aninle;Xis38 aninsZ2;Xis38 anin523;Xis38 anins
24;Xis38anins 38 anin526;Xis 38 anins27; Xis38 anin528;Xis38
anin529;Xis38 anins 38 anins31;Xis38 anins32;Xis 38 anins33;X
is38anins34;Xis38 anins35;Xis38 anins36;Xis38 anins37;Xis38 anins
38;Xis38 anins39;Xis38 anins40;Xis38anins41;Xis38 anins42;Xis38
anins43;Xis 38 anins44;Xis38 anins45;Xis38 anins46;Xis38 anins47;X
is38anins48;Xis38anins49;Xis38 aninsSO;Xis38 aninsSl;Xi538 anins
38 aninsS3gXis 38 anins S4;Xi538 anins 55; Xis383nin556;Xis38
anins57;Xis38 8;XisSSaninsS9;Xis38 anin360;Xis38 anins61;X
is38 anins 62;Xis 38 anins63;Xis38 anins64;Xis38 anins 65;Xis38 anins
66;Xis s67;Xis38 anins68;Xis 38 anins69;Xis 38 anins 70;Xis38
anins71;Xis38 anins 72;Xis38 anins73;Xis 38 anins74;Xis38 anins75;X
i338 anins76;Xis38 anins77;Xis38 anins78;Xis38 anins79;Xis38 anins
38 anins 81;Xis38 anins 82;Xis 38 anins 83;Xis38anins 84;Xis38
anins 85;Xis38 anin386;Xis 38 anins87;Xis38 anins 88;Xis 38 anins 89;X
is 38 anins90;Xis 38 anins91;Xis 38 anins92;Xis 38 anins 93;Xis38 anins
94;Xis38 anins 95;Xi338 anins96;Xis 38 anin397;Xis38 anin598;Xis38
9;Xis 38 anins 100;Xis38anins 101;Xis38anin5102;Xis 38anins
s 38 anins 104;Xis 38 anins 105;Xis38 anin8106;Xis38 anins 107;Xis
38 anins 108;Xis 38 anins 109;Xis38 anins 110;Xis38 aninslll;Xis 38 andY
is 112;Xis38anins113;Xis38anins 114;Xis38aninsllS;Xis38anins116;X
is38anins117;Xis38aninsll8;Xis3Sanins119;Xis38anins120;Xis38 and
Yis 121;Xis 38 anins 122;Xis 38 anins 123;Xis 38 anins 124;Xis 38 deis 125;
Xis 38 anins 126; Xis 38 deis 127; Xis 38 anins 128;Xis 38 anins 129;Xis 38
anins s 38 anins 131;Xis 38 anins 132;Xis 38 anins 133;Xis 38 anins
134;Xis 38 anins 135;Xis 38 anins s 38 anins 137;Xis38 anins s
38 anins 139;Xis 38 anins 140;Xis 38 anins 141;Xis 38 anins 142;Xis 38 andY
W0 2016/110584
is 143;Xis 38 anins 144;Xis 38 anins 145;Xis 38 anins 146;Xis 38 anins 147;X
is 38 anins 148;Xis 38 anins 149;Xis 38 anin3150;Xis 38 anins 151;Xis 38 and
Yis 152;Xis 38 anins 153;Xis 38 anins 154;Xis 38 anins 155;Xis 38 anins 156;
Xis 38 andY is 157;Xis 38 anins 158;Xis 38 anins 159;Xis 38 anins I60;Xis 38
anins 161;Xis 38 anins 162;Xis 38 anins 163;Xis 38 anins 164;Xis 38 anins
165;Xis 38 anins 166;Xis 38 anins 167;Xis 38 anins 168;Xis 38 anin5169;Xis
38 anins 170;Xis 38 anins s 38 anins s38 anins 173;Xis38 andY
is 174;Xis 38 anins 17S;Xis 38 anins 176;Xis 38 anins s 38 anins 178;X
is 38 anins s 38 anins 180;Xis 38 anins 181;Xis 38 anins 182;Xis 38 and
Yis 183;Xis38 anins 184;Xis38 anins 185;Xis 38 anins 186;
Xis39 aninsl;Xis 39 anin32;Xis39 anins3;Xis39anins4;Xis39anin55;
Xis39anins6;Xis39 anins7;Xis39anins8;Xis39 anins9;Xis39anins
;Xis39 anins11;Xis39anins12;Xis39aninsl3;Xis39aninsl4;Xis39
anins15;Xi539anins16;Xis39anins17;Xis39anins18;Xis39aninsI9;X
is 39 and Yis 20;Xis 39 anins 21;Xis 39 anins 22;Xis 39 anins 23;Xis 39 anins
39 aninsZS;Xis39aninsZ6;Xis39aninsZ7;Xis39anins 28;Xi339
anins29;Xis39 anins30;Xis39 anins31;Xis39anins32;Xis39anins33;X
is39anin534;Xis39anins3S;Xis 39anins36;Xis39anins37;Xis39 anins
38;Xis 39 anins39;Xis 39andYis40;Xis39anins4l;Xis39anins42;Xis39
anins43;Xis39anins44;Xis39anins45;Xis39andYis46;Xi339anins47;X
is39anins48;Xis39anins49;Xis39aninsSO;Xis39anins51;Xis39anins
52;Xis 39 anins 53;Xis39anins 54;Xis39anin855;Xis 39 anins 56;Xis39
7;Xis39anins58;Xis39andYis59;Xis39andYis60;Xis39anin561;X
is39 2;Xis39anin363;Xis 39anins64;Xis39anins65;Xis39anins
66;Xis 39anins 67;Xis39anins68;Xis39anin369;Xis39 anins70;Xis39
anins71;Xis39anins72;Xis39andYis73;Xis39 anins74;Xis39anins75;X
is39anins76;Xis39anins77;Xis39anins78;Xis39anins79;Xis39anins
80;Xis 39anins 81;Xis39 anins82;Xis39anin883;Xis 393nins 84;Xis39
anins85;Xis39anin386;Xis39anins87;Xis39anin588;Xis39anins89;X
is39anins90;Xis39anins91;Xi839anins92;Xis 39anins93;Xis39 anins
94;Xis39anins 95;Xis39 anins96;Xis39 7;Xis39anins 98;Xis39
anins99;Xis 39 anins 100;Xis39anins s39anins102;Xis39anins
103;Xis 39 anins 104;Xis 39 anins 105;Xis 39 anins 106;Xis 39 anins 107;Xis
39anins108;Xis39anins109;Xis39anins110;Xis39anins111;Xis39andY
is 112;Xis39anins113;Xis39anins114;Xis39aninsllS;Xis39anins 116;X
W0 2016/110584
is 39 anins 117;Xis 39 anins s39 aninsll9;Xis 39 anins 120;Xis 39 and
Yis 121;Xis 39 anins 122;Xis 39 anins s 39 anins 124; Xis 39 anins 125;
Xis 39 anin8126;Xis 39 andY is 127; Xis 39 anins 128;Xis 39 anins 129;Xis 39
anins 130;Xis 39 anins s 39 anins 132;Xis 39 anins 133;Xis 39 anins
134;Xis 39 anins 13S;Xis 39 anins 136;Xis 39 anins137;Xis 39 anins 138;Xis
39 anins 139;Xis 39 anins s 39 anins s 39 andY is 142;Xis 39 andY
is 143;Xis 39 anins 144;Xis 39 anins 145;Xis 39 anins 146;Xis 39 anins 147;X
is 39 anins 148;Xis 39 anins 149;Xis 39 anins150;Xis 39 anins 151;Xis 39 and
Yis152;Xis 39 anins 153;Xis 39 anins 154;Xis39 andY is 155;Xis 39 aninslSG;
Xis 39 anins s 39 deis 158; Xis 39 anins 159;Xis 39 anins 160;Xis 39
anins 161; Xis 39 anins s 39 anins 163;Xis 39 and Y is s 39 anins
I65;Xis 39 anins 166;Xis 39 anins 167; Xis 39 anins 168;Xis 39 anins 169;Xis
39 anins 170;Xis 39 anins s 39 anins 172;Xis 39 andY is is39 andY
is 174; Xis 39 anins 175;Xis 39 anins 176;Xis 39 anins 177;Xis 39 anins 178;X
is 39 anins 179;Xis 39 anins 180;Xis 39 anins 181;Xis 39 anins 182;Xis 39 and
Yis 183;Xis 39 anins 184;Xis 39 anins 185;Xis 39 andY is 186;
Xis40anins1;Xis40anins2;Xis40anins3;Xis40andYis4;Xis40anins5;
Xis40anin56;Xis40 anins 7;Xis40 anins 8;Xis40 anins9;Xis40anins
;Xis40anins 11;Xis40anins 12;Xis40anins 13; Xis40anins 14;Xis40
anins15;Xis40anins16;Xis40anins 17;Xis40anins18;Xis40anins19;X
i340 anins 20;Xis 4O aninle;Xis40 anin522;Xis4O anins23;Xis40 anins
24;Xis40andYi325;Xis40aninsZ6;Xis40anins27;Xis40anin528;Xis40
anins29;Xis40 anins30;Xis40 anins31;Xis40 anins 32;Xis40 3;X
is40anins34;Xis40anins35;Xis40anin836;Xis40 anins37;Xis40anins
38;Xis40 anins39;Xis40anins40;Xis40anins41;Xis40anins42;Xis40
anins43;Xis40 anins44;Xis40andYis45;Xis40anins46;Xis40 anins47;X
is40anins48;Xis40anins49;Xis40anins SO;Xis4O aninsSl;Xis40anins
52;Xis40anins 53;Xis40anins 54;Xis40aninSSS;Xis40anin556;Xis40
anins 57;Xis40 aninsS8;Xis40 anins 59;Xis40anins60;Xis40 anins61;X
is40anins62;Xis40anins63;Xis40 anins64;Xis40anins65;Xis40anins
66;Xis40 anins67gXis40anins68;Xis40anins69;Xis40anins70;Xis40
anins71;Xis40 anins72;Xis40anins73;Xis40anins74;Xis40 anins75;X
is40anins76;Xis40anins77;Xis40anins78;Xis40anins79;Xis40anins
80;Xis 40anins 81;Xis40anins 82;Xis40 anins 83;Xis40anins 84;Xis40
anins85;Xis40aninsS6;Xis40anins 87;Xis40anins88;Xis40aninsS9;X
W0 2016/110584
is40anins90;Xis40anins91;Xis40 anins92;Xis40 anins93;Xis40anins
94;Xis40anins95;Xis 40anins96;Xis40anins 97; Xis40anins98;Xis40
anins 99;Xis 40 anins 100;Xis 40anins 101;Xis 40 anins 102;Xis 40anins
103;Xis 40 anins 104;Xis 40 anins 105;Xis 40 anins 106;Xis 40 anins s
40aninSIO8;Xis40anins109;Xis40anins110;Xis40anins111;Xis40andY
is112;Xis40anins113;Xis40édeis114;Xis40anins115;Xis40aninsll6;X
is40anins 117;Xis40anins 118;Xis40anins s 40anins 120;Xis40 and
Yi5121;Xis40anins122;Xis403nins123;Xis40anins 124;Xis40anins 125;
Xis 40 anins 126; Xis 40 deis 127; Xis 40anin5128;Xis 40 anins 129;Xis 40
anins s40 anins 131;Xis40 anins 132;Xis 40 anins 133;Xis40 anins
134;Xis40 anins 135;Xis 40 anins s 40 anins 137;Xis 40 anins 138;Xis
40anins 139;Xis 40 anins 140;Xis40 anins 141;Xis40 anins 142;Xis40 andY
is 143;Xis40 anins 144;Xis 40 anins 145;Xis 40 anins 146;Xis 40 anins 147;X
is 40 anins 148;Xis 40 anins 149;Xis 40 anins 150; Xis 40 anins 151;Xis 40 and
Yi3152;Xis 40 anins 153;Xis40 anins s40 anins 155;Xis40 anins 156;
Xis 40 anins 157;Xis 40 anins 158;Xis 40 anins 159;Xis40 deis 160; Xis 40
anins161;Xis40anins162;Xis40anins 163;Xis40anins164;Xis40anins
165;Xis 40 anins 166;Xis 40 anins 167;Xis 40 anins l68;Xis40anins 169;Xis
40anins 170;Xis 40 anins 171;Xis40 anins 172;Xis40 anins 173;Xis 40 andY
is 174;Xis 40 anins 175;Xis 40 anins 176;Xis 40 anins 177;Xis40 anins 178;X
is40anins179;Xis40anins180;Xis40anins181;Xis40anins182;Xis40and
Yis s 40 anins s 40 anins 185;Xis40 anins 186;
Xis4laninsl;Xis41aninsZ;Xis4lanins3;Xis41anins4;Xis41aninsS;
Xis4lanins6;Xis41anins7;Xis4lanins8;Xis41anins9;Xis41anins
10;Xis41anins11;Xis41anin312;Xis4laninsl3;Xis41aninsl4;Xis41
anins 15;Xis41 anins 16;Xis4l anins 17;Xis41 anins 41 anins 19;X
is41aninsZO;Xis41aninle;Xis41anins22;Xis41aninsZ3;Xis41anins
24;Xis 41 anins 2S;Xis 41 aninsZ6;Xis4l anin327;Xis41 anins28;Xis4l
anin529;Xis41anins30;Xis41anins31;Xis41anins32;Xis41anins33;X
is4lanins34;Xis41anins35;Xis41anins36;Xis41anins37;Xis41anins
38;Xis41anins39;Xis41anins40;Xis41anins41;Xis41anins42;Xis41
anins43;Xis41anins44;Xis41anins45;Xis41anins46;Xis41anins47;X
is41anins48;Xis4lanins49;Xis41aninsSO;Xis41aninsSl;Xis41anins
52;Xis41aninsS3;Xis41aninsS4;Xis41anins55gXis4laninsS6;Xis4l
aninsS7;Xis41 anins58;Xis41aninsS9;Xis4l anins60;Xis4l anins61;X
W0 2016/110584
1 10
is41anins62;Xis41anins63;Xis41anins64;Xis41anins65;Xis4lanins
66;Xis 41 anins 67;Xis41 anins68;Xis4l anins69; Xis41 anins70;Xis41
1;Xis41anins72;Xis41anins73;Xis41anins74;Xis41anins75;X
i541anins76;Xis41anins77;Xis41anins78;Xis41anins79;Xis41anins
80; Xis 41 anins 81;Xis 41 anins 82;Xis41 anins 83; Xis41 anins84;Xis41
anins85;Xis41anins86;Xis41aninsS7;Xis41anins88;Xis41anins89;X
is 41 and Y is 90; X is 41 2111in5 91; Xis 41 anins 92; Xis 41 and Y is 93; Xis 41 anins
94;Xis41anins95;Xis41anins96;Xis41anins97;Xis41anins98;Xis41
andY is 99; Xis 41 andY is 100; X is 41 andY is 101; X is 41 andY is 102;-X is 41 anins
103;Xis 41 anins 104; Xis 41 deis 105; Xis 41 anins 106; Xis 41 anins 107; Xis
41 anins 108;Xis41 anins 109;Xis41 anins 110;Xis41 anins 111;Xis41 andY
is!12;Xis4l l3;Xis41aninsll4;Xis4l anins 115;Xis4l anin5116;X
i541 anins117;Xis41aninsll8;Xis41 aninsll9;Xis 41 anins 120;Xis41 and
Yis s 41 anins 122; Xis 41 deis 123; Xis 41 andY is 124; Xis 41 deis 125;
Xis 41 anins 126;Xis 41 anins 127; Xis 41 anins 128;Xis 41 anins 129;Xis 41
aninsl30;Xis4l anins131;Xis41 anins 132;Xis41 anins 133;Xis41 anins
134;Xis 41 anins 135;Xis 41 anins s 41 deis 137; Xis 41 anins 138;Xis
41aninsl39;Xis41anins140;Xis41anins141;Xis41anins142;Xis41andY
is 143; Xis 41 deis 144; Xis 41 andY is 145; Xis 41 deis 146; X is 41 andY is 147; X
is 41 anins 148;Xis41 anins 149;Xis 41 anins 150;Xis 41 anins s 41 and
Yis 152;Xis41 anins 153;Xis 41 anins 154;Xis 41 anins 155;Xis 41 deis 156;
Xis41 anins 157;Xis 41 deis 158; Xis41 anins 159; Xis4l anins 160; Xis41
anins 161;Xis 41 deis 162; Xis41 anins 163;Xis 41 anins 164; Xis 41 anins
165;Xis 41 anins 166;Xis 41 anins 167;Xis 41 deis 168; Xis 41 anins 169;Xis
41 anins 170;Xis 41 anins 171;Xis 41 anins 172;Xis41 anins 173;Xis 41 andY
is 174;Xis 41 anins 175; Xis 41 andY is 176;Xis 41 anins 177;Xis 41 anins 178;X
is 41 anins 179;Xis 41 anins 180;Xis 41 anins 181;Xis41 deis 182; Xis 41 and
Y is 183;Xis 41 anins 184;Xis 41 andY is 185; Xis 41 andY is 186;
nins1;Xis42aninsZ;Xis42anins3;Xis42anins4;Xis42aninsS;
Xis42anins6;Xis42anins7;Xis423ninsS;Xis42anins9;Xis42anins
;Xis42 anins 42 anins12;Xis42anins13;Xis42anins14;Xis42
anins15;Xis42anins16;Xis42anins l7;Xis42anins18;Xis42aninsl9;X
is42anin520;Xis42anin321;Xis42anins22;Xis423nins23;Xis42anins
24;Xis42 anins25;Xis42aninsZ6;Xis42aninsZ7;Xis42anins28;Xis42
anin529;Xis42anins30;Xis42anin531;Xis42anins32;Xis42anin533;X
W0 2016/110584
1 1 l
is42 anins34gXis42anins35;Xis42anins36;Xis42 anins37;Xis42 anins
38;Xis42 anins 39;Xis 42 anins40;Xis42 anins41; Xis 42 anins42;Xis42
anins43;Xis42 anins44;Xis42 anins45;Xis42 anins46;Xis42anins47;X
i542 anins48;Xis42anins49;Xis42anins 50;Xis42 aninsSI;Xis42anins
52;Xis42 anins 53;Xis42 aninsS4;Xis4Zanin555; Xis 42 anins 42
aninsS7;Xis42anin358;Xis42 anins 59;Xis 42 anins 60;Xis42 anins 61;X
is42anins62;Xis42 anin363;Xis42 anins64;Xis42 5;Xis42anins
66;Xis42 anins 67;Xis42 anins 68;Xis 42 anins 69; Xis 42 anins 70;Xis42
anins71;Xis42anins72;Xis42anins73;Xis423nins74;Xis42anins75;X
i542 anins76;Xis42anins77;Xis42anins78;X1542 anins79;Xis42 anins
80;Xis42 anins 81;Xis42 anins 82;Xis42anins83; Xis 42 anins 84;Xis42
anin585;Xis42 aninsS6;Xis42anins 87;Xis42 8;Xis42 anins89;X
i542 O;Xis42 aninsQl;Xis42 andYis92;Xis42anins93;Xis42 anins
94;Xis42 anins 95;Xis42anins 42anins97; Xis 42 anins 98;Xis42
anins 99;Xis 42 anins 100; Xis 42 andY is 101;Xis 42 anins 102;Xis 42 anins
103;Xis 42 anins 104;Xis42 anins 105;Xis 42 anins 106;Xis 42 anins 107;Xis
42 anins 108;Xis42 anins 109;Xis42 anins 110;Xis42 anins 111;Xis42 andY
is s 42 anins 113;Xis42 anins 114;Xis 42 anins 115;Xis42 anins 116;X
ins117;Xis42anins118;Xis42anins119;Xis42anins120;Xis42and
Yis 121; Xis 42 anins 122; Xis 42 anins 123; Xis 42 anins 124; Xis 42 anins125;
Xis 42 anins 126; Xis 42 anins 127;Xis42 anins 128;Xis 42 anins 129; Xis42
deis 130; Xis 42 anins 131;Xis42 anins 132;Xis42 anins 133;Xis 42 anins
134;Xis 42 anins 135;Xis 42 anins 136;Xis 42 anins s 42 anins 138;Xis
42 anins 139;Xis42 anins 140;Xis42 anins 141;Xis42 anins 142;Xis 42 andY
is 143;Xis 42 anins 144;Xis 42 anins 145;Xis 42 anins 146;Xis42 anins 147;X
i542 anins 148;Xis 42 anins 149;Xis42 anins 150;Xis42 anins 151;Xis42 and
Yis 152;Xis 42 anins 153;Xis42 anins 154;Xis 42 anins 155;Xis 42 deis 156;
Xis 42 andY is 157;Xis 42 deis 158; Xis 42 andY is 159;Xis 42 anins 160; Xis 42
anins 161;Xis42 anins 162;Xis 42 anins 163;Xis42 anins s42 anins
165;Xis 42 anins 166;Xis 42 anins 167;Xis 42 anins 168;Xis 42 anins s
42 anins 170;Xis42 anins 171;Xis 42 anins 172;Xis42 anins 173;Xis 42 andY
is 174;Xis42 anins 175;Xis42 anins 176;Xis42 anins 177;Xis42 anins 178;X
i342 anins 179;Xis 42 anins 180;Xis42 anins 181;Xis42 anins s42 and
Yis 183;Xis42 anins 184;X1's42 anins 185;Xis42 deis 186;
W0 10584
1 12
Xis43 anins 1;Xis43 anins2;Xis43 anins3;Xis43 anins 3aninsS;
Xis43 anins6;Xis43 anins7;Xis43 anins 8;Xis43 andY is 9;Xis43 anins
;Xis43 anin311;Xis43 anins 12;Xis43 anins 13; Xis43 anins 43
anins 15;Xis43 anins 43 anins 17;Xis43 anins 18; Xis43 anins19;X
is43 anins20;Xis43 anins21;Xis43 anin322;Xis43 anins 23;Xis43 anins
24;Xis43 anins 25;Xis43 anin526;Xis43 anin327; Xis43 andY1528;Xis43
anins29;Xis43 anins 30;Xis43 anins31;Xis43 anins32;Xis43 anins33;X
is 43 anins 34;Xis 43 anins 35;Xis43 anins36;Xis43 anins37;Xis43 anins
38;Xis43 anins39;Xis43 anins40;Xis43anins41;Xis43 anins42;Xis43
anins43;Xis 43 anins44;Xis43 anins45;Xis43 anins46;Xis 43 anins47;X
is43 anins48;Xis43 anins49;Xis43 aninsSO;Xis43 andY isSl;Xis43 anins
52;Xis43 aninsS3;Xis43 anins 54;Xis43 aninsSS; Xis43 anins56;Xis43
anins 57;Xis43 anins 58;Xis43 anins 59;Xis43 anins60; Xis43 anins61;X
is43 anins 62;Xis43 anins63;Xis43 anins64;Xis43 anins 65;Xis43 anins
66;Xis43 anins67;Xis43 anins68;Xis43 anin369;Xis43 anins70;Xis43
anins71;Xis43 anins72;Xis43 anins 73;Xis43 anins74;Xis43 anins75;X
is43 anins76;Xis43 anins77;Xis43 anins78;Xis43 anins79;Xis43 anins
80;Xis43 anins 43 anin382;Xis43 anins 83;Xis43 anins 84;Xis43
;Xis43 anins 43 anins87;Xis43 anins 88;Xis43 anins89;X
is43 anins90;Xis43 anins91;Xis43 2;Xis43 anins93;Xis43 anins
94;Xis43 anins95;Xis43 anin596;Xis43 anins97;Xis43 anins98;Xis43
anins 99; Xis 43 deis 100; Xis 43 andY is 101; Xis 43 anins 102; Xis 43 anins
s43 anins 104;Xis 43 anins 105;Xis 43 anins 106;Xis 43 anins s
43 anins s43 anins 109;Xis43 anins110;Xis43anins s43andY
i3112;Xis43anins113;Xis43aninsll4;Xis43 anins 115;Xis43 anins 116;X
is43 anins 117;Xis43 anins 118;Xis43 aninsll9;Xis43anins120;Xis43 and
Yis 121;Xis 43 anins 122;Xis 43 anins 123;Xis 43 anins 124;Xis 43 anins 125;
Xis 43 anins 126;Xis 43 anins 127; Xis 43 andY is 128; Xis 43 anins 129; Xis 43
anins 130;Xis 43 deis 131; Xis43 anins 132;Xis43 anins 133;Xis 43 anins
134;Xis 43 anins 135; Xis 43 anins 136;Xis 43 anins 137;Xis 43 anins 138;Xis
43 anins 139;Xis 43 anins 140;Xis43 anins 141;Xis43 anins142;Xis43 andY
is 143;Xis 43 anins 144;Xis 43 anins 145;Xis 43 anins 146;Xis 43 anins 147;X
is 43 anins 148;Xis 43 anins 149;Xis 43 deis 150; Xis 43 anins 151; Xis 43 and
Yi3152;Xis43 anins 153;Xis43 anins 154;Xis43 anins155;Xis43anins 156;
Xis 43 anins 157;Xis 43 anins 158;Xis43 anins 159;Xis43 anins 160;Xis43
W0 2016/110584
1 13
anins s43 anins162;Xis43anins163;Xis43anins164;Xis43anins
165;Xis 43 anins s 43 anins 167;Xis 43 anins 168;Xis 43 anins 169;Xis
43 anins 170;Xis43 anins 171;Xi_s43 anins 172;Xis43 anins173;Xis43andY
is 174;Xis 43 anins s43 anins 176;Xis43 anins 177;Xis43 anins 178;X
i543 anins179;Xis43anins180;Xis43anins181;Xis43 anins 182;Xis43 and
Yis 183;Xis 43 anins s43anins185;Xis43andY is 186;
Xis44anins1;Xis443nins2;Xis44anins3;Xis44anins4;Xis44aninsS;
Xis44anins6;Xis44anins7;Xis44anins8;Xis44 anins9;Xis44anins
;Xis44anins 11;Xis44anins 12;Xis44anins 13; Xis44anins 14;Xis44
5;Xis44anins16;Xis44anins17;Xis44anins18;Xis44anin319;X
is44aninsZO;Xis44andYile;Xis44anins22;Xis44 anins23;Xis44anins
24;Xis44anins25;Xis44anins26;Xis44and‘{is27; Xis44andY1's 28;Xis44
anins29;Xis44anins30;Xis44andYisSngis44andYis32;Xis44anins33;X
i544anins34;Xis44andYis35;Xis44anins36;Xis44 anins37;Xis44anins
38;Xis44anins39;Xis44anins40;Xis44anins4l; Xis44anins42;Xis44
anins43;Xis44anins44;Xis44anins45;Xis443ndYis46;Xis44anins47;X
is44anins48;Xis44anins49;Xis44anins 50;Xis44 anins 51;Xis44anins
52;Xis44anins53;Xis44anins S4;Xis44aninsSS; Xis44anins 56;Xis44
7;Xis44anins58;Xis443nins59;Xis443ndYis60;Xis44anins6l;X
is44anins62;Xis44aninsé3;Xis44anins64;Xis44 anins65;Xis44anins
66;Xis44anins67;Xis44anins68;Xis44anins 69; Xis44 anins 70;Xis44
anins71;Xis44anins72;Xis44anins73;Xis44andYis74;Xis44anins75;X
is44anins76;Xis44anins77;Xis44anins78;Xis44 anins79;Xis44anins
80;Xis 44anins 81;Xis44anin382;Xis44anins83;Xis44 anins 84;Xis44
anins85;Xis44anins86;Xis44anins87;Xis44anins88;Xis44aninsS9;X
is44anins90;Xis44andYis9l;Xis44anins92;Xis44anins93;Xis44anins
94;Xis44anins95;Xis44andYis96;Xis44anins97;Xis44 anins 98;X1’s44
anins99gXis44anins100;Xis44aninslOngis44anins102;Xis44anins
103;Xis 44 anins 104;Xis 44 anins 105;Xis 44 anins 106;Xis44anins 107;Xis
44anins108;Xis44anins109;Xis44anins110;Xis44anins111;Xis44andY
is 112;Xis44anins113;Xis44anins114;Xis44anins115;Xis44aninsll6;X
insll7;Xis44anins118;Xis44anins119;Xis44anins120;Xis44and
Yis 121;Xis 44 anins 122;Xis 44 anins 123;Xis 44 anins 124;Xis 44 anins 125;
Xis 44 andY is 126;Xis 44 anins 127;Xis44anins 128;Xis 44 anins 129;Xis 44
anins130;Xis44aninsl31;Xis44anins132;Xis44anins133;Xis44anins
W0 2016/110584
1 14
134;Xis 44 anins 135;Xis 44 anins 136;Xis 44 anins 137;Xis 44anins 138;Xis
44 anins 139;Xis443nins 140;Xis443nins 141;Xis44andY is 142;Xis44andY
is 143;Xis44anins 144;Xis 44 anins s 44 anins 146;X is 44 anins 147;X
i544 anins s 44 anins 149;Xis44anins 150;Xis 44 anins 151;Xis44and
Yi5152;Xis44anins 153;Xis44anins 154;Xis44andY is 155; Xis44anins 156;
Xis44anins157;Xis44anins158;Xis44anins159;Xis44 anins 160;Xis44
anins161;Xis44anins162;Xis44anins163;Xis44anins164;Xis44anins
165;Xis 44 anins s 44 anins 167;Xis 44 anins s 44 anins 169;Xis
44 anins 170;Xis 44 anins 171;Xis44a.nins 172;Xis 44 andY is 173;Xis44 andY
is s443nins 175;Xis 44 anins 176;Xis 44 anins 177;Xis 44 anins 178;X
is44anins179;Xis44and‘{is180;Xis44anin3181;Xis44 anins s 44 and
Yis183;Xis44anins184;Xis44anins185;Xis44andYisl86;
Xis 45 anins 1;Xis 45 anins2;Xis45 aninsS;Xis45 anins 4;Xis45 anins 5;
Xis 45anins 6;Xis45 anins7;Xis45 anin58;Xis45 anins9;Xis45 anins
10;Xis45 anins 45 anins 12;Xis45 deis 13; Xis45 anins 14;Xis45
anins 15;Xis45 anins 45 anins 17;Xis45 anins 18;Xis45 anins 19;X
is45anin520;Xis45 aninle;Xis45 anin822gXis45 anins23;Xis45 anins
24;Xis45 anins 25;Xis45 anins 26;Xis45 aninsZ7;Xis45 anins 28;Xis45
anins29;Xis45 anins 30;Xis45 anins31;Xis45 anins 32;Xis45 anins 33;X
i345 anin534;Xis45 anins35;Xis45 anins36;Xis4S anins37;Xis45 anins
38;Xis45 anins 39;Xis45 anins40;Xis45 anins41;Xis45 anins42;Xis45
anins43;Xis45 anins44;Xis4S anins45;Xis45 anins46;Xis45 anins47;X
i545 anins48;Xis45 anins49;Xis45 0;Xis4S anins51;Xis45 anins
52;Xis45 aninsS3;Xis45 aninsS4;Xis45 anins 55;Xis45 anins 56;Xis45
anin357;Xis45 8;Xis45 anin559;Xis45 0;Xis45 anins61;X
i545 anins62;Xis45 anins63;Xis45 anins 64;Xis45 anins65;Xis 45 deis
66; X is 45 and Y is 67; Xis 45 andY is 68; Xis 45 andY is 69; X is 45 andY is 70; X is 45
anins71;Xis45 anins72;Xis45 anins73;Xis45 anins74;Xis45 anins75;X
is45 anins76;Xis45 anins77;Xis45 anins78;Xis4Sanins79;Xis45 anins
80;Xis45 anins 81;Xis45 anins 82;Xis45 anins 83;Xis45 anins 84;Xis45
anins 85;Xis45 anins 86;Xis45 anins 87;Xis45 anins 88;Xis45 9;X
is 45 anins90;Xis45 anins91;Xis45 anin592;Xis45 anins 93;Xis 45 anins
94;Xis 45 anins 95;Xis45 6;Xis45 anins97;Xis45 anins 98;Xis45
deis 99; Xis 45 anins 100; Xis 45 anins 101;Xis45 anins 102;Xis 45 deis
103; Xis 45 anins 104;Xis 45 anins 105;Xis 45 anins 106;Xis45 andY is 107;Xis
W0 2016/110584
1 15
45 anins 108;Xis45 anins 109;Xis45 anins 110;Xis45 anins111;Xis4SandY
is 112;Xis45 anins 113;Xis45 anins 114;Xis45 anins 115;Xis45 anins 116;X
i545 aninsll7;Xis 45 anins 118;Xis45 anins 119;Xis 45 anin3120;Xis45 and
Yis 121;Xis 45 anins 122;Xis 45 anins 123;Xis 45 andY is 124;Xis45 3125;
Xis 45 anins 126; Xis 45 anins 127; Xis 45 anins 128; Xis 45 anins 129;Xis 45
anins 130;Xis 45 anins 131;Xis 45 anins 132;Xis 45 anins 133;Xis 45 anins
134;Xis 45 anins 135;Xis45 anins 136;Xis45 anins 137; Xis 45 anins 138;Xis
45 anins 139;Xis 45 anins 140;Xis45 anins 141;Xis45 anins142;Xis45andY
is s 45 anins 144;Xis 45 anins 145;Xis 45 anins 146;Xis 45 anins 147;X
i545 anins148;Xis45anins149;Xis45anins150;Xis 45 anin3151;Xis45 and
Yis 152;Xis45 anins 153;Xis45 anins 154;Xis45 anins 155;Xis 45 deis 156;
Xis 45 anins 157;Xis 45 anins 158; Xis 45 anins 159;Xis 45 andY is I.60;Xis 45
anins 161;Xis 45 anins 162; Xis 45 anins 163;Xis 45 anins 164;Xis 45 andY is
s 45 anins166;Xis45anins167;Xis45anins168;Xis45anins169;Xis
45 anins 170;Xis45 anins s45 anins 172;Xis45 anins173;Xis45andY
is s 45 anins 175;Xis45 anins 176;Xis45 anins 177;Xis45 anins 178;X
i545 anins s 45 anins 180;Xis 45 anins 181;Xis 45 anins 182;Xis45 and
Yis 183;Xis 45 anins 184;Xis 45 anins 185;Xis 45 deis 186;
Xis46anins1;Xis46anins2;Xis46anins3;Xis46anins4;Xis46aninsS;
Xis46anin56;Xis 46anins 7;Xis46anin58;Xis46 anins 9;Xis46anins
;Xis46anins11;Xis46anins 12;Xis46anins13;Xis46anins14;Xis46
anins15;Xis46anins16;Xis46anins17;Xis46anins18;Xis463ninsl9;X
is46 aninsZO;Xis46anins21;Xis46anins22;Xis46aninsZ3;Xis46 anins
24;Xis46anins25;Xis46 anin326;Xis46anin527;Xis 46anins28;Xis46
aninsZ9;Xis46anins30;Xis46anins31;Xis46anins32;Xis46anins33;X
i346anins34;Xis46anins35;Xis46anins36;Xis46anins37;Xis46anins
46 anins39;Xis46 andYis40;Xis46anins41;Xis46 anins 42;Xis46
anins43;Xis46 andYis44;Xis46anins45;Xis46 anins46;Xis46 anins47;X
i546 anins48;Xis46anins49;Xis46anins50;Xis46aninsSl;Xis46anins
52;Xis46 anins 53;Xis46 aninsS4;Xis46 aninsSS;Xis46 anins 56;Xis46
7;Xis46anins58;Xis46aninsS9;Xis46andYis60;Xis46aninsél;X
is46anins62;Xis46anins63;Xis46anins64;Xis46andYis65;Xis46anins
66;Xis46 7;Xis46 anins68;Xis46anins69;Xis46anins 70;Xis46
anins 71;Xis46 anins 72;Xis46 anins 46 anins 74;Xis 46 anins 75;X
i346 anins76;Xis46 anins77;Xis46anins78;Xis46anins79;Xis46anins
W0 2016/110584
1 16
80;Xis46 anins 81;Xis 46 anins 82;Xis46 anins 83; Xis46 aninsS4; Xis46
anins 85;Xis46 anins 86;Xis46 anins 87;Xis46andY is 88;Xis46 anins 89;X
is46anin390;Xis 46anins91;Xis46 anins92;Xis46 anins 93;Xis46 deis
94; Xis46 anins 95;Xis 46 anins96;Xis46 deis 97; Xis46 anins98;Xis46
andY is 99; Xis 46 andY is 100; Xis 46 andY is 101; Xis 46 andY is 102; Xis 46 andY is
103; Xis 46 anins 104; Xis 46 deis 105; Xis 46 deis 1106; Xis 46 anins 107;Xis
46 anins 108;Xis 46 deis 109; Xis46 Aflins 110;Xis 46 andY is s46 andY
is 112;Xis 46 anins 113;Xis 46 anins 114;Xis 46 anins 115;Xis 46 anins 116;X
is46 anins 117;Xis46 anins s46 anins 119;Xis 46 anins 120;Xis46 and
Yis 121; Xis 46 anins 122; Xis 46 anins 123; Xis 46 andY is 124; Xis 46 anins 125;
Xis 46 deis 126; Xis 46 deis 127; Xis 46 deis 128; Xis46 anins 129;Xis 46
anins 130; Xis 46 anins 131;Xis46 anins 132;Xis 46anins 133; Xis46 anins
134;Xis 46 andY is 135;Xis 46 andY is 136; Xis46 deis 137', Xis 46 andY13138;Xis
46 deis 139; Xis 46 anins 140; Xis 46 deis 141; Xis 46 anins 142; Xis 46 andY
is 143; Xis 46 anins is 46 anins 145;Xis 46 anins 146; Xis 46 anins 147;X
is 46 anins s 46 deis 149; Xis46 anins 150;Xis 46 anins 151;Xis 46 and
Yis 152;Xis 46 anins 153;Xis 46 anins 154;Xis 46 anins 155;Xis 46 deis 156;
Xis46 anins 157;Xis46 anins 158;Xis46 deis 159; Xis46anins 160;Xis46
anins 161; Xis 46 anins 162;Xis46 anins 163;Xis 46 deis 164; Xis 46 deis
165; Xis 46 deis 166; Xis 46 anins 167; Xis46 deis 168; Xis 46 deis 169; Xis
46 anins 170;Xis 46 anins 171;Xis 46 anins 172;Xis46 anins 173;Xis46andY
is 1174; Xis 46 anins s 46 anins 176;Xis 46 deis 177; Xis 46 anins 178;X
is 46 anins 179;Xis 46 anins 180;Xis 46 anins s46 anins 182;Xis 46 and
Yis 183;Xis46 anins 184;Xis 46 anins 185;Xis46 anins 186;
Xis47 anins 1; Xis 47 anins 2;Xis47 anins3;Xis47 anins4;Xis47 aninsS;
Xis47anins6; Xis47anins7;Xis47anins8;Xis47 anins9;Xis47 anins
47 anins 11;Xis 47 anins 12;Xis 47 anins 13;Xis47 anins 14;Xis47
aninslS;Xis47anins16;Xis47anins17;Xis47anins18;Xis47aninsl9;X
i347 aninsZO; Xis47 anin521;Xis47 anins 22;Xis 47 aninsZ3;Xis 47 anins
24;Xis47 anins25;Xis 47 anins26;Xis 47anins 27;Xis47 anins 28;Xis47
aninsZ9;Xis47 anins30;Xis47 anins31;Xis47 anins 47 anins33;X
is47 anins34; nins 35;Xis47 anins 36;Xis47 anins 37;Xis 47 anins
38;Xis 47 anins 47 anins40;Xis47anins41;Xis47anins 42;Xis47
anins43;Xis47 anins44;Xis47 anins45;Xis47 anins46;Xis47 anins47;X
is 47 anins48;Xis 47 anins49;Xis47 anins 50;Xis47 anins 51;Xis 47 anins
W0 2016/110584
1 17
52;Xis 47anin553;Xis47anins 54;Xis47 anin555;Xis 47 anins 56;Xis47
anins57;Xis47anins58;Xis47anin359;Xis47anins60;Xis47anins61;X
is47anin362;Xis47 anins63;Xis47anins64;Xis47 anin565;Xis47 anins
66;Xis 47anins67;Xis47andYis68;Xis47anins69;Xis47 anins 70;Xis47
anins71;Xis47anins72;Xis47anins73;Xis47anins74;Xis47anins7S;X
is47anins76;Xis47anins77;Xis47anins78;Xis47anins79;Xis47 anins
80;Xis47 anins 81;Xis47anins 82;Xis47 anins 83;Xis47 anin584;Xis47
anins 85;Xis47 andY is47 anins 47 anins 88; Xis47 anins 89;X
is47anins90;Xis47anins91;Xis47anins92;Xis47 anins93;Xis47anins
94;Xis47 anins 95;Xis47anins96;Xis47 anins97gXis47 andY1598;Xis47
anins99;Xis47anins100;Xis47anins101;Xis47anins102;Xis47anins
s 47 anins 104;Xis 47 anins 105;Xis 47 anins 106;Xis47 anins 107;Xis
47 anins 108;Xis47 anins 109;Xis47 anins 110;Xis 47 anins111;Xis47 andY
i3112;Xis47anins113;Xis47anins114;Xis47a.nins 115;Xis47anins116;X
is47anins117;Xis47anins118;Xis47anins ll9;Xis47anins 120;Xis47 and
Yis s 47 anins 122;Xis 47 anins 123;Xis 47 anins 124;Xis 47 2111in3 125;
Xis 47 26;Xis 47 deis 127; Xis 47 anins 128;Xis47 anins 129;Xis47
anins 130;Xis 47 anins 131;Xis 47 anins 132;Xis 47 anins 133;Xis47 anins
l34;Xis47anins135;Xis47anins136;Xis47anins137;Xis47anins138;Xis
47 anins 139;Xis47 anins 140;Xis47anins 141;Xis 47 anins s47 andY
is143;Xis47anins144;Xis47anins14S;Xis47anins146;Xis47aninsl47;X.
is 47 anins s 47 anins 149;Xis 47 anins s 47 anins 151;Xis 47 and
Yis 152;Xis 47 anins 153;Xis 47 anins 154;Xis 47 anins 155;Xis 47 anins 156;
Xis 47 anins 157; Xis 47 anins 158;Xis 47 anins 159;Xis 47 anins 160; Xis47
anins161;Xis47anins162;Xis47anins 163;Xis47anins164;Xis47anins
165;Xis 47 anins s 47 anins 167;Xis 47 anins 168;Xis 47 anins 169;Xis
47anins170;Xis47anins171;Xis47anins172;Xis47 anins 173;Xis47 andY
is 174;Xis 47 anins 175;Xis 47 anins 176;Xis 47 anins 177;Xis 47 anins 178;X
is47anins179;Xis47 anins 180;Xis47 anins 181;Xis 47 anins 182;Xis 47 and
Yis 183;Xis 47 anins 184;Xis 47 anins 185;Xis 47 anins 186;
Xis48anins1;Xis48aninsZ;Xis48anins3;Xis48anins4;Xis48aninsS;
Xis48 anins 6;Xis48 anins7;Xis48 anins 8;Xis48 anins9;Xis48 anins
;Xis48anins11;Xis48anins12;Xis48anins13;Xis48anins14;Xis48
anins15;Xis48anins16;Xis48anins17;Xis48anins18;Xis4Sanins19;X
i348 O;Xis48 aninle;Xis48 anins22;Xis48aninsZ3;Xis48 anins
W0 2016/110584
1 18
24;Xis48 anin325;Xis48 anins 26;Xis48 deis 27; Xis48 anin328;Xis 48
anin529;Xis48 anins 30;Xis48 anins31;Xis48 anins32; Xis48 anins 33;X
1348 deis 34;Xis48 anins 35;Xis48 andY is 36;Xis 48 andY is 37;Xis48 anins
38;Xis48anins39;Xi.s48anins40;Xis48anins41;Xis48 anins42;Xis48
anins43;Xis48 anins44;Xis48 anins45;Xis48 6; Xis48 anins47;X
i348 anins 48 anins49;Xis48 anins 50;Xis48 andY is 51;Xis48anins
52;Xis48 anins 48 anins 54;Xis48 anins 55; Xis48 6;Xis48
anins 48 anins 48 anins 59;Xis48 anins 60; Xis48 anins 61;X
i348 anins 62; Xis 48 anins63;Xis48 anins64;Xis48 andY is 65;Xis48 anins
66;Xis48 anins 67;Xis48 anins68;Xis48 anin369; Xis 48 anins70;Xis48
anins71;Xis48 anins 72;Xis48 3;Xis48 anins 74; Xis48 anins75;X
is48 anins 76; Xis48 anins77;Xis48 anins78; Xis48 andY is 79;Xis48 anins
80;Xis48 anins 81;Xis48 anins 82;Xis48 anins 83; Xis48 anin584;Xis48
anins 85;Xis48 anins 86;Xis48anins 87;Xis48 anins 88;Xis48 anins 89;X
i548 anins90;Xis48 anins91;Xis48 anins92;Xis 48 andY is 93;Xis48 deis
94; Xis 48 anins 95;Xis 48 deis 96; Xis 48 anins 97;Xis 48 deis 98; Xis 48
andY is 99; Xis 48 deis 100; Xis 48 andY is 101; Xis 48 anins 102; Xis 48 anins
s 48 anins 104;Xis 48 anins 105;Xis 48 deis 106; Xis 48 anins 107;Xis
48 anins 108;Xis 48 anins 109;Xis48 anins 110;Xis48 anins 111;Xis48 andY
is 112;Xis48 anins 113;Xis48 anins 114;Xis48 anins 115;Xis48 anins 116;X
i348 anins 117;Xis48 anins 118;Xis48 anins 119;Xis48anins 120;Xis48 and
Yis 121; Xis 48 andY is 122;Xis 48 anins 123;Xis 48 anins 124;Xis 48 anins 125;
Xis 48 deis 126; Xis 48 andY is 127; Xis 48 deis 128; Xis 48 and Y is 129; X is 48
anins 130;Xis 48 deis 131; Xis48 anins s48 anin3133;Xis48 anins
134;Xis 48 andY is 135;Xis 48 andY is 136; Xis48 andY is 137;Xis 48 andY is 138;Xis
48 anins 139;Xis 48 anins 140;Xis 48 anins 141;Xis 48 anins 142;Xis 48 andY
is 143; Xis 48 anins 144;Xis 48 anins 145; Xis 48 anins 146;Xis 48 anins 147;X
1548 deis 148; Xis48 anins 149;Xis48 anins 150;Xis48 anins 151;Xis48 and
Yis s 48 anins 153;Xis 48 anins 154; Xis 48 anins 155;Xis 48 anins 156;
Xis 48 anins 157;Xis 48 andY is 158; Xis 48 anins 159;Xis48 deis 160; Xis48
anins 161;Xis 48 anins 162;Xis 48 anins 163; Xis 48 deis 164; Xis 48 deis
165; Xis 48 anins 166;Xis 48 anins 167; Xis 48 anins 168;Xis 48 anin8169;Xis
48 andY is 170; Xis 48 deis 171; Xis 48 anins 172; Xis 48 anins 173;Xis 48 andY
is 174;Xis 48 anins 175;Xis 48 deis 176; Xis 48 andY is 177;Xis 48 anins 178;X
W0 2016/110584
1 19
i548 anins 179;Xis 48 anins 180;Xis48 anins 181;Xis 48 anins I82;Xis 48 and
Yis 183;Xis48anins184;Xis483nins 185;Xis48anins 186;
Xis49anins1;Xis49aninsZ;Xis49anins3;Xis49anins4;Xis49aninsS;
Xis49anins6;Xis49anins 7;Xis49anins 8;Xis49 anins9;Xis49anins
;Xis49anins11;Xis49anins12;Xis49anins13;Xis49aninsl4;Xis49
anins 15;Xis49anins16;Xis49 anins 17;Xis49anins18;Xis49anins l9;X
i349anins20;Xis49anins21;Xis49anins22;Xis49aninsZ3;Xis49anins
49 anins 25;Xis49 aninsZ6;Xis49 anin827;Xis49 anins28;Xis49
anins29;Xis49anins30;Xis49 anins31;Xis49anins32;Xis49anins33;X
is49anins34;Xis49anins35;Xis49anins36;Xis49anins37;Xis49anins
38;Xis49&nins 39;Xis49anins40;Xis49anins4l;Xis49anins42;Xis49
anins43;Xis49anins44;Xis49 anins45;Xis49anins46;Xis49anins47;X
i349 anins48;Xis49anins49;Xis49 anins50;Xis49aninsSl;Xis49 anins
52;Xis 49 anins 53; Xis 49 anins 54;Xis 49 anins 55;Xis 49 anins 56; Xis49
7;Xis49anins58;Xis49 anins59;Xis49andYis60;Xis49anins61;X
is49anins62;Xis49anins63;Xis49anins64;Xis49anins65;Xis49 anins
66;Xis49anins67;Xis49 anins68;Xis49anins69;Xis49 anins 70;Xis49
anins71;Xis49 anins72;Xis49anins73;Xis49 anins 74;Xis49 anins75;X
i349anins76;Xis49anins77;Xis49anins78;Xis49anins79;Xis49anins
80;Xis49anins 81;Xis49anins82;Xis49anins83;Xis49anins 84;Xis49
anins85;Xis492deis86;Xis49anin587;Xis49anin588;Xis49anins89;X
ins 90;Xis49anins91;Xis49anins92;Xis49anins93;Xis49anins
49anins95;Xis49andYis96;Xis49anins97;Xis49anins98;Xis49
9;Xis49anins100;Xis49anins101;Xis49anins102;Xis49anins
103;Xis 49 anins s 49 anins 105;Xis49 anins 106;Xis 49 anins 107;Xis
49anins108;Xis49anins109;Xis49anins110;Xis49anins111;Xis49andY
is112;Xis49anins113;Xis49anins114;Xis49anins115;Xis49anins116;X
is49anins 117;Xis49 anins118;Xis49anins119;Xis493nins 120;Xis49 and
Yis 121;Xis 49 anins 122;Xis 49 anins 123;Xis 49 anins 124;Xis 49 anins 125;
Xis 49 anins 126;Xis 49 deis 127; Xis 49 anins 128;Xis 49 deis 129; Xis 49
anins 130;Xis 49 anins 13I;Xis s 132;Xis49 anins 133;Xis 49 anins
134;Xis 49 anins 135;Xis 49 anins 136;Xis 49 anins 137;Xis49 anins 138;Xis
49anins 139;Xis49anins140;Xis49anins 141;Xis49 aninsI42;Xis49andY
is 143;Xis 49 anins 144;Xis 49 anins 145;Xis 49 anins 146;Xis 49 anins 147;X
i549 anins 148;Xis49 anins s 49 anins 150;Xis49 anins 151;Xis49 and
W0 2016/110584
Yis 152;Xis 49 anins 153;Xis49anins 154;Xis 49 deis 155; Xis 49 anins 156;
Xis 49 anins 157;Xis 49 anins 158; Xis 49 deis 159; Xis 49 anins 160;Xis 49
anins 161;Xis 49 anins 162;Xis 49 anins s 49anins 164; Xis49 anins
165;Xis 49 anins 166;Xis 49 anins 167;Xis49 anin3168;Xis 49 anins 169;Xis
49 anins 170;Xis49 anins 171;Xis49anins 172;Xis49 andY is 173;Xis49 andY
is 174;Xis 49 anins 175;Xis 49 anins 176;Xis 49 anins 177;Xis49 anins 178;X
is 49 anins 179;Xis 49 anins iSG;Xis 49 anins 181;Xis 49 anins 182;Xis49 and
Yis s49 anins s49anins s49 andY is 186;
XisSOanins1;XisSOanin32;Xis50anins3;XisSOanins 4;Xis 50aninSS;
Xis50anins6;XisSOanins7;Xis50anins8;XisSOandY i39;Xis50anins
;Xis50anins11;Xi550anins12;XisSOanins13;XisSOaninsl4;XisSO
anin315;Xis 50 anins 16;Xis 50 anins 17;Xis 50 anins 18; Xis SOanins 19;):
is 50anins20;Xis SOanin321;Xis SOanin322;Xis 50 anins23;XisSO anins
24;Xis 50 aninsZS;Xis sZ6;XisSO anins27;Xis 50anin528;Xis 50
aninsZ9;Xis 50anins30;Xis SOanins31;Xi350anins 32;XisSOanins33;X
is 50anins34;XisSOanins35;Xis 50anins36;XisSOanins37;XisSO anins
SOanins39;Xis 50anins40;Xis 50anins41;Xis 50anins42;Xis 50
anins43;Xis SOanins44;Xis 50 anins45;Xis 50 anins 46;Xis 50 anins47;X
isSOanins48;Xis50anins49;Xis SOaninsSO;Xis50aninsSl;XisSOanins
52;Xis 50 aninsSS;XisSOanins 54;Xis 50anins 55;Xis 50 anins 56;Xi350
anins 57;Xis 50 aninsS8;XisSO anins 59;Xis 50anins 60;Xis SOanins61;X
isSOanins62;XisSOanins63;Xis 50anins64;XisSOanins65;XisSOanins
66;XisSOandYis67;XisSOanins68;Xis 50anins69;Xis 50anins70;XisSO
anins 71;Xis 50anins72;Xis SOanins 73;XisSOanins74;Xis 50 anins75;X
is 50 anins76;Xis 50 anins77;Xis SOanins 78;Xis 50anins79;Xis 50 anins
80;Xis 50 anins 81;Xi350 anins 82;Xis SOanin583;Xis 50 anins 84;XisSO
anin585;Xis 50anins86;XisSOanins 87;XisSOanins88;Xis$0anin389;X
isSOanins90;XisSOanins91;Xi350 anins92gXiSSOanin593;Xis 50anins
94;Xis 50 anins95;XisSOanins96;Xis 50anins97;XisSOanins 98;Xi550
deis 99; Xis 50:111in3 100;XisSO anins sSO anins 102; Xis 50 deis
103; Xis 50 anins 104;Xis 50 anins s 50 anins 106;Xis 50 anins 107;Xis
50anins108;XisSOanins109;XisSOaninsllO;Xis 50aninslll;Xis SOandY
isll2;Xis50anins113;XisSOanins114;XisSOanins115;XisSOanins116;X
is 50 anins 117;Xi550 anins 118;Xis 50 anins s 50anins 120; Xis 50 and
Yis 121;XisSOanins 122;XisSOanins123;XisSOanins124;Xis50anins 125;
W0 2016/110584
XisSOanins126;Xis50anins127;Xis50anins128;Xis50anins 129;Xis50
anins 130;Xis sl31;XisSOanins132;Xi850anins133;Xis50anins
sSOanins135;Xis50aninsl36;Xis50anins137;Xis50andY15138;Xis
SOanins139;XisSOanins140;XisSOanins141;XisSOanins142;Xis50andY
is s 50 anins s 50 anins 145;Xis 50 anins 146;Xis 50 anins 147;X
is 50 anins 148;Xis 50 anins 149;Xis 50 anins 150;Xis 50 anins 151;Xis 50 and
Yis s 50 anins 153;Xis 50 anins 154;Xis 50 andY is 155;Xis 50 anins 156;
Xis 50 anins 157;Xis 50 anins 158;Xis 50 anins 159;Xis 50 anins 160;Xi550
anins161;Xis50anins162;Xis§0anins163;XisSOanins164;XisSOanins
165;Xis 50 anins 166;Xis 50 anins 167;Xis 50 anins 168;Xis 50 anins 169;Xis
SOanins170;XisSOanins171;XisSOanins l72;XisSOanins173;Xi350andY
is 174;Xis 50anins175;XisSOanins176;XisSGanins177;Xis 50anins178;X
is 50 anins 179;Xis 50 anins 180;Xis 50 anins 181;Xis 50 anins 182;Xis 50 and
Yis 183;Xis SOanins 184;Xis 50 anin3185;Xis 50anins 186;
XisSl aninsl;Xis 51 aninsZ;XisSl anins 3;XisSl anins4;XisSl aninsS;
XisSlanins6;XisSl anins7;XisSl anins8;XisSl anins9;Xis51anins
;Xi351aninsll;XisSlanins12;Xi351anin313;Xis51aninsl4;XiSSI
anins15;Xi851 anins 16;XisSl anins 17;Xi351 anins 18;XisSl anins 19;X
i551aninsZO;XisSlaninle;XisSlanin522;Xis51anins23;Xi551anins
24;Xi551 anins25;Xis 51 anins26;Xi351 anin827;Xis 51 anins 28;XisSl
aninsZ9;XisSlanin530;Xi551anins31;XisSlanins32;XisSlanins33;X
i551 anins34;XisSl 5;XisSl anins36;Xis 51 anins37;XisSl anins
38;X1551 anins39;Xis 51 anins40;XisSl anins41;XisSl 2;Xi351
anins43;Xis51anins44;XisSlanins45;XisSlanins46;XisSlanins47;X
i351anins48;XisSlanins49;XisSlanin550gXi851aninsSl;XisSIanins
52;Xis51 anins 53;XisSl anins 54;Xis 51 aninsSS;Xis 51 anins 56;Xis51
anins57;Xi351anin358;Xis51aninsS9;XisSlanins60;XisSl aninsfil;X
i351 2;XisSl anins63;XisSl anins64;Xis 51 anins65;XisSl anins
66;Xi351 7;Xis 51 anins68;XisSl anins69;Xis 51 0;XisSl
anins71;XisSl anins72;XisSl anins73;Xis51anins74;Xi551anins75;X
i551 anins76;XisSl anins77;Xi351 anins78;Xis 51 anins79;Xis 51 anins
80;XisSl anin581;Xi551anins82;Xis51aninsS3;XisSlaninsS4;XisSl
anins85;XisSlanins86;Xis51anins87;XisSlanins88;XisSl anins89;X
is 51 aninsQO;XisSl anins9l;Xi351 anins92;Xis 51 anin593;X1351 anins
94;Xi351 5;Xis 51 anins96;Xis 51 anins97;Xis 51 anins 98;Xis51
W0 2016/110584
anins 99; Xis 51 anins 100;Xis 51 anins 101;Xis 51 anins s 51 anins
103; Xis 51 anins104;Xis 51 deis 105; Xis 51 anins 106; Xis 51 anins 107; Xis
51 anins 108;X1351 anins 109;Xis 51 aninsllO;Xis51 aninslll;Xis51 andY
is112;XisSlaninsll3;XisSlaninsll4;XisSlanins115;XisSlaninsll6;X
is 51 anins 117;Xis 51 anins 118;Xis 51 anins 119;Xis 51 and Yis 120;Xis 51 and
Y is 121;Xis 51 deis 122; Xis 51 anins 123; Xis 51 andY is 124; Xis 51 andY is 125;
X is 51 andY is 126;Xis 51 andY is 127; Xis 51 anins 128;Xis 51 anins 129; Xis 51
anins 130;Xis 51 anins 131;Xis 51 anins 132;Xis 51 anins 133;Xis 51 deis
134; X1551 deis 135; Xis 51 anins 136;Xis 51 deis 137; Xis 51 anins138;Xis
51 anins 139;Xis 51 anins 140;Xis 51 anins 141;Xis 51 andY is 142;Xis 51 andY
is 143; Xis 51 anins 144; Xis 51 anins 145; Xis 51 anins 146;Xis 51 anins 147; X
is 51 anins 148; Xis 51 anins 149;Xis 51 deis 150; Xis 51 anins 151; Xis 51 and
Yis 152;Xis 51 andY is 153;Xis 51 andY is 154;Xis 51 andY is 155; Xis 51 anins 156;
Xis 51 deis 157; Xis 51 anins 158;Xis 51 anins 159;Xis 51 anins 160;Xis 51
anins 161;Xis 51 anins s 51 anins 163;Xis 51 anins 164;Xis 51 and Yis
165; X is 51 andY is 166; X is 51 deis 167; X is 51 anins 168; Xis 51 anins 169; Xis
Slanins 170;Xis 51 aninsl71;Xi351 anins 172;Xis 51 anins s 51 andY
is 174; Xis 51 andY is 175; Xis 51 anins 176; Xis 51 anins 177;Xis 51 anins 178;X
is51anins 179;Xis 51 aninslSO;XisSlanins 181;Xis 51 anins182;Xis 51 and
Yis s 51 anins 184;Xis 51 anin5185;Xi551 deis 186;
nins1;Xi352aninsZ;Xis52anins3;XisSZanins4;XisSZanins5;
XisSZanins6;Xi552 anins7;Xi352anins 8;Xi352 ;Xi352 anins
;Xis52anins11;Xis52anins 12;Xi552anins 13;XisS2a11ins 14;Xi552
aninslS;Xis52anins16;Xis52anins17;Xi552anins18;Xis52aninsl9;X
isSZanins20;Xis52adeile;Xi352andY1322;Xis52 aninsZS;XisSZanins
24;Xi352 anin525;Xis52anin326;Xi852anins27;XisSZanin528;Xi352
anins29;Xi352anins3O;XisSZanins31;XisSZanins32;Xi552aninSB3;X
ins34;Xis52anins3S;Xi352anins36;X1552anins37;X1552anins
38;Xi552 anins39;Xis52anins40;Xis 52anins41;XisSZandYis42;Xi552
3O anins43;Xis52anins44;XisSZanins45;Xis52anins46;Xi552anins47;X
ins48;Xis52anins49;Xis52anins50;Xi552 aninsSl;Xi552anins
52;Xi552 anins 53;XisS2anins54;Xis 52 aninsSS;XisSZanins 56;X1552
aninsS7;X1552 aninsSS;Xis52 anins59;XisSZanin360;Xis52 anins61;X
i552anins62;Xis52anin563;Xi552anins64;XisSZanins65;Xis52anins
66;Xis52anins67;X1552 anins68;XisSZanins69gXi852anins 70;Xis52
W0 2016/110584
anins71;Xis 52anins72;Xi852 anins73;XisSZandYis74;Xis52anins75;X
isSZanins76;Xis52anins77;Xi352 anins78;Xi552 anins79;Xi352anins
80;Xis 52 anins 81;Xis52 anins82;Xis 52 anins83;Xis 52 aninsS4;Xi552
anins 85;Xis 52 anins 86;Xis 52 anins 87;Xis 52 anins 88;Xis 52 anins 89;X
isSZanins90;Xis 52anins91;XisSZanin892;Xi552 anins93;Xi552 anins
94;Xi352anins 95;XisS2anins96;XisSZanins97;Xi352 anins 98;Xis 52
anins 99;Xis 52 anins s 52 anins lOl;Xis 52 deis 102; Xis 52 and Y is
103;Xis 52 anins 104;Xis 52 anins 105;Xis 52 anins 106;Xis 52 anins 107;Xis
52 anins 108;Xis 52 anins 109;Xis 52 anins 110;Xi352 anins 111;Xis 52 andY
is 112;Xi352anins 113;Xis 52 anins 114;Xi552 anins 115;Xis 52 anins 116;X
is 52 anins 117;Xis 52 anins 118;Xis 52 anins 119;Xis 52 anins s 52 and
Yi5121;Xis 52 anins 122;Xis 52 anins 123;Xis 52 anins 124;Xis 52 andY is 125;
Xis 52 anins 126;Xis 52 anins 127;Xis 52 anins 128;Xis 52 anins 129;Xis 52
anins s 52 anins s 52 anins 132;Xis 52 anins 133;Xis 52 anins
134;Xis 52 anins 135;Xis 52 anins 136;Xis 52 anins 137;Xis 52 anins 138;Xis
52 anins 139;Xis 52 anins 140;Xis 52 anins 141;Xis 52 anins 142;Xis 52 andY
is 143;Xis 52 anins 144;Xis 52 andY is I45;Xis 52 anins 146;Xis 52 anins 147;X
is 52 anins 148;Xis 52 anins 149;Xis 52 anins 150;Xis 52 anins151;Xis 52 and
Yis152;Xis 52 anins 153;Xis 52 anins s 52 anins 155;Xis 52 anins 156;
Xis 52 anins 157;Xis 52 anins 158;Xis 52 anins 159;Xis 52 anins 160;Xis 52
anins 161;Xis 52 anins 162;Xis 52 anins 163;Xis 52 anins s 52 anins
165;Xis 52 anins 166;Xis 52 anins s 52 anins 168;Xis 52 anins s
52 anins 170;Xis 52 anins s 52 anins 172;Xis 52 anins 173;Xis 52 andY
is 174;Xis 52 deis 175; Xis 52 anins 176;Xis 52 anins s 52 anins 178;X
is 52 anins 179;Xis 52 anins 180;Xis 52 anins 181;Xis 52 anins 182;Xis 52 and
Yis 183;Xis 52 anins 184;Xis 52 anins 185;Xis 52 anins 186;
Xi353 anins 1;Xis 53 anin52;Xis 53 anins3;XisS3 anins4;Xi553 ;
XisS3 anins 6;Xi853 anins 7;XisS3 aninsS;XisS3 anin59;Xis53 anins
;Xi353 anins 11;XisS3 anins 12;XisS3 anins 13;Xis 53 anins 14;XisS3
anins 15;Xis53 anins 16;Xi353 anins 17;Xis53 anins 18;XisS3 anins 19;X
is 53 aninsZO;XisS3 aninsZI;Xi553 anin522;Xi553 anins23;XisS3 anins
24;Xis 53 anins25;Xis 53 anins26;Xis 53 anins27;Xis 53 anins28;Xi553
anin529;X1'553 0;XisS3 anins31;Xis53anins32;Xis53 anins33;X
isS3anins34;XisS3 anins35;Xis53anins36;XisS3anins37;XisS3 anins
38;XisS3 anins39;XisS3 anins40;Xis 53 anins41;Xis 53 anins 42;XisS3
W0 2016/110584 2016/050308
anins 43;Xis 53 anins 44;Xis 53 anins45;Xis 53 anins46;XisS3 anins47;X
i553 anins48;XisS3 anins49;XisS3 aninsSO;XisS3 anins 51;Xi353 anins
52;Xis 53 anins 53;Xis 53 4;XisS3 aninsSS;XisS3 anins 56;XisS3
7;Xis 53 anins 58;Xis53 anins 59;Xis53 anins60;Xis53 anins61;X
is53 anins 62;Xis 53 anins 63;Xis 53 anins 64;Xis 53 anins 65;Xi353 anins
66;Xis 53 anins 67;Xi353 anins68;Xis 53 anin569;Xis53 anins 70;Xi353
anins 71;Xis 53 anins72;XiSS3 anins 73;Xis§3 anins74;XisS3 anins 75;X
is 53 anins76;Xis 53 anins77;Xis 53 anins78;Xi553 anins 79;Xis 53 anins
80;Xis 53 anins8l;Xis 53 anin382;Xis 53 anins83;XisS3 anins84;XisS3
anins 85;Xis 53 anins S3 anins 87;Xis 53 anins 88;Xi553 anins 89;X
is 53 anins90;Xis 53 anins91;Xis 53 anin592;Xi553 anins 93;Xis53 anins
94;Xis 53 anins S3 anins96;Xis 53 anins97;XisS3 aninsQ8;XisS3
anins 99; Xis 53 anin3100;Xis 53 anins 101;Xis 53 anin8102;Xis 53 anins
103;Xis 53 anins 104;Xis 53 anins s 53 anin5106;Xis 53 anins s
53 anins108;XisS3anins109;Xis$3anins110;Xi553 anins 111;Xis$3 andY
is 112;Xis 53 anins 113;Xis 53 anins 114;Xis 53 anins 115;Xi353 anins116;X
is53 anins 117;Xis 53 anins 118;Xis 53 anins 119;Xis 53 anins 120;Xis 53 and
Yi5121;Xi353 anin5122;Xis 53 anins 123;Xis 53 andY is 124;Xis 53 deis 125;
Xis 53 anins 126;Xis 53 27;XisS3 anins 128;Xis 53 anins129;Xis 53
anins s 53 anins 131;Xis 53 anins s 53 anins 133;Xis 53 anins
134;Xis 53 anins 135;Xis 53 anins 136;Xis 53 anins 137;Xis 53 anins 138;Xis
53 anins 139;Xis 53 anins I40;Xis 53 anins 141;Xi353 anins 142;Xis 53 andY
is 143; X1853 anins 144;Xis 53 anins 145;Xis 53 anins146;Xis53 anins 147;X
is 53 anins 148;Xis 53 anins 149;Xis 53 anins 150;Xis 53 anins 151;Xis 53 and
Yi5152;XiSS3anins153;XisS3 anins 154;XisS3 anins 155;Xis 53 anins 156;
Xis 53 anins 157; Xis 53 deis 158; Xis 53 anins 159;Xis 53 deis 160; Xis 53
anins 161;Xis 53 anins 162;Xis 53 anins 163;Xis 53 anins 164; Xis 53 anins
165;Xis 53 anins 166;Xis 53 anins 167;Xis 53 anins 168;Xis 53 anins 169;Xis
53 anins 170;Xis 53 anins171;XisS3anins172;XisS3anins173;XisS3andY
is 174;Xis 53 anins s 53 anins 176;Xis 53 anins 177;Xis 53 anins 178;X
is 53 anins 179; Xis 53 anins 180;Xis 53 anin5181;Xis 53 deis 182; Xis 53 and
Yi5183;Xis 53 anins 184;Xis 53 anins 185;Xis 53 deis 186;
XisS4anins 1;Xis 54anin82;Xis54anins3;Xis 54anins4;XisS4 aninsS;
Xis 54anins6;Xis 54anins7;Xis 54anins 8;XisS4anins9;Xis 54 anins
10;XisS4anins11;XisS4anins12;XisS4anins l3;XisS4anins 14;XisS4
W0 10584 2016/050308
anins15;XiSS4anins16;XisS4aninsl7;XisS4anins18;Xis§4aninsl9;X
isS4anin320;Xis 54aninle;XisS4anins22;Xis 54 aninsZ3;XisS4anins
24;XisS4anin825;Xis 54aninsZ6;Xis 54anin527; Xis 54 aninsZ8;XisS4
9;Xis 54anins30;Xis 54 anins3];Xi354 anin832;Xi354 anins33;X
is54anins34;Xis 54anins35;XisS4anins36;Xis 54 anins37;XisS4anins
38;XisS4anins39;Xis 54anins40;Xis 54anins4l; Xis 54anins42;Xis 54
anins43;Xis .54 anins44;Xis 54 anins 45;XisS4 anins46;Xis 54 anins47;X
is s48;Xis 54anins49;XisS4 aninsSO;XisS4 anins51;Xi554anins
52;Xi354anins 53;XisS4 4;XisS4anin855; Xis 54anins 56;Xi554
anins57;Xis54anin558;XiSS4anins59;XiSS4andYis60;XisS4anins6l;X
isS4anins62;Xis 54anins63;XisS4anins64;XisS4 5;Xis 54anins
66;Xis54anins67;Xi354 anins68;Xis 54anins69;Xis 54anins 70;XisS4
anins71;Xis 54 anins 72;Xi354 anins 73;Xis 54anins74;Xis 54 anins 75;X
is 54anins 76;Xis54anins77;XisS4anins78;Xis54 anins79;Xis 54anins
80;Xis$4anins 81;Xis 54anins 82;Xi354anins 83; Xis 54anins 84;XisS4
anins85;Xis54anins86;Xis54anins 87;Xis54anin388;Xiss4anin589;X
isS4anins90;Xis s91;XisS4 anins92;Xis 54 anin593;Xis54anins
94;Xis 54anins95;Xis 54anins96;XisS4anins97;Xis 54 anins98;XisS4
anins 99;Xis 54anins100;XisS4anins101;Xis54anins102;XisS4anins
103;Xis 54 anins 104;Xis 54 anins 105;Xis 54 anins 106;Xis 54 anins 107;Xis
54anin5108;Xis 54anins 109;Xis 54anins s 54 anins 111;Xis 54andY
is112;XisS4anins113;Xis54anins114;Xis54anins115;XisS4anins116;X
isS4anins117;XisS4anins118;Xis54anins119;XisS4anins120;Xi354and
Yis 121;Xis 54 anins s 54 anins 123;Xis 54 andY is 124;Xis 54 anins 125;
Xis 54 anins 126; Xis 54 deis 127; Xis 54 deis 128; Xis 54 anins 129;Xis 54
anins 130;XisS4a.nins 131;XisS4anins132;XisS4anins133;Xis 54 deis
134; Xis 54anins135;XisS4anins136;Xis54anins137;Xis 54 anins 138;Xis
54 anins 139;Xis 54 anins 140;Xis 54 anins 14];Xis 54 anins 142;Xis 54 andY
is 143; Xis 54 anins 144;Xis 54 anins 145;Xis 54 anins 146;Xis 54 anins 147;X
is 54anins 148;Xis 54 anins 149;Xis 54 anins 150;Xis 54 anins 151;Xis 54 and
Yis 152;Xis 54 anins 153;Xis 54 anins 154;Xis 54anins 155;Xis 54 anins 156;
Xis 54 anins s 54 anins 158;Xis 54 anins s 54 anins 160;Xis 54
anins 161;Xis 54 anins 162;Xis 54 anins 163;Xis 54 anins 164;Xis 54anins
165;Xis 54 anins 166;Xis 54 anins 167;Xis 54 anins 168;Xis 54 anins 169;Xis
54anins 170; Xis 54 anins 171;Xis 54 anins 172;Xis 54 anins 173;Xis 54andY
is 174;Xis 54 anins 175;Xis 54 anins 176;Xis 54 anins 177;X is 54 anins 178;X
is 54 anins 179;Xis 54 anins 180;Xis 54 anins 181;Xis 54 and Y15182;Xi854and
Yis 183;Xis 54 anins s 54anins 185;Xis 54 deis 186;
X1355 anins 1;Xi355 aninsZ;Xis 55 anin33;X_i555 anins 4;Xi355anin55;
XisSS anins 6;Xis 55 anins7;Xis 55 anins 8;Xi355 andY is 9;XisSS anins
;Xis55 anins 11;XisSS anins 12;Xis 55 anins 13; X1355 anins 14;Xis 55
anins 55 anins 16;Xis55 anins 17;XisSS andY is 18; XisSS anins 19;X
is 55 aninsZO;Xis 55 anin321;Xis 55 2;Xis 55 andY is 23;Xi355 anins
24;Xis 55 anins 25;Xis 55 anin326;Xis 55 aninsZ'l; Xis55 anins28;Xis 55
anin329;Xis 55 anins30;XisSS anins3l;Xis 55 andY is32;Xi355 anins33;X
is55 anins34;Xi355 anins35;Xis55 anins36;Xis 55 andY is37;Xis55 anins
38;Xis$5anins39;XisSSanins40;Xis55anins41;XisSSanins42;XisSS
anins43;Xis 55 4;Xis 55 anins45;Xis 55 andY is46;Xis 55 7;X
isSSanins48;Xis 55 9;Xis55 anins 50;XisSS aninsSl;Xis55 anins
52;Xis 55 anins 53;Xis 55 aninsS4;Xis 55 anins 55; Xis 55 anins 56;Xis 55
anins 57;Xis 55 anins 58;Xi355 anins 59;Xis 55 anins60;XisSS anins61;X
1355 anins62;Xis 55 anins63;Xis55 anin564;Xis 55 anin565;X1555 anins
66;Xi355 anins 67;Xi355 8;XisSS anins69; XisSS anins70;Xis 55
anins71;Xi555 anins 72;Xis 55 anins73;Xis 55 anins74;Xis 55 anins75;X
i355 anins 76;Xis 55 anins77;Xi555 anins78;XisSS anins79;Xi555 anins
80;Xis 55 anins81;Xi355 anins 82;Xis 55 anins 83;Xis55 anins 84;Xi355
anins 85;Xis 55 anins 86;Xis 55 anins 87;Xis 55 anins 88;Xis 55 anins 89;X
i355 anins90;Xis 55 1;Xi355 anins92;Xi855 anins93;Xis 55a11ins
94;Xis 55 anins95;Xi355 anins96;Xis 55 anins 97;Xis 55 anins 98;Xis55
anins 99;Xis 55 anins 100;Xis 55 anins101;Xi355anins102;Xis 55 anins
103;Xis 55 deis 104; Xis 55 anins 105;Xis 55 aninS 106;Xis 55 anins 107;Xis
SSanins108;Xi555anins109;Xi855anins110;XisSSanins111;Xis55andY
isll2;Xis 55 anins 113;Xi355 anins114;Xi355 anins115;Xis 55 anins 116;X
is 55 anins s 55 anins 118;Xis 55 anins 119;Xis 55 anins 120;Xis 55 and
;Xis55 anins122;Xis55 anins 123;Xis 55 anins 124;Xis 55 deis 125;
Xis 55 anins 126; Xis 55 anins 127; Xis 55 anins 128; Xis 55 anins 129;Xis 55
anins s 55 anins 131;Xis 55 anins132;Xi355 anins 133;Xis 55 anins
134;Xis 55 anins 135; Xis 55 anins 136;Xis 55 anins 137;Xis 55 anins 138;Xis
55 anins 139;Xis 55 anins 140;Xis 55 anins 141;Xis55 anins 142;Xis 55 andY
is 143; Xis 55 andY is 144;Xis 55 anins 145;Xis 55 anins 146;Xis 55 deis 147; X
W0 2016/110584
is 55 anins 148;Xis 55 anins 149;Xis 55 anins 150;Xis 55 anins 151;Xis 55 and
Yis 152;Xis 55 anins 153;Xis 55 anins s 55 anins 155;Xis 55 anins 156;
Xis 55 anins 157;Xis 55 anins 158;Xis 55 anins 159;Xis 55 anins 160;Xis 55
anins s 55 anins 162;Xis 55 anins 163;Xis 55 anins s 55 anins
s 55 anins 166;Xis 55 anins 167;Xis 55 anins 168;Xis 55 anins s
55 anins I70;Xis 55 anins 171;Xis 55 anins 172;Xis 55 anins 173;Xis 55 andY
is 174;Xis 55anins175;Xi355anins176;Xis55anins177;XisSSaninsl78;X
is 55 anins 179;Xis 55 anins 180;Xis 55 anins 181;Xis 55 anins 182;Xis 55 and
Yis 183;Xis 55 anins 184;Xis 55 anins 185;Xis 55 anins 186;
XisS6anins 1;Xis 56 aninsZ;Xis56 anins3;XisSGanins4;XisS6anins5;
XisS6anins6;Xis56anins7;XisS6anins8;Xi356 aninsQ;XisS6 anins
;Xis56 l;Xis 56anins 12;Xis56anins 13;Xis 56 anins 14;Xis 56
anins 15;Xis 56 anins 16;Xis 56anins I7;XisS6 anins 18;XisS6anins 19;X
isSéanins20;Xis56anin321;Xi856anin322;XisS6anins23;XisS6anins
24;Xis 56 anin525;Xis 56anins26;XisS6anin327;Xis 56 anin328;XiSS6
aninsZ9;Xis 56 anins30;XisS6anins31;XisSéanins32;Xis56 anins33;X
is56andYis34;XisS6anins35;Xis 56 anins36;Xis56 anins37;XisS6anins
38;Xis56anins 39;Xis 56anins40;XiSS6anins4l;Xis 56 anins42;XisS6
anins43;Xi856 anins44;XisS6anins45;XisS6anins46;XisS6 anins47;X
isS6anins48;Xis 56anins49;XisS6aninsSO;Xi356 anins51;Xi356anins
52;Xis56anins 53;Xis 56anin354;Xis 56 anins 56anins 56;Xi856
anins57;Xis56anins58;Xi556andYisS9;XisSéaninsGO;XisSGanin361;X
is 56anins62;XisSGanins63;Xi356 anins64;XisS6 anins65;XisS6anins
66;Xis56anins67;Xis 56deis68;XisS6anins69;Xis56anins 70;XisS6
anins71;XisS6anins72;XisS6anins73;Xis56 anins74;Xi556anins75;X
ins 76;Xi556anins77;XisS6anins78;Xi356 anins79;Xi356anins
80;XisS6anins 81;XisS6anins82;Xis56anin383;Xis 56anins84;Xis 56
anins85;XisS6anins 86;XisSGanins 87;Xis56 anins88;Xi556anins89;X
isS6anins90;Xis 56anin391;Xis56anins92;XisS6anins93gXiSS6anins
94;XisS6anins 95;Xis 56 anins96;XisS6anins97;Xis 56anins98;XiSS6
anins 99;Xis 56 anins 100;Xis 56 deis 101; Xis 56 anins 102;Xis 56 anins
103;XisS6anins104;XisS6anins105;Xis56anins106;Xi356anins107;Xis
56anins s56aninle9;Xi556anins110;X1'sS6a.nins111;Xi556andY
is 112;XisS6 anins sS6anins 114;Xis 56aninS115;XisS6aninsll6;X
is 56aninsll7;Xis 56 anins 118;Xi556anins‘119;Xis 56anins 120;XisS6and
W0 2016/110584 2016/050308
Yis 121;Xi356 anins s 56 anins 123;Xis 56 andY is 124; Xis 56 anins 125;
Xis 5126;Xis 56 anins 127; Xis S6 28;Xis 56 anins 129;Xis 56
anins 130;Xis 56 anins 131;Xis 56 anins 132;Xis 56 anins 133;Xis 56 anins
134;Xis 56 anins 135;Xis 56 anins 136;Xis 56 anins 137;Xis 56 anins 138;Xis
56anins139;XisS6anins140;Xis56anins141;Xis56anins142;Xis 56 andY
is 143;Xis 56 anins 144;Xis 56 anins 145;Xis 56 anins 146;X.is 56 anins 147;X
is 56 anins 148;Xis 56 anins 149;Xis 56 anins 150;Xis 56 anins 151;Xis 56 and
Yis 152;XisS6anins 153;Xis 56anins 154;Xis56anin3155; XisS6anins 156;
Xis 56 anins 157; Xis 56 anins 158;Xis 56 andY is 159;Xis 56 anins 160;Xis 56
anins 161;Xis 56anins162;XisS6anins163;Xis56anins164;Xi356anins
165;Xis 56 anins 166;Xis 56 anins 167;Xis 56 anins 168;Xis 56anin5169;Xis
56 anins 170;Xis 56 and Y is 171;Xis 56 and Y is 172;Xis 56 anins 173;Xis 56 andY
is 174; Xis 56 anins 175; Xis 56 anins 176;Xis 56 anins 177; Xis 56 anins 178;X
is 56 anins s 56 anins 180;Xis 56 anins 181;Xis 56 anins 182;Xis 56 and
Yis 183;Xis56anins 184;Xi556anins185;Xi356anin3186;
XisS7anins1;Xis57anins2;XisS7anins3;XisS7anins4;XisS7aninsS;
Xis 57 anins6;Xis 57 anins73Xis 57 anins 8;Xis 57 anins9;XisS7 anins
;XisS7anins11;XisS7aninsl2;XisS7anins13;XisS7aninsI4;XisS7
anins15;Xis57aninsl6;XisS7anins17;XisS7anins18;XisS7aninsl9;X
i557 aninsZO;Xis 57andYile;XisS7anins22;Xis 57 aninsZ3;XisS7 anins
24;Xis 57anins 25;Xis 57 anins26;XiSS7 7;Xis 57 anin528;XiSS7
aninsZ9;Xi557anins30;XisS7 anins31;Xis57anins32;Xi557anin333;X
is 57anins34;Xis 57 anins 35;Xi557 anins36;XisS7anins37;XisS7anins
38;Xis 57 £111in539;XisS7anins40;Xis57 anins 41;XisS7 anins42;Xis57
anins43;Xis 57 anins44;Xis s45;XisS7 anins46;Xis 57 anins47;X
is 57anins48;Xis 57 anins49;Xis57 aninsSO;Xis 57aninsSl;XisS7anins
52;Xis 57aninsS3;Xis 57anins 54;Xi557aninsSS;Xis 57anins 56;Xis57
aninsS7;Xis 57 anins 58;Xis 57 anins 59;Xis 57 anins 60;Xis 57 anins61;X
is 57 anins 62;Xis 57 anins63;Xis 57 anin564;Xis 57adeis 65;Xis 57 anins
66;Xis 57 anins 67;Xis 57 anins68;Xis 57anins 69;XisS7anins 70;XisS7
anins71;Xis 57 anins72;Xi857 anins73;Xis 57anins74;Xis 57 anins75;X
is 57 anins76;Xis 57 anins77;XisS7anins78;XisS7anins79;Xis 57 anins
80;Xis 57 anins 81;Xis 57 andY1382;Xis 57anins83;XiSS7anins 84;XisS7
anin585gXiSS7 anins86;Xis 57anins87;Xis 57 8;Xiss7anin389;X
i557 0;Xis 57 anins91;XisS7 anins92;XisS7anins93;Xis 57anins
W0 2016/110584
57 anins95;Xis57 anins96;Xis 57 anins97;Xis 57 anins98;XisS7
anins 99; Xis 57 anins 100;Xis 57 anins 101;Xis 57 anins 102;Xis 57 anins
103;XisS7anins104;XisS7aninleS;XisS7anins106;XisS7anins107;Xis
57anin5108;Xi557a.nins109;XisS7anins 110;Xis57anins111;XisS7andY
is 112;XisS7anins 113;Xis57anins114;Xi357anins 115;Xis57anin3116;X
is 57 anins 117;Xis 57 anin5118;Xis 57 anins 119;Xis 57 anins 120;Xis 57 and
Yis121;Xis57anins 122;XisS7anins123;XisS7anins124;Xi557anins 125;
Xis 57 anins126;Xis 57 anins 127;Xis 57 anins 128;X is 57 deis 129; Xis 57
anins 130;XisS7anins s$7anins132;XisS7anins 133;XisS7anins
134;Xis 57 anins s 57 anins 136;Xis 57 anins 137;Xis 57 anins 138;Xis
57anin8139;XiSS7 anins 140;Xis 57 anins s 57 anins 142;Xis 57 andY
is 143;Xis 57 anins 144;Xis 57 anins 145;Xis 57 anins 146;Xis 57 anins 147;X
is 57 anins 148;Xis 57 anins 149;Xis 57 anins 150;Xis 57 anins151;Xi557 and
Yis 152;Xis 57 anins 153;Xis 57 anins 154;Xis 57 anins 155;Xis 57 deis 156;
Xis 57 anins 157;Xis 57 58;Xis57anins159;Xis57anins160;Xi557
anins 161;Xis 57 62;XiSS7anins163;Xis 57anins 164;XisS7a11ins
165;Xis 57 anins 166; Xis 57 anins 167;Xis 57 anins 168;Xis 57 anins 169;Xis
57anins 170;Xis 57 anins171;XisS7aninsl72;XisS7anins173;XisS7andY
is 174;Xis 57 anins I75;Xis 57 anins 176;Xis 57 anins 177;X1's 57 anins 178;X
is 57 anins 179;Xis 57 anins 180;Xis 57 anins 181;Xis 57 anins 182;Xis 57 and
Yis 1’83;Xis 57 anins 184;Xis 57 anins 185;Xis 57anins 186;
Xis58 anins 1;Xis 58 anins2;Xis58 anins3;Xis583nins4;X1358 aninsS;
Xis58 ;Xis 58 anins 7;Xis 58 anins8;Xis 58 anins 9;Xis 58anins
;Xis 58 anins 11;Xis 58 anins 12;Xis 58 anins 13;Xis 58anins 58
anins15;Xi358anins16;Xis58aninsl7;Xis58anins18;Xi358aninsl9;X
is58 aninsZO;XisS8aninle;Xi558 anin322;XisSSanin523;Xi358 anins
24;Xis 58 anins 25;Xis 58 anin326;Xis 58 anin527;Xis 58anin328;X1558
aninsZ9;Xi358 0;XisSSanins31;XisSS anins32;Xi558 anins33;X
i558 andYis34;Xi558anins35;XiSS8 anins36;XiS 58anins37;Xis 58 anins
38;Xis 58 anins39;XisS8 anins40;Xis 58 anins41;Xis s42;Xi358
anins43;Xis58anins44;Xis58 anins45;Xi558anins46;Xis58 anins47;X
i558 anins48; X1558 anins49;XisS8 anins 50;Xis 58aninsSl;Xi558 anins
52;Xis 58 anins 53;Xi358 aninsS4;Xis 58 anins 55;Xis58 anins 56;Xi858
anins57;Xi358 anin558;Xi358 aninsS9;Xi558anins60;Xis58 anins61;X
i358 2;Xis 58 anin363;Xis 58 anins64;XisS8anins65;Xis 58 anins
W0 2016/110584
66;Xis 58 anins 67;X1358 anins68;Xis 58 anin569;Xis 58 anins70;Xis 58
anins 71;Xis 58 anins 72;Xi35821nins73;Xis 58 anins74; Xis 58 anins75;X
i558 anins76;Xis 58anins77;Xi358 anins78;Xis 58 andY is 79;XisS8 anins
80;Xi558 anins 81;Xis 58 anins 82.;Xi558 deis 83; Xis 58 anin584;Xi558
anins 85;Xis 58 anins 86;Xis 58 anins 87;Xi358 deis 88; Xis 58 anins 89;X
is 58anins90;Xis58anins91;Xis58 2;Xi858 andY is 93;Xis58anins
94;Xis 58 andY is 95;Xis 58 anins 96; Xis 58 anins 97; Xis 58 and Y is 98;Xis 58
anins 99;Xis 58 anins 100;Xis 58 andY is s 58 deis 102; Xis 58 anins
103;Xis 58 anins 104;Xis 58 anins 105;Xis 58 anins s 58 anins 107;Xis
58 anins 108;XisSSanins 109;Xis$8 anins 110;Xis58 anins111;Xis58andY
is 112;Xis 58 anins 558 anins 114;XisS8 anins 115;Xi558 aninsll6;X
ins117;XisS8aninsll8;XisS8anins1193Xi358 anins 120;Xi558 and
Yis s 58 anins 122;Xis 58 anins 123;Xis 58 anins s 58 aninleS;
Xis 58 anin3126gXi358 anins 127;Xis 58 anins 128; Xis 58 anins 129;Xis 58
anins 130; Xis 58 anins 131;Xis 58 anins 132;Xis 58 anins 133; Xis 58 anins
134;Xis 58 anins 135;Xis 58 anins 136;Xis 58 deis 137; Xis 58 anins 138;Xis
58 anins s 58 anins 140;Xis 58 anins 141;Xi858anins 142;Xis 58 andY
is 143;Xis 58 anins 144;Xis 58 anins 145;Xis 58 anins 146;Xis 58 anins 147;X
isS8anins148;Xi558anins149;Xis58anins150;XisS8 anins 151;Xis 58 and
Yis 152;Xis 58 anins 153;Xis 58 anins 154;Xis 58anins155;Xis 58 anins 156;
Xis 58 anins 157;Xis 58 anins 158;Xis 58 deis 159; Xis 58 andY is 160; Xis 58
anins 161; Xis 58 anins 162;Xis 58 anins 163; Xis 58 anins 164;Xis 58 anins
165;Xis 58 anins 166;Xis 58 anins 167;Xis 58 anins 168;Xis 58 anins 169;Xis
58 anins 170;Xis 58 anins 171;Xis 58 anins 172;Xis 58 anins 173;Xis 58 andY
is 174;Xis 58 anins 175; Xis 58 anins 176;Xis 58 anins 177;Xis 58 anins 178;X
is 58 anins 179;Xis 58 anins 180;Xis 58 anins 181;Xis 58 anins 182;Xis 58 and
Yis 183;Xi358 anins 184;Xis 58 anins 185;Xis 58 anins 186;
nins1;XisS9andYis2;Xi559anins3;Xi559 anins4;XisS9 aninsS;
nins6;Xis59anins7;Xis5921deis8;XisS9anins9;XisS9anins
10;XisS9anins11;XisS9anins12;XisS9anins l3;XisS9anins l4;XisS9
anins15;XisS9anins16;XisS9anins17;Xi559anins18;XisS9anins19;X
is 59 aninsZO;Xis 59 1;Xis59 anins22;XiSS9 aninsZ3;Xi559anins
24;Xis 59 anins 25;Xis SQanin326;Xis 59 aninsZ7;XisS9 anins 28;Xi359
aninsZ9;Xis 59 anins 30;Xi859 anins31;Xis 59anins32;Xi559 anins33;X
isS9anins34;Xis 59 anins35;Xis 59 anins36gXiSS9anins37;Xis 59 anins
W0 2016/110584
38;Xis 59 anins 39;Xi559 anins40;XisS9anins4l; Xis 59anins42;XisS9
3;Xis59anins44;XisS9andYis45;XisS9andY is46;XisS9anins47;X
is59andYis48;XisS9anins49;XisS9anins 50;Xis 59 anins 51;XisS9anins
52;Xis 59 anins 53;Xis 59 aninsS4;XisS9anin855; Xis 59 aninsS6gXi559
anins57;Xis59anins58;XisS9anins59;XisS9andY is60;XisS9anin561;X
i559anins62;Xis59anins63;Xis59anins64;Xis 59anins65;Xi559 anins
66;Xis 59anins67;Xis 59anins68;Xis 59 anin569; Xis 59anins70;XisS9
anins71;Xis 59 anins72;XisS9 anins73;Xis 59andY is?4;XisS9 anins75;X
isSQanins76;Xis59anins77;Xis59anins78;Xis SQanins79;Xis59anins
80;Xis s 81;Xi359 anins 82;Xi3593nins 83; Xis59anins84;XiSS9
anins85;Xis59anins86;XisS9aninsS7;XisS9andY isS8;Xi559anins89;X
isS9anins90;Xi559anins9l;XisS9anins92;Xis 59anin593;Xis59 anins
94;XisS9anins95;Xis 59 anins96;XisS9anins97;XisS9anins98;XisS9
anins 99;Xis 59 anins 100;Xis 59 anins 101;Xis 59 deis 102; Xi359 anins
103;Xis 59 anins s 59 anins 105;Xis 59 anins 106;Xis 59 anins s
59anin3108;Xi359anins109;XisS9anins llO;Xis59anins111;Xi559andY
is 112;XisS9anins sSQanins114;Xis59anins 115;XisS9anins 116;X
is 59 anins 117;Xis 59 anins 118;Xis 59 anins 119;Xis 59 anins 120;Xis 59 and
Yis 121; Xis 59 anins 122;Xis 59anin3123;Xis 59 andY is 124;Xis 59 deis 125;
Xis 59 anins 126;Xis 59 anins 127;Xis 59 anins 128;Xis 59 anins129;XiSS9
anins 130; Xis 59 anins 131;Xis 59 anins 132;Xis 59 anins s 59 anins
134;Xi559aninsl35;XisS9anins136;Xi859311ins137;Xis59anins138;Xis
59 anins 139;Xis 59 anins I40;XisS9 anins 141;Xis59 anins 142;Xis 59de
is 143;Xis 59 anins 144;Xis 59 anins 145;Xis 59 anins 146;Xis 59 anins 147;X
is 59 anins 148;Xis 59 anins 149;Xis 59 anins 150;Xis 59 anins 151;Xis 59 and
Yis 152;Xis 59 anins 153;Xis 59 anins 154;Xis 59 anins 155;Xis 59 aninslS6;
Xis 59 anins 157;Xis 59 anins 158;Xis 59 anins 159;Xis 59anin5160;Xis59
anins161;Xi359anins162;Xis59anins163;XisS9anins164;Xis59anins
s 59 anins 166;Xis 59 anins 167;Xis 59 anins 168;Xis 59 anins 169;Xis
59 anins 170; Xis 59 anins 171;Xis 59 anins 172;Xis 59 anins 173;Xis 59 andY
is 174;Xis s175;XisS9a.nins176;XisS9anins177;Xis59 anins 178;X
is 59 anins 179;Xis 59 anins 180;Xis 59 anins 181;Xis 59 anins 182;Xis 59 and
Yis s 59 anins 184;Xis 59 anin3185;Xis 59 anins 186;
Xis60anins1;Xis60anins2;Xis60anins3;Xis60anins4;Xis60aninSS;
Xis60 anins 6;Xis60 anins7;Xis 60anins 8;Xis60anins 9;Xis60anins
W0 10584
;Xis60anins11;Xis60anins 12;Xi360anins 13; XiséO anins 60
anins 15;Xis 60 anins 16;XiséOanins 17;Xis60andY is 18;Xis60anins 19;X
is60aninsZO;Xis 60anins21;Xis 60 anin322;Xis60 anins 23;XiséOanins
24;Xis 60 aninsZS;Xis60aninsZ6;XiséOanin327; Xis 60 anin328;Xi360
aninsZ9;Xis60anins 30;Xis 60anins31;Xis6O anins32;Xis60anins 33;X
is60anins34;Xis 60anins35;Xis60anins36;Xis 60 anins37;Xi560anins
38;Xis60anins39;Xis60anins40;Xis60anins41;Xis60 anins42;Xis60
3;Xi360 anin544;Xis60 5;Xi560 anins46;Xis60 anins47;X
i360anins48;Xi560anins49;Xis60anin350gXis60 aninsSl;Xis60anins
52;Xis 60anins 60anins 60anins 55; Xis60 aninsS6;Xi560
aninsS7;Xis60 anin358;Xis60 aninsS9;Xis60anins60;Xis60 anins61;X
is602nins62;Xis60anin363;Xis60anins64;Xi360 aninséS;Xi360anins
66; Xis 60 and Y is 67; X is 60 and Y is 68; Xis 60 and Y is 69; Xis 6O andY is 70; X is 60
anins71;X1560anins72;Xis60anin_s73;Xis60 4;Xis60 anins 75;X
i560anins76;Xi560a11ins77;Xis60anins78;Xis60anins79;Xis60anins
80;Xis60anins 81;Xis 60anins 82;Xis60anins 83;Xi560 anins 84;Xis60
anins85;Xis60anins86;Xi360anins87;Xis60anins88;Xis60aninsS9;X
is 60anins90;Xis 60 anins 91;Xis60 anins 92;Xis 60 anins 93;Xis 60 anins
94;Xis 60anins 95;Xis 60anin596;Xi360anins97;Xis 60 anins98gXis60
anins 99;Xis 60 anins 100;Xis 60 anins 101;Xis 60 anins 102;Xis 60 anins
103;Xis 60 anins 104;Xis 60 anins 105; Xis 60 anins 106;Xis 60 anins 107;Xis
60anins108;Xis60anins109;Xis60anins110;Xi560anins111;Xis60andY
is 112;Xis60anins 113;Xis60 anins 114;Xis60 anins 115;Xis 60 anins 116;X
is 60 anins 117;Xis 60 anins 118;Xis 60 anins s 60anins 120;Xis60 and
Yis 121;Xis 60 anins 122;Xis 60 anins 123;Xis 60 anins 124;Xis 60 deis 125;
Xis 60 anins 126;Xis 60 anins 127;Xis 60 anins 128;Xis 60anins 129;Xis 60
anins 130; Xis 60 anins I31;Xis60 anins s 60 anins 133;Xis 60 anins
134;Xis60anins135;Xi360anins136;Xis60anins137;Xis60anins138;Xis
60 anins 139;Xis 60 anins 140;Xis60 anins 141;Xis 60 anins 142;Xis 60 andY
is 143;Xis 60 anins 144;Xis 60 anins 145; Xis 60 anins 146;Xis 60 anins 147;X
i860 anins 148;Xis 60 anins 149;Xis 60 anins 150;Xis 60 anins 151;Xis 60and
Yis 152;Xis 60 anins 153;Xis 60 anins 154;Xis 60 anins 155;Xis 60 anins 156;
Xis 60 anins 157;Xis 60 anins 158;Xis 60 anins 159;Xis 60anins 160;Xis 60
anins 161;Xis 60 anins 162;Xi560 anins 163;Xis 60 anins 164;Xis 60 anins
s 60 anins 166;Xis 60 deis 167; Xis 60 anins s 60 anins 169;Xis
W0 2016/110584
60anins 170;Xis 60 anins 171;Xis s 172;Xis 60 anins 173;Xis 60 andY
is 174;Xis 60 anins 175;Xis 60 anins 176;Xis 60 anins 177;Xis 60 anins 178;X
is 60 anins 179;Xis 60 anins 180;Xis 60 anins 181;Xis 60 anins 182;Xis 60 and
Yis 183;Xis 60 anins s60anins s60anins 186;
Xis61aninsl;Xis61aninsZ;Xis61anins3;Xis6lanins4;Xis61aninsS;
Xis61anins6;Xis61anins7;Xi361anins8;Xis61anins9;Xiséla.nins
;Xis61aninsll;Xis61aninsl2;Xis61anin513;Xis61aninsl4;Xis61
aninslS;Xis61aninsl6;Xi561anins17;Xis6lanin318;Xis61aninsl9;X
i561aninsZO;Xis61anin321;Xis61aninsZ2;Xis61anins23;Xi361anins
24;Xis61anin525;Xis61anins26;Xis61aninsZ7;Xi361anin528;Xis61
anin329;Xis61anins30;Xis61anins31;Xis61anins32;Xis61anins33;X
i561 anins34;Xis 61 anins 35;Xi361 andY1336;Xis61 anins37;Xi361 anins
38;Xis61aninsS9;Xis61anins4O;Xis61anins41;Xis61anins42;Xi561
anins43;Xis61anins44;Xis61anins45;Xis61anins46;Xis61anins47;X
is6lanins48;Xis61anins49;Xis61aninsSO;Xis6lanins51;Xis61 anins
52;Xis61anin353;Xi561aninsS4;Xis61aninsSS;Xis6laninsS6;Xi861
aninsS7;Xis61aninsSS;Xis6l anins59;Xis6l anins60;Xis61 anin861;X
is61anins62;Xi561anins63;Xis61anin364;Xis6lanins65;Xis61anins
66;Xi561anins67;Xis6lanins68;Xis61anins69gXi361anins70;Xis61
anins7l;Xis61anins72;Xis61anins73gXi361anins74;Xis61anins75;X
is61anins76;Xis6lanins77;Xis61anins78;Xis61anins79;Xis61anins
61 anins 81;Xis 61 anins 82;Xis 61 anin883;Xis 61 anins 61
anin585;Xis61anins86;Xis61aninsS7;Xis6lanins88;Xis61anins89;X
i561anins90;Xis61anins9l;Xis61anins92;Xis61anin593;Xis61anins
94;Xi361anins95;Xis61anins96;Xis61anin397;Xis61anins98;Xis61
anins99;Xis6l anins 100;Xis61 anins 101;Xis6l anins 102;Xis61 anins
103;Xis 61 anins 104;Xis 61 anins 105;Xis 61 anins 106;Xis 61 anins 107;Xis
61 anins 108;Xis61 anins 109;Xis 61 aninsllO;Xis61 aninsllI;Xis 61 andY
is 112;Xis61 aninsll3;Xis61 anins 114;Xis61 anins 115;Xis61 anins116;X
i361 anins 117;Xis61 anins 118;Xis61 aninsll9;Xis 61 anins s 61 and
Yis 121;Xis 61 anins 122;Xis 61 anins 123;Xis 61 anins 124;Xis 61 anins 125;
Xis 61 anins s 61 anins 127;Xis 61 anins 128;Xis 61 anins 129;Xis 61
anins 130;Xis 61 anins 131;Xis 61 anins 132;Xis 61 anins 133;Xis 61 anins
134;Xis61 anins 135;Xis61 anins 136;Xis 61 anins 137;Xis 61 anins 138;Xis
61 anins 139;Xis 61 anins 140;Xis 61 anins 141;Xis 61 anins 142;Xis 61 andY
W0 2016/110584 2016/050308
is 143;Xis 61 anins s 61 anins 145;Xis 61 anins 146;X is 61 anins 147;X
is 61 anins 148;Xis 61 anins 149;Xis 61 anins 150;Xis 61 and Yis 151;Xis 61 and
Yis 152;Xis61 anins 153;Xis61 anins 154;Xi561 andY 13155; Xis 61 anins 156;
Xis 61 anins 157;Xis 61 anins s 61 anins s 61 anins 160;Xis 61
anins 161;Xis 61 anins 162;Xis 61 anins 163;Xis 61 anins 164; Xis 61 anins
165;Xis 61 anins 166;Xis 61 anins 167;Xis 61 anins 168;Xis 61 anins 169;Xis
61 anins 170;Xis61 anins 171;Xis 61 anins 172;X1561 andY is 173;Xi561 andY
is 174;Xis 61 anins 175;Xis 61 anins 176;Xis 61 anins 177;Xis 61 anins 178;X
is 61 anins 179;Xis 61 anins 180;Xis 61 anins 181;Xis 61 anins 182;Xis 61 and
Yis 183;Xis 61 anins 184;Xis 61 anins 185;Xis 61 andY is 186;
Xis62anins1;Xis62anin32;Xis62anins3gXiS62anins4;Xis62aninsS;
Xis 62 anins 6;Xis62anins7;Xis62aninsS;Xis62 anins 2 anins
623nins11;Xis623nins12;Xis623ninsl3; Xis62aninsl4;Xis62
anins 15;Xis 62 anins 16;Xis62 anins 17;Xis 62 anins 18;Xis62 anins 19;X
i562 aninsZO;Xis 62 anins21;Xis62 anins22;Xis62 anin523;Xi562 anins
24;Xis62 anin325;Xis62 aninsZ6;Xis62anin327;Xis62andY1328;Xi362
anin529;Xis62 anins30;Xis62anins31;Xis62 anin532;Xis62 anins33;X
is 62 anins 34;Xis 62 anins35;Xis62 anins36;Xis 62 anins 37;Xis 62 anins
38;Xis62anins 39;Xis62 anins40;Xis62 1;Xis62 anins42;X1562
anins43;Xis62 anins44;Xis62anins45;Xis62 6;Xis62anins47;X
is62anins48;Xis62 anins49;Xis62 anins50;Xis 62aninsSl;Xis62 anins
52;Xis62anins 53;Xis62 anins 54;Xis62 anin555;Xis62 anins 56;Xis62
aninsS'I;Xis62anins58;Xis62anin559;Xi562anins60;Xis62 anins61;X
is 62 anin362;Xis 62 anins63;Xis62 anins64;Xis 62 anins 65;Xis 62 anins
66;Xis62 anins67;Xis62 anins68;Xis62anins 69;Xis62 anins 70;Xis62
anins71;Xis62 anins72;Xis62 anins 73;Xis62anins 74;Xis62anins7S;X
is62anins76;Xis62anins77;Xis62 anins78;Xis62anins79;Xi562 anins
80;Xis62 anin381;Xis6Zanins 82;Xis62 anins 83;Xis623nins 84;Xis62
anin385;Xis62 anins86;Xis62 anins 87;Xis62anins88;Xis62 anins89;X
i562anins90;Xis 62 anins9l;Xis62 anins92;Xi362anin593;Xis 62anins
62 andYis95;Xis62anins96;Xis62 anins97;Xis62anins98;Xis62
anins 99;Xis 62 deis 100; Xis 62 anins s 62 deis 102; Xis 62 anins
103;Xis 62 anins 104;Xis 62 anins 105;Xis 62 anins 106;Xis 62 anins s
62anins 108;Xis 62 anins 109;Xis62 anins 110;Xis 62 anins 111;Xis 623ndY
is 112;Xis 62 anins 113;Xis 62 anins 114;Xis 62anins 115;Xis62 anins116;X
W0 2016/110584
is 62 anins 117;Xis62 anins 118;Xis62 anins 119;Xis 62 anins 120;Xis62 and
Yis 121;Xis 62 anins 122;Xis 62 anins 123;Xis 62 anins 124;Xis 62 deis 125;
Xis 62 anins 126; Xis 62 andY is 127; Xis 62 anins 128;X is 62 anins 129; Xis 62
anins 130;Xis 62 31;Xis62anins132;Xis62anins133;Xis62anins
134;Xis 62 anins 135;Xis 62 anins 136;Xis 62 deis 137; Xis 62 anins s
62 anins 139;Xis 62 anins 140;Xis 62 anins 141;Xis 62 anins 142;Xis 62 andY
is s 62 anins 144;Xis 62 anins 145;Xis 62 anins 146;Xis 62 anins 147;X
is 62 anins 148;Xis 62 anins 149;Xis 62 anins 150;Xis 62 aninslSl;Xis 62 and
Yis 152;Xis 62 anins 153;Xis62 anins 154;Xis 62 anins 155;Xis62 deis 156;
Xis 62 anins 157;Xis 62 anins 158;Xis 62 anins 159;Xis 62 anins 160;Xis62
anins 161;Xis 62 anins 162;Xis 62 anins 163; Xis 62 anins 164;Xis 62 anins
s 62 anins 166;Xis 62 anins 167;Xis 62 anins 168;Xis 62 anins 169;Xis
62 aninS 170;Xis 62 anins 171;Xis 62 anins 172;Xis 62 anins 173;Xis 62 andY
is 174;Xis 62 anins 175;Xis62 anins 176;Xis62 anins 177;Xis 62 anins 178;X
is 62 anins 179;Xis 62 anins 180;Xis62 anins 181;Xis62 anins 182;Xis 62 and
Yis 183;Xis 62 anins 184;Xis 62 anins 185;Xis 62 anins 186;
Xis63 anins 1;Xis63 anin52;Xis63 ;Xis63 anins4;Xis63 aninsS;
Xi563 anins 6;Xis 63 anins 7;Xis63 anins 8;Xis63 anins 9;Xis63 anins
63 anins 11;Xis63 anins 63 anins 63 anins 14;Xis63
anins 15;Xis63 anins16;Xis63anins17;Xis63anins18;Xi563 anins 19;X
i563 aninsZO;Xis63anin521;Xis63 anin522gXis63 anin523;Xis63 anins
24;Xis63 anins25;Xis63 anins26;Xis63 anin327;Xis 63 anins 28;Xis63
aninsZ9;Xis63 anins30;Xis63anins31;Xis63 anins32;Xis63 anins33;X
i563 anins34;Xis 63 aninsSS;Xi863 6;Xis 63 anins37;Xis63 anins
38;Xis63 anins39;Xis63 anins40;Xis63 anins4l;Xis 63 anins42;Xis63
anins43;Xis63 anins44;Xis63 anins45;Xis63 anins46;Xis63 anins47;X
i363 anins48;Xis 63 9;Xis63 aninsSO;Xis 63 aninsSl;Xis63 anins
52;Xis63 aninsS3;Xis63 anins 54;Xis63 anins 55;Xis 63 aninsS6;Xis63
aninsS7;Xis63 anin358;Xis63 aninsS9;Xi363 anins60;Xis63 anins6l;X
is63 anins62;Xis63 anins63;Xis63anins64;Xi563anins65;Xis63 anins
63 anins67;Xis63 anins68;Xis63 anins69;Xis 63 anins70;Xis63
anins71;Xi563 anins72;Xis63 anins73;Xis63 anins74;Xis63 anins75;X
i563 anins76;Xis63 7;Xis63 anins78;Xis63 anins79;Xis63 anins
80; Xis 63 deis 81; Xis 63 anins 82;Xis63 anins 83;Xis 63 anins 84;Xis63
anins 85;Xis 63 anins 86;Xis63 anins87;Xis63 anins 88;Xis 63 anins 89;X
W0 2016/110584
is63 anins90;Xis63 anins91;Xis63 anins92;Xis63 anins 93;Xis63 anins
94;Xis 63 anins 95;Xis63 anins96;Xis63 anins97;Xis63 anins98;Xis63
anins 63 anins 100;Xis 63 anins 101;Xis63 anins 102;Xis63 anins
103;Xis 63 anins104;Xis63 anins 105;Xis 63 anins 106;Xis 63 anins 107;Xis
63 anins 108;Xis63 aninle9;Xi863anins110;Xis63 anins111;Xis63 andY
is 112;Xis 63 l3;Xis63 anins114;Xis 63 anins 115;Xis 63 anins116;X
i563 anins 117;Xis63 anin3118;Xis 63 l9;Xis 63 anins s 63 and
;Xis63 anins 122;Xis 63 anins 123;Xis 63 andY is 124; Xis 63 anins 125;
Xis 63 anins s 63 anins 127;Xis 63 anins 128;Xis 63 anins 129;Xis 63
anins 130;Xis 63 anins131;Xis63 anins 132;Xis 63 deis 133; Xis63 deis
134; Xis 63 anins 135;Xis 63 anins 136;Xis 63 deis 137; Xis 63 anins 138;Xis
63 anins 139;Xis 63 anins 140;Xis 63 anins 141;Xis 63 anins 142;Xis 63 andY
is 143;Xis 63 anins144;Xis63 anins 145;Xis 63 anins 146‘,Xis 63 anins 147;X
is 63 anins 148;Xis63 anins s 63 anins 150;Xis 63 51;Xi563 and
Yis 152;Xis 63 anins 153;Xis 63 anins 154;Xis 63 anins 155;Xis 63 anins 156;
Xis 63 anins 157;Xis 63 anins 158;Xis 63 anins 159;Xis 63 anins 160;Xis 63
anins 161; Xis 63 anins 162; Xis 63 deis 163; Xis 63 anins 164;Xis 63 anins
165;Xis 63 anins 166;Xis 63 anins 167;Xis 63 anins 168;Xis 63 anins169;Xis
63 anins 170;Xis 63 anins 171;Xis 63 anins 172;Xis 63 anins 173;Xis 63 andY
is 174;Xis 63 deis 175; Xis 63 anins s 63 anins 177;Xis 63 anins 178;X
is 63 anins 179;Xis63 anins 180;Xis 63 anins 181;Xis 63 anins 182;Xis 63 and
Y13183;Xis63 aninslS4;Xis63 anins l85;Xis63 deis 186;
Xis64anins1;Xis64anin32;Xis64anins3;Xis64anins4;Xis64anins5;
Xis 64anins6;Xis64anins7;Xis64anins 8;Xis643nins 9;Xis64anins
10;Xis64anins11;Xis64anins12;Xis64anins13;Xis64anins14;Xi364
anins 15;Xis64anins 16;Xis64anins l7;Xis64anin518;Xi364anins19;X
is64andYi320;Xis64anins21;Xis64anins22;Xis64aninsZ3;Xis64 anins
24;Xis 64 anin325;Xis64 anins26;Xis64anin527;Xis64anins 28;Xis64
9;Xis 64 anins30;Xis64andYi531;Xis64anins32;Xis64anins33;X
is64 anins34;Xis64 anins 35;Xis64andYis36;Xisfi4aninsS7;Xis64 anins
38;Xis64anins39;Xis64anins40;Xi564anins41;Xis64anins42;Xis64
anins43;Xis 64 anins44;Xis64 anins 45;Xis 64anins46;Xis 64 anins47;X
is64anins48;Xisé4anins49;Xis64anins50;Xis64anin351;Xis64anins
52;Xis64aninsS3;Xis 64anins 64anins 55;Xi564anins 56;Xis64
anins57;Xi564anins 58;Xis64anins 59;Xis64anins60;Xis64anins6l;X
W0 10584
is64anins62;Xi564anins63;Xis64anins64;Xis64 anins65;Xis64anins
66;Xis64a.nins67;Xis 64anins68;Xis64anins69; Xis 64anins 70;Xis64
anins71;Xis 64 anins72;Xis 64anins 73;Xis 64 anins74;Xis64anins 75;X
is64anins76;Xi364anins77;Xis64anins78;Xis 64 anins79;Xis64anins
80;Xis64anins 81;Xis64deis82;Xis64anins83; Xis 64anins 84;Xi564
anins85;Xis64aninsS6;Xis64anins 87;Xis64andYi388;Xi364anins89;X
in590;Xis 64anins91;Xi_s 64anin392;Xis64 anins93;Xis64anins
94;Xis64anins95;Xis s96;Xis64anins97; Xis 64anins 98;Xis64
anins 99;Xis 64 anins 100; Xis 64 anins 101;Xis64 anins 102;Xis 64 anins
103;Xis 64 anins s 64 anins 105;Xis 64 anins s 64 anins 107;Xis
64aninle8;Xis64anins109;X1's64a.nins110;Xis64anins 111;Xis64andY
is112;Xis64anins113;Xis64anins114;Xi364anins115;Xis64aninsll6;X
is 64 anins 117;Xis 64 anins118;Xis64anins 119;Xis 64 anins 120;Xi364 and
Yis s 64 anins 122;Xis 64 anins 123;Xis 64 andY is 124;Xis 64 deis 125;
Xis 64 anins 126;Xis64anins 127;Xis 64 anins 128;Xis 64anins 129;Xis64
anins 130;Xis 64 anins 131;Xis 64 anins 132;Xis64anins 133;Xis 64 anins
134;Xis 64 anins s 64 anins 136;Xis 64 anins 137;Xis 64 anins 138;Xis
64 anins 139;Xi364 anins 140;Xis 64anins 141;Xis 64 anins 142;Xis64 andY
is 143;Xis 64 anins 144;Xis 64 anins 145;Xis 64 anins 146;Xis64anins 147;X
is 64 anins 148;Xis 64 anins 149;Xi364 anins 150;Xis 64 anins 151;Xis 64and
Yis152;Xis64anins153;Xis64anins154;Xis64anins155;Xis64aninslS6;
Xis 64 anins s 64anins 158;Xis 64 anins s 64 anins 160;Xis64
anins 161;Xis 64 anins 162;Xis 64 anins 163;Xis 64anins 164; Xis 64anins
165; Xis 64 anins 166', Xis 64 anins 167;Xis 64 anins 168;Xis 64 anins 169;Xis
64anins 170;Xis 64anins 171;Xis 64anins 172;Xis 64 anins 173;Xis 64 andY
1's 174;Xis 64 anins 175;Xis 64 anins 176;Xis 64 anins 177;Xis 64 anins 178;X
is 64 anins179;Xi364anins180;Xis64anins181;Xis64andY1's182;Xis64and
Yis 183;Xis64anins184;Xis64anins185;Xis64anins 186;
Xis65anins1;Xis65anins2;Xis65anins3;Xis65anins4;Xi365 aninsS;
Xis65 anins 6;Xis65 anins7;Xis65 anins 8;Xis65 ;Xis 65 anins
;Xi565 anins 11;Xis 65 anins 12;Xis65 anins 13; Xis 65 anins 14;Xis65
anins 15;Xis65 anins 16;Xis65 anins 17;Xis65 anins18;Xis65 anins 19;X
is65 aninsZO;Xis65 aninle;Xis65 anins22;Xis65 aninsZ3;Xis65 anins
24;Xis65 anins 25;Xis65 aninsZ6;Xis65 anins27;Xis 65 anins 28;Xis 65
anin529;Xis65 0;Xis 65 anins 31;Xis65 anins32;Xis65 anin333;X
W0 2016/110584
1 38
i865 anins 34;Xis 65 anins35;Xis65 anins 36;Xis65 andY is 37;Xi365 anins
38;Xis 65 anins39;Xis65 anins40; Xis 65 anins41; Xis 65 anins42;Xis 65
anins43;Xis65 4;Xis 65 5;Xis65 andY i346; Xis65 anins47;X
i365 anins48;Xis 65 anins49;Xis 65 anins 50;Xis 65 andY is 51;Xis65 anins
52; Xis 65 anins 53;Xis 65 deis 54; Xis 65 deis 55; Xis65 aninsS6;Xis 65
aninsS7;Xis65 anins 58;Xi565 anins 59;Xis65 andY is 60; Xis65 anins6l;X
is65 anins62;Xi365 anins63;Xis 65 anins 64;Xis 65 anins 65;Xis65 anins
66; X is 65 andY is 67; Xis 65 andY is 68; X is 65 andY is 69', Xis 65 andY is 70; X is 65
anins71;Xis 65 anins72;Xis65 anins73;Xis65 anins74;Xis65 anins75;X
i565 anins 76;Xis 65 anins77;Xis65 anins78;Xis65 anins 79;Xis65 anins
80;Xis 65 anins 81;Xis 65 anins 82;Xis 65 deis 83; Xis65 anins 84;Xis65
anins 85;Xis65 anins 86;Xis65 and‘i’is 87;Xis65 deis 88; Xis 65 anins 89;X
is65 anins90;Xi565 1;Xis65 anins92;Xis 65 anins 93;Xis65 deis
94; Xis 65 deis 95; Xis65 anins 96;Xis 65 anins97; Xis 65 8; Xis65
andY is 99; Xis 65 andY is 100; Xis 65 andY is 101; Xis 65 andY is 102; X is 65 and Y is
103; Xis 65 anins 104;Xis 65 anins 105; Xis 65 deis 106; Xis 65 deis 107; Xis
65 anins 108;Xis 65 anins 109;Xis 65 anins 110;Xis 65 anins 111;Xis 65 andY
is 112;Xis 65 anins 113;Xis 65 anins 114;Xis65 anins 115;Xis 65 anins 116;X
is 65 anins 117;Xis 6Sanins 118;Xis 65 anins 119;Xis 65 anins 120;Xis 65 and
Yis 121;Xis 65 anins 122;Xis 65 anins 123;Xis 65 anins 124;Xis 65 anins 125;
Xis 65 deis 126; Xis 65 deis 127; Xis 65 anins 128; Xis 65 anins 129;Xis 65
anins 130;Xis 65 deis 131; Xis 65 anins 132;Xis65 anins 133;Xis 65 deis
134; Xis 65 deis 135; Xis 65 anins 136;Xis 65 andY is 137; Xis 65 deis 138; Xis
65 andY is 139; Xis 65 deis 140; Xis 65 anins 141;Xis 65 andY is 142;Xis 65 andY
is 143; Xis 65 deis 144; Xis 65 anins 145; Xis 65 anins 146;Xis 65 anins 147;X
is 65 anins 148;Xis 65 anins s 65 anins 150;Xis65 anins 151;Xis65 and
Yis 152; Xis 65 anins 153;Xis 65 anins 154;Xis 65 anins 155;Xis 65 anins 156;
Xis 65 deis 157; Xis 65 deis 158; Xis 65 anins 159; Xis 65 anins 160;Xis 65
anins 161;Xis 65 anins s 65 anins 163;Xis 65 anins 164; Xis 65 deis
165; Xis 65 anins 166;Xis 65 deis 167; Xis 65 andY is 168; Xis 65 andY is 169;Xis
65 anins 170;Xis 65 anins s 65 andY is 172;Xis 65 anins 173; Xis 65 andY
is 174; Xis 65 anins 175; Xis 65 anins 176; Xis 65 anins s 65 anins 178;X
is 65 anins 179;Xis 65 anins 180;Xis 65 anins 181;Xis 65 anins 182; Xis 65 and
Yis 183; Xis 65 anins 184;Xis 65 anins s 65 2111in3186;
W0 2016/110584
Xis66anins1;Xis66anin52;Xis66anins3;Xis66anins4;Xisé6anins5;
Xis66 anins 6;Xis 66 anins7;Xis66anins8;Xis66 anins 9;Xi566anins
;Xis66 anins lngis 66 anins 12;Xis 66anins 13; Xis 66 anins 14;Xis66
aninslS;Xis66anins16;Xis66anins 17;Xis66anins18;Xis66anin319;X
is66anin520;Xis66anins21;Xis66anin322;Xis66 aninsZ3;Xi566anins
24;Xis 66anins 25;Xis66aninsZ6;Xis 66anin327; Xis 66 aninsZ8;Xi366
anin329;Xis66anins30;Xis66anins31;Xis66anin532;Xis66anins33;X
i366 anins34;Xis 66anins35;Xis66anins36;Xi566 anin537;Xis66anins
38;Xis66andYis39;Xis66anins40;Xis66anins4l; Xis66anins42;Xis66
anins43;Xis 66 anins44;Xis66 anins45;Xis66andYis46;Xis66 anins47;X
is66anins48;Xis66anins49;Xis66aninsSO;Xis 66 aninsSl;Xis66anins
52;Xis 66 anins 53;Xisé6aninsS4;Xis66 aninsSS; Xis66anins56;Xis66
anins57;Xis66 8;Xisé6 aninsS9;Xis66a.nins60;Xis66anins61;X
is66anins62;Xis66anin563;Xis66anin364;Xis66 anins65;Xis66anins
66;Xi566 anins 67;Xis66anins68;Xis 66anins 69; Xis66anins70;Xis 66
anins71;Xis66anins72;Xis66anins73;Xis66anins74;Xis66anins75;X
ins76;Xis66 anins77;Xis66anins78;Xis66 anins79;Xis66anins
66anins 81;Xis66anins82;Xis66 anin583;Xis66aninsS4;Xis66
anin385;Xis66 anin386;Xis66 anins 87;Xis66anins88;Xis66aninsS9;X
i366anins90;Xis66anins91;Xis66anins92;Xis66 3;Xi366anins
94;Xi366anins95;Xis66anins96;Xis66anins97;Xis 66anins98;Xis66
anins99;Xis 66 anins s 66 anins 101;Xis66 anins102;Xis 66 anins
103;Xis 66 anins 104;Xis 66 anins 105;Xis 66 anins 106;Xis 66 anins 107;Xis
66anins108;Xis66anins109;Xis66anins110;Xis66anins111;Xis66andY
Xi566anins11.3;Xis66anins114;Xi566adeis115;Xis66aninsll6;X
is66anins117;Xis663nins118;Xis66anins119;Xis66anins120;Xis66and
Yis 121;Xis 66 anins 122;Xis 66 anins 123;Xis 66 anins 124;Xis 66 anins 125;
Xis 66 deis 126; Xis 66 anins 127;Xis 66 anins 128;Xis 66 anins s 66
anins 130;Xis66anins 131;Xis66anins132;Xis66anins 133;Xis66 anins
134;Xis 66 anins 135;Xis 66 anins s 66 anins 137;Xis 66 anins 138;Xis
66 anins 139;Xis 66 anins 140;Xis 66anins 141;Xis66 anins s66 andY
is 143;Xis 66 anins 144;Xis 66 anins 145;Xis 66 deis 146; Xis 66 anins 147;X
i366 anins 148;Xis 66 anins 149;Xis 66 anins 150;Xis 66 anins 151;Xis66and
Yis 152;Xis 66anins s 66 anins 154;Xis 66 anins 155;Xi366 deis 156;
Xis 66 anins 157;Xis 66 anins 158;Xis 66 anins 159;Xis 66 anins 160;Xis 66
W0 2016/110584
deis 161; Xis 66 anins 162;Xis 66 anins 163;Xis 66 anins s 66 anins
165;Xis 66 anins 166;Xis 66 anins 167;Xis 66 anins 168;Xis 66 deis 169; Xis
66 anins 170;Xis66 anins 171;Xis 66 anins 172;Xis 66 andY is 173;Xis 66 andY
is s 66 anins 175;Xis 66 anins 176;Xis 66 anins 177;X is 66 anins 178;X
is 66 anins 179;Xis 66 anins 180;Xis 66 anins 181;Xis 66 and Yis 182;Xis 66 and
Yis 183;Xi366anins 184;Xis66anins185;Xis66anins 186;
nins1;Xis67anins2;Xis67anins3;Xisé'.’anins4;Xis‘67aninsS;
Xis67 anins 6;Xis67 anins7;Xis67 aninsS;Xis67 andY is9;Xis 67 anins
;Xis 67 anins 11;Xi367 anins 67anins 13; Xis67 anins 14;Xis67
anins 15;Xis67 anins 16;Xis 67 anins 17;Xis67 andY is 18;Xis67 anin319;X
is67 aninsZO;Xis67aninle;Xis67anin322;Xis67 anin523;Xi367 3.11in3
67 anins 25;Xis67 anins26;Xis67 7; Xis67 anins28;Xi567
anin329;Xis67 anins30;Xis67 anins31;Xis67 anins 32;Xis 67 anins33;X
i367anins34;Xis67andYis35;Xis67aninsS6;Xis67 anins37;_X_i367 anins
.15 67andYis39;Xis67anins4O;Xi367anins41;Xis67anins42;Xis67
3;Xis 67 anins44;Xis67 anins45;Xis67 anins 46;Xis 67 anins47;X
is67anins48;Xis67 anins49;Xis67 aninsSO;Xi567 aninsSl;Xis67 anins
52;Xis67anins 53;Xis 67 aninsS4gXis67 aninsSS; Xis67 aninsS6;Xis67
anins 57;Xi367 anins 58;Xis67 aninsS9;Xis67 anins 60;Xis67 anins61;X
i367anins62;Xis67anins63;Xis67anin364;Xis67 anins65;Xis67 anins
66;Xis67anins67;Xis67andYis68;Xis67anin869; Xis67 anins 70;Xis67
anins 71;Xis67 anins 72;Xis67 anins73;Xis67 anins74;Xis 67 anins 75;X
is 67anins76;Xis 67anins77;Xis67 anins78;Xis67 anins79gXis67anins
80;Xis 67 anins 81;Xis67 anins 82;Xi567 anins 67anins 84;Xi867
anins 85;Xis67 anins 86;Xis67anins 87;Xis67 anins 88;Xi367anins 89;X
i367 anins90;Xis67anins91;Xis67anin892;Xis67 anins93;Xis67anins
94; Xis67 S;Xis 67 anins96;Xis67 anins 97; Xis67 anins 98;Xis67
anins99;Xis67anins100;Xis67anins101;Xis67anins102;Xis67anins
103;Xis 67 anins 104;Xis 67 anins 105;Xis 67 anins 106;Xis 67 anins 107;Xis
s108;Xis67anins109;Xis67anins110;Xis67anins111;Xis67andY
is 112;Xis 67 anins 113;Xis 67 anins 114;Xis67 anins 115;Xis 67 anins 116;X
is 67 anins 117;Xis 67 aninsllS;Xis 67 anins 119;Xi567 anins 120;Xis67 and
Yis 121;Xis 67 anins 122;Xis 67 anins 123;Xis 67 anins 124;Xis 67 deis 125;
Xis 67 deis 126; Xis 67 anins 127; Xis 67 anins 128; Xis 67 anins 129;Xis 67
anins 130;Xis 67 anins 131;Xis 67 anins 132;Xis 67 anins 133;Xis 67 anins
W0 2016/110584
134;Xis 67 anins 135;Xis 67 anins 136;Xis 67 anins 137;Xis 67 anins 138;Xis
67 anins 139;Xis67 anins 140;Xis67 anins 141;Xis67 anins 142;Xis67 andY
is 143;Xis 67 anins s 67 anins 145;Xis 67 anins 146;Xis 67 anins 147;X
is 67 anins 148;Xis 67 anins 149;Xis 67 anins 150;Xis 67 anins 151;Xis 67 and
Yis 152;Xis 67 anins 153;Xis 67 anins 154;Xis 67 anins 155;Xis 67 anins 156;
Xis 67 anins 157;Xis 67 anins 158;Xis 67 anins s 67 anins 160;Xis67
anins 161;Xis 67 anins 162;Xis67 anins 163;Xis 67 anins 164;Xi367 anins
165;Xis 67 anins 166;Xis 67 anins 167;Xis 67 anins s 67 anin3169;Xis
67anins170;Xis67anins171;Xis67anins172;Xis67 anins 173;Xis 67 andY
is 174;Xis 67 anins 175;Xis 67 anins I76;Xis 67 anins 177;Xis 67 anins 178;X
i367 anins 179;Xis 67 aninslSO;Xis67 anins 181;Xis 67 anins 182;Xis 67 and
Yi3183;Xis 67anins 184;Xis 67anins 185;Xis 67anins 186;
Xis68 aninsl;Xis68 anins2;Xis68anins3;Xis68 anins4;Xis68anin35;
Xis68 anins 6;Xis68 anins 7;Xis68 anin38;Xi368 anin59;Xis 68 anins
10;Xis 68 anins 68 anins 12;Xis68 anins 13;Xis 68 anins 14;Xis68
anins15;Xi568anins16;Xi568anins17;Xis683nins18;Xis68aninsl9;X
i368 anins20;Xis68anin521;Xis68 Z;Xis68anins23;Xis68 anins
24;Xis 68 anin525;Xis 68 anins26;Xis 68 anins 27;Xis 68 anin528;Xis68
aninsZ9;Xis68 0;Xis68anins31;Xis68 2;Xis68 anins33;X
i568 anins34;Xis68anins35;Xis68anins36;Xis68anins37;Xis68 anins
38;Xis 68 anins 39;Xis68anins40;Xis68 anins41;Xis 68 anins42;Xis68
anins43;Xis68 anins44;Xis68anins45;Xis68 6;Xis68anins47;X
is68anins48;Xis68anins49;Xis68 anins 50;Xis683ninsSl;Xis68 anins
52;Xis68 anins 53;Xis68 aninsS4;Xis68 anins55;Xis68 anins 56;Xi368
aninsS7;Xis68 aninsSS;Xis68 aninsS9;Xis68 anin560;Xis68anins6l;X
1568 2;Xis68 anins63;Xis68 anins64;Xis68anins65;Xis68 anins
66;Xis 68 anins 67;Xis68 8;Xis68 anins69;Xi568anins70;Xis68
anins71;X1's68 anins72;Xi368 anins73;Xis68anins74;Xi568anins75;X
is68 anins 76;Xis 68 anins77;Xis68 anins 78;Xis68anins79;Xis68 anins
80;Xis 68 anins 81;Xis 68 anins 82;Xis68 anin383;Xi568anins 84;Xi568
anin385;Xis68 anin586;Xis68anins87;Xi568 anin388;Xis68aninSS9;X
i568 anins90;Xis68 anins9l;Xis68 anins92;Xis68anins93;X1568 anins
94;Xis68 5;Xis68 anins96;Xis68 anins97;Xis68anins98;Xis68
anins99;Xis68anins100;Xis68anins101;Xis68anins102;Xis68anins
103;Xis 68 anins 104;Xis 68 anins 105;Xis 68 anins 106;Xis 68 anins 107;Xis
W0 20161110584
68 anins 108;Xis 68 anins 109;Xis68 anins 110;Xis 68 andY is 111;Xis68 andY
isllZ;Xis 68 aninS 113;Xis 68anins 114;Xis68 anins 115;Xis 68 anins 116;X
is 68 aninsll7;Xis 68 aninsllS;Xis 68 anins 119;Xis 68 anins 120;Xis 68 and
Yis 121;Xis 68 anins s 68 anins 123;Xis 68 andY is 124; Xis 68 anins 125;
Xis 68 anins126;Xis 68 anins 127; X is 68 anin5128;Xis 68 anins 129; Xis 68
anins 130;Xis 68 anins 131;Xis 68 anins 132;Xis 68 anins s 68 anins
134;Xis 68 anins I35;Xis 68 anins136;Xis68anins137;Xis 68 anins 138;Xis
68 anins 139;Xis 68 anins 140;Xis 68 anins 141;Xis 68 andY is 142;Xis 68 andY
is 143;Xis 68 anins 144;Xis 68 anins 145;Xis 68 anins 146;Xis 68 anins 147;X
is 68 anins 148;Xis 68 anins 149;Xis68 anin3150;Xis 68 anins 151;Xis 68 and
Yis 152;Xis 68 anins 153;Xis 68 anins 154;Xis 68 andY is 155;Xis 68 anins 156;
Xis 68 anins 157;Xis 68 anins 158; Xis 68 anins 159;Xis 68 anins 160;Xis 68
anins161;Xis68anins162;Xi3688nins163;Xis68anins164;Xis68anins
165;Xis 68 anins 166;Xis 68 anins 167;Xis 68 anins 168;Xis 68 anins 169;Xis
68 anins 170;Xis 68 anins s 68 anins 172;Xis 68 anins 173;Xis 68 andY
is 174;Xis 68 anins 175;Xis 68 anins 176;Xis 68 anins 177;Xis 68 anins 178;X
is 68 anins 179;Xis68 anins 180;Xis 68 anins 181;Xis 68 anins 182;Xis 68 and
Yis 183;Xis 68 anins 184;Xis 68 anins 185;Xis 68 deis 186;
Xis69anins1;Xis693.deisZ;Xis69aninsS;Xis69anins4;Xis69anins5;
Xis69anins 6;Xis69 anins7;Xis69anins 9 anins 9;Xis69 anins
;Xis69 anins 11;Xis69 anins 12;Xis69 deis 13; Xis69 anins l4;Xis69
aninslS;Xi369anins16;Xis69anins17;Xis69anins18;Xis69anins19;X
ins20;Xis69aninle;Xis69 aninsZ2;Xis69 anin523;Xis69 anins
24;Xis69anin525;Xis69 anins26;Xi369 aninsZ7;Xis69anins28;Xis69
aninsZ9;Xis69 anins30;Xis69anins31;Xis69anins32;Xis69anins33;X
is69 anins34;Xis69anins35;Xis69anin336;Xis69 7;Xis69anins
69anins 39;Xis69anins40;Xis69anins41;Xis69 anins42;Xis69
anins43;Xis 69 anins44;Xis69anins45;Xis 69anins 46;Xis69 anins47;X
is69anins48;Xis69anins49;Xis69aninsSO;Xis69aninsSl;Xis69 anins
52;Xis69 anins 53;Xis69anins 54;Xis 69anins 55;Xis69 anins 56;Xis69
anins 57;Xis 69 anin358;Xis 69 anins 59;Xis69anins60;Xis69 anin361;X
iséQanins62;Xis69anins63;Xis69anins64;Xis69anins65;Xis s
66;Xis69anins 69 8;Xis69 anins69gXis69anins 70;Xis69
anins7l;Xis69anins72;Xis69anins73;Xis69anins74;Xis69 anins75;X
1569 anins76;Xis69 anins77;Xis69 anins78;Xis69anins79;Xis 69anins
W0 2016/110584
80;Xis 69anin381;Xis69anins 69anins 83;Xis 69anins 84;Xis69
anins85;Xis69anins86;Xis69 anins87;Xis69anins 88;Xis69anin589;X
is69anins90;Xis 69anins91;Xis69anins92;Xis69anins93;Xi369anins
94;Xis 69anin595;Xis 69anins96;Xis69anins97;Xis 69anins98;Xis69
anins 99;Xis 69 anins s 69 deis 101; Xis 69 anins 102;Xis 69 anins
s 69 anins 104;Xis 69 anins 105;Xis 69 anins 106;Xis 69 anins 107;Xis
69anins108;Xis69anins109;Xis69anins110;Xis69anins111;Xi569andY
is]12;Xi569 3.11in5 113;Xis 69 anins 114;Xis 69 anins s 69 anins 116;X
is 69 anins 117;Xis 69 lS;Xis s 119;Xis 69 anins s 69and
Yis s 69 anins 122;Xis 69 anins 123;Xis 69 anins 124;Xis 69 deis 125;
Xis 69 anins 126; Xis 69 anins 127;Xis 69 anins 128;X is 69 anins 129;Xis 69
anins 130;Xis 69 anins 131;Xis 69 anins 132;Xis 69 anins 133;Xi369 anins
134;Xis 69 anins 135;Xis 69 anins 136;Xis 69 anins 137;Xis 69 anins 138;Xis
69anins 139; Xis 69 anins 140;Xis 69 anins 141;Xis 69 anins142;Xis69andY
is s 69 anins I44;Xis 69 anins 145;Xis 69 anins 146;Xis 69 anins 147;X
is 69 anins 148;Xis 69 anins 149;Xis69 anins 150;Xis 69 anins 151;Xis 69 and
Yis 152;Xis 69 anins 153;Xis 69 anins 154;Xis 69 anins 155;Xis 69 deis 156;
Xis 69 anins 157;Xis 69 anins 158; Xis 69 anins 159;Xis69 anins160;Xis69
anins 161;Xis 69 anins 162;Xis 69 anins 163;Xis 69 deis 164; Xi369 anins
165;Xis 69 anins 166;Xis 69 anins l67;Xis 69 anins 168; Xis 69 anins 169;Xis
69 anins 170;Xis 69 anins 171;Xis 69 anins 172;Xis 69 anins 173;Xis 69 andY
is s 69 anins s 69 anins 176;Xis 69 anins 177;Xis 69 anins 178;X
is69anins 179;Xis 69 anins 180;Xis 69 anins 181;Xis 69 anins 182;Xis 69 and
Yisl83;Xis 69 anins 184;Xis69 anins 185;Xis 69anins 186;
Xis70anins1;Xis70anins2;Xis70anins3;Xis70anins4;Xis70aninss;
Xis70anins6;Xis70 anins7;Xis70anins8;Xis70 anins9;Xis70anins
lO;Xis70anins11;Xis70anins12;Xis70anins13;Xis70anins14;Xis70
anin515;Xis70anins 16;Xis70anins l7;Xis70anins 18;Xis70anins19;X
is70anin520;Xis70aninle;Xis 7Oanins22;Xis70anin523;Xis70 anins
24;Xis70anin525;Xis70aninsZ6;Xis70aninsZ7;Xis70 anins 28;Xis70
anin529;Xis70anins3O;Xis7Oanins31;Xis70anins32;Xis70anins33;X
is 70anins34;Xis70anins35;Xis70auins36;Xis70anins37;Xis70 anins
38;Xis70 anins 39;Xis 70anins40;Xis70anins41;Xis70anins42;Xis70
andYis43;Xis70anins44;Xis70anins45;Xis70anins46;Xis70anins47;X
is70anins48;Xis70anins49;Xis70anins 50;Xis70aninsSl;Xis70 anins
W0 2016/110584
52;Xis 70 anins 53;Xis 70 anins 54;Xis 70 deis 55; Xis 70 6;Xis70
anins 70 anins 58;Xis 70 anins 70 andY is60;Xis 70 anins 61;X
i370 anins 62;Xis70 anins 63;Xis 70 anins64;Xis70 andY is 65;Xis70 anins
66;Xis70anins67;Xis 70anins68;Xis70anins69; Xis70 anins70;Xis70
anins71;Xis 70 anins72;Xis70 anins 73;Xis 70 andY is 74; Xis 70 anins 75;X
i570anins 76;Xis 70 anins77;Xis 70 anins78;Xis70 andY is 79;Xis70 anins
80; Xis 70 andY is 81;Xis 70 anins 82; Xis 70 anins 83; Xis 70 andY is 84; Xis70
anins 85;Xis 70 anins 86;Xis70 anins 87;Xis70 S; Xis70 anins 89:X
is 70 anins 90;Xis 70 anins9l;Xis70anins 92;Xis 70 andY is93;Xis7O anins
94;Xis 70 anins 95; Xis 70 anins 96;Xis 70 anin597; Xis 7O anins98;Xis 70
anins 99;Xis 70 deis 100; Xis 70 andY is 101; Xis 70 deis 102; Xis 70 anins
103;Xis 70 anins 104;X1's 70 anins 105;Xis 70 anins 106;Xis 70 anins 107;Xis
70 anins 108;Xis 70 anins 109;Xis 70 anins 110;Xis70 anins 111;XiS70 andY
is 112;Xis 70 anins 113;Xis 70 anins 114;Xis 70 anins s 70 anins 116;X
is 70 anins 117;Xis70anins 118;Xis70anins 119;Xis 70 anins s 70and
Yis 121; Xis 70 anins 122; Xis 70 anins 123;Xis 70 andY is 124; Xis 70 anins 125;
Xis 70 deis 126; Xis 70 deis 127; Xis 70 deis 128; Xis 70 anins 129; Xis 70
anins 130;Xis 70 anins 131;Xis 70 anins 132;Xis 70 anins 133;Xis 70 anins
134;Xis 70 anins s 70 anins 136; Xis 70 anins 137; Xis 70 anins 138;Xis
70 anins 139;Xis 70anins 140;Xis 70 anins s70 anins 142;Xis 70 andY
is 143; Xis 70 anins 144;Xis 70 deis 145; Xis 70 anins 146;Xis 70 anins 147; X
is 70 anins 148;Xis 70 anins 149;Xis 70 anins s 70 anins 151;Xis 70 and
Yis 152;Xis 70 anins 153;Xis 70 anins 154;Xis 70 anins 155;Xis 70 anins 156;
Xis 70 deis 157; X is 70 andY is 158; Xis 70 andY is 159; X is 70 andY is 160; Xis 70
anins 161;Xis 70 deis 162; Xis 70 anins 163; Xis 70 anins 164;Xis 70 anins
165;Xis 70 andY is 166; Xis 70 deis 167; Xis 70 andY is 168; Xis 70 anins 169;Xis
70 anins 170;Xis 70 anins 171;Xis 70anins 172;Xis 70 deis 173; Xis 70 andY
is 174; Xis 70 anins 175; Xis 70 anins 176;Xis 70 anins 177;Xis 70 anins 178;X
is 70 anins 179;Xis 70 anins 180;Xis 70 anins 181;Xis 70 deis 182; Xis 70 and
Yis 183;Xis 70 anins 184;Xis 70 anins 185;Xis 70 deis 186;
Xis71 anins 1; Xis7l anin52gXis7l anins 3;Xis71 anins4;Xis 71 aninsS;
Xis 71 anins 6;Xis 71 anins 7; Xis 71 anins 8;Xis7l anins 9; Xis 71 anins
;Xis71 anins 11;Xis71 anins 12;Xis71 anins 13;Xis71 anins 14;Xis7l
anins 15;Xis 71 anins 16;Xis 71 anins 17;Xis71 anins 18;Xis 71 anins 19;X
is71 anin320;Xis 71 aninle;Xis 71 aninsZZ; Xis71 andY1323;Xis 71 anins
W0 2016/110584 2016/050308
24;Xis71aninsZS;Xis71aninsZ6;Xis71aninsZ7;Xis71aninsZ8;Xis71
aninsz9;Xis71anins30;Xis7lanins31;Xis71anins32;Xis71anins33;X
is71anins34;Xis71anins35;Xis71anins36;Xis71anins37;Xis7lanins
38;Xis71anins39;Xis71anins40;Xis71anins41;Xis71anins42gXis71
anins43;Xis71anins44;Xis7lanins45;Xis7lanins46;Xis7lanins47;X
is 71 anins48;Xis 71 anins49;Xis7l aninsSO;Xis71 aninsSl;Xis7l anins
52;Xis 71 aninsSS;Xis71 aninsS4;Xis 71 anins 55;Xis 7‘1 anins56;Xis71
anins 57;Xis71 anins 58;Xis 71 anins 59;Xis 71 anins60;Xis 71 anins61;X
is7lanins62;Xis71anins63;Xis71aninsG4;Xis71anins65;Xis71 anins
66;Xis71anins67;Xis71 anins68;Xis71anins69;Xis71anins70;Xis71
anins71;Xis71 anins72;Xis71anins73;Xis7lanins74;Xis71anins75;X
is71anins76;Xis71anins77;Xis71anins78;Xis71anins79;Xis71anins
80;Xis71andY1581;Xis71anin382;Xis71anin583;Xis71aninSS4;Xis71
anins85;Xis7laninsS6;Xis7laninsS7;Xis71aninsSS;Xis7lanins89;X
i371 anins 90;Xis 71 anins91;Xis 71 aninsQZ;Xis71 3;Xis 71 anins
94;Xis 71 anins95;Xis7l anins96;Xis71 7;Xis 71 anins98;Xis71
anins 99;Xis 71 anins 100;Xis 71 anins 101;Xis71 anins 102;Xis 71 anins
103;Xis 71 anins 104;Xis71 anins 105;Xis71 anins106;Xis71aninle7;Xis
71 anins 108;Xis7l anins 109;Xis71 anins s71 anins 111;Xis71 andY
is 112;Xis71 anins 113;Xis71 I4;Xis7l anins 115;Xis71 aninsll6;X
i571 anins 117;Xis71 anin5118;Xis71 andY15119;Xis 71 anins 120;Xis71 and
Yis 121;Xis71 anins 122;Xis 71 anins 123;Xis 71 anins 124;Xis 71 anins 125;
Xis 71 anins 126;Xis 71 anins 127; Xis 71 anins 128;Xis 71 anins s 71
anins 130;Xis 71 anins 131;Xis 71 anins 132;Xis 71 anins s 71 anins
134;Xis 71 anins 135;Xis 71 anins 136;Xis 71 anins 137;Xis 71 anins 138;Xis
71 anins 139;Xis7l anins 140;Xis 71 anins 141;Xis 71 anins 142;Xis 71 andY
is 143;Xis 71 anins 144;Xis 71 anins 145;Xis 71 anins 146;Xis 71 anins 147;X
is 71 anins 148;Xis 71 anins 149;Xis 71 anins 150;Xis 71 anins 151;Xis71 and
Yis 152;Xis 71 anins 153;Xis 71 anins 154;Xis 71 anins 155;Xis71 anins 156;
Xis 71 anins 157;Xis 71 andY is 158;Xis 71 anins 159;Xis 71 anins 160;Xis 71
anins 161;Xis 71 anins 162;Xis 71 anins 163;Xis 71 anins 164;Xis 71 anins
165;Xis 71 anins 166;Xis 71 anins s 71 anins 168;Xis 71 anins s
71 anins 170;Xis 71 anins 171;Xis 71 anins 172;Xis 71 anins 173;Xis 71 andY
is 174;Xis 71 anins 175; Xis 71 anins 176;Xis 71 anins 177; Xis 71 anins 178;X
W0 2016/110584
is 71 anins 179;Xis 71 anins 180;Xis 71 anins 181;Xis 71 anins 182;Xis 71 and
Yis s71 anins 184;Xis71 anins 185;Xis 71 andY is 186;
Xis72anins1;Xis72anins2;Xis72aninsS;Xis72anins4;Xis72aninsS;
Xis 72 anins 6;Xis72 anins7;Xis 72 aninsS;Xis72 anins 9;Xis72 anins
;Xis72 aninsll;Xis72 anins 12;Xis72 deis 13; Xis 72 anins l4;Xis72
anins15;Xis7Zanins16;Xis7Zanins17;Xis72anins18;Xis72aninsl9;X
is72anins20;Xis72 anin521;Xis7Zanin322;Xis72 3;Xis72 anins
24;Xis 72 andY is 25;Xis 72 anins 26;Xis72 anins 27; Xis72 anins28;Xis72
aninsZ9;Xis 72 anins 30;Xis72 anins31;Xis 72 anins32;Xis72 anins33;X
is72anins34;Xis72anins35;Xis72anins36;Xis72 anin537;Xis72 anins
38;Xis72 anins 39;Xis72 anins40;Xis72 anins41;Xis72 anins42;Xis72
anins43;Xis72 anins44;Xis72 anins45;Xis72 6;Xis 72 anins47;X
i572 anins48;Xis72 anins49;Xis72anins 50;Xis72 anins 51;Xis72anins
52;Xis 72 3;Xis72 anins 54;Xis72 S;Xis72 aninsS6;Xis72
anins 57;Xis 72 aninsSS;Xis72anins 59;Xis72 anins60;Xis 72 anins6l;X
is72 anins62;Xis72anins63;Xis72 4;Xis72 anins65;Xis72 anins
66;Xis72anins67;Xis 72 8;Xis72 anins69;Xis72 anins70;Xis72
anins71;Xis 72anins 72;Xis 72 anins 73;Xis 72 anins 74;Xis72 anins 7S;X
is 72anins76;Xis72 anins77;Xis72andYis78;Xis72anins79;Xis72 anins
80;Xis 72 anins 81;Xis 72 anins 82; Xis 72 anins 83;Xis 72 anins 84;Xis 72
anins 85;Xis72 anins 86;Xis72 anin587;Xis 72 anins 88;Xis 72 aninsS9;X
is 72anins90;Xis7Zanins91;Xis72 anins92;Xis72anins93;Xis72anins
94;Xis72 aninsQS;Xis72anins96;Xis72 anins97;Xis72anin598;X1572
anins99;Xis 72 anins 100;Xis 72 anins 101;Xis72 anins 102;Xis 72 anins
103;Xis 72 anins 104;Xis 72 anins 105;Xis 72 aninS 106; Xis 72 anins 107;Xis
72 anins 108;Xis72 anins 109;Xis72 lO;Xis72 anins 111;Xis 72 andY
is 112;Xis 72 anins 113;Xis 72 anins 114;Xis 72 anins 115;Xis 72 anins116;X
is72anins117;Xis72anins118;Xis72anins119;Xis72anins120;Xis72and
Yis 121;Xis 72 anins 122;Xis 72 anins 123;Xis 72 anins 124;Xis 72 deis 125;
Xis 72 anins 126; Xis 72 anins 127; Xis 72 anins 128;Xis 72 anins 129;Xis 72
deis 130; Xis 72 anins 131;Xis 72 anins 132;Xis 72 anins 133;Xis 72 anins
134;Xis 72 anins 135;Xis 72 anins 136;Xis 72 anins 137;Xis 72 anins s
72 anins 139;Xis 72 anins 140;Xis72 anins 141;Xis 72 anins 142;Xis 72 andY
is 143;Xis 72 anins 144;Xis 72 anins s 72 anins 146;Xis 72 anins 147;X
is 72 anins 148;Xis 72 anins 149;Xis 72 anins 150;Xis 72 anins 151;Xis72 and
W0 2016/110584
Yis 152;Xis 72 anins 153;Xis 72 anins 154;Xis 72 andY is 155;Xis 72 anins 156;
Xis 72 anins 157;Xis 72 anins 158;Xis 72 anins 159;Xis 72 anins 160;Xis 72
anins 161; Xis 72 anins s 72 anins 163;Xis 72 anins s 72 anins
165;Xis 72 anins 166;Xis 72 anins 167;Xis 72 anins 168;Xis 72 anins 169;Xis
7Zanins 170;Xis72 anins 171;Xis72 anins 172;Xis 72 anins 173;Xis72 andY
is 174;Xis 72 anins 175;Xis 72 anins 176;Xis 72 anins 177; Xis 72 anins 178;X
is 72 anins s 72 anins 180;Xis 72 anins 181;Xis 72 anins 182;Xis 72 and
Y is 183;Xis '72 anins 184;Xis 72 anins 185;Xis 72 anins 186;
Xis73 anins 1;Xis 73 anin32;Xis 73 anins3;Xis73 anins4;Xis73 aninsS;
Xis73 anins6;Xis73 anins7;Xis73 anin38;Xis73 anin39;Xis73 anins
;Xis73 anins 11;Xis73 anins 12;Xis 73 anins 13;Xis73 anins 14;Xis73
anins 73 anins 16;Xis73anins17;Xis73anins18;Xis73anins 19;X
is73 anin320;Xis73 anins21;Xis73 2;Xis73 anins23;Xis73 anins
24;Xis73 aninsZS;Xis73 anin326;Xis 73 anins 27;Xis73 anins28;Xis73
anins29;Xis 73 and‘{is30;Xis 73 anins3l;Xis73 anins32;Xis73 anins 33;X
i373 anins34;Xis73 anins3S;Xis73 anins36;Xis73 anins37;Xis73 anins
38;Xis73 anins 39;Xis73 anins40;Xis 73 anins4l;Xis73 anins42;Xis73
3;Xis 73 anins44gXis 73 anins45;Xis 73 6;Xis73 anins47;X
is 73 anins48;Xis 73 9;Xis 73 aninsSO;Xis73 anins 51;Xis 73 anins
73 aninsS3;Xis73 aninsS4;Xis73 anins 55;Xis73 aninsS6;Xis73
aninsS7;Xis73 anins58;Xis73 anins59;Xis73 anins60;Xis73 anins61;X
is 73 anins62;Xis73 anin563;Xis73 anins64;Xis73 anins6S;Xis73 anins
66;Xis 73 anins 67;Xis73 anins68;Xis73 anins69;Xis73 anins 70;Xis73
anins71;Xis73 anins72;Xis73 anins73;Xis73 anins74;Xis73 anins75;X
i573 anins76;Xis 73 anins77;XiS73 8;Xis73 9;Xis73 anins
80;Xis73 anin381;Xis 73 anins 82;Xis73 anins83;Xis73 anins 84;Xis73
anins85;Xis 73 anins 86;Xis73 anins 87;Xis73 anins 88;Xis73 anins89;X
i373 anins90;Xis73 anins91;Xis73 anins92;Xis73 3;Xis73 anins
94;Xis73 anins95;Xis 73 anins96;Xis73 anins97;Xis73 anins 98;Xis73
anins 99;Xis 73 anins 100;Xis 73 deis 101; Xis 73 anins 102; Xis 73 anins
103;Xis 73 anins 104;Xis 73 anins 105;Xis 73 anins 106; Xis 73 anins 107;Xis
73 anin5108;Xis73 aninle9;Xis73 anins 110;Xis73 anins 111;Xis 73 andY
is 112;Xis73 anins 113;Xis73 anins 114;Xis73 15;Xis73 l6;X
is 73 anins 117;Xis73 anins 118;Xis73 anins 119;Xis73 anins 120;Xis73 and
Yis 121;Xis 73 anins 122;Xis 73 anins 123;Xis 73 anins 124;Xis 73 anins
125;
Xis 73 deis 126; Xis 73 anins 127;Xis 73 anins 128;Xis 73 anins 129; Xis 73
anins 130; Xis 73 anins 131;Xis 73 anins s 73 anins 133;Xis73 anins
134;Xis 73 anins 135;Xis 73 anins 136;Xis 73 anins s 73 anins 138;Xis
73 anins s73 anins 140;Xis 73 anins 141;Xis 73 andY is 142;Xis 73 andY
is 143;Xis 73 anins 144;Xis 73 anins s 73 anins 146; X is 73 anins 147;X
is 73 anins 148; Xis73 anins 149;Xis 73 anins s 73 anins 151;Xis 73 and
Yis 152;Xis 73 anins 153;Xis 73 anins 154;Xis73 andY is 155; Xis 73 anins 156;
Xis 73 andY is 157;Xis 73 andY is 158; Xis 73 andY is 159;Xis 73 anins 160;Xis 73
anins 161;Xis 73 anins 162;Xis 73 anins 163;Xis 73 anins 164; Xis 73 anins
165;Xis 73 anins 166;Xis 73 anins 167;Xis 73 anins 168; Xis 73 anins 169;Xis
73 anins 170;Xis 73 anins 171;Xis73 anins 172;Xis 73 anins 173;Xis 73 andY
is 174;Xis 73 and Y is 175;Xis 73 and Y is 176;Xis 73 anins 177;Xis 73 andY is 178;X
is 73 anins179;Xis73anin3180;Xis73 anin5181;Xis 73 anin3182;Xis73 and
Yis 183;Xis73 aninslS4;Xis73 anins185;Xis73 andY is 186;
Xis74anins1;Xis74aninsZ;Xis74anins3;Xis74anins4;Xis74aninsS;
Xis74 anins 6;Xis74 anins7;Xis74aninsS;Xis 74 anins 9;Xis74anins
;Xis74anins 1];Xis74anins 12.;Xis74anins 13; Xis74anins 14;Xis74
anins15;Xis74anins 16;Xis74anins17;Xis74anins18;Xis74anins 19;X
is 74aninsZO;Xis74anin321;Xis74anins22;Xis74 3;Xis74anins
24;.Xis74 anins2S;Xis74anin526;Xis74anin527; Xis74anins 28;Xis74
9;Xis74anins30;Xis74anins31;Xis74anins 32;Xis 74 anins 33;X
ins34;Xis74anins35;Xis74anins36;Xis74 anins37;Xis74anins
38;Xis74anins39;Xis74anins40;Xis74anins41;Xis74 anins42;Xis74
3;Xis 74 anins44;Xis74 anins45;Xis74 anins46;Xis74anins47;X
is74anins48;Xis74anins49;Xis74aninsSO;Xis74aninsSl;Xis74anins
52;Xis74anins53;Xis74andYis54;Xis74andY'1355;Xis74anins 56;Xis74
anins 57;Xis 74 anins 58;Xis74 anins 59;Xis74 anins 60;Xis 74 anins61;X
is 74 andY1562;Xis 74 anins63;Xis74anins 64;Xis 74anins65;Xis 74 anins
66;Xis74anins67;Xis 74anins68;Xis74anins 69;Xis74 anins 70;Xis74
anins7l;Xis 74 anins72;Xis74 anins 73;Xis74 anins74;Xis74 anins75;X
is74 anins76;Xis74anins77;Xis74anins78;Xis74anins79;Xis 74anins
80;Xis74anins 81;Xis74anin382;Xis74anins 83;Xis74anins 84;Xis74
aninsSS;Xis74anins86;Xis74anins 87;Xis74anins88;Xis74 anins89;X
ins90;Xis74anins91;Xis74anins92;Xis74anin393;Xis 74:111in3
94;Xis74 anins 95;Xis74anins96;Xis74anins97;Xis74anins 98;Xis74
W0 2016/110584
anins 99;Xis 74 anins 100;Xis 74 anins 101;Xis 74 anins 102;Xis 74 deis
103; Xis 74 anins 104;Xis 74 anins 105;Xis 74 anins 106;Xis 74 anins 107;Xis
74anin5108;Xis74anins109;Xis74anins110;Xis74anins111;Xis74andY
is112;Xis74anins113;Xis74anins114;Xis74anins115;Xis74aninsll6;X
is 74 aninS s 74 anins 118;Xis 74 anins 119;Xis 74anins 120;Xis74 and
Yis s 74 anins 122;Xis 74 anins 123; Xis 74 andY is 124;Xis 74 deis 125;
Xis 74 26;Xis 74 anins 127;Xis 74 anins 128;Xis 74 anins 129;Xis 74
anins 130;Xis 74 anins 131;Xis 74 andY is 132;.Xis 74 anins 133;Xis 74 anins
134;Xis 74 anins 135;Xis 74 anins s 74 anins s 74 anins 138;Xis
74 anins 139;Xis 74 anins 140;Xis 74 anins 141;Xis 74 anins 142;Xis 74 andY
is 143;Xis 74 anins 144;Xis 74 anins 145;Xis 74 anins 146;Xis 74 anins 147;X
is 74 anins 148;Xis 74anins 149;Xis 74anins 150;Xis 74 anins 151;Xis 74 and
Yi5152;Xis74anins 153;Xis74anins154;Xis74anins155;Xis74anin3156;
Xis 74 anins 157;Xis 74 deis 158; Xis 74 anins 159;Xis 74 anins 160;Xis 74
anins 161;Xis 74 anins 162;Xis 74 anins 163;Xis 74 anins 164;Xis 74 and Y is
s 74 anins 166;Xis 74 anins 167;Xis 74 anins 168;Xis 74 anins 169;Xis
74 anins 170;Xis 74 anins 171;Xis 74 anins 172;Xis 74 anins 173;Xis 74 andY
is 174;Xis 74 anins 175;Xis 74 anins 176;Xis 74 anins 177;Xis 74 anins 178;X
is 74 anins 179;Xis74 anins 180;Xis 74 anins 181;Xis 74 anins 182;Xis 74 and
Yis 183;Xis 74 anins 184;Xis 74anins 185;Xis74anins 186;
Xis753nins1;Xis75aninsZ;Xis75anins3;Xis75anins4;Xis75aninsS;
Xis75 anins 6;Xis 75 anins 7;Xis75 anins8;Xis 75 anins9;Xis75 anins
;Xis 75 anins 11;Xis75 anins 12;Xis 75 anins 13;Xis75 anins 14;Xis75
anins15;Xis75anins16;Xis75anins17;Xis75aninsl8;Xis75anins19;X
is75anin520;Xis75anins21;Xis75anins22;Xis75 aninsZ3;Xis75 anins
24;Xis 75 anin325;Xis75 anin326;Xis75 aninsZ7; Xis 75 anin528;Xis75
anin829;Xis75anins30;Xis75 anins31;Xis75anins32;Xis75 anins33;X
is75 aninsS4;Xis75anin335;Xis75 anins36;Xis75 anins37;Xis75 anins
38;Xis75 anins39;Xis75 anins40;Xis 75 1;Xis75 anins42;Xis75
anins43;Xis 75 anins44;Xis75 anins45;Xis75 anins46;Xis 75 anins47;X
i575 anins48;Xis75anins49;Xis75aninsSO;Xis75 anins51;Xis75 anins
52;Xis 75 aninsS3;Xis75 aninsS4;Xis75 aninsSS;Xis 75 anins 56;Xis75
aninsS7;Xis75anin358;Xis75 anins 59;Xis75 anins60;Xis75 anin361;X
is 75 anins 62;Xis 75 3;Xis75 4;Xis 75 5;Xis75 anins
66;Xis75 7;Xis75 anins68;Xis 7S anins69; Xis75 anins 70;Xis75
W0 2016/110584
deis 71;Xis 75 anins72;Xis75 anins73;Xis75 andY is 74; Xis75 anins 75;X
i575 6;Xis 75 anins77;Xis 75 anins78;Xis75 anins 79;Xis75 anins
80;Xis 75 anins 81;Xis 75 anins 82;Xis75 anins 83;Xis 75 anins84;Xis75
anins 85;Xis 75 anins 86;Xis75 anins 87;Xis 75 andY is 88; Xis 75 9;X
is75 anins 90;Xis75 anins91;Xis75 aninsQZ; Xis75 anins 93; Xis75 anins
94;Xis 75 anins 95;Xis 75 anins 96;Xis 75 anins 97; Xis 75 8;Xis 75
deis 99; Xis 75 anin3100;Xis 75 anins 101; Xis 75 anins 102; Xis 75 anins
103;Xis 75 andY is 104;Xis 75 anins 105;Xis 75 anins 106; Xis 75 anins 107;Xis
75 anins 108;Xis 75 anins 109;Xis 75 anins 110;Xis 75 anins 111;Xis75 andY
is 112;Xis75 anins s 75 anins 114;Xis75 anins 115;Xis75 anins 116;X
is 75 anins117;Xis75anins118;Xis75anins119;Xis 75 anins 120;Xis 75 and
Y13121;Xis75 anins 122;Xis 75 anins 123;Xis 75 andY is 124; Xis 75 deis 125;
Xis 75 deis 126; Xis 75 anins 127; Xis 75 andY is 128; Xis 75 and Y is 129;Xis 75
anins 130;Xis 75 anins 131;Xis 75 anins 132;Xis 75 anins 133; Xis 75 deis
134; Xis 75 anins 135; Xis 75 andY is 136; Xis 75 anins 137; Xis 75 anin8138;Xis
75 anins 139;Xis 75 anins 140;Xis 75 anins 141;Xis 75 anins142;Xis75 andY
is 143; Xis 75 anins 144;Xis 75 deis 145; Xis 75 anins 146; Xis 75 anins 147;X
is 75 anins 148;Xis 75 anins 149;Xis 75 anins 150;Xis 75 anins 151;Xis 75 and
Yis 152;Xis 75 anins 153;Xis 75 anins 154;Xis 75 anins 155;Xis 75 deis 156;
Xis 75 anins 157;Xis 75 anins 158; Xis 75 anins 159; Xis 75 anins 160;Xis 75
anins 161;Xis 75 anins 162; Xis 75 anins 163;Xis 75 deis 164; Xis 75 anins
165;Xis 75 anins 166;Xis 75 anins 167;Xis 75 anins 168; Xis 75 anins 169;Xis
75 anins 170;Xis 75 anins s 75 anins 172;Xis75 anins 173;Xis 75 andY
is 174; Xis 75 anins 175;Xis 75 anins 176;Xis 75 anins 177; Xis 75 anins 178;X
is 75 anins s 75 anins 180;Xis 75 anins 181;Xis 75 deis 182; Xis 75 and
Yis 183;Xis 75 anins 184;Xis 75 anins 185;Xis 75 deis 186;
X1576 anins 1;Xis 76 anin52;Xis 76 anins 3;Xis 76anins4;Xis 76 anins 5;
Xis76 anins 6;Xis s7;Xis76anins 8;Xis76 anins 9;Xis76 anins
;Xis 76 anins 11;Xis76anins 12;Xis76 anins 13;Xis76 anins 76
3O anins15;Xis76anins16;Xis763nins17;Xis76anins18;Xis76anins19;X
is76anin520;Xis 76 anins 21;Xis76 anins22;Xis 76 anin323;Xis 76 anins
24;Xis 76 anin325;Xis 76 anin326;Xis 76 aninsZ7;Xis76anins 28; Xis76
aninsZ9;Xis76 anins 30;Xis76aninsSl;Xis76 anins32;Xis 76 anins33;X
is76anins34; Xis 76 anins 35;Xis 76 anins36;Xis 76 anins 37;Xis 76 anins
38; Xis 76 deis 39; Xis 76anins40;Xis76anins41;Xis76 deis 42; Xis76
W0 2016/110584
anins43;Xis 76 anins44;Xis76 anins45;Xis76 anins46; Xis76 anins 47;X
is76 anins48;Xis76anins49;Xis 76 aninsSO;Xis76 l;Xis76anins
52;Xis76anins 53;Xis76 aninsS4;Xis76anin555; Xis76 anin356;Xis76
andYis57;Xis76aninsS8;Xis76anins 59;Xis76anins60;Xis76anins61;X
is76 anins62;Xis763nin363;Xis76anins64;Xis76 anins65;Xis76anins
66;Xis76anins67;Xis 76 anins68;Xis76anins69;Xis76anins70;Xis76
anins 7.1;Xis 76 anins 72;Xis 76anins 73;Xis 76 anins74;Xis 76 anins75;X
is76 anins76;Xis76andYis77;Xis76anins78;Xis76 anins79;Xis76anins
80;Xis76aninsSl;Xis 76 anin582;Xis76 anins 83;Xis76anin384;Xis76
anins85;Xis76ar1ins86;Xis76anins 87;Xis76andYis88;Xis76anin589;X
is76anins90;Xis76anin591;Xis 76anins92;Xis76 anins93;Xis76anins
76 anins95;Xis 76 anin896;Xis76 anins97;Xis 76anins98;Xis76
anins99;Xis76 anins100;Xis76anins101;Xis76anins102;Xis76anins
103;Xis 76 anins 104; Xis 76 anins s 76 andY15106;Xis76anins107;Xis
76anins108;Xis76anins109;Xis76anins110;Xis76anins 111;Xis76andY
is112;Xis76anins113;Xis76aninsll4;Xis76anins115;Xis76aninsll6;X
is76 anins 117;Xis76 anin3118;Xis 76 anins119;Xis 76anins 120;Xis 76and
Yis 121;Xis 76 anins 122;Xis76anins 123;Xis 76anins 124;Xis 76 deis 125;
Xis 76 anins 126;Xis 76 andY is 127;Xis 76 anins 128;Xis 76 anins 129;Xis 76
anins 130;Xis 76 anins 131;Xis 76 anins 132;Xis 76 anins 133;Xis 76 anins
134;Xis 76 anins 135;Xis 76 anins 136;Xis 76 anins s 76 anins 138;Xis
76 anins 139;Xis76 anins s 76anins 141;Xis 76 anins s 76 andY
is 143;Xis 76 anins 144;Xis 76 anins 145;Xis 76 anins s 76 anins 147;X
is 76 anins s 76 anins 149;Xis 76 anins 150;Xis 76 anins 151;Xis 76 and
Yis s76 anins 153;Xis 76 anins 154;Xis 76anins 155;Xis 76 anins 156;
Xis 76 anins 157;Xis 76 deis 158; Xis 76 anins 159;Xis 76 anins 160; Xis 76
anins 161;Xis 76 anins 162;Xis76 anins 163;Xis 76 anins 164;Xis 76 anins
165;Xis 76 anins 166;Xis 76 anins 167;Xis 76 anins 168;Xis 76 anins 169;Xis
76 anins 170;Xis 76 anins 171;Xis 76 anins 172;Xis76 anins 173;Xis 76:1de
is 174;Xis 76 anins 175;Xis 76 anins 176;Xis 76 anins 177;Xis 76 anins 178;X
is 76 anins 179;Xis 76 anins 180;Xis 76 anins 181;Xis 76 anins 182;Xis 76 and
Yis 183;Xis 76 anins 184;Xis 76 anins 185;Xis 76 anins 186;
Xis77 anins 1;Xis 77 aninsZ;Xis77anins3;Xis77anins4;Xis77 aninsS;
Xis77 anins 6;Xis 77anins 7;Xis77 anins 8;Xis77anin39;Xis77 anins
10;Xis77anins11;Xis77anins12;Xis77anins13;Xis77aninsl4;Xis77
W0 2016/110584
anins15;Xis77anins16;Xis77anins17;Xis77anins 18;Xis77anins 19;X
is77 anin520;Xis77anin321;Xis77anin522;Xis77andYisZ3;Xis77 anins
77 anin525;Xis77 anin326;Xis77 anins27;Xis77 S;Xis77
aninsZ9;Xis77 anins30;Xis77anins31;Xis 77andY is32;Xis77 3;X
is 77 anins 34;Xis 77 anins 35;Xis 77 anins 36;Xis 77 andY is 37;Xis77 anins
38;Xis77 anins 39;Xis77 anins40;Xis77 anins41;Xis 77 anins42;Xis77
anins43;Xis 77 anins44;Xis77anins45;Xis 77anins46; Xis 77 anins47;X
is77 anins 48;Xis 77 anins49;Xis77 anins 50;Xis77 anins 77 anins
52;Xis77 anins 53;Xis77a;nins 54;Xis77 deis 55; Xis77 aninsS6;Xis77
anins 57;Xis 77 anin358;Xis77 anins 77 anins60;Xis77 anins61;X
is77anins62;Xis77 anins63;Xis77anins64;Xis77 anins 65;Xis77 anins
66;Xis77 aninsG73Xis77 anins68;Xis77anins69; Xis77 anins70;Xis77
anins71;Xis 77 anins72;Xis77 anins73;Xis77 andY is74', Xis77 andY is75;X
is77anins76;Xis77anins77;Xis77 anins78;Xis77 anins79;Xis77anins
80;Xis77 anins 81;Xis77anin582;Xis 77anins 83; Xis77 anins 84;Xis77
anins 85;Xis77 anins86;Xis 77anins 87;Xis77anins 88;Xis77 anins 89;X
is77 anins90;Xis 77 anins91;Xis77anins 92;Xis 77 anins 93;Xis77 anins
94;Xis77 anins95;Xis77anins96;Xis77anins97; Xis77 anins 77
anins 99;Xis 77 anins 100;Xis 77 anins 101;Xis 77 anins 102; Xis 77 anins
103;Xis 77 anins 104;Xis 77 anins 105;Xis 77 anins s 77 anins 107;Xis
77anins108;Xis77anins109;Xis77anins110;Xis77anins111;Xis77andY
is s 77 aninsll3;Xis77 anins s 77 anins s 77 anin3116;X
is 77 anins 117;Xis 77 anins 118;Xis77 anins 119;Xis 77 anins 120;Xis 77 and
Yis 121;Xis 77 anins 122;Xis 77 anins 123;Xis 77 anins 124;Xis 77 anins 125;
Xis 77 anins 126;Xis 77 anins 127;Xis 77 deis 128; Xis 77 anins s77
anins 130;Xis 77 anins 131;Xis 77 andY15132;Xis 77 anins 133;Xis 77 anins
134;Xis 77 anins 135;Xis 77 anins 136;Xis 77 anins 137;Xis 77 anins 138;Xis
77 anins 139;Xis 77 anins 140;Xis 77 anins 141;Xis77 anins 142;Xis 77 andY
is 143;Xis 77 anins s 77 anins 145;Xis 77 anins 146;Xis 77 anins I47;X
is 77 anins 148;Xis 77 anins 149; Xis 77 anins 150;Xis 77 anins 151;Xis 77 and
Yis 152; Xis 77 anins 153;Xis 77 anins 154;Xis 77 anins 155;Xis 77 deis 156;
Xis 77 anins 157; Xis 77 anins 158; Xis 77 deis 159; Xis 77anins 160;Xis 77
anins 161;Xis 77 anins 162;Xis 77 anins 163;Xis 77 anins 164;Xis 77 anins
165; Xis 77 anins 166;X1's 77 anins 167;Xis 77 anins 168;Xis77 anins 169;Xis
77 anins 170;Xis 77 anins 171;Xis 77 anins 172;Xis77 anins 173;Xis77 andY
W0 2016/110584
is 174;Xis 77 anins 175;Xis 77 anins 176;Xis 77 anins I77;Xis 77 anins 178;X
is 77 anins 179;Xis 77 anins s 77 anins 181;Xis 77 anins 182;Xis 77 and
Yis 183;Xis 77 anins184;Xis 77 anins 185;Xis 77 deis 186;
X1578 anins1;Xis 78anin32;Xis 78 anins3;Xis 78 anins4;Xis78 aninsS;
Xis78 anins6;Xis78 anins7;Xis78anins8;Xis78 anins9;Xis78anins
78anins11;Xis78anins12;Xis78aninsl3;Xis78aninsl4;Xis78
anins 15;Xis78anins16;Xis78anins 17;Xis78anins18;Xis78anins19;X
is78 ZO;Xis78 ;Xis78 anin322gXis78 aninsZ3;Xis78 anins
24;Xis78 5;Xis78 anin326;Xis 78aninsZ7;Xis78 anin528;Xis78
aninsZ9;Xis 78 anins30;Xis78 anins31;Xis78 anins32;Xis78anins33;X
is 78 anins 34;Xis 78 anins 35;Xis 78 anins 36;Xis 78 anins 37;Xis78 anins
38;Xis78 anins 39;Xis78 anins4G;Xis78 anins41;Xis78 2;Xis78
anins43;Xis 78 anins44;Xis78 anins45;Xis78 anins46;Xis78 anins47;X
is78anins48;Xis78anins49;Xis78aninsSO;X1378 l;Xis78anins
52;Xis78 anins 53;Xis 78 anins54;Xis 78 anins 55;Xis78 aninsS6;Xis 78
anins57;Xis78anins58;Xis78 anins 59;Xis78anins60;Xis78anins6l;X
i378 aninséZ;Xis78anins63;Xis78 anins64;Xis78 anins65;Xis78 anins
66;Xis 78 anins 67;Xis 78 anins 68;Xis 78 deis 69; Xis78 anins 70;Xis78
anins71;Xis78anins72;Xis782deis 73;Xis78 anins74;Xis78anins75;X
i578 anins76;Xis78anins77;Xis78anins 78;Xis78 anins79;Xis78 aninS
80;Xis 78 anins 81;Xis 78 anins82;Xis 78 anins 83;Xis78 anins84;Xis78
anins85;Xis78 anins86;Xis78 anins 87;Xis78anins88;Xis78 anins89;X
i578 andYis90;Xis783nins9l;Xis78 anins92;Xis78 anins93;Xis78 anins
94;Xis78 anins 95;Xis 78anins96;Xis 78anins97;Xis78 anins98;Xis78
anins99;Xis78anins100;Xis78anins101;Xis78anins102;Xis783nins
103;Xis 78 anins s 78 anins 105;Xis 78 anins 106;Xis 78 anins 107;Xis
78anins108;Xis78anins109;Xis78anins110;Xis78anins111;Xis78andY
isllZ;Xis78.anins113;Xis78anins114;Xis78anins 115;Xis78anins116;X
i578 anins 117;Xis 78 aninslIS;Xis 78 anins 119;Xis 78 anins 120;Xis 78 and
3O Yis 121;Xis 78 anins 122;Xis 78 anins 123;Xis 78 anins 124;Xis 78 anins 125;
Xis 78 anins 126;Xis 78 anins s 78 anins 128;Xis 78 anins 129;Xis78
anins 130;Xis 78 anins s 78 anins 132;Xis78 anins s 78 anins
134;Xis 78 anins 135;Xis 78 anins 136;Xis 78 anins 137;Xis 78 anins 138;Xis
78 anins 139;Xis 78 anins 140;Xis 78 anins 141;Xis 78 anins 142;Xis 78 andY
is 143;Xis 78 anins 144;Xis 78 anins 145;Xis 78 anins 146;Xis 78 anins 147;X
W0 2016/110584
is 78 anins 148;Xis 78 anins 149;Xis 78 anins s 78 and Yis 151;Xis 78 and
Yis 152;Xis 78 anins 153;Xis78 anins 154;Xis78 deis 155; Xis 78 deis 156;
Xis 78 anins 157;Xis 78 anins 158;Xis 78 anins 159;Xis 78 andY is 160;Xis 78
anins 161;Xis 78 anins 162;Xis 78 anins 163;Xis 78 anins 164;Xis78 anins
165;Xis 78 anins 166;Xis 78 anins 167;Xis 78 anins 168;Xis 78 anins 169;Xis
78 anins 170;Xis 78 anins 171;Xis 78 anins 172;Xis 78 anins 173; Xis 78 andY
is 174;Xis 78 anins 175;Xis 78 anins 176;Xis 78 anins 177;Xis 78 anins 178;X
is 78 anins 179;Xis 78 anins 180;Xis 78 81;Xis 78 anins 182;Xis 78 and
Yis 183;Xis 78 anins 184;Xis78 anins s78 deis 186;
Xis79anins1;Xis79anins2;Xis79anins3;Xis79anins4;Xis79aninsS;
X1579 anin56;Xis79 anins7;Xis 79 anins 8;Xis 79 andY is9;Xis79anins
;Xis79 anins 11;Xis 79 anins 12;Xis79anins 13; Xis79 anins 14;Xis79
S;Xis 79 anins 16;Xis79 anins 17;Xis79 deis 18; Xis79 anins 19;X
ins20;Xis79andY1521;Xis79anin522;Xis79 anin323;Xis79anins
24;Xis79anins25;Xis79anins26;Xis79 anin327; Xis79 anin528;Xis79
anin529;Xis79 0;Xis79anins31;Xis79 anins 32;Xis79 anins33;X
ins34;Xis79anins35;Xis79 anins36;Xis 79 anins37;Xis79anins
38;Xis 79anins 39;Xis79anins40;Xis79 anins4l;Xis 79 anins42;Xis79
andYi543;Xis79anins44;Xis79anins4S;Xis79anins46;Xis79anins47;X
1879 anins48;Xis 79 anins49;Xis79 anins 50;Xis 79 anins 51;Xis79 anins
52;Xis79 aninsS3;Xis79 aninsS4;Xis 79anins 55;Xis79 anins 56;Xis79
aninsS7;Xis79anin558;Xis79anins 59;Xis79 anins60;Xis79 anin361;X
ins62;Xis79anins63;Xis79anins64;Xis79anins65;Xis79anins
66;Xis79anins 67;Xis79 8;Xis79anins 69;Xis79 0;Xis79
anins71;Xis79 anins72;Xis79anins73;Xis79anins74;Xis79anins75;X
is79 anins76;Xis79anins77;Xis79 anins78;Xis79anins79;Xis s
80;Xis79anins 79anins 82;Xis79anins 83;Xis 79anins 84;Xis79
anins 85;Xis 79 anin586;Xis79anins 87;Xis79 anins88;Xis79 anins89;X
i379 anins90;Xis79anins91;Xis79anins92;Xis79anins93;Xis 79anins
94;Xis79 anins 95;Xis79anins96;Xis79 anins97;Xis79anins98;Xis79
deis 99; Xis 79 anins 100;Xis 79 anins 101; Xis 79 anins102;Xis 79 anins
103;Xis 79 anins 104;Xis 79 anins 105;Xis 79 anins 106;Xis 79 anins 107;Xis
79 anins 108;Xis 79 anins 109;Xis 79 anins 110;Xis 79 anins 111;Xis 79 andY
is 112;Xis79 anins 113;Xis79 anins 114;Xis79 anins 115;Xis 79 anins 116;X
is 79 anins 117;Xis 79anins 118;Xis 79 anins 119;Xis 79anins 120;Xis 79and
W0 2016/110584 2016/050308
Yis 121;Xis79 anins 122;Xis 79 anins 123;Xis 79 anins 124;Xis 79anins
125;
Xis 79 anin8126;Xis 79 deis 127; Xis 79 anin3128;Xis 79 anins‘129; Xis 79
anins 130;Xis79 anins 131;Xis 79 anins 132;Xis 79 anins 133;Xis 79 anins
s 79 anins 135;Xis 79 anins 136;Xis 79 anins 137;Xis 79 anins 138;Xis
79 anins 139;Xis 79 anins 140;Xis 79 anins 141;Xis79 anins 142;Xis 79 andY
is 143;Xis 79 anins 144;Xis 79 anins 145;Xis 79 anins 146;Xis 79 anins
147;X
is 79 anins 148;Xis 79anins s 79 anins 150;Xis 79 anins 151;Xis 79and
Yis 152;Xis 79 anins 153;Xis 79anins s 79 andY is 155;Xis 79 anins
156;
Xis 79 anins 157;Xis 79 anins 158;Xis 79 anins 159;Xis 79 anins 160;Xis
deis 161; Xis 79 anins 162;Xis 79 anins 163;Xis 79 anins s 79 anins
165;Xis 79 deis 166; Xis 79 anins 167;Xis 79 anins 168;Xis 79 anins 169;Xis
79anins 170;Xis 79 anins 17];Xis 79 anins 172;Xis 79 anins
173;Xis79 andY
is 174;Xis 79 anins 175;Xis 79 and Y is 176;Xis 79 anins 177;Xis 79 anins 178;X
is 79 anins 179;Xis 79anins 180;Xis 79 anins 181;Xis 79 anins182;Xis79and
;Xis 79 anins 184;Xis 79 anins s79 anins 186;
XisSOanins1;XisSOaninsZ;Xis80anin53;Xis80anins4;Xis80aninsS;
Xis 80anins6;Xis80anins7;Xis 80anins 8;XisSOanins9;Xi580anins
;Xi580anins ll;Xis80anins12;Xi580anins13;Xi580anins14;Xis80
anins 15;Xis 80 aninsl6;Xis80anins 17;Xis 80anins 18;Xis 80 anins 19;X
iS8Oanins20;Xis8Oaninle;Xis80anin522;Xis80aninsZ3;Xis80anins
24;Xis80anin325;Xis 80anin326;Xis80aninsZ7;Xis 80anins28;Xis80
aninsZ9;Xis80anins30;Xi880anins3I;XisSOanins32;Xis80anins33;X
is SOanins34;Xis 80anins35;Xi880 anins36;Xis 80aninsS7;Xis80anins
38;Xis80anins 39;Xis s40;Xis 80anins41;Xis 80 anins42;Xi380
anins43;Xi380anins44;Xis80anins45;Xis SOanins46;Xi380anins47;X
is 80anins48;Xis80anins49;Xis80aninsSO;XisSOaninsSl;XisSOanins
52;Xis 80anins 53;Xis 80aninsS4;XisSOanins55;Xis 80anins 56;Xis80
anins57;XisSOanin558;Xis80anins 59;XisSOanins60;XisBOanins6l;X
is is62;Xis80anin863;Xis 80anins64;Xis 80anin365;Xis 80 anins
3O 66;Xis 80anins67;Xis 80anins68;Xis 80anins69;Xis80anins 70;Xis80
anins71;Xis803nins72;Xis80anins 73;Xis SOanins 74;Xis80anins75;X
is s76;Xis 80anins77;Xi380 anins78;Xis 803nins79;XisSOanins
80;Xis 80 anins 81;Xis SOanins 82;XisSOanins 83;Xis 80 anins 80
anins85;X1580anins86;XisSOanins87;Xis80anins 88;Xis80anins89;X
i580 anins90;Xis80anins91;Xis 80anins92;Xis 80anins93;X1380
anins
W0 2016/110584
94;Xis80and‘x'is95;Xis80anins96;Xis80anins97; Xis80anins98;Xi580
anins 99;Xi5‘. :30 anins 100;Xis 80 anins 101;Xis 80 anins 102;Xis 80 deis
103; X is 80 and 'z’ is 104; Xis 80 andY is 105; Xis 80 andY is 106; Xis 80 andY is 107; Xis
803.11ins 108: .‘iisSOanins109;Xi380anins110;Xis80andYis111;XiSSOandY
is112;Xi380a!'f:iYis113;XisSOanins114;Xis 803nins 115;Xis80aninsll6;X
is 80aninsii',7:X1380anins 118;Xis SOaninsll9;Xis 80 O;Xis 80 and
Yis 121; Xis 8’1} andY is 122; Xis 80 andY is 123; Xis 80 andY is 124; Xis 80 anins 125;
Xis 80 anins s 80 anins 127;Xis 80 anins 128;Xis 80 anin3129;Xis8O
deis 130; X i»: 80 andY is 131; Xis 80 anins 132; Xis 80 anins 133; Xis 80 andY is
134; Xis 80 and a is 135; X is 80 andY is 136; Xis 80 deis 137; Xis 80 anins 138; Xis
80 and Y is 139; x is 80 anins 140;Xis 80 anins 141;Xis 80 andY is 142; Xis 80 andY
is 143; Xis 80 and Y is 144; Xis 80 andY is 145; Xis 80 anins 146; X is 80 andY is 147; X
is 80 anins 148;Xis80 anins 149;Xis 80anins 150;Xis 80 anins 151;Xis 80 and
Yis 152;Xis 80 anins 380anins 154;Xis 80adeis 155;Xis 80 anins 156;
Xis 80 anins 157;Xis 80anins 158;Xis 80 and}“ is 159; Xis 80 anins 160;Xis 80
anins 161;Xis 80 anins 162;Xis80anins 163;Xis SOanin3164;Xis 80 deis
165; Xis 80 andY is 166; Xis 8O andY is 167; X is 80 andY is 168;:Xis 80 deis 169; Xis
80anins 170;XisSOanins s 803.11in5 172;Xis803nins 173;Xi580andY
is 174; Xis 80 anins175;Xis 80 anins 176; Xis 80 deis 177; X is 80 andY is 178; X
is 80anins s 80 80;Xis s 181;Xis 80 anins 182;XisSOand
Yis183;Xis80anins184;Xis80anins185;Xis80anins186;
Xis 81 anins 1;Xis 81 ELTIinSZ;X15818.ndY153;X1$81 anins4;Xis 81 aninsS;
Xis 81anins6;Xis81anins7;Xis 81 aninsS;Xis 81 anins 9;Xi581 anins
; Xis 81 anins 11;Xis 81 anins 12;Xis 81 anins 13;Xis 81 anins 14;Xis 81
aninsiS;Xis81anins16;Xi381aninsl7;Xis81 anin318;Xis81aninsl9;X
i581aninsZO;Xis81anins21;Xi581anin322;Xi881aninsZ3;Xis81anins
24;Xis 81 aninsZS; Xis 81 aninsZ6;Xis 81 anins27;Xis81 anin328;Xis 81
anins29;XisSlanins3O;Xi581anins31;Xi581anins32;Xi381anins33;X
isSlanins34;Xi381anins35;Xis81anins36;Xis81anins37;XisSlanins
3O 38; Xis 81 deis 39; Xis 81 anins40;Xis 81 anins 41;Xis 81 anins 42;Xis 81
anins43;XisSlanins44;Xi581anins45;Xis81anins46;XisS1anins47;X
is 81 anins48;Xis 81 anins49;Xis 81 anins 50;Xi881 anins 51;Xis 81 anins
52;Xis 81 anins 53;Xis 81 anins 54;Xis 81 anins 55;Xi581 anins 56;Xis81
aninsS7;Xis81anin358;Xi581anins59;Xis81anins60;XisSl anins61;X
is81anins62;Xis81anin363;Xis81anins64;Xi881anins65;Xis81anins
W0 2016/110584
66;Xis 81 andes 67;Xis 81 anins 68; Xis 81 anins 69; XisS] anins 70; Xis 81
anins7l;Xis 81 2;Xis 81 anins73;Xis 81 anins74;Xis 81 anins 75;X
isSlanins76;X1381anins77;X1581anins78;XisSl 9;Xi581anins
80;Xis 81 anins 81;Xis 81 anins82;Xis81 anins 83;Xis 81 anins 84;Xis81
anins85;Xis81anins86;Xis81anin387;Xis81anin588;Xis81anin589;X
is 81 anins90;Xis81 anins91;Xis 81 anins92;Xis81 anins93;Xi381 anins
81 aninsQS;Xis 81 anin396;Xis 81 anins97;Xis 81 anins98;Xis 81
anins 99;Xis 81 anins 100;Xis 81 anins 101; Xis 81 anins 102;Xis 81 anins
103; Xis 81 anins 104;Xis 81 anins 105;Xis 81 anins 106;Xis 81 anins 107;Xis
81 anin5108;Xis 81 anins s 81 anins s 81 anins 111;Xis 81 andY
is 112;Xis81 anins 113;Xi581 aninsll4;Xi381 anins 115;Xis 81 anins 116;X
is 81 anins 117;Xis 81 aninsll8;Xis 81 anins 119;Xis 81 anins 120;Xis 81 and
Yis121;Xis 81 anins 122;Xis 81 anins 123;Xis 81 anins 124;Xis 81 anins 125;
Xis 81 anins 126;Xis 81 deis 127; Xis 81 andY18128;Xis 81 deis 129; Xis 81
anins 130;Xis 81 anins 131;Xis 81 anins 132;Xis 81 anins 133;Xis 81 anins
134;Xis 81 anins 135;Xis 81 anins 136;Xis 81 anins 137;Xis 81 anins 138;Xis
81 anins 139;Xis 81 anins s 81 anins 141;Xis 81 anins 142;Xis 81 andY
is 143;Xis 81 anins 144;Xis 81 anins s 81 anins 146;Xis 81 anins 147;X
is 81 anins 148;Xis 81 anins s 81 anins 150;Xis 81 anins 151;X1881 and
Yis 152;Xis 81 anins 153;Xis 81 anins 154;Xis 81 anins 155;Xis 81 anins 156;
Xis 81 anins 157;Xis 81 deis 158; Xis 81 anins 159;Xis 81 anins 160;Xis 81
anins 161; Xis 81 anins 162;Xis 81 anins s 81 anins 164;Xis 81 anins
165;Xis 81 66;Xis 81 anins 167;Xis 81 anins 168;Xis 81 anins 169;Xis
81 anins 170;Xis 81 anins 171;Xis 81 anins 172;Xis 81 anins 173;Xis 81 andY
is 174;Xis 81 anins 175;Xis 81 anins 176;Xis 81 anins 177;Xis 81 anins 178;X
is 81 anins 179;Xis 81 anin3180;Xis 81 anins 181;Xis 81 anins 182;Xis 81 and
Yis 183;Xis 81 anins 184;Xis 81 anins 185;Xis 81 deis 186;
Xi382anins 1;Xis 82anins2;Xi382 anins3;Xis82 ;Xis 82 aninsS;
Xis 82 anins6;Xis 82anins 7;Xis 82anins 8;Xis 82 anin59;Xis82 anins
10;X1582anins11;Xis82anins12;Xis82anins13;X1382anins14;Xi382
anins15;Xi582anins16;Xis82aninsl7;Xi582anins18;Xi582aninsl9;X
is 82 anin520;Xis82anin321;Xis 823nins22;Xis 82anin523;Xis 82anins
24;Xis 82 anins 25;Xis82 6;XisS2 anins27;Xis 82anin328;Xis 82
anin529;Xis 82 anins 30;Xis82 anins31;Xis 82anins 32;Xis 82 anins33;X
is 82 anins34;Xi582anins35;Xis82anins36;Xis82anins37;Xis82anins
W0 2016/110584
38;Xis 82 anins 39;Xis 82 anins40;Xi382anins4l; Xi382 anins42;Xis82
anins43;Xis 82anins44;Xis s45;Xis 82 6; X1582anins47;X
i382anins48;X1582anins49;Xis82anins50;Xis82 andY is 51;Xis82 anins
52;Xis 82 anins 53;Xis 82 anins54;Xis 82 deis 55; Xis82 6;Xi382
aninsS7;Xis 82 anins 58;Xis 82 anins 59;Xis82 anins60; Xis 82 aninséI;X
is 562;Xis 82anins63;Xis82anins64;X1382 anins65;X1582anins
66;Xis 82anins67;Xis 82 anins68;Xis 82 anins69; Xis 82 0;Xis 82
anins71;Xis82anins 72;Xis 82 anins73;Xis 82 anins74;Xis 82 anins75;X
is 82anins76;Xis82 anins77;Xi582 anins78;Xis 82 andY is 79;Xis82 anins
80;Xis 82anins 81;Xis 82 anin382;Xis 82anins 83; Xi582 aninsS4;Xis 82
andY is 85;Xis 82 anins 86;Xis 82 anins 87;Xis 82 anins 88;Xis 82 anins 89;X
is 82anin390;Xis 82 anins9l;Xis82 anins92;Xis 82 aninsQ3;Xis82 deis
94; Xis 82 anins95;Xis 82 anins 96;Xis 82 anins97; Xis 82 anins98;Xis 82
anins 99; Xis 82 anins 100;Xis 82 anins 101;Xis 82 anins 102;Xis 82 anins
'15 103;Xis 82 anins 104;Xis 823.11in3 105;Xis 82 anins 106;Xis 82 anins 107;Xis
82 anins 108;Xis 82 anins 109;Xis 82anins110;Xis 82 aninslll;Xis 82andY
is 112;Xis 82 anins 113;Xi582 anins 114;Xi382 anins 115;Xi582 anins 116;X
is 82 anins s 82anin3118;Xis 82 anins 119;Xis82 anins 120;Xis 82 and
Yis 121;Xis 82 anins 122;Xis 82 anins 123;Xis 82 anins 124;Xis 82 deis 125;
Xis 82 anins 126; Xis 82 anins 127; Xis 82 andY is 128; Xis 82 anin8129;Xis 82
anins 130;Xis 82 anins 131;Xis 82 anins 132;Xis 82 deis 133; Xis 82 andY'is
134;Xis 82 anins 135;Xis 82 anins 136;Xis 82 anins 137;Xis 82 anins 138;Xis
82 anins 139;Xis 82 anins 140;Xis 82 anins 141;Xis 82 anins 142;Xis 82 andY
is 143;Xis 82 anins 144;Xis 82 anins 145;Xis 82 anins s 82 anins 147;X
is 82 anins 148;Xis 82 anins 149;Xis 82 anins 150;Xis 82 anins 151;Xis 82 and
Yis 152;Xis 82 anins s 82 anins 154;Xis 82 anins 155;Xis 82 deis 156;
Xis 82 anins 157; Xis 82 anins s 82 deis 159; Xis 82 anins 160;Xis 82
anins 161; Xis 82 anins 162;Xis82 anins 163;Xis 82 anins 164;Xis 82 anins
165;Xis 82 anins 166;Xis 82 anins 167;Xis 82 anins 168;Xis 82 anins 169;Xis
82 anins 170;Xis 82 anins 171;Xis 82 anins 172;Xis 82 anins 173;Xis 82 andY
is s 82 anins 175;Xis 82 anins 176;Xis 82 anins 's 82 anins 178;X
is 82 anins 179;Xis 82 anins 180;Xis 82 anins 181;Xis 82 anins 182; Xis 82 and
Yis 183;Xis 82 anins 184;Xis 82 anins 185;Xis 82 deis 186;
Xi583 anins 1;Xis 83 aninsZ;Xis 83 anin53;Xis83 anins4;Xis 83 aninsS;
Xi583 anins 3 anins7;Xi383 anin58;Xis83 anins 9;Xis 83 anins
;Xis 83 anins 11;Xis 83 anins 12;Xis 83 anins 13; Xis 83 anins l4;Xis83
anins 15;X1883 anins 83 anins 17;Xis83 anin518;Xis83 anins 19;X
i583 aninsZO;Xis 83 anins21;Xis83 anin322;Xi583 aninsZ3;Xis83anins
24;Xis 83 5;Xi383 anins26;Xis 83 aninsZ7; Xis 83 anins28;Xi383
anins29;Xis 83 anins30;Xis83 anins31;Xis 83 anins32;Xis83 anins33;X
is 83 4;Xi383 anins35;Xis83 anins36;Xis 83 7;Xis83 anins
38;Xis 83 anins39;Xis 83 anins40;Xis83 anins41;Xis 83 anins42;Xis83
anins43;Xis 83 anins44;Xis 83 anins45;Xis 83 anins46;Xis 83 7;X
is 83 anins48;Xis 83 anins49;Xis 83 aninsSO;XisS3 aninsSl;XisS3 anins
52;Xis 83 anins 53;Xis 83 anins 54;Xis 83 anin555;Xis 83 anins 56;X1583
aninsS7;Xis83 aninsSS;XisS3 anins 59;Xis 83 0;XisS3 anins61;X
is 83 anins 62;Xis 83 anins 63;Xis 83 anins64;Xis 83 anins65;Xis 83 anins
66;Xis 83 anin567;Xis 83 anins 68;Xis 83 anins 69; Xis 83 anins 70;Xis 83
anins71;Xis 83 anins72;Xis83 anins73;Xis 83 anins74;XisS3 anins7S;X
is83 anins76;Xis 83 anins77;Xis 83 anins78;Xis 83 anins79;Xis 83 anins
80;Xis 83 anins 81;XisS3 anins82;Xis 83 anins83;Xis 83 anin384;Xi583
anins 85;Xis 83 anins 86;Xis 83 anins 87;Xis 83 anins 88;Xis 83 anins 89;X
is 83 anins90;Xis83 1;XisS3 anins92gXis 83 anins93;XisS3 anins
94;Xis 83 anins 95;Xis83 anins96;Xis 83 anins97;Xis 83 anins98;Xis83
anins 99;Xi583 anins 100;Xi383 anins 383 anins s 83 anins
103;Xis 83 anins 104;Xis 83 anin3105;Xis 83 anins106;Xi883 anins 107;Xis
83 anins 108;Xis 83 anins 109;Xi383 anins 110;Xis 83 aninsll];Xis 83 andY
is 112;Xis 83 anins 113;Xis 83 anins 114;Xis 83 anins 115;Xis 83 anins 116;X
is83 anins 117;Xis 83 anins 118;Xis83 anins 119;Xis 83 anins 120;Xi383 and
Yis 121;Xis 83 anin5122;Xis 83 anins 123;Xis 83 anins 124;Xis 83 anins 125;
Xis 83 anins 126; Xis 83 anin3127;Xis 83 anin3128;Xis 83 andY is 129;Xis 83
deis 130; Xis 83 anins 131;Xis 83 anins 132;Xis 83 anins 133;Xis 83 anins
134;Xis 83 anins 13S;Xis 83 anins 136;Xis 83 anins s 83 anins138;Xis
83 anins 139;Xis 83 anins 140;Xis 83 anins 141;Xis 83 anins 142;Xis 83 andY
is 143; Xis 83 anins 144; Xis 83 anins 145; Xis 83 deis 146; Xis 83 andY is 147;X
is 83 deis 148; Xis 83 anins 149;Xis 83 anins 150;Xis 83 anins 151;Xis 83 and
Yis 152;Xis 83 anins 153;Xis 83 anins 154;Xis 83 anins 155;Xis 83 deis 156;
Xis 83 anins 157;Xis 83 anins 158;Xis 83 andY is 159;Xis 83 anins 160;Xis 83
anins 161;Xis 83 anins 162;Xis 83 anins s 83 deis 164; Xis 83 anins
165;Xis 83 anins 166;Xis 83 deis 167; Xis 83 anins 168;Xis 83 anins169;Xis
W0 2016/110584
83 anins 170;Xis83 anins 171;Xis 83 anins 172;Xis 83 andY is 173;Xis 83 andY
is 174;Xis 83 deis 175; Xis 83 anins s 83 anins 177;X is 83 anins 178;X
is 83 anins 179;Xis 83 anins 180;Xis 83 anin8181;Xis 83 and Yis 182;Xis 83 and
Yis 183;Xis 83 anins 184;Xis 83 anin3185;Xis 83 andY is 186;
XisS4anins1;Xi384anins2;Xi384anins3;Xis84anins 4;Xis s 5;
Xis s 6;Xis 84anins7;Xis 84anins 8;Xis 84 andY is 9;Xis 84anins
;Xis 84 anins 11;Xis 84anins 84anins 13; X1584 anins 84
anins 15;Xis 84 anins 16;Xis$4anins 17;Xis84anins 18;Xis 84 anins 19;X
is84aninsZO;Xis 84aninle;Xis843.11ins22;Xi584 anin523;Xis84anins
24;Xis 843.11in525;Xis84aninsZ6;Xis84aninsZ7; Xis84aninsZ8;Xi584
aninsZ9;Xis 84anins30;Xis84anins31;Xi384anins32;XisS4anins33;X
isS4anin534;Xis s35;Xis84anins 36;XisS4 anins37;XisS4anins
38;Xis 84 anins39;Xis84anins40;Xis84anins41; Xi584 anins42;XisS4
anins43;Xis 84 anins44;Xis84anins45;Xis 84anins46;Xis84 anins47;X
ins48;Xis 84anins49;XisS4aninsSO;Xis 84 aninsSl;XisS4anins
52;Xis 84aninsS3;X1884 aninsS4;Xis 84anin855;Xis84andY1356;Xi884
anins57;Xis 84anins 58;Xis 84anins 59;Xis84 anins 60;Xis 84 anins 61;X
is 84anins 62;Xis 84anins63;Xis 84 anins 64;Xis 84 anins 65;Xis84anins
66;Xis84anin567;Xis 84anins68;XisS4anins69;Xis 84 anins 70;Xis 84
anins71;Xi384 anins72;Xis 84anins73;Xis84anins74;Xis 84anins 7S;X
is 84anins76;Xis 84anins77;Xi584anins78;Xis 84anins79;X1384anins
0;Xis 84anins 81;Xis 84anin382;Xis 84anin383;Xis84anins 84;Xis 84
anins85;Xis84aninsS6;XisS4anins 87;Xis84anins88;Xis84aninsS9;X
is 84 anins 90;Xis 84anins91;Xis 84 anins 92;Xis 84 anins 93;Xis 84 anins
94;Xis 84anins 95;Xis84anins96;Xis 84 anins 97;Xis84anins98;XisS4
anins99;Xis 84 anins 100;Xis84anins lOl;Xis$4anins 102;Xis s
103;Xis 84 anins 104;Xis 84 anins 105;Xis 84 aninle6;Xis 84 anins 107;Xis
84andY13108;Xi584anins109;Xis84anins110;Xi884anins111;Xi584andY
is 112;Xis84anins 113;Xi584anins s 84anins 115;X1384anins 116;X
is 84 anins s84 anins 118;Xis 84 anins 119;Xis 84 anins 120;Xis 84and
Yis 121;Xis 84 anins 122;Xis 84 anins 123;Xis 84 anins 124;Xis 84 deis 125;
Xis 84 anin5126;Xis 84 anins 127; Xis 84 anins 128; Xis 84 deis 129; Xis 84
deis 130; Xis 84 anins 131;Xis 84 anins 132;Xis 84 deis 133; Xis 84 anins
134;Xis 84 anins 135;Xis 84 anins 136;Xis 84 anins 137;Xis84 anins 138;Xis
84 anins 139;Xis 84 anins 140;Xis 84anins 141; Xis84 anins 142;Xis 84 andY
W0 10584
is 143;Xis 84 anins 144;Xis 84 anins 145;Xis 84 anins 146;Xis 84 anins 147;X
is 84 anins 148;Xis 84anins 149;Xis 84 anins 150;Xis 84 anins 151;Xis 84 and
Yis 152;Xis 84 aninslS3;Xis 84 anins 154;Xis 84 anins 155;Xis 84 deis 156;
Xis 84 anins 157;Xis 84 anins s 84 anins 159;Xis 84 anins s 84
anins 161;Xis 84 anins 162;Xis 84 anins 163;Xis 84anins 164;Xis 84 anins
165;Xis 84 anins 166;Xis 84 anins s 84 anins 168;Xis 84 anins 169;Xis
84 anins 170;Xis 84 anins 17I;Xis 84 anins 172;Xis 84 anins 173;Xis 84 andY
is 174;Xis 84 anins 175;Xis 84 anins 176;Xis 84 anins 177;Xis 84 anins 178;X
is 84 anins 179;Xis 84anins 180;Xis 84 anins 181;Xis 84anins 182;Xis 84and
Yis 183;Xis 84 anins s84a.nins s 84 anins 186;
Xis85anins1;Xis85aninsZ;Xis85 anins3;Xis85anins4;Xi585aninsS;
Xis85 anins 6;Xis 85anins7;Xis85anins8;Xis 85 anins9;Xi585anins
;Xis 85 aninsll;Xi385 anins 12;Xis85 anins 13;Xis 85 anins 14;Xis 85
anins15;XiSSSaninsI6;Xis85anins l7;Xis85anins 18;Xi585aninsI9;X
is 85 aninsZO;Xis85 anin321;Xis 85 anin522;Xis 85anins23;Xi585 anins
24;Xis85 anins 25;Xis 85 aninsZ6;Xi385 aninsZ7;Xis 85 anins 28;Xis85
aninsZ9;Xis85 anins30;Xis85anins31;Xis85 anins32;Xis85 anins33;X
is85anins34;Xis 85 anins35;Xi385 anins36;Xis 85anins37;Xis85 anins
38;Xis 85 anins 39;Xis85 anins40;Xis85 anins4l;Xis 85 anins 42;Xis 85
anins43;Xis85anins44;X1885anins45;Xi585anins46;Xis85 anins47;X
is 85 anins48;Xi385anins49;Xis 85 aninsSO;Xis85anin551;Xis85 anins
52;Xis85 anins 85 anins 54;Xis85 anin555;Xis 85 anins 56;Xis 85
aninsS7;Xis85 anins58;Xis85 anin359;Xis8S anins60;Xis85 anins61;X
is 85 anin362;Xis 85 anins63;Xis85 anins64;Xis85 anins65;Xis85 anins
66;Xis 85 anins 67;Xis 85 anins 68;Xis 85 anin869;Xis 85 anins 70;Xis 85
anins71;Xi585 anins72;Xis85 anins73;Xis 85 anins74;Xis85 5;X
is 85 anins 76;Xis 85 anins77;Xis 85 anins78;Xi385 anins79;Xis85 anins
80;Xis85 anins 81;X1's 85 anin382;Xis 85 anin383;Xis 85 anins 84;Xis85
anins 85;Xi585 6;Xi585 anins 87;Xi585 anins88;Xis85 anins89;X
is 85 anins90;Xis 85 anins9l;Xis85 anins92;Xis 85anins93;Xi385 anins
94;Xis 85 anins95;Xis 85 anins96;Xis 85 anins97;Xis 85 anins 98;Xis 85
anins 99;Xis 85 anins 100;Xis 85 anins s 85 anins 102;Xis 85 anins
103;Xis 85 anins s 85 anins 105;Xis 85 anins 106;Xis 85 anins 107;Xis
85anins108;Xis85anins109;Xis85aninsllO;Xis85anins111;Xi385andY
is 112;Xis85anins 113;Xis85aninsll4;Xis85anins115;Xis85anins116;X
W0 2016/110584
is 85 anins s 85 anin3118;Xis 85 anins 119;Xis 85 anins 120;Xis 85 and
Yis 121;Xis 85 22;Xis 85 andY13123;Xis 85 andY is 124; Xis 85 anins 125;
Xis 85 anins 126;Xis 85 anins 127;Xis 85 an Yis s 85 anins 129;Xis 85
anins 130;Xis 85 anins 131;Xis 85 anins 132;Xis 85 anins 133;Xis 85 anins
134;Xis 85 anins 135;Xis 85 anins 136;Xis 85 anins 137;Xis 85 anins 138;Xis
85 anins 139;Xis 85 anins 140;Xis 85 anins 141;Xis 85 andY is 142;Xis 85 andY
is 143;Xis 85 anins 144;Xis 85 anins 145;Xis 85 anins 146;Xis 85 anins 147;X
is 85 anins 148;Xis 85 anins 149;Xis 85 anins 150;Xis 85 anin5151;Xis 85 and
Yis 152;Xis 85 anins 153;Xis 85 anins 154;Xis 85 andY is 155; Xis 85 deis 156;
Xis 85 anins 157;Xis 85 anins 158;Xis 85 anins s 85 anins 160;Xis 85
anins161;Xis 85 anins 162;Xis 85 anins 163;Xis 85 anins 164;Xis 85 anins
165;Xis 85 anins 166;Xis 85 anins 167;Xis 85 anins 168;Xis 85 anins 169;Xis
85 anins 170;Xis 85 anins 171;Xis 85 anins 172;Xis85 anins 173;Xis 85 andY
is s 85 anins 175;Xis 85 anins 176;Xis 85 aninS 177;Xis 85 anins 178;X
is 85 anins 179;Xis 85 anins 180;Xis 85 anins 181;Xis 85 anins 182;Xis 85 and
Yis 183;Xis 85 anins 184;Xis 85 anins 185;Xis 85 aninsl86;
Xis86anins1;Xis86anin52;Xi586anins3;Xis86anins4;Xis86aninsS;
Xis 86anins6;Xis 86 anins7;Xi586anins 8;Xis86anin39;Xis86anins
;Xis86anins 11;Xis86anins12;Xis86anins13;Xi886anins 14;Xis86
anins 15;Xis 86 anins 16;Xis 86 anins 17;Xis 86 anins s 86 anins 19;X
is 86 anin320;Xis 86 anin321;Xis 86 anins22;Xis86 anin523;Xis 86 anins
24;Xi386 aninsZS;XisS6aninsZ6;Xis 86 anin527;Xis86 anin528;Xi586
anin529;Xis 86 anins 30;Xis 86anins31;Xis86anins32;Xis 86 anins33;X
is 86 anins34;Xis 8621.11in535;Xi586anins36;Xis86anins37;Xis86anins
38;Xis86anins 39;Xis 86 anins40;Xis s41;Xis86 anins42;Xis86
anins43;Xis86 anins44;Xis86anins45;Xi386anins46;Xi586 7;X
is 86 anins48;Xis 86 anins49;Xis86anin350;Xi586anins 51;Xi586anins
52;Xi586 anins53;Xis86anins54;Xis 86 anins 55;Xis86anins 56;Xi586
anins57;Xis 86anin358;Xis 86anin359;Xis86anin860;Xis86 anins6l;X
is 86anins62;Xis 86 3;Xis 86anins64;XisS6anins65;XisS6 anins
66;Xis86anins67;Xis86anins68;Xis 86 anin569;Xis 86 anins 70;Xi586
anins71;Xis 86 anins 72;Xis 86 anins73;Xis 86 anins74;Xis 86anins 75;X
is s76;Xis 86anins77;Xis 86 anins78;Xis 86anins79;Xis 86anins
80;Xis 86 anins 81;Xis 86 anins82;Xis 86 3;Xis 86aninS 84;Xi386
anin585;Xis 86anin886;Xis86 anins 87;Xis86 8;Xis 86anins 89;X
W0 2016/110584
i386anins90;Xis 86anins91;Xis 86 andY1592;Xis 86anins93;Xi386anins
94;Xis 86anins95;Xis s96;Xis s97; Xis 86anins98;Xi586
anins99;Xis 86 anins 100;Xis 86 anins 101;Xis 86 anins 102;Xis 86 anins
103;Xis 86 anins s 86 anins 105;Xis 86 anins 106;Xis 86 anins s
86 anins s 86 anins 109;Xis 86 aninsllO;Xis 86 anins 111;Xis 86 andY
is 112;Xis 86anins 113;Xis 86 anins 114;Xis 86anins 115;Xis 86 aninS 116;X
is 86anins 117;Xis 86anins 118;Xis86anins 119;Xis 86aninsl20;Xis 86and
Yi3121;Xis 86 anins 122;Xis 86 anins 123;Xis 86 anins 124;Xis 86 anins 125;
Xis 86 anins 126; Xis 86 anins s 86 deis 128; Xis 86 deis 129; Xis 86
anins 130;Xis 86 anins 131;Xis 86 anins s 86 anins 133;Xis 86 anins
134; Xis 86 anins 135;Xis 86 anins 136;Xis 86 anins 137;Xis 86 anins 138;Xis
86261in3 139;Xis 86 anins 140;Xis86 aninsl 1;Xis 86 anins 142;Xis 86 andY
is s 86 deis 144; Xis 86 anins 145;Xis 86 deis 146; Xis 86 anins 147',X
is 86 anins 148;Xis 86anins 149;Xis 86 anins 150;Xis 86 anin3151;Xis 86 and
Yi3152;Xis 86 anins 153;Xis 86 anins 154;Xis 86 anins 155;Xis 86 anins 156;
Xis 86 deis 157; Xis 86 anins 158;Xis 86 anins 159‘,Xis 86 anins s 86
deis 161; Xis 86 anins 162;Xis 86 anins 163;Xis 86 anins 164;Xis 86 anins
165; Xis 86 deis 166; Xis 86 andY is 167;Xis 86 anins 168;Xis 86 anins169;Xis
86 anins 170;Xis 86 anins 171;Xis 86anins 172;Xis 86 anins 173;X1's 86 andY
is 174;Xis 86 anins 175;Xis 86 anins I76;Xis 86 anins 177;Xis 86 anins 178;X
is 86 anins s 86 anins 180;Xis 86 anins 181;Xis 86 anins 182;Xis 86 and
Yis 183;Xis 86 anins s 86anins 185;Xi386 deis 186;
Xis 87andY1's 1;Xis 87anin52;Xis87 anins3;XisS7anins4;Xis87aninsS;
Xis 87anins 6;Xis 87 anins7;Xis 87anins 8;Xis 87 anins9;Xis 87 anins
10;Xis 87anins 11;Xis 87 anins 12;Xis 87 anins 13;Xis 87 anins l4;Xis 87
aninslS;Xis87anins 16;Xi387anins17;Xi387anins18;XisS7anins19;X
is 87aninsZO;Xis 87anin321;Xis87anin522;Xis87 anins23;Xis87anins
24;Xis s25;Xis 87 anin326;Xis 87 aninsZ7;Xis 87 anin328;Xis 87
anin529;Xis87anins30;XisS7anins31;Xis87anins32;Xis87anins33;X
i887anins34;Xis87aninsBS;Xis 87 aninsS6;Xis 87anins37;Xis 87anins
38;Xi587anins 39;Xis 87 anins40;Xis87anins 41;Xis 87 anins42;Xis 87
anins43;Xis87anins44;Xis87anins45;Xis87anins46;Xis87anins47;X
is 87anins48;Xi587anins49;Xis 87 aninsSO;Xis 87aninsSl;Xis 87anins
52;Xis 87 aninsSS; Xi387 anins54;Xis87aninsSS;Xis 87 anins S6;X1887
aninsS7;Xis 87 anins 58;Xis87anins 59;XisS7anins60;Xis87anins61;X
W0 2016/110584
is 87 anins62;Xis87anins63;Xis87 anins64;Xis 87anins 65;Xi587 anins
66;Xi387 anins 67;Xis87 anins68;Xis87anins69;Xis 87 anins70;Xis87
anins 71;Xis 87 anins72;Xis87 anins73;Xis 87 anins74;Xis 87 anins75;X
is s76;Xis87anins77;Xis 87 anins 78;Xis 87anins79;XisS7 anins
80;Xis87anins81;Xis 87 andY1582;Xis 87 anins 83;Xis 87 anins84;Xis87
anins 85;Xis 87 anins 86;Xis 87 anins 87;Xis87 aninsSS; Xis 87 anins 89;X
is s90;Xis87anins91;Xis 87 2;Xis 87anins 93;Xis87anins
94;Xi587 anins95;Xis87 anins96;XisS7anin397;Xi587 anins98gXi387
anins 99; Xis 87 anins s 87 anins 101;Xis 87 anins 102;Xis 87 anins
103;Xis 87 anins s 87 anins 105;Xis 87 aninS 106;Xis 87 anins 107;Xis
87 anins 108;Xis 87 anins 109;Xis87 anins110;Xis 87 anins s 87 andY
is sS7anins 113;Xis 87 anins 114;Xis 87 anins s s 116;X
is 87 anins 117;Xis 87 anins 118;Xis 87 anins 119;Xis 87 anins 120;Xis 87 and
Yis 121;Xis 87 anins 122;Xis 87 anins 123;Xis 87 andY is 124;Xis 87 deis 125;
Xis 87 anins126;Xis 87 anins 127;Xis 87 anins 128;Xis 87 anins 129;Xis 87
anins 130;Xis 87 anins 131;Xis 87 anins 132;Xis 87 anins 133;Xis 87 anins
134;Xis 87 anins s 87 anins 136;Xis 87 anins 137; Xis 87 anins 138;Xis
87 anins 139;Xis 87 anins 140;Xis 87 anins 141;Xis 87 anins 142;Xis 87 andY
is 143;Xis 87 anins 144;Xis 87 anins 145;Xis 87 anins 146;Xis 87 anins 147;X
is 87 anins 148;Xis 87 anins 149;Xis 87 anins 150;Xis 87 anins 151;Xis 87 and
Yis 152;Xis 87 anins 153;Xis 87 anins 154;Xis 87 anins 155;Xis 87 anins 156;
Xis 87 anins 157;Xis 87 anins s 87 anins 159;Xis 87 anins s 87
anins 161;Xis 87 anins 162;Xis 87a11ins s 87 anins 164;Xis 87 anins
165;Xis 87 anins 166;Xis 87 anins 167;Xis 87 anins 168;Xis 87 anins 169;Xis
87 anins 170;Xis 87 anins 171;Xis 87 anins 172;Xis 87anins 173;Xis 87andY
is 174;Xis 87 anins 175;Xis 87 anins 176;Xis 87 anins 177;Xis 87 anins 178;X
is 87 anins 179;Xis 87 anins 180;Xis 87 anins 181;Xis 87 anins 182;Xis 87 and
Yis 183;Xis 87 anins 184;Xis 87 anins 185;Xis 87 deis 186;
Xis88anins 1;Xis 88 aninsZ;Xis 88 anin33;Xis88anins4;Xi388 aninsS;
Xis 88 anins6;Xis 88 anins7;Xi388anins 8;Xis 88anins 9;Xis 88 anins
;Xis 88 anins 11;X1388 anins 12;Xis 88 anins 13;Xis88anins 14;Xi388
anins 15;Xis 88 aninsl6;Xis 88 anins 17;Xi888 aninsl8;Xis 88 anins 19;X
is 88 aninsZO;Xis 88 anins 21;Xis88 anins22;Xis 88 aninsZ3;Xis 88 anins
24;Xi588 anin525;Xis 88 anin326;Xi388 anin527;Xis 88anins 28;Xis88
auinsZ9;Xis88 anins3O;Xi388anin331;Xi588 anins32;Xis 88anins33;X
W0 2016/110584
is88anins34;XisSSanins35;Xis 88 aninsS6;Xi388 anins37;Xis88anins
38;Xi388anins 39;Xis 88 anins40;Xis 88anins41;Xis 88 anins42;Xis 88
anins43;Xis 88 anins44;Xis88 anins45;Xis88anins46;Xis88 anins47;X
i588 anins48;Xis 88anins49;Xis 88 anin350;Xis88 aninsSl;Xis88anins
52;Xis88 anins 53;Xis 88 anins 54;Xis 88 anins 55;Xis 88 aninsS6;Xis 88
anins 57;Xis 88 anins 58;Xis 88 anins 59;Xis 88 anins 60;Xis 88 anins 61;X
is 88 anins62;Xis 883ninsé3;Xi388 anins 88 anin565;Xis88anins
66;Xis88 anins 67;Xis 88 anins68gXis 88 anins69;Xis 88 anins70;Xis88
I;Xis 88 anins72;Xis 88anins73;Xis 883nins74;Xis 88 anins 75;X
is 88 anins76;Xi5883nins77;Xis 88 anins78;XisSSanins79;Xis88 anins
80;Xis 88 anins 81;Xis 88anins82;Xis 88 anins83;Xis 88anins84;Xis 88
anins 85;Xis 88 anins 86;Xis 88 anins 87;Xis 88 anin588;Xis88 anins89;X
is 88 anins 90;Xis 88 anins91;Xis 88 anins92;Xi888 anins93;Xis 88 anins
94;Xis88anins 95;Xis 88 anins96;Xi588 anins97;Xis 88 8;Xi888
anins 99; Xis 88 anins 100;Xis 88 deis .101; Xis 88 deis 102; Xis 88 anins
103;Xis 88 anins 104;Xis 88 anins 105; Xis 88 anins 106;Xis 88 anins 107;Xis
88 anins 108;Xis 88 anins 109;Xis 88 anins s 88 anins111;Xis 88 andY
is 112;Xis 88 anins 113;Xis 88 anins 114;Xis 88 anins 115;Xis 88 anins 116;X
is 88 anins 117;Xis 88 anins 118;Xis 88 aninsll9;Xis 88 anins 120;Xis 88 and
Yis 121;Xis 88 anins 122;Xis 88 anins 123;Xis 88 anins 124;Xis 88 deis 125;
Xis 88 anin5126gXis 88andY13127;Xis 88 anins 128;Xis 88 anins 129;Xis 88
anins 130;Xis 88 anins 131;Xis 88 anins 132;Xis 88 anins s 88 anins
134;Xis 88 anins 135;Xis 88 anins 136;Xis 88 anins s 88 anins I38;Xis
88 anins 139;Xis 88 anins 140;Xis 88 anins 141;Xis 88 anins 142;Xis 88 andY
is 143;Xis 88 anins s 88 anins 145;Xis 88 anins I46;Xis 88 anins 147;X
is 88 anins 148;Xis 88 anins s 88 anins 150;Xis 88 anins 151;Xis 88 and
Yis 152;Xis 88 anins 153;Xis 88 anins 154;Xis 88 anins 155;Xis 88 deis 156;
Xis 88 anins 157;Xis 88 andY is 158; Xis 88 anins 159;Xis 88 anins 160;Xis 88
anins s 88 anins162;Xis 88 anins 163; Xis 88 anins 164;Xis 88 anins
165;Xis 88 anins 166;Xis 88 deis 167; Xis 88 anins 168;Xis 88 anins 169;Xis
88 anins 170;Xis 88 anins 171;Xis 88 anins 172;Xis 88 anins s 88 andY
is 174;Xis 88 deis 175; Xis 88 anins 176;Xis 88 anins 177;Xis 88 anins 178;X
is 88 anins 179;Xis 88 anins 180;Xis 88 anins 181;Xis 88 anins 182;Xis 88 and
Yis 183;Xis 88 anins 184;Xis 88 anins 185;Xis 88 deis 186;
W0 2016/110584
XisS9anins1;Xis89anins2;Xis89anins3;Xis89anins 4;Xis 89aninSS;
Xis 89anins6;Xis89anins7;Xis89andYisS;Xis89 andY is9;Xis89anins
;Xis 89anins 11;Xis s 12;X1589anins l3;Xis 89 aninsl4;Xi889
anins 15;Xis89anins 16;Xi589 anins 17;Xis89&nins 18; Xis89 anins 19;X
is 89 anins 20;Xis 89 anin321;Xis89 anins 22;Xi389 andY isZ3;Xi589 anins
24;Xi589 anin525;Xis 89 anins26;Xis89 anin327;Xis 89 8;Xi589
aninsZ9;XisS9 anins30;Xi589 anins31;Xis89 anin532; Xi589anins33;X
is 89 anins 34;Xis 89 anins 3S;Xis 89 anins36;Xis 89 andY is37;Xis89 anins
89 anin539;Xis 89anins4O;Xis89anins41;Xi389 2;Xi589
anins43;Xis 89 anins44;Xi589 anins45;Xis89anins46; Xis 89 anins47;X
isS9anins48;Xi589anins49;Xis 89 aninsSO;Xis89 andY is 51;Xi589anins
52;Xis89 anins 53;Xis 89 anins 54;Xis 89 aninsSS; Xis89 aninsS6;XisS9
anins 57;Xis 89 anins 89 anins 59;Xi589 0; Xi389 anins6l;X
is 89anins 62;Xis 89anins63;Xi589anins64;Xis 89 anins65gXi589 anins
66;Xis 89anins 67;Xi389anins68;Xis89anins69; Xis 89 anins70;Xi389
anins71;Xis 89anins72;Xis 89 anins 73;Xis 89anins74;Xis89anins75;X
is 89 anins76;Xis89anins77;Xis89 anins78;Xis 89 9;XisS9anins
80;Xis 89anins 81;Xis 89 anins 82;Xis 89 deis 83; Xis 89 anins 84;Xis 89
aninsSS;Xis 89 anins 86;Xis89 anin587;Xis89anins 88;Xis 89 anins 89;X
i589 anins90;Xis 89adeis91;Xis 89 anins 92;Xis 89 anins 93;Xis 89 anins
94;Xis 89 anins95;Xis 89anins96;Xis89anins 97;Xis89anins98;Xi389
anins99;Xi389anins100;Xi389a.nins101;XisS9anins102;Xi589anins
103;Xis 89 anins 104;Xis 89 anins 105;Xis 89 anins 106;Xis 89 anins 107;Xis
89 anins 108;Xis 89 anins 109;Xis 89 anins 110;Xis89 anins 111;Xis 89andY
Xis89aninsii3;Xis89anins114;Xis89anins 115;Xis89anins 116;X
is 89 anins 117;Xis 89anins 118;Xis 89 anins 119;Xis 89 anins 120;Xis89 and
Yis 121;Xis 89 anins 122;Xis 89 anins 123;Xis 89 anins 124;Xis 89 anins 125;
Xis 89 anins 126;Xis 89 andY is 127; Xis 89 deis 128; Xis 89 anins 129;Xis 89
anin5130;Xis 89 anins s 89 anins 132;Xis 89 anins 133;Xis 89 anins
134;Xis 89 anins 135;Xis 89 anins 136;Xis 89 anins137;Xis 89 anins 138;Xis
89 anins 139;Xis 89 anins 140;Xis 89 anins 141;Xis 89 anins 142;Xis 89 andY
is 143;Xis 89 anins 144;Xis 89 anins 145;Xis 89 anins s 89 anins 147;X
is 89 anins 148;Xis 89 anins 149;Xis 89 anins 150;Xis 89 deis 151; Xis 89 and
Yis 152;Xis 89 anins s 89 anins 154;Xis 89 anins 155;Xis 89 anins 156;
Xis 89 anins 157;Xis 89 anins 158;Xis 89 anins 159; Xis 89 anins 160;Xis 89
W0 2016/110584
anins 16I;Xis 89 anins 162;Xis 89 anins 163;Xis 89anins 164;Xis 89 anins
165;Xis 89 anins 166;Xis 89 anins 167;Xis 89 68;Xis 89 anins 169;Xis
89aninsl70;Xi389anins171;XisS9anins172;X1889aninsl73;Xis89andY
is 174; Xis 89 anins 175;Xis 89 anins 176;Xis 89 anins 177;Xis 89 anins 178;X
is 89 anins 179;Xis 89 anin5180;Xis 89 anins s 89 anins s 89 and
Yis 183;Xis 89 aninsl84;Xis 89 85;Xis 89 andY is 186;
XisQOanins1;Xis90aninsZ;Xis90anins3;Xis90anins4;Xis90aninsS;
Xis90anins6;Xis90anins7;Xis90anins8;Xis90 anins9;Xis90anins
;Xis90anins11;Xis90anins12;Xis90anins l3; Xis90anins 14;Xis90
anins15;Xis90anins16;Xis90anins l7;Xi390anins18;Xis90aninsl9;X
is 90anins20;Xis90anin321;Xis90anin322;Xis90 aninsZ3;Xis90anins
24;Xis90andY1325;Xis 9Oanin526;Xis 527; Xis 90anins28;Xis90
aninsZQ;Xis90anins30;Xis90anins31;Xis9OandYi332;Xis90anin533;X
i390anins34;Xis9Oanins35;Xis90anins36;Xis90anins37;Xis90anins
38;Xis90anin539;Xis90anins40;Xis90anins41;Xis90anins42;Xis9O
anins43;Xis90anins44;Xis90anins45;Xis90anins46;Xi390anins47;X
is90anins48;Xis90anins49;Xis90aninsSO;Xis 90 aninsSl;Xis90anins
52;Xis 90 aninsS3;Xis 90aninSS4;Xis90anins 55; Xis 90 anins 56;Xi890
aninsS7;Xis90aninsS8;Xis90anins59;Xis90andYis60;Xis90anins61;X
i390anins62;Xis90anins63;Xis90anins64;Xis90andYi365;Xis90anins
66;Xis90anins67;Xis90anins68;Xis90anins69; Xis903nins70;Xis90
anins71;Xis90anins72;Xis90anins73;Xis90anins74;Xis90anins75;X
is90anins76;Xis90anins77;Xis90anins78;Xis90anins79;Xis90anins
80;Xis90anins 81;Xis90anin582;Xis90anin883;Xis90anins 84;Xis90
anin385;Xis90anins86;Xis9Oanin587;Xis9Oanins 88;Xi590anins89;X
i390 anins 90anins91;Xis90anins92;Xis 90anins93;Xis90 anins
94;Xis9Oanins95;Xis90anin396;Xis90anins97;Xis 90anins98;Xis90
anins99;XisQOanins100;Xis90anins101;Xis90anins102;Xis90anins
s 90 anins 104;Xis 90 anins 105;Xis 90 anins 106;Xis 90 anins 107;Xis
3O 90anin5108;Xis90anins109;Xis90anins110;Xis90anins111;Xis90andY
is 112;Xis90anins113;Xis90anins114;Xis90anins115;Xis90aninsll6;X
is90anins117;Xis90anins118;Xi390anins119;Xis9Oanins120;Xis90and
Yis 121; Xis 90 anins 122;Xis 90 anins 123;Xis 90 anins 124;Xis 90 anins 125;
Xis 90 anins 126;Xis 90 anins 127; Xis 90 anins s 90 anins 129;Xis 90
anins 130;Xis 90:111in3 131;Xis 90anins 132;Xis90aninsl33;Xis90anins
W0 2016/110584
134;Xis 90 anins 135;Xis 90 anins 136;Xis 90 anins 137;Xis 90 anins 138;Xis
90 anins 139;Xis 90 anins s 90 anins 141;Xis 90 andY is s 90 andY
is 143;Xis 90 anins 144;Xis 90 anins 145;Xis 90 anins 146;Xis 90 anins 147;X
is 90 anins 148;Xis 90 anins 149;Xis90 anins 150;Xis 90 anins 151;Xis 90 and
Yis 152;Xis 90 anins 153;Xis 90 anins s 90 anins 155; Xis 90 anins 156;
Xis 90 anins 157;Xis 90 anins 158;Xis 90 anins 159;Xis 90 anins 160; Xis 90
anins 161; Xis 90 anins 162;Xis 90anins s 90 anins 164;Xis 90 anins
165;Xis 90 anins 166;Xis 90 anins 167;Xis 90 anins 168;Xis 90 anins s
90 anins 170;Xis 90 anins 171;Xis 90anins 172;Xis90 andY is 173;Xis 90 andY
is 174;Xis 90 anins 175;Xis 90 anins 176;Xis 90 anins 177;Xis 90 anins 178;X
is 90 anins s 90 anins 180;Xis 90 anin8181;Xis 90 andY is 182;Xis 90 and
Yis 183;Xis 9O anins‘184;Xis 90 andY is 185;Xis90 anins 186;
Xis91aninsl;Xis91anins2;Xis91aninsB;Xi391anins4;XisQlaninsS;
Xis 91 anins 6;Xis91 anins7;Xis91 anin38;Xis 91 anins 9;Xis91 anins
10;Xis91 aninsll;Xis9l anins 12;Xis91 anins 13; X1591 anins 14;X1391
anins15;Xis91aninsl6;Xis91aninsl7;Xi391aninslS;Xis91aninsl9;X
is91anin520;Xis91aninle;Xis9lanin522;Xis91 anin323;Xis91anins
24;X1591 anins25;Xis91 andY1326;Xis9l aninsZ’T; Xis 91 aninsZS;Xis9l
anins29;Xis91anin330;Xis91anins31;Xis91anins32;Xis9lanins33;X
is91anins34;Xis9lanins35;Xi591anins36;Xis91anins37;Xis9lanins
38;Xis 91 9;Xis9l anins40;Xis91 anins41; X1591 anins42;Xis91
3;Xis9lanins44;Xis9lanins45;Xis91anins46;Xis91anins47;X
is 91 anins48;Xis9l 9;Xis91 anins 50;Xi591 aninsSl;Xis9l anins
52; Xis 91 anins 53; Xis 91 andY is 54;Xis 91 anins 55; Xis 91 anins 56;Xis 91
aninsS7;Xis91aninsS8;Xis91aninsS9;Xis91anins60;Xis91anins61;X
is91anins62;Xi391anins63;Xis91anins64;Xis91anins65;Xis91anins
66;Xis91anins67;Xis91anins68;Xis91anins69;XisQlanins70;Xis9l
anins71;Xis91anins72;Xis91anins73;Xis91anins74;Xis91anins75;X
is91anins76;Xis91anins77;Xis91anins78;Xi591anins79;Xi391anins
80;Xis91aninsSl;Xis91anin382;Xi891anin383;Xis91anins 84;Xis91
anins85;Xi591anin586;Xis91aninsS7;Xis91aninsS8;Xis91anin389;X
is 91 aninsQO;Xis 91 anins91;Xis 91 anins92;Xis91 anins 93;Xis 91 anins
94;Xi891andY1395;Xis91anins96;Xis91anins97;Xis91andY1898;Xis91
anins99;Xis 91 deis 100; Xis 91 anins 101;Xis91 anins 102;Xis 91 anins
103; Xis 91 anins 104; Xis 91 anins 105;Xis 91 anins 106;Xis 91 andY is 107;Xis
W0 10584
91 anins 108;Xi591 anins 109;Xis 91 aninsllO;Xis91 anins s91 andY
is112;Xis91anins113;Xis91aninsll4;Xis91anins115;Xi591anin5116;X
is91anins117;Xis91aninsllS;Xis9l anins119;Xis91 anin5120;Xis9l and
Yis 121;Xis 91 anins 122;Xis91 anins s 91 anins 124;Xis 91 deis 125;
Xis 91 anins 126;Xis 91 anins 127;Xis91 anins 128;Xis 91 anins 129;Xis91
anins 130;Xis 91 anins 131;Xis 91 anins s 91 anins 133;Xis 91 anins
134;Xis 91 anins 135;Xis91 anins 136;Xis 91 anins 137;Xis 91 anins 138;Xis
91 anins 139;Xis91 anins 140;Xis91 anins s91 anins 142;Xis91 andY
is 143;Xis 91 anins 144;Xis 91 anins 145;Xis 91 anins 146;Xis 91 anins 147;X
i591 anins 148;Xis 91 anins 149;Xis 91 anins 150;Xis 91 anins 151;Xis 91 and
Yis 152;Xis91 anins 153;Xis91 anins 154;Xis 91 anins 155;Xis 91 anins 156;
Xis 91 anins 157;Xis 91 anins 158;Xis91 anins 159;Xis 91 anins s91
anins 161;Xis91 anins 162;Xis91 anins 163;Xis 91 anins 164;Xis 91 andY is
165;Xis 91 anins 166;Xis 91 anins 167;Xis 91 anins 168;Xis 91 anins 169;Xis
91 anins 170;Xis91 anins 171;Xis9l anins s91 aninsl73;Xis91 andY
is 174;Xis 91 anins 175;Xis 91 anins 176;Xis 91 anins 177;Xis 91 anins 178;X
is 91 anins 179;Xis 91 anins 180;Xis 91 anins 181;Xis 91 anins s 91 and
Yis 183;Xis 91 anins 184;Xis 91 anins 185;Xis 91 deis 186;
XisQZanins1;Xis92anins2;Xis92andYis3;Xis92anins4;Xis92aninsS;
Xis92anin36;Xis92anins7;Xis92 anins 8;Xis92 anins9;Xis92anins
;Xis92anins11;Xis92anins12;Xis92aninS13;Xis9Zaninsl4;Xis92
anins15;Xis92anins16;Xis92aninsl7;Xis92anins18;Xis92aninsl9;X
is9Zanins20;Xis92anin821;Xis92anins22;Xis92 aninsZ3;Xis92 anins
92anin325;Xis92anins26;Xis92anin527;X1592 anins28;Xis92
andYisZ9;Xis92anins30;Xis92 anins31;Xis92anins32;Xis92anins33;X
is92anins34;Xis92 anins35;Xis92anins36;Xi392 anins37;Xis92 anins
38;Xis92anins39;Xis9Zanins40;Xis92 anins41;Xis 92anins42;Xis92
anins43;Xis92anins44;Xis92 anins45;Xis92anins46;Xis92 anins47;X
i392 anins48;Xis92andYis49;Xis92aninsSO;Xis92aninsSl;Xis92 anins
3O 52;Xi392 anins 53;Xis92aninsS4;Xis92anins55;Xis92 aninsS6;Xis92
andYis57;Xis92andYis58;Xis92anin359;Xis92 anins60;Xis92 anins6l;X
is9Zanins62;Xi592anin363;Xis92anins64;Xis92anins65;Xis92 anins
66;Xis92 anins 67;Xis 92 anins 68;Xis 92 anins 69;Xis 92 anins 70;Xis 92
anins71;Xis92 anins72;Xis923ndYis73;Xis92 anins74;Xis92 anins75;X
is92 anins76;Xis 92 anins77;Xis92 anins 78;Xis92 anins79;Xis92 anins
W0 10584
80; Xis 92anins 81;Xis 92 anins 82;Xis92 anins 83;Xis 92 anins84; Xis92
anins 85;Xis 92 anins 86;Xis92 anins87;Xis92 anins88;Xis 92 anins 89;X
is 92anins 90;Xis 92 anins91;Xis92 anins92;Xis92 anins 93;Xis92 anins
94;Xis 92 anins 95;Xis 92 anins 96;Xis 92 anins 97;Xis 92 8; Xis 92
anins 99; Xis 92 deis 100; Xis 92 anins 101; Xis 92 anins 102; Xis92 deis
103; Xis 92 anins 104; Xis 92 anins 105; Xis 92 anins 106; Xis 92 anins 107;Xis
92 anins 108;Xis 92 anins 169;Xis92 anins 110;Xis92 anins 111;Xis 92 andY
is 112;Xis92 anins 113;Xis 92 anins 114;Xis92 anins 115;Xis92 anins 116;X
is 92 anins 117;Xis92anins 118;Xis92 anins 119;Xis 92 anins 120;Xis 92and
Yis 121; Xis 92 anins 122; Xis 92 andY is 123; Xis 92 anins 124; Xis 92 anins 125;
Xis 92 anins 126; Xis 92 anins 127; Xis 92 andY15128;Xis92 anins 129; Xis92
anins s 92 anins 131;Xis 92 anins 132;Xis 92 anins 133;Xis92 anins
134;Xis 92 deis 135', Xis 92 anins 136;Xis 92 deis 137; Xis 92 deis 138; Xis
92 anins 139; Xis 92 anins 140; Xis 92 anins 141; Xis 92 deis 142; Xis 92 andY
is 143;Xis 92 andY is 144; Xis 92 anins 145; Xis 92 anins 146; Xis 92 anins 147;X
is 92 anins 148;Xis 92 anins 149;Xis 92 anins s 92 anins 151;Xis 92 and
;Xis92 anins 153;Xis 92 anins s 92 andY is 155;Xis 92 anins 156;
Xis 92 anins 157;Xis 92 anins 158;Xis 92 anins 159;Xis 92 anins160;Xis92
anins 161;Xis 92 anins 162;Xis92 anins 163;Xis92 deis 164; Xis92 anins
165; Xis 92 deis 166; Xis 92 anins 167; Xis 92 anins 168; Xis 92 anins 169;Xis
92 anins 170;Xis 92 anins 171;Xis 92 anins 172; Xis 92 anins 173;Xis 92 andY
is 174;Xis 92 anins 175;Xis 92 anins176;Xis 92 deis 177; Xis 92 anins 178;X
is 92 anins 179; Xis 92 anins 180; Xis 92 deis 181; Xis 92 anins 182; Xis 92 and
Yis 183;Xis 92 anins 184;Xis 92 anins 185;0rXis 92 anins 186.
In one embodiment, X is 3 and Y is 5.
The term “one or more CDRs”, as used in connection with the above embodiments, refers to one
of the CDRS HCDRl, HCDR2, HCDR3, LCDRl, LCDR2 and LCDR3 (e.g., HCDR3), or
several (i.e., 2, 3, 4, 5 or 6) of the CDRs, such as a set of HCDRI, HCDRZ and HCDR3 or a set
of LCDRl, LCDR2 and LCDR3. In a preferred embodiment, the term “one or more CDRs”
refers to all six CDRs, i.e., HCDRl, HCDR2, HCDR3, LCDRl, LCDR2 and LCDR3.
W0 10584
The term “one or more le domains”, as used in connection with the above embodiments,
ably refers to one of the VH domain and the VL domain or, more preferably, to both the
VH domain and the VL domain.
The term “nucleic acid molecule”, as used herein, is ed to include DNA and
RNA, such as
genomic DNA, cDNA, mRNA, recombinantly produced and chemically synthesized molecules.
A nucleic acid molecule may be -stranded or double-stranded. RNA includes
in vitro
ribed RNA (IVT RNA) or synthetic RNA.
In the context of the present invention, the term “DNA” relates to
a molecule which comprises
deoxyribonucleotide residues and preferably is entirely or substantially composed of
deoxyribonucleotide residues. “Deoxyrihonucleotide” relates to a nucleotide which lacks a
hydroxyl group at the 2’-position of a bofuranosyl group. The term "DNA" comprises
isolated DNA such as partially or completely purified DNA, ially
pure DNA, synthetic
DNA, and inantly generated DNA and includes modified DNA which s from
naturally occurring DNA by addition, deletion, substitution and/or alteration of one or more
tides. Such alterations can include addition of non-nucleotide material, such
as to the
end(s) of a DNA or internally, for example at one or more nucleotides of the DNA. Nucleotides
in DNA molecules can also comprise non-stande tides, such
as non-naturally occurring
nucleotides or chemically synthesized nucleotides. These altered DNAs
can be referred to as
analogs or analogs of naturally-occurring DNA.
In the context of the present invention, the term “RNA” relates to
a molecule which comprises
ribonucleotide residues and preferably being entirely or substantially composed of ribonucleotide
es. “Ribonucleotide” relates to a nucleotide with a hydroxyl
group at the 2'—position of a B-
D-ribofuranosyl group. The term includes double ed RNA, single stranded RNA, isolated
RNA such as partially purified RNA, essentially pure RNA, synthetic RNA, recombinantly
produced RNA, as well as modified RNA that differs from naturally occurring RNA by the
addition, deletion, substitution and/or alteration of one or more nucleotides. Such alterations
3O include on of non-nucleotide material, such as to the end(s) of
a RNA or internally, for
example at one or more nucleotides of the RNA. Nucleotides in RNA molecules can also
comprise non-standard nucleotides, such as non-naturally occurring nucleotides or chemically
synthesized nucleotides or deoxynucleotides. These altered RNAs can be referred to as analogs
or analogs of naturally-occurring RNA. According to the present invention, the term “RNA”
includes and preferably relates to “mRNA” which means “messenger
RNA” and relates to a
W0 2016/110584
transcript which may be produced using DNA as template and encodes a peptide or protein.
mRNA typically comprises a 5‘ non translated region (5'-UTR), a protein or peptide coding
region and a 3' non translated region {3‘-UTR). ...R A has a limited halftime in cells and in
vitro, Preferably, mRNA is produced by in vitro transcription using a DNA template. In one
embodiment of the invention, the RNA is obtained by in vitro transcription or al
synthesis. The in vitro transcription methodology is known to the skilled person. For example,
there is a variety of in vitro transcription kits commercially available.
The nucleic acid molecule according to the t invention may be contained/comprised in a
vector. The term “vector”, as used herein, includes any s known to the skilled person,
including plasmid vectors, cosmid vectors, phage vectors, such as lambda phage, viral vectors,
such as adenoviral or baculoviral vectors, or ial some vectors such as bacterial
artificial chromosomes (BAC), yeast artificial somes (YAC), or P1 artificial
chromosomes (PAC). Said s include expression as well as cloning vectors. Expression
vectors comprise plasmids as well as viral vectors and generally contain a desired coding
sequence and appropriate DNA sequences necessary for the expression of the ly linked
coding ce in a particular host organism (e.g., bacteria, yeast, plant, insect, or mammal) or
in in vitro expression systems. Cloning vectors are generally used to engineer and y a
certain desired DNA fragment and may lack functional sequences needed for expression of the
desired DNA fragments.
The term “cell” or “host cell” ably relates to an intact cell, i.e. a cell with an intact
membrane that has not released its normal intracellular components such as enzymes, organelles,
or genetic material. An intact cell ably is a viable cell, ie a living cell capable of carrying
out its normal metabolic functions. Preferably said term relates according to the ion to any
cell which can be transfected with an exogenous nucleic acid. Preferably, the cell when
transfected with an exogenous c acid and transferred to a recipient can express the nucleic
acid in the recipient. The term "cell" includes bacterial cells; other useful cells are yeast cells,
fimgal cells or mammalian cells. Suitable ial cells include cells from gram-negative
bacterial strains such as strains of Escherichia coli, Proteus, and Pseudomonas, and gram-
positive bacterial strains such as strains of Bacillus, Streptomyces, Staphylocowus, and
Lactococcus. Suitable fimgal cell include cells from s of Trichoderma, Neurospora, and
Aspergillus. le yeast cells include cells fi'om species of Saccharomyces (Tor example
Saccharomyces cerevisiae), saccharomyces (for example Schizosaccharomyces pombe),
Pichia (for example Pichia pastoris and Pichia methanolica), and Hansenula. Suitable
W0 2016/110584
mammalian cells e for example CHO cells, BHK cells, HeLa cells, COS cells, 293 HEK
and the like. However, ian cells, insect cells, plant cells, and
any other cells used in the
art for the expression of heterologous proteins can be used as well. Mammalian cells are
particularly preferred for adoptive transfer, such as cells fi‘om humans, mice, hamsters, pigs,
goats, and primates. The cells may be derived from a large number of tissue types and include
primary cells and cell lines such as cells of the immune system, in ular antigen-presenting
cells (APCs), such as dendritic cells, and T cells, stem cells, such as hematopoietic
stem cells and
mesenchymal stem cells, and other cell types. An antigen-presenting cell is a cell that displays
antigen in the context of major histocompatibility complex on its surface. T cells may recognize
this complex using their T cell receptor (TCR).
The binding agents of the invention can be produced either intracellularly (e.
g. in the cytosol, in
the periplasma or in inclusion ) and then isolated from the host cells and optionally further
purified; or they can be produced extracellularly (e.g. in the medium in which the host cells are
cultured) and then isolated from the culture medium and optionally further purified. Methods and
reagents used for the recombinant tion of ptides, such as specific le
expression vectors, transformation or transfection methods, selection markers, methods of
induction of protein expression, culture conditions, and the like, are known in the
art. Similarly,
n isolation and purification techniques are well known to the skilled person.
The binding agents, c acid molecules or cells described herein
may be administered in the
form of any suitable pharmaceutical composition.
The ceutical compositions of the invention are preferably sterile and contain
an effective
amount of the binding agents, nucleic acid molecules or cells described herein
to generate the
desired reaction or the desired effect.
Pharmaceutical compositions are usually provided in a uniform dosage form and may be
prepared in a manner known per so. A ceutical composition may, e.g., be in the form of a
solution or suspension.
A pharmaceutical composition may further se one or more carriers and/or excipients, all
ofwhich are preferably phannaceutically acceptable. The term "pharmaceutically acceptable",
used herein, refers to the non-toxicity of a material which, preferably, does
not interact with the
action of the active agent of the ceutical composition.
W0 2016/110584
The term “carrier" refers to an organic or inorganic component, of a l or synthetic nature,
in which the active ent is combined in order to facilitate, enhance or enable application.
According to the invention, the term “carrier” also includes one or more compatible solid or
liquid fillers, diluents or encapsulating substances, which are suitable for administration to a
subject.
Possible r substances for parenteral administration are, e.g., sterile water, Ringer, Ringer
e, sterile sodium chloride on, polyalkylene glycols, hydrogenated naphthalenes and, in
particular, biocompatible lactide polymers, lactide/glyoolide oopolymers or
p0lyoxyethylene/polyoxy—propylene copolymers.
The term “excipien ”, as used herein, is intended to include all sub s which may be present
in a pharmaceutical ition and which are not active ingredients, such as salts, binders,
lubricants, thickeners, surface active agents, preservatives, emulsifiers, buffer substances,
flavouring agents, or colorants.
Salts, which are not phannaceutically acceptable, may be used for preparing pharmaceutically
acceptable salts and are ed in the invention. Pharmaceutically acceptable salts of this kind
comprise in a non limiting way those prepared from the following acids: hydrochloric,
hydrobromic, ic, nitric, phosphoric, maleic, acetic, salicylic, citric, , c,
succinic acids, and the like. Pharmaceutically acceptable salts may also be prepared as alkali
metal salts or alkaline earth metal salts, such as sodium salts, potassium salts or calcium salts,
Suitable vatives for use in a pharmaceutical composition include benzalkonium chloride,
chlorobutanol, paraben and thimerosal.
Suitable buffer substances for use in a pharmaceutical composition include acetic acid in a salt,
citric acid in a salt, boric acid in a salt and phosphoric acid in a salt.
The agents and compositions described herein may be administered via any conventional route,
such as by parenteral administration including by injection or infilsion. stration is
preferably parenterally, e.g. intravenously, intraarterially, subcutaneously, intradermally or
intramuscularly.
W0 2016/110584
Pharmaceutical compositions suitable for parenteral administration usually comprise a sterile
aqueous or non-aqueous preparation of the active compound, which is preferably isotonic to the
blood of the recipient. Examples of compatible carriers/solvents/diluents
are Ringer solution and
isotonic sodium de solution. In addition, usually sterile, fixed oils
are used as solution or
suspension medium.
The agents and compositions described herein are administered in effective amounts. An
“effective amount” refers to the amount, which achieves a desired reaction
or a desired effect
alone or together with fiirther doses. In the case of treatment of a particular disease or of a
particular condition, the desired reaction preferably relates to inhibition of the course of the
disease. This comprises slowing down the progress of the disease and, in particular, interrupting
or reversing the progress of the disease. The desired reaction in a treatment of
a disease or of a
condition may also be delay of the onset or a prevention of the onset of said e
or said
condition. An effective amount of an agent or ition described herein will depend
on the
condition to be treated, the severeness of the disease, the individual
parameters of the patient,
including age, physiological condition, size and , the on of treatment, the type of an
accompanying therapy (if present), the specific route of administration and similar factors.
Accordingly, the doses administered of the agents described herein may depend on various of
such parameters. In the case that a reaction in a patient is insufficient with
an initial dose, higher
doses (or effectively higher doses ed by a ent, more localized route of
administration) may be used.
As used herein, the term “kit of parts (in short: kit)” refers to an article of manufacture
sing one or more containers and, optionally, a data carrier. Said one or more containers
may be filled with one or more of the above mentioned means or reagents. Additional containers
may be included in the kit that contain, e.g., ts, s and fiirther reagents. Said data
carrier may be a non-electronical data carrier, e. g., a graphical data can-ier such
as an information
leaflet, an information sheet, a bar code or an access code, or an electronical data carrier such as
a floppy disk, a compact disk (CD), a l versatile disk (DVD),
a microchip or r
semiconductor-based electronical data carrier. The access code may allow the access to a
database, e.g., an intemet database, a centralized, or a decentralized database. Said data r
may se ctions for the use of the binding agent, nucleic acid molecule, cell and/or
pharmaceutical composition of the present invention.
W0 2016/110584
The agents and compositions described herein can be administered to patients, e.g., in vivo, to
treat or t a variety of disorders such as those described herein.
The term “medicament”, as used herein, refers to a substance/composition used in therapy, i.e.,
in the ent of a disease.
According to the invention, the term “disease” refers to any ogical state, in particular
cancer, infectious diseases, inflammatory diseases, lic diseases, autoimmune disorders,
degenerative diseases, apoptosis-associated diseases and transplant rejections.
As used herein, the term “cancer” includes a e characterized by aberrantly regulated
cellular growth, proliferation, differentiation, on, and/or migration. By “cancer cell” is
meant an abnormal cell that grows by a rapid, uncontrolled cellular proliferation and continues to
grow after the stimuli that initiated the new growth cease. The term “cancer” according to the
invention comprises leukemias, mas, melanomas, teratomas, lymphomas,
neuroblastomas, gliomas, rectal , endometrial cancer, kidney , adrenal cancer,
thyroid cancer, blood cancer, skin cancer, cancer of the brain, cervical cancer, inal cancer,
liver cancer, colon cancer, stomach cancer, intestine cancer, head and neck cancer,
gastrointestinal cancer, lymph node cancer, esophagus cancer, colorectal cancer, pancreas
cancer, ear, nose and throat (ENT) cancer, breast cancer, te cancer, cancer of the uterus,
ovarian cancer and lung cancer and the metastases thereof. Examples thereof are lung
carcinomas, ma.-.rna carcinomas, prostate carcinomas, colon carcinomas, renal cell omas,
cervical carcinomas, or metastases of the cancer types or tumors described above.
The term “cancer” according to the invention also comprises cancer metastases. By "metastasis"
is meant the spread of cancer cells from its original site to another part of the body. The
formation of metastasis is a very complex process and depends on detachment of malignant cells
from the primary tumor, on of the extracellular matrix, penetration of the endothelial
basement membranes to enter the body cavity and vessels, and then, afier being transported by
the blood, infiltration of target organs. Finally, the growth of a new tumor, i.e. a secondary tumor
or metastatic tumor, at the target site depends on angiogenesis. Tumor metastasis often occurs
even afier the removal of the y tumor because tumor cells or components may remain and
develop metastatic potential. In one embodiment, the term "metastasis" according to the
ion relates to "distant metastasis" which relates to a asis which is remote from the
primary tumor and the al lymph node system.
W0 2016/110584
The term tious disease” refers to any disease which can be transmitted from individual to
individual or from organism to organism, and is caused by a microbial agent (e.
g. common cold).
Examples of infectious diseases include viral infectious diseases, such as AIDS (HIV), tis
A, B or C, herpes, herpes zoster (chicken-pox), German measles (rubella virus), yellow fever,
dengue etc. flaviviruses, influenza viruses, hemorrhagic infectious diseases (Marburg or Ebola
viruses), and severe acute respiratory syndrome (SARS), bacterial infectious es, such as
Legionnaire's disease (Legionella), sexually itted diseases (e. g. chlamydia or gonorrhea),
gastric ulcer (Helicobacter), cholera (Vibrio), tuberculosis, diphtheria, infections by E. coli,
Staphylococci, Salmonella or Streptococci (tetanus); infections by protozoan ens such as
malaria, sleeping sickness, leishmaniasis; toxoplasrnosis, i.e. infections by Plasmodium,
Trypanosoma, Leishmania and Toxoplasma; or fungal ions, which are caused, e.g., by
Cryptococcus neoformans, Histoplasma capsulatum, Coccidioides immitis, Blastomyces
itidis or Candida albicans.
The term “inflammatory disease” refers to any disease, which is characterized by
or associated
with high levels of inflammation in tissues, in particular connective tissues,
or degeneration of
these s. A chronic inflammatory disease is a medical condition which is characterized by
persistent inflammation. Examples of (chronic) inflammatory diseases include celiac disease,
vasculitis, lupus, chronic obstructive pulmonary disease (COPD), ble bowel disease,
atherosclerosis, arthritis, ankylosing spondylitis, Crohn’s disease, colitis, chronic active hepatitis,
dermatitis and psoriasis.
The term “metabolic e” refers to any e or disorder that disrupts normal lism.
es e cystinosis, diabetes, idemia, hyperthyroidism, hypothyroidism,
hyperlipidemia, hypolipidemia, galactosemia, r’s e, obesity and phenylketonuria.
The term “autoimmune disorder” refers to any disease/disorder in which the body produces
immunogenic (i.e. immune system) response to some constituent of its own tissue. In other
words, the immune system loses its ability to recognize some tissue or system Within the body as
self and targets and attacks it as if it were foreign. Autoimmune diseases can be classified into
those in which predominantly one organ is affected (eg. hemolytic anemia and anti-immune
thyroiditis), and those in which the autoimmune disease process is diffused through many tissues
(6.g. systemic lupus erythematosus). For example, multiple sclerosis is thought to be caused by T
cells ing the sheaths that surround the nerve fibers of the brain and spinal cord. This results
in loss of coordination, weakness, and blurred . Autoimmune diseases
are known in the art
W0 20161110584
and include, for instance, Hashimoto's thyroiditis, Grave's disease, lupus, multiple sclerosis,
rheumatic arthritis, hemolytic anemia, anti-immune thyroiditis, systemic lupus matosus,
celiac disease, Crohn‘s disease soriasis and the like.
2 colitis, diabetes, scleroderma, 7
The term erative disease” refers to any disease in which the function or ure of the
affected tissues or organs will increasingly deteriorate over time. Examples include Alzheimer’s
disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s e, macular
degeneration, multiple sclerosis, muscular dystrophy, Niemann Pick disease, osteoporosis and
rheumatoid arthritis.
The term “apoptosis-associated diseases” refers to any disease in which alterations of apoptosis
are involved. Examples include cancer, neurological disorders, such as Alzheimer’s e,
Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS) and stroke, heart
diseases, such as ischemia reperfusion and c heart failure, infectious diseases and
autoimmune diseases.
The term “transplant rejection” refers to the ion of a lanted tissue or organ by the
recipient’s immune system, which may, ultimately, destroy the transplanted tissue or organ.
By ” is meant to administer a compound or composition or a combination of compounds or
compositions to a subject in order to t or eliminate a disease, ing reducing the size
of a tumor or the number of tumors in a subject; arrest or slow a disease in a subject; inhibit or
slow the development of a new disease in a subject; decrease the frequency or severity of
symptoms and/or recurrences in a subject who currently has or who usly has had a disease;
and/or prolong, i.e. increase the lifespan ofthe subject.
In particular, the term “treatment of a disease” includes curing, shortening the duration,
ameliorating, preventing, slowing down or ting progression or worsening, or preventing or
ng the onset of a disease or the symptoms thereof.
The term “subjec ” means according to the invention a subject for ent, in particular a
diseased subject (also referred to as “patient”), including human beings, man primates or
other animals, in particular mammals, such as cows, horses, pigs, sheep, goats, dogs, cats,
s, guinea pigs, hamsters or rodents, such as mice and rats. In a particularly preferred
embodiment, the subject/patient is a human being.
W0 2016/110584 2016/050308
The agents and compositions provided herein may be used alone or in combination with
therapeutic regimens.
Examples
Example 1: Generation of agonistic anti~CD27, anti—CD134 and anti-CD137 antibodies
1.1 Immunization and collection of B-cell clones
9 s were immunized with a mixture of human CD27 (Enzo Life es, ALX031-
0000), human CD134 (0X40; AdipoGen, AG-40B-0014) and human CD137 (4-lBB; Enzo Life
Sciences, ALX029-0000), wherein each protein was fused to the Fc portion of human
IgGl. Blood was taken at 4 different time points and enriched for B-lymphocytes (also referred
to as B-cells). Single B-cells were sorted by fluorescence-activated cell sorting (FACS) into
wells of a l microtiter plate and ated for 8 days, releasing antibodies into the
cultivation medium. The B-cell tants were removed and prepared for testing.
1.2 Screening for target-binding antibodies by ELISA
In order to identify antibodies that bind to human CD27, CD134 and CD137, reSpectively,
enzyme-linked immunosorbent assay (ELISA) was ished. For this purpose, CD27 protein
(His-tagged, Sino Biological Inc. 10039-H08B1), CD134 protein (His-tagged, Sino Biological
Inc. 10481-H08H) and CD137 protein (His-tagged, Sino Biological Inc. 10041-H08H),
respectively, were coated onto microtiter plates. PBS containing 2% BSA and 0.05% Tween was
used for blocking. After incubation with B-cell atants, bound antibodies
were detected by
using a peroxidase-labeled anti-rabbit—Fc antibody.
Commercially available antibodies were used as reference dies for assay development.
Figure 1A shows binding curves of reference anti-CD27 antibodies (Armenian hamster
monoclonal anti-human CD27 clone LG7F9 and mouse onal anti-human CD27 clone
0323, both sed from eBiosciences) to recombinant protein. Figure 1B shows binding
curves of a reference anti-CD134 antibody (mouse monoclonal anti-human CD134 clone Ber—
ACT35, purchased from eBiosciences) to recombinant n. Figure 1C shows binding curves
of reference anti-CD137 antibodies (mouse anti-human CD137 clone 4B4—1 from Biolegend and
rat monoclonal anti-human CD137 from Biozol BZL06614) to recombinant protein. For all three
W0 20161110584
ELISAs, OD 450 urn/620 nm values > 0,5 indicated g, and the maximum value was at
about 3,6.
In total, 47.471 B-cells were , cultivated and screened for binding to CD27, CD134 and
CD137 by ELISA. 5.096 antibodies were fied to bind to at least to one of the three targets.
1.3 Identification of cell-binding antibodies
The 5.096 ELISA hits were then tested in a cellular binding assay for binding to cell surface
expressed CD27, CD134 and CD137, respectively. For this purpose, following stable
ectants of the HT1080 cell line were used: HT1080_CD27, HT1080_OX40 and
HT1080_4-1BB. Cells were ated in RPMI 1640 GlutaMAX supplemented with 5% PCS,
100 IU/mL penicillin, and 100 ug/mL streptomycin. Cell surface expression ofTNF receptors on
HTlOSO-transfectants was analyzed by FACS, n cells were stained using antibodies
against CD27-PE (BD), OX40-PE (BD) and 4-1BB-PE (BD) (Figure 2).
In order to test cellular binding of the antibodies, HTlOSO cells overexpressing the respective
target (1.000 cells per well of a 384-we11 microtiter plate) were incubated together with samples
for 18 hours. After gentle g, an labeled detection antibody and Hoechst dye were
added, and fluorescence intensity was read in the cell imager Celllnsight (Thermo). Data analysis
was based on the calculation of the mean object spot average intensity.
cially ble antibodies were used as reference antibodies for assay development.
Figure 3A shows binding curves of reference anti—CD27 antibodies (Armenian r
monoclonal anti-human CD27 clone LG7F9) to HT1080_CD27 cells. Figure ""1 shows bindingVJ"
curves of reference anti-CD134 antibodies (mouse monoclonal anti-human CD134 clone Ber-
ACT35) to HT1080_OX40 cells. Figure 3C shows binding curves of reference anti-CD137
antibodies (mouse anti-human CD137 clone 4B4—1) to HT1080_4-1BB cells. For all three cell
lines, a mean spot intensity > 25 indicated binding, and the maximum values were at about 300.
3.176 antibodies out of the 5.096 ELISA hits were identified to bind at least to one of the three
cell surface expressed targets by the cellular binding assay.
1.4 Recombinant antibody production
W0 10584
644 antibody hits, identified by ELISA and the cellular binding
assay as described above, were
selected. These hits were picked, their RNA was extracted, and sequencing
was performed. 582
unique sequences were identified, and the corresponding variable regions of heavy and light
chains were gene synthesized. The variable regions were cloned in front of human
immunoglobulin constant parts (IgGl/K). HEK293 cell transient transfections protocols were
executed by a Tecan Freedom Evo device on a Dionex Ultimate 3000 with
a plate auto-sampler.
Alter normalization, 531 dies were available for confirmation of the r , screening
data set , cellular binding) and for functional
assays.
1.5 Analysis of recombinantly expressed antibodies
In order to confirm the primary screening data set, all 531 recombinantly produced antibodies
were retested (i) for their binding to the correSponding inant protein in the ELISA and (ii)
for their g to the corresponding target expressed on the cell surface of HT1080 cells in the
cellular binding assay (both assays as bed .
Furthermore, for the analysis of agonistic antibody functions, target-overexpressing HT1080
cells were used, wherein ation of the targets (CD27, CD134 and CD137, tively)
induced IL-8 release from these cell lines. The recombinant CD27-, CD134- and CD137-
overexpressing HT1 080 cells (5.000 cells per well of a 384-well microtiter plate) were incubated
for 6 hours at 37°C with the antibody samples. IL-8 concentrations in the
supematants were then
determined by using an IL-8 ELISA kit (BD Bioscience). In a second ch, antibodies
were
cross-linked. Therefor, the target-overexpressing HTIOSO cells were incubated with
a mixture of
the antibody sample and a F(ab ’)2 fiagrnent goat anti-human IgG (Dianova). An agonistic
reference anti-CD27 antibody {described in US 2013/0183316 A1 (sequences 3 and 4,
hCD27.15)] was used for assay development. Figure 4 shows results of the IL—8 ELISA upon
antibody ion with and without cross-linking. For all three IL—8 ELISAs, OD 450 nm/620 nm
values > 0,5 indicated agonistic antibody activities, the maximum values being at about 3.
3O ther, 186 agonistic anti-CD27 antibodies, 92 agonistic anti-CD134 antibodies and 12
agonistic anti-CD137 antibodies were identified by the fianctional assay under cross-linking
conditions. To some extent, antibodies already showed agonistic activity t cross-linking.
The data of the ELISAs, the cellular binding assays and the functional
assays are summarized in
Table 1 for the agonistic anti-CD27 antibodies, in Table 2 for the agonistic anti-CD134
antibodies and in Table 3 for the agonistic anti-CD137 antibodies.
W0 2016/110584
ECSO values of the agonistic on of anti-CD27, anti-CD134 and anti-CD137, respectively,
upon cross-linking were determined by measuring IL-S release values of 12 different antibody
concentrations applied in the above—described functional assay. The ECSO value was calculated
using Xlfit-analysis tools (Fit Models 205). Resulting typical sigmoidal curve progression is
exemplarily shown in Figure 5 for one anti-CD27 antibody (P018.SO9.A.A06; ECSO: 387,2
ng/mL), for one anti-CD134 antibody (P018.SO2.A.H03; EC50: 214,9 ng/mL) and for one anti-
CD137 antibody (P018.SOS.A.EO3; ECSO: 4963,8 ng/mL). ECSO values of the dies are
listed in Table 4 (anti-CD27), Table 5 (anti-CD134) and Table 6 (anti-CD137).
ce information of the tested antibodies are listed in Table 7 CD27), Table 8 (anti-
CD134) as well as Table 9 (anti-CD137), wherein the sequences of the CDR regions are given
ing to the IMGT unique numbering scheme for V— and V-like—domains (Lefranc, M.-P.,
The Immunologist, 7, 132-136 (1999)).
W0 2016/110584
Cellular g
Functional assay
assay
Anti-C027
Antibody ID
[abs. corn] Cross-linked by Fiab'n fragment
lL-8 [abs. corn]
.01.A.GO4 3,765 388 0 273
P018.S.04.A.D04 0 486
P018.S.01.A.GOZ 0 848I
P018.S.07.A.BO4 ‘ 0 304
P018.S.06.A.303 424
P018.S.03.A.H04 0,211
.08.A.H02 0,328
P018.S.09.A.H03 0 578I
P018.S.09.A.E06 307
018.8.09.A.C03 0,464
P018.S.07.A.F03 3,528 380 0,444 1,413
P018.S.03.A.C04 3,524 0 394
P018.S.09.A.E05
P018.S.O4.A.E02 m
P018.S.01.A.BOS 37 m6 1,882
P013.S.04.A.B05 414 1,084
P018.S.01.A.GO3
P018.S.10.A.F05
P018.S.02.A.BOS 0 201 1,761
P018.S.04.A.GO4 3,479
P018.S.07.A.H02 3,471 0,107
P013.S.05.A.H02 3,469 336
0 736’
O 302
O 448
. . . 379
1,230
394 1,120
448 1,570
P018.S.06 A A03 387
W0 20161110584
'Po13.s.10.A.c06
P018.S.OZ.A.HOS
—_“_—
__mum
P018.S.03.A.D02
PbNN
I.”NN 9WHU'I
.07.A.602
lp0| 9UItoM
P018.S.03.A.F04
W0 20161110584
P018.S.06.A.E02
P018.S.10.A.EOI 227 0,257
P018.S.01,A.EO3 3,297 1,220
P018.S.01.A.H02 0,300
P018.S.01.A.C06 0,325 fw8
P018.S.05.A.F02 472
P018.S.03.A.E04 0,200
P018.S.04.A.A05
.07.A.C06 0,408 1,044
—P018.S.09.A.DOS 0,187
0,262
_m 0,444
_m- 0,264
0,123
0,394 1,971
P018.S.09.A.E03 3,272 334 0,099 1,545
P018.S.01.A.D02 3,258 323 0,675 1,667
P018.S.10.A.B06 0,455
P018.S.10.A.H02 1,573
.02.A.803 0,120
P018.S.01.A.C02 0,395
.O7.A.H05 —0,160 1.186
P018.S.01.A.A04 0,236
P018.S.01.A.C04 0,383
P018.S.02.A.F06 0,094 1,728
P018.S.06.A.H04 U)3 9.. 0, 173
.06.A.C02
P018.S.06.A.A02 0,737
P018,S.02.A.A01 0.400
P018.S.01.A.E05 0,209
P018.S.03.A.D03 3,216 0,281
P018.S.08.A.A03 W4N 0,276
P018.S.10.A.C03 0,079
P018.S.03.A.G03
P018.S.O7.A.E05 3,198 31 0,055 1,151
P018.S.03.A.D06 0,245
P018.S.01.A.C05 0,327
P018.S.02.A.GO4 3,188 0,205 1,674
P018.S.10.A.B01 0,080 1,037
P018.S.10.A.A06 -0, 130
P018.S.06.A.F04 0,678
P018.S.09.A.A05 1,953
P018.S.04.A.C05 3,173 0,382
P018.S.01.A.606 3,17 1 313 0,491 1,088-
P018.S.06.A.F06 3,170 0,700
W0 20161110584
P018.S.09.A.A03
P018.S.06.A.E04 281 0,327 1,223
P018.S.06.A.FO3 3,157
P018.S.07.A.GO4 p\l PN\lb
P01 .S.10.A.E04
P018.S.03.A.H02 0,130 1,071
P018.S.03.A.H03 iInNN
P018.S.03.A,F03
P018.S.01.F\.A05 3,148 0,328 1,086
.06.A.C03 0,272 1,131
P018.S.10.A.C05 11
P018.S.01.A.D05
P018.S.03.A.BOS "m:-
.10.A.A04 1,778 2,159
P018.S.05.A.C06 3,132
P018.S.02.A.GO3
P013.S.07.A.C02
P018.S.02.A.A06 0,299 1,476
P018.S.01.A.EOZ
P018.S.09.A.F05
P018.S.09.A.GOS
P018.$.03.A.D05
P018.S.10.A.BOZ ‘Op\10 1,907
P018.S.04.A.E05
P018.S.05.A.A05 0,324 1,582
P018.S.05.A.D03 9:pO01 1,278
P013.S.08.A.F01
P018.S.05.A.306
P018.S.03.A.DO4 3,098
P018.S.01.A.A06
P018.S.09.A.A06_mm“
P018.S.07.A.A02 3.081 314 m
P018.S.O7.A.D05 _-z-m
P018.S.05.A.E03 “
.10.A.E02 n—
P018.S.03.A.GOS 0,031
P018.S.09.A.EOZ 0,172
P018.S.09.A.F06 0,530
P018.S.06.A.H05
.10.A.H05
P018.S.06.A.A05
P018.S.09.A.A02
P018.S.09.A.C02
P018.S.06.A.B01 0,106 1,176
P018.S.10.A.C01
P018.S.05.A.D06
W0 20161110584
P018.S.02.A.B01 m
P018.s.1o.A.c02m
P018.S.10.A.FO4 2,889
P018.S.10.A.A03
Cellular g
Functional assay
assay
Anti-CD134
Antibody ID
Cross-linked by F(ab')z fragment
IL-S [abs. corn]
419 0,314
rrrrr
P018.S.05.A.GO3
—-m-
P0185 04 A A06
P013 5 04 A F06 2,358 402 2,071
P018 5 11 A C04m 406 0,253
P0185 12 A H05
. 527 QWJ:00 2,190
—m570
2,171
P018.S.12.A.F05 m
—m537
—m 5)OJOJ0
—-m-
——1 898
P0188 12 A A01m 0,071
P018 5 11 A F04 m 486 0,568
P018.S 04 A 304
P0185 12 A cos m
P0188 12 A 801m
W0 10584
P018.S.12.A.AO6
P018.S.11.A.E02 2,652 525 0,214 V 21043
P018.S.11 A A03
"Ia-m
P018.S.12.A.BOZ_“ 0,157 1,955
“mm-m“
_-m-
P018 5 12 A E02 2,589 497
P018 5 11 A H04
P018.S.13 A 605 0,002
P018.S.12.A.A02 1,577 .
P018.S.04.A.F04 0,000
Table 2. Binding and functional ty properties of agonistic anti-CD134 antibodies
ar binding
Functional. assay
Anti-c0137
Antibody ID
Cross-linked. by F(ab’)z fragment
IL-8 [abs. corn]
P018.S.13.A.A05 0,687
P018.S.14.A.H01 2 968I
P018.S.08.A.E03 m 9
P018.S.13.A.GO4 0. 1
P018.S.13.A.A06 3 388l
P018.s.os.A.A04m
P018.S.14.A.D06
Table 3. Binding and onal activity properties of agonistic anti-CD137 antibodies
Anti-C027
EC 50 [ng/mL]
Antibody ID
W0 10584
P0185. 10A. E04 233,6
P018.S,09.A.H06 329,1
P018.S.10.A.AO4 334,7
P018.S.10.A.C05 340, 1
Po1‘s.‘s.05.A. F05
P018.S.09.A.A06
P013..s.o4.A.Aos
P018.S.10.A.C02
P018.S.07.A.GOZ
P018.S.10.A.H01
P018.S.09.A.E05
P018.S.10.A.A03
P018.S.02.A.GO3
P018.S.09.A.DOS
.0.6.A.A02
P018.$.10.A.E01
P018.S.07.A.CO4
P018.S.03.A.A02 834,9
Table 4. ECSO values of agonistic anti-CD27 antibodies
Anti-(3313Al
EC 50 [nglmL]
Antibody ID
mam-Bus
P018.5.02.A.H03 '
214,9
W0 20161110584
P018.S.05.A.GOS
P018.S.12.A.F03
P018.S.11.A.A05
P018.S.12.A.DOS 2401,8
P018.S.12.A.DOG
P018.S.05.A.F05 7119,8
Table 5. B050 values of agonistic anti-CD134 antibodies
Anti-C0137
EC 50 [ng/mL]
Antibody ID
P018-5.08-A-503
P018.S.08.A.A04 5152,23
99185.1 .A.H01 5818.0
P018.S.14.A.A04 6789.0
P018.S.13.A.A06 7785,1
P018.S.14.A.DO6 0
P018.S.13.A.GO4 ,8 .
Table 6. ECSO values of agonistic anti—CD137 antibodies
WO 10584
. SEQ ID NOs of CDRs
SEQ “3 "05 0333:1444 °°mams
Anti-CD27 Antibody ID HCDR1/HCDR2/HCDR3
LCDRI/LCDRZ/LCDR3
, ,4 373 / 374/ 375
ASL—1 P"18.5.01.A.A04 “2
376/377/378
379 I 380/ 381
A3273 1 P018.S.01.A.A05 3/4
382 / 383/ 384
-_—273 P018.S.01.A.A06 385/386/387
6
4444444//
391 / 392 / 393
ABZ7_4 P018 s 01 A 303. . . . 7/8 I 394/395 ,/ 396 I
397 / 39s / 399
I AB2 _S7 P018501A30. . . . 4 9/10
400/401/402
-__403 /404 / 405 7 6 P018.s,o1.A.305 11 12
406/407 / 408
409 /410 / 411
7 7 P018.S.01.A.C 1 14
412 / 413 I414
415 I416 / 417
AB27 8 P018. 5 0. 1.A.C04 15 16
" I
418 I419 / 420
421 /422 / 423
A327 9 P018. .01.A.C 17 / 18
444/4244/
427 / 428 / 429
AB27 10 P018 5. .01.A.C06 19 20
- /
430/431/432
22:;121224:
2244:2122:
" "
A32 _167 P01850. . 1.14.504 31 / 32 463/464/465
. 466/467/468
469 [470 / 471
A827 17 P 1 . . 1.A.E 5 33 34
AB27 P° 85°1 6] 477
38 . . 1.A.EOG 35 36
473/479/480
A327 19 P 481/ 482/ 483
085°1 . . 1.A.F02 37 38
- 484/485/486
487 / 488 / 489
AB27_20 P013501AF05. . . . 39/ 40
490/491/492
W0 2016/110584
_538/ 539/540
AB27 29 P018.S.02.A.B01 541/ 542/543
_ 57 /58 —
544/ 545 I 546
547 I 548 I 549
ABZ7_30 P018.S.02.A.303 59/ 60 —
550/551 I 552
P018.S.02.A.805 553/ 554 I 555
7 I P018.S.02.A.601 ‘ 73/74 233/2323: ]
595 I 596 I 597
ABZ7_38 P018.S.02.A.603 75 I76
598 / 599/ 600
601 / 602 I 603
ABZ7~39 P018.S‘.02.A.GO4 77/ 78
, 604 I 605 I 606
AB27_40 .02.A.H05 607/ 608 I 609
79/80
610/ 611 I 612
1 613 / 514 I 615
P018.S.03-.A.A02 81 I' 82
616 I 617 / 618
ABZ7_42 619 I 620 / 621
P018.S.03.A.BOZ 83/ 84
622 I 623 I 624
AB27_43 625 / 626 I 627
P018.S.03.A..BDS 85/86
628 I 629 I 630
ABZ7_44 --
P018.S.03<A.C02. . . 631/632/633
87/88
634/ 635 I 636
AB27_45_P018.-S.03.A.C04 637/ 638 I 639
89/ 90
640/ 641 I 642
P018.S.03.A.GOZ-
——_-1Em_
W0 2016/1 10584
_——712/713/714
715 / 716 / 717
ABZ7~58 P018.S.03.A.G05 115 / 116
718 / 719 / 720
721/ 722 / 723
ABZ7_59 P018.S103.A.G(}6 117/ 118
724 /725/726
ABZ7_60 . 9018.S.03.A.!-!02 119/120 3/729
730/731/732
A327 61 P018'.S.03.A.HO3 733/734/735
121 122
- _—73677377733
ABZ7_62 P018.S.03.A.HO4 123 / 124
i ’1 740/. 741
- 742 , 743; 744
745 / 746 I 747
1182163 P018.S.03..A.H05 125/ 126
748 / 749 / 750
751/ 752 / 753
AB27_54 P0181S.041A.A01 127 / 128
754 / 755 / 756
760 / 761/ 762
763 l 764 I 755
A327_66 P018.S.04.A.B,01 131 / 132
766/767 / 763
769 / 77o / 771
A827 67 .04.A.BO3 133 134
- /
772 / 773 / 774
85:23:22
3:282:82:
ABZ7_71 P018.S.04.A.D02 $333133:
A827_72 P018.s.04.A.Do4 gag/Eggjggi
282;
811/ 812/ 813
A327 74 P018.S.04.A.E02 147 4
_ l1 8
814 / 815 /' 816
817/ 818 / 819
ABZ7_75 P018.S.O4.A.EO4 14g / 150
820/ 821 / 822
823/ 824 / 825
AB27 76 P018.S.04.A.EOS 151 152
829/830 / 831
ABZ7_77 P018.S.04.A.F04 153 / 154
832/ 833 / 834
835 / 836 / 837
ABZ7_78 P018.S.O4.A.GO4 155 / 156
838/839 / 840
841 / 842 I 843
A327 79 P018.S.04.A. 157 153
847 / 848 / 849
A827_80 P018.S.05.A.A02
850/ 851 / 852
853/ 854 / 855
A827 81 P018.S.05.A.A04 1 1 152
859/ 860/ 861
ABZ7_82 .05.A.A06 163 / 164
862/ 863 / 864
865 / 866 / 867
A827 83 P018.s.05.A.302 155 165
871 / 872 / 873
AB27_84 P018.S.OS.A.B06 167 / 168
874 / 875 / 876
877 /878 / 879
ABZ7_85 P018.S.05.A.C06 159 / 1.70
880/ 881 / 882
ABZ7_86 P018.S.05.A.D03 171 / 172 883 I 884/ 885
10584
——886 / 887/888
889 / 890 I891
A32 _877 P018.S.05.A.DO4 173/ 174
892 i 893 {894
895 / 896/ 897
ABZ7_88 P018.S.05.A.DOG 175 / 176
898 / 899/900
A2w3 7 89 P01. 8.5.05.A.E03 177 I18_.
901 /902/903
904/905/906
907 / 908/909
A327 90 P 18.5. .A.E04 17
‘ 9/180
910/ 911/ 912
913 /914 /915
ABZ7_91 P018.5.05.A. F02 181/132
; 916/91?/918
mm . 3:343:93;
212292;;
2:333:32:
323222532:
943 / 944/ 945
A827_96 P018.s 06 A A03 ’
. ., . 191 , 192
946 / 947 / 948
949 / 950 /951
Aa27 97 P018.S.-06.A.A 50
_ 193/194
952 / 953/954,
32722322:
3:212:29:
3:212:72:
22:92:92:
985 / 986 / 987
ABZ7_103 .0018,5.06 A 004. . 205" 205
988 / 989/ 990
991/ 992/ 993
A 2_B 7 104 .06 .A. E01 207/208
/996
99? / 998 / 999
ABZ7_105 P018.S.06.A.E02 209/ 210
1000/ 1001/1002
1003/ 1004/ 1005
06 P018.S.06.A.E04 211 / 212
1006 I 1007 / 1008
13232312131:
13131319132;
131132232:
1322;133:132:
1222;132:232:
1323;132:022:
1322;132:1131;
1051/1052 / 1053
4 P018.S.07.A.AOS 227 I 228
1054/1055 / 1056
ABZ7_115 P018.5.07.A.303 229 / 230 1057 / 1058 / 1059
W0 2016/1 10584
—__—
ABZ7__116 P018.S.07.A.BO4 231 / 232
I 10
AB27_118 .07.A.806 13;: / 10:: j 12;;
ABZ7_121 P018.S.07.A.C06 241 / 242 :33: j :33: 5 :33:
1099/ 1100 / 1101
ABZ7_122 P018.S.07.A.D03 243 I 244
1102 / 1103/ 1104
1105 / 1106 / 1107
ABZ7_123 .07.A.DO4 245 / 246
1108 / 1109 / 1110
I ABZ7_124 , P018.S,07.A.DOS 1111/ 1112 / 1113
1 247/ 248
1114 / 1115 / 111
1117 / 1118 / 1119
A827_125 P018.S407.A.E03 249/250
1120 / 1121 / 1122
1123 / 1124/ 1125
AB27H126 P018.$.07.A.E05 251 I 252
1126 / 1127/ 1128
1129 / 1130 / 1131
AB27_‘127 P018.S.07.A.F03 253 / 254
1132 / 1133 / 1134
1135 / 1136 / 1137
ABZ7_128 P018.S.07.A.F04 255 / 256
1138 / 1139 / 1140
1141/ 1142 / 1143
ABZ7_129 P018.S.07.A.602 257/ 258
1144 I 1145 / 1146
ABZ7_130 P018.S.07.A.GO4 2 1147/ 1148/ 1149
59 / 260
1150/ 1151 / 1152
4927 131 02 I 1153 / 1154/ 1155
P018.S.O7.A.H 261 262
_ /
1156 / 1157 / 1153
1159 / 1160 / 1161
AB27 132 P018.5.07.A.H04 263 264
— I
1162 / 1163/ 1164
AB27 133 P018.S.07.A.H05 1165/ 1166 / 1167
265 266
- l
1168 l 1169 I 1170
1171 / 1172/ 1173
4927 134 P018.S.07.A.H06 267 / 268
- 1174/1175 /1176
1177 / 1178/ 1179
4327 135 P018.S.08.A.A01 269
- / 270
1180/ 1181/ 1182
1183 / 1184/ 1185
4927 136 .08.A.AO3 271 272
‘ _ l
1186 I 1187/ 1188
4327 137 P018.S.08.A.DOI 1189/ 1190/ 1191
273 274
‘ _ /
1192 / 1193 / 1194
1195/ 1196/ 1197
ABZ7_138 P018.S.08.A.DOZ 275 / 276
1198 / 1199/ 1200
1201 / 1202/ 1203
A827 139 P018‘S..08.A.E02 277 278
- I
1204/ 1205 / 1206
1207 / 1208/ 1209
4327 140 P018.5.08.A.F01 279 / 280
- - 211/1212
4927_141 P018.S.08-.A.GOZ 1213/ 1214/ 1215
281/282
1216 / 1217 / 1218
1219 l 1220/ 1221
4327_142 P018.S.08..A.H02 283 / 284
1222/ 1223/ 1224
1225 l 1226 l 1227
4827_143 P018.s.09.4.402 235 / 286
1228 / 1229/ 1230
ABZ7_144 P018.S.09.A1A03 287/ 288 1231 / 1232 / 1233
W0 20161110584
_———
A327_145 P018.S.09.A.AOS 289 / 290
- 11111111151111
1111111111111 |
1 11111111151111
A327_151 P018 s..09 A DO. » 1273/ 1274 / 1275
. 4 301/ 302.-
1276 / 1277/ 1278
A327 152 P018.S.09.A.D 1279 / 1280/ 1281
OS .
' 303/3 04
. 1282/1283/1284
11111111111111
AB27_155 P018.S.09.A.EOS 309 / 31? 1:335 1:321; / 1:3:
56 P018.S.O9.A.E0‘6 311/312 1:3: ; 33:; :33:
'. '
AB27_157 P0185309.A.F05 4. » 1309/1310/1311
1312/1313/1314
AB27 158 P018.5 09..A.F06 315 / 31. 1315/ 1316 / 1317
~ 6
1318/ 1319 / 1320
AB27 159 P018.S.09.A. .. 1321/ 1322 / 1323
- GOG 317 / 318
1324/ 1325 / 1326
AB27 160 P018 s 09. .A.H0 1327/ 1323 / 1329
. 3 31 v
- 9 l 320
1330/ 1331 / 1332
ABZ7_161 .09.A.H04 1333 I 1334 / 1335
321 / 322
1336/ 1337/ 1338
A327 162 P018.S.09.A.H06 1339/ 1340 / 1341
- 323 I 324
1342/ 1343/ 1344
A327_163 11111111111111
AB27_164 11111111111111
ABZ7_165 11111111111111
ABZ7_166 11115111111111
AB27_167 11115111111111
AB27_168 P018.s.10.A.303 Egg/1:331:33
ABZ7_169 11115111111111
f ' '
ABZ7¢170 P018 S 10.A.C01 339 I 3401 1387/1388/ 1389
1390/ 1391/ 1392
AB27 171 .10.A.C02 4, 1393/ 1394/ 1395
- _ 3 1’ 342
1396/1397/ 1398
1399 / 1400 / 1401
AB27 172 P018 s. 10.4.003 4 344_ - ' 3 3’
1402/1403 / 1404
73 P018.S.10.A.C05 mm 1405/ 1406 / 1407
W0 2016/110584
— 1408 / 1409/ 1410
1411 / 1412/ 1413
A327 174 P018.S.10.A.C06 347 348
. 1417 [1418/ 1419
A327 175 P018.S.10.A.E01 349 ’ 350
- 1420 / 1421 / 1422
1423 / 1424 / 1425
A327 176 P018.S.10.A.EOZ 351 352
1429 / 1430/ 1431
A327 177 P018.S.10.A.E04 353 354
1435 / 1436/ 1437
4327 178 P018.S.10.A.E06 355 356
1441 / 1442 / 1443
A327 179 P018.S,10.A.F01 57 358
1447 / 1448 / 1449
A327 180 .10.A.F04 359 360
1453 / 1454/ 1455
A327 181 P018.S.10.A.F05 361 / 362
_ 1456/ 1457/ 1458
1459/ 1460/ 1461
A327 182 P018.S.10.A.GU3 363 364 I
‘ I l
1462/ 1463/ 1464
1465 / 1466/ 1467
A327 183 P018.s..10.A.c-ios 365 366
1458/1469,1470
1471 / 1472/ 1473
A 7 1 4 P° 851 . .10.A.H01 367 368
14747147571476
1477/ 1473/ 1479
A327_185 301331041402 369/370
1480/ 1481/ 1482
-—-1483 / 1484 / 1485 AB27 186 P018.S.10.A.H05 371 372
14867148771488
Table 7. Sequence information of agonistic anti-CD27 antibodies ble domains and CDRs)
"3 "05 °f CDRS
SEQ ID NOs of Variable Domains
Short iD Anti-C5134 Afiiibfidv i0 HCDRZ/HCDRB, EEO
VHIVI.
LCDR1/LCDR2/LCDR3
1673 / 1674 / 1575
A3134 1 P018.S.02.A.F01 1439 1490
——_15767167771678
1679/ 1530/ 1681
A3134_2 P018.S.02.A.FO3 1491/ 1492
1682 / 1683 / 1684
1688 / 1689 /1690
1691/ 1592 I 1593
AB134_4 P018.S.03.A.E03 1495 / 1496
1694/ 1695 / 1696
1697 I 1698 / 1599
A3134_5 P018.S.04.A.A06 1497 / 1498
1700 / 1701 / 1702
1706 / 1707 / 1708
1709/ 1710/1711
A3134_7 P018.S.04.A.806 1501/ 1502
1712/ 1713/ 1714
1715/ 1716’ 1717
A3134 3 P018.S.O4.A.C06 1503/1504
7 1718 / 1719 / 1720
1721 / 1722 / 1723
A3134 9 .O4.A.D06 1505 1506
725/1726
1730/ 1731/ 1732
1733 / 1734/ 1735
A3134_11 P018.S.04.A.E06 1509 / 1510
1736/ 1737/ 1738
1739 / 174° / 1741
AB134_12 P018.S.04.A.F05 1511 / 1512
1742/ 1743 / 1744
W0 2016/1 10584
-— 1745/ 1746/ 1747
3134 13 P018.S.04.A.F06 1513/ 1514
1751] 1752/ 1753
B134 14 P018.S.04.A.GOS 1515 l 1516
1754/ 1755/ 1756
1757 / 759
A8134 15 P018.5704A Hos. . 1517
‘ / 1518
1760/ 1761/1762
1763/ 1764/ 1765
A3134 16 P013.S.05.A.F05 1 20
" 519/15
1766 / 1767/ 1768
-——1769/ 1770/ 1771 A3134 17 P018.S.05.A.603 1 1 1522
, ,
PO18.5.05.A,605 ' 1523/1524 2;
1331;323:332
3:233:13: .
1799 / 1300/ 1301
A313 324 P018.S.11.A.A05 153 1 l 1532
1302/ 1303 / 1804
1847/ 1848/ 1849
A3134 30 P018.S.11.A.003 1547 I 1548
_ 1850 / 1851/ 1852
ABI34~35 P018.S.11.A.E04 1557/ 1558
AB134_36 P018.S.11.A.E05 1559 I 1560
“3134-40
AB134_41 P018‘S.11.A.F05 1559 /'1570
W0 2016/1 10584
1919 / 1920/ 1921
34 42 P018.S.11.A. 02 1571 1 7
7 ,
1925 / 1926/1927
A3134 43 P018.S.11.A 603. 1573 / 1 745
1928/ 1929/ 1930
1931 / 1932 ,I 1933
3134 44 P018.5.11.A.Go4 1575 157
1937 x 1938 / 1939
A3134 45 P018511.A605. 1577 / 1578
1940 /1941 /1942
-— 1943 / 1944/ 1945
A3134 46 P018.S.11.A.H02 1579 / 1580
1946 /1947 [1948
. . 1949 I 1950 I 1951
A3134 47 P018.S.11.A.H04 1581 1582 ' '
_ /
1952 / 1953 / 1954
I 1957
A3134 48 1955/ 1956
.11.A.H05 1583 1584 '
1958 / 1959 / 1960
-_—1961 / 1962 / 1963 A3134 49 P018.S.11.A,H06 1585 1586
, ,
1967 / 1968 / 1969
A3134 50 P018.S.12.A.A 1 1587 1588
1970/ ,
1973 / 1974 / 1975
A3134 51 P018.S.12.A.A0 2 1589 I 1590
1976 I 1977 / 1978
-_—. 1979/ 1980/ 1981 A3134 52 P018.S212.A.A03 1591 1 92
, ,
1985 i 1986/ 1987
A3134 53 P018.S212.A.A 40 1593 1 4 59
_ l
1988/1989/ 1990
22:2222:
22222222252222
2222;222:2222:
2222222252222
2075/2076 / 2077
A3134 68 P018.S.12.A.D03 1623 1624
‘ /
2078/2079 / 2080
A3134 69 P018.S212.A.D04 2081/ 2082 / 2083
1625 1626
2087/ 2088/ 2089
A3134 70 P018.S.12.A.DOS 1627
-— I 1628
220,291,212
W0 2016/110584 2016/050308
P018.S.12.A.E02 1633/ 1634
AB134 70~ - , "018. :2.- __ 2123/2124/2125
r >1 A505.3 540 ' '
2126/2127/2128
I P018.S.12.A.E06 1641 / 1642 2129/ 2130 / 2131
2132 / 2133 / 2134
2135/ 2136/ 2137
2138/ 2139/ 2140
' '
AB134_30 P018.S.12.A.F04 1547/1648 3:3; 3:3; :12: I
AB134_81 P018.s.12.A.I=05 1649 / 1650
AB134_82 P018.S.12.A.F06
AB134_83 P018.s.12.A.601
AB134_84 P018.S.12.A.GOZ
A3134_85 .12.A.G03
ABI34_86 P018.S.12.~A.G 40 ‘ 2183 / 2184 / 2185
1659 / 1660'
" 2186 / 2187 / 2188
7 2189/ 2190 / 2191
1661 l 1662
2192/ 2193 / 2194 I
| 33331333313333
AB134_90 P018.S.12.A.‘H04
ABI34_91 P018.S.12‘.A.H05
A8134_92 P018.S.13.A.»GO$'
Table 8. Sequence information of agonistic anti-CD134 antibodies (variable domains and CDRs)
SEQ '0 NOs 1:73?” ”mam. . SEQ ID NOs of cons
Anti-C0137 Antibody ID HCDRI/HCDRZ/HCDR3
LCDRl/LCDRZ/LCDRS
AB137_1 P018 s 03 A A0. 4 2249/ 2250 / 2251
. 2225/ 2226
2252 / 2253 / 2254
P018308 A E03 2227 2255/2256 / 2257
[2228
2258/2259/2260
A8137 3 P018.5.08.A.F03 2261/ 2262 / 2263
2229/ 223°
2264/2265 [2266
AB137_4 P018.S 13 A A05 m 2267/ 2268/2269
_——2270/ 2271/ 2272
' 2273 / 2274/ 2275
A3137 5 P018.S.13.A.A06 2233 2234
-_ /
2276/ 2277/ 2278
22791228012281
P018.S.13.A.C02 2235 I 2236
2282 / 2233 / 2284
_ ._ , 2285 ,l 2286 / 2287
I 9018 S. . .13 .A.603 2237 / 2238
2288 / 2289 l 2290
-—_2291 / 2292 / 2293 A 137 8 P018.S.13.A.GO4 2239 2240
2294 / 2295 / 2296
I 2297 / 2298 / 2299
”137-9 P018 s. .14.A.A 40 2241 I 2242
2300 / 2301 / 2302
2303/2304/2305
A3137w10 P013 S 14. . .A.D06 2243 l 2244
2306 / 2307/ 2308 l
2309/ 2310 / 2311
A31 7-113 ms 5 1. . 4.A 603. 224 224
2312 / 2313/ 2314
-——2315 I 2315 / 2317 37 12 P018.S.14.A.H01 2247 2248
2318/2319/2320
Table 9. Sequence information of agonistic anti-CD137 antibodies (variable domains and CDRs)
Exam 1e 2: Bis ecific antibodies tar etin CD40 and CD27 CD40 and CD137 or CD40 and
CD134
2.1 Reporter assay measuring trans-activation
CD40 is inantly expressed on antigen-presenting cells (APCs), such as dendritic cells,
whereas CD27, CD134 and CD137 are predominantly expressed on T cells. Thus, ific
antibodies binding to CD40 and CD27, to CD40 and CD137 or to CD40 and CD134 are able to
bind simultaneously to APCs and T cells expressing these receptors. Thereby, these bispecific
antibodies are able (i) to mediate cell—to-cell interaction between APCs and T cells by or
binding and (ii) to activate both indicated receptors at once, which is primarily induced by cross-
linking and receptor ring upon cell-to-cell interaction and not necessarily dependent on
agonistic activity of the parental monospecific bivalent antibodies. Thus, these trans-activating
bispecific dies exert costimulatory activity in the context ofAPC : T cell interactions.
A corresponding reporter assay system was established. To that end, HEK293_NFK_gfp_luc
cells were stably transduced with human ”INF-receptors, CD27, CD40, CD134 and CD137,
respectively. HEK293_NFK_gfp_luc B/293/GFP-LucTM Transcriptional Reporter Cell
Line obtained from System ences ) is a reporter cell line which allows to monitor the NF-
KB pathway by the detection of GFP fluorescence as well as luciferase activity for quantitative
transcription activation reporter assays. onally, K562 cells were stably uced with
human TNF-receptors, CD27, CD40, CD134 and CD137, as well, in order to generate cell lines
W0 2016/1 10584 2016/050308
mediating trans-presentation of the indicated receptors. Cell surface expression of the receptors
on HEK293_NFK_gfp_luc cells and K562 cells was analyzed by flow cytometry depicted in
Figure 6A and Figure 6B.
The er assay measuring trans-activation was set up as follows: HEK293_NFK_gfpdluc
cells expressing one of the 4 indicated TNF-receptors were seeded in multi-weli culture .
Bispecific antibodies and corresponding monospecific control antibodies were added in
concentrations from 100 ng/ml to 10.000 ng/ml. K562 cells expressing the second TNF-receptor
or wildtype K562 (K562_wt) were added to ted wells. Thus, the bispecific antibodies are
able to bind to the first "INF-receptor on the _NFK_gfp_~luc cell line and, at the same
time, to the second ceptor on the K562 ceil line mediating trans-presentation. Only
or activation of the first TNF receptor on HEK293_NFK_gfp_luc cells is measured by
luciferase activity d upon NF-KB -signaling. Thus, biSpecific antibodies targeting CD40
and CD27, CD40 and CD137 or CD40 and CD134 were analyzed by tw0 reporter assays: (i) the
first assay measuring CD27—, CD134— or CD137—activation upon cross—presentation by
K562_CD40 and (ii) the second assay measuring CD40-activation upon cross-presentation by
K562_CD27, K562_CD134 or D137, respectively.
2.2 Analysis of CD40xCDl37 bispecific antibodies
Bispecific antibodies binding with one arm to CD40 and with the second arm to CD137 were
produced and analyzed by the two Trans-reporter assays using HEK293_NFK_CD40wgfp_luc +
K562_CD137 and HEK293_NFK_CD137_gfp_luc + K562_CD40. Two different bispecific
antibodies as well as the control antibodies, the parental ecific nt anti-CD40 and
anti-CD137 antibodies and corresponding monovalent antibodies with one irrelevant arm, were
tested (Figure 7A and 7B). All antibodies were tested under the indicated trans—presentation
conditions using K562 cells expressing the second TNF-receptor and for control without trans-
presentation using K562_wt. None of the l antibodies, neither the parental monospecific
bivalent antibodies nor the monovalent antibodies with one irrelevant arm, induced luciferase
activity in HEK293_NFK“CD40__gfp_1uc cells or in HEK293_NFK_CD137_gfp_Iuc cells. Only
the two bispecific CD40XCD137 antibodies resulted in luciferase activity upon addition of
antibodies (100 ng/ml and higher trations) to _NFK_CD40_gfp_luc or
HEK293gNFK_CDl37Mgfpkluc cells under trans-presentation conditions. Thus, even if the
parental monOSpecific, bivalent anti—CD40 and anti-CD137 IgGl antibodies do not show
W0 2016/110584 2016/050308
agonistic activity, the bispecifie CD40xCD137 antibody is able to induce activation of both
receptors resulting in intracellular signaling and NF-KB pathway activation.
2.3 Analysis of D27 ific antibodies
A bispecific antibody binding with one arm to CD40 and with the second arm to CD27 was
produced and analyzed by the two Trans-reporter assays using HEK293_NFK_CD40__gfi9_luc +
KS62_CD27 and HEK293_NFK_CD27_gfp_luc + K562_CD40. The bispecific antibody as well
as the control antibodies, the parental monospecific bivalent anti-CD40 and anti-CD27
antibodies and ponding monovalent antibodies with one irrelevant arm, were tested
(Figure 8): All antibodies were tested under the indicated trans-presentation conditions using
K562 cells expressing the second "INF-receptor and for control without trans-presentation using
K562_wt. The bispecific antibody (100 ng/ml and higher concentrations) induced strong
luciferase activity in HEK293_NFK_CD40wgfp_luc and in HEK293_NFK_CD27_gfp_luc cell
lines, respectively, under presentation conditions. Thus, the bispecific CD40xCD27
antibody is able to induce activation of both receptors resulting in strong intracellular signaling
and NF-KB pathway activation.
2.4 Analysis of CD40xCD134 bispecific antibodies
Bispecific antibodies binding with one arm to CD40 and with the second arm to CD134 were
produced and ed by the two reporter assays using HEK293_NFK_CD40_gfp_luc +
K562_CD134 and HEK293fiNFK_CD134_gfp_luc + K562_CD40. Two different bispecific
antibodies as well as the control dies, the parental monospecifie nt anti-CD40 and
anti-CD134 antibodies and the ponding monovalent antibodies with one vant arm,
were tested e 9A and 98). All antibodies were tested under the indicated trans-
presentation conditions using K562 cells expressing the second TNF-receptor and for control
without trans-presentation using K562_wt. The parental monospecific bivalent anti-CD134
antibodies induced only very weak luciferase activity. However, the bispecific antibodies (100
ng/ml and higher concentrations) induced strong luciferase activity in
HEK293_NFK_CD40_ fp_1uc and in HEK293_NFK_CD134_gfp_”luc cell lines, respectively,
under trans-presentation conditions. Thus, even if the parental ecific, bivalent anti-CD40
and anti-CD134 IgG1 antibodies show only slight agonistic activity the bispecific CD40xCD134
antibody is able to induce activation of both receptors resulting in strong intracellular signaling
and NF-KB y activation.
W0 2016/1 10584
Example 3: Bispecific antibodies targeting CD134 and CD27: CD134 and CD137 or CD27 and
CD137
3.1 Reporter assay measuring cis—activation
CD27, CD134 and CD137 are inantly expressed on T cells. While CD27 is constitutivcly
expressed and CD27 expression density only varies upon T cell activation, C0134 and CD137
expression is only induced upon T cell activation. Thereby, bispecific antibodies binding to
CD134 and CD27, to CD134 and CD137 or to CD27 and CD137 most probably target two
receptors expressed on the same T Cell. However, the activity of these bispecific antibodies
depends on the co-expression of the two receptors and thereby on the tion status of the T
cells. Activation of these TNF-receptors is dependent on receptor cross-linking and receptor
clustering, respectively, which can be achieved by binding agents simultaneously g to
different receptors. If T cells co-express the indicated receptors, these bispecific antibodies can
act as costimulatory agents mediating receptor-induced signaling in T cells upon binding of two
different "INF-receptors on the same T cell.
A corresponding reporter assay system was established using TNF-receptor double transfectants.
To that end, HEK293_NFK_gfp_luc cells were stably transduced with two of the indicated
human TNF-receptors, CD27, CD134 and CD137, respectively. Cell surface expression of the
ors was analyzed by flow try ed in Figure 10A and Figure 193.
3.2 Analysis of CD134xCD27 bispecific dies
A bispecific antibody binding with one arm to CD134 and with the second arm to CD27 was
produced and analyzed by a Cis-reporter assay using HEK293_NFK_CD27_CD134_gfp_"luc
cells. The bispecific antibody as well as the control antibodies, the parental monospecific
bivalent anti-CD134 and anti-CD27 antibodies and the corresponding lent antibodies
with one irrelevant arm, were tested (Figure 11). The bispecific antibody d the strongest
luciferase activity in HEK293_NFK_CD27_CD134_gfp_1uc cells. Thus, the bispecific
CD134xCD27 antibody is able to induce a strong activation of cells expressing both ors
resulting in strong NF-KB ing.
3 .3 Analysis ofCDl 34XCD 137 bispecific antibodies
W0 2016/110584
Bispecific antibodies binding with one arm to CD134 and with the second arm to CD137 were
produced and analyzed by a Cis-reporter assay using the
HEK293_NFK_CD134_CD137_gfp_luc cell line. Two different bispecific antibodies as well as
the control antibodies, the al monospecific bivalent anti-CD134 and D137 antibodies
and corresponding monovalent antibodies with one irrelevant arm, were tested (Figure 12A and
128). None of the control antibodies, r the parental monospecific bivalent antibodies nor
the monovalent antibodies with one irrelevant arm, induced luciferase ty in the
HEK293_NFK_CD134_CD137mgfp_luc. Only the bispecific CD134xCDl37 antibody resulted
in luciferase activity. Thus, even if the parental monospecific, bivalent anti-CD134 and anti-
CD137 IgG1 antibodies do not show any tic activity, the bispecific CD134xCD137
antibody is able to induce activation in the cell line sing both receptors resulting in NF-K‘B
pathway activation.
3.3 Analysis of CD27xCD137 bispecific antibodies
Bispecific antibodies binding with one arm to CD137 and with the second arm to CD27 were
produced and analyzed by a Cis«reporter assay using HEK293_NFK_CD27_CD137_gfp_1uc
cells. Two different ific antibodies as well as the control antibodies, the parental
ecific bivalent anti—CD137 and anti-CD27 antibodies and corresponding monospecific
antibodies with one irrelevant arm, were tested (Figure 13A and 133). In this case, the parental
menospecific nt anti-CD27 dies d luciferase activity, whereas the parental
monospecific bivalent anti-CD137 resulted only in extremely weak maximum activation signals.
Both control monovalent antibodies consisting of one irrelevant arm d very weak
activation of HEK293_NFK_CD27_CD137_gfp__1uc cells. However, the bispecific antibodies
induced stronger luciferase activity in HEK293_NFK__CD27_CD137_gfpwluc cells than the
control antibodies with one irrelevant arm.
Claims (10)
1. A bispecific antibody sing two binding domains, wherein a first binding domain binds to CD40 and the second binding domain binds to 4-1BB (CD137), , wherein the first g domain binding to CD40 is selected from a first group ting of: (a) the heavy chain complementarity determining region HCDR1 having the amino acid sequence of SEQ ID NO: 2323, the HCDR2 having the amino acid sequence of SEQ ID NO: 2324 and the HCDR3 having the amino acid sequence of SEQ ID NO: 2325, and the light chain complementarity determining region LCDR1 having the amino acid ce of SEQ ID NO: 2326, the LCDR2 having the amino acid sequence of SEQ ID NO: 2327 and the LCDR3 having the amino acid sequence of SEQ ID NO: 2328; and (b) the heavy chain variable domain (VH) having the amino acid sequence of SEQ ID NO: 2321 and the light chain variable domain (VL) having the amino acid sequence of SEQ ID NO: 2322; and wherein the second binding domain binding to 4-1BB (CD137) is selected from a second group consisting of: (a) the heavy chain complementarity determining region HCDR1 having the amino acid sequence of SEQ ID NO: 2297, the HCDR2 having the amino acid sequence of SEQ ID NO: 2298 and the HCDR3 having the amino acid sequence of SEQ ID NO: 2299, and the light chain complementarity determining region LCDR1 having the amino acid sequence of SEQ ID NO: 2300, the LCDR2 having the amino acid sequence of SEQ ID NO: 2301 and the LCDR3 having the amino acid ce of SEQ ID NO: 2302; (b) the heavy chain variable domain (VH) having the amino acid sequence of SEQ ID NO: 2241 and the light chain variable domain (VL) having the amino acid sequence of SEQ ID NO: 2242; (c) the heavy chain complementarity determining region HCDR1 having the amino acid sequence of SEQ ID NO: 2255, the HCDR2 having the amino acid sequence of SEQ ID NO: 2256 and the HCDR3 having the amino acid sequence of SEQ ID NO: 2257, and the light chain complementarity determining region LCDR1 having the amino acid sequence of SEQ ID NO: 2258, the LCDR2 having the amino acid sequence of SEQ ID NO: 2259 and the LCDR3 having the amino acid sequence of SEQ ID NO: 2260; (d) the heavy chain variable domain (VH) having the amino acid sequence of SEQ ID NO: 2227 and the light chain variable domain (VL) having the amino acid sequence of SEQ ID NO: 2228; (e) the heavy chain complementarity determining region HCDR1 having the amino acid sequence of SEQ ID NO: 2315, the HCDR2 having the amino acid sequence of SEQ ID NO: 2316 and the HCDR3 having the amino acid sequence of SEQ ID NO: 2317, and the light chain complementarity determining region LCDR1 having the amino acid sequence of SEQ ID NO: 2318, the LCDR2 having the amino acid ce of SEQ ID NO: 2319 and the LCDR3 having the amino acid sequence of SEQ ID NO: 2320; and (f) the heavy chain variable domain (VH) having the amino acid sequence of SEQ ID NO: 2247 and the light chain variable domain (VL) having the amino acid sequence of SEQ ID NO: 2248.
2. The bispecific antibody according to claim 1 , which is an agonistic binding agent.
3. The bispecific antibody ing to claim 1 or 2, wherein said antibody is in the format of a full-length antibody or an antibody fragment.
4. A nucleic acid molecule encoding a bispecific antibody according to any one of claims 1 to 3.
5. A vector sing, the nucleic acid molecule according to claim 4.
6. A cell sing a nucleic acid molecule according to claim 4 or the vector according to claim 5, wherein the cell is not a cell in a human.
7. A pharmaceutical composition comprising, as an active agent, a bispecific antibody ing to any one of claims 1 to 3, a c acid molecule according to claim 4, or a cell according to claim 6.
8. The ceutical composition according to claim 7, further comprising a pharmaceutically acceptable carrier and/or excipient.
9. A kit sing a ific antibody according to any one of claims 1 to 3, a nucleic acid molecule according to claim 4, a vector according to claim 5, a cell according to claim 6, or a pharmaceutical composition according to claim 7 or 8.
10. Use of a bispecific antibody according to any one of claims 1 to 3, a nucleic acid molecule according to claim 4, a vector according to claim 5, a cell according to claim 6, or a pharmaceutical composition according to claim 7or 8 for use as a medicament. WO 10584
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP2015/050255 | 2015-01-08 | ||
EP2015050255 | 2015-01-08 | ||
PCT/EP2016/050308 WO2016110584A1 (en) | 2015-01-08 | 2016-01-08 | Agonistic tnf receptor binding agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ733157A NZ733157A (en) | 2021-10-29 |
NZ733157B2 true NZ733157B2 (en) | 2022-02-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11814411B2 (en) | Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137) | |
TW201632559A (en) | Antibody therapeutics that bind CD137 | |
TW202124438A (en) | Novel anti-sirpa antibodies | |
JP2021533203A (en) | A novel fusion protein specific for CD137 and PD-L1 | |
US20240067740A1 (en) | Antibodies to tnfr2 and uses thereof | |
CN114144429B (en) | Bispecific antibodies against PD-1 and LAG-3 | |
NZ733157B2 (en) | Agonistic tnf receptor binding agents | |
RU2821343C2 (en) | Tnf receptor-binding agonists | |
BR122021000902B1 (en) | TNF RECEPTOR BINDING AGONISTIC AGENTS |